UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                    FORM 10-Q

             (x) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

                For the Quarterly Period Ended September 30, 1996
                         Commission File Number 0-21104

                                 CRYOLIFE, INC.
             (Exact name of registrant as specified in its charter)

                                    ---------
                 Florida                          59-2417093
       (State or other jurisdiction             (I.R.S. Employer
     of incorporation or organization)         Identification No.)

                       2211 New Market Parkway, Suite 142
                             Marietta, Georgia 30067
                    (Address of principal executive offices)
                                   (zip code)

                                 (770) 952-1660
              (Registrant's telephone number, including area code)

                                 Not Applicable
              (Former name, former address and former fiscal year,
                         if changed since last report)

Indicate  by check  mark  whether  the  registrant:  (1) has filed  all  reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

YES    X    NO 
     -----     -----

The number of shares of common stock, par value $0.01 per share,  outstanding on
November 5, 1996 was 9,573,382.






Part I - FINANCIAL INFORMATION
Item 1. Financial statements
CRYOLIFE, INC. AND SUBSIDIARIES SUMMARY CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended Nine Months Ended September 30, September 30, ------------- ------------- 1996 1995 1996 1995 ---- ---- ---- ---- (Unaudited) (Unaudited) Revenues: Cryopreservation $ 10,137,550 $ 7,878,183 $ 28,016,480 $21,447,252 Research grants, licenses, lease and interest revenue 273,074 469,076 525,846 734,633 -------------------------- ---------------------------- 10,410,624 8,347,259 28,542,326 22,181,885 Costs and expenses: Preservation 3,563,200 3,159,805 9,731,419 8,280,740 General, administrative and marketing 4,238,862 3,480,462 12,045,891 9,453,953 Research & development 615,315 651,183 2,005,833 2,005,217 Interest expense 39,268 1,308 39,269 3,929 -------------------------- ---------------------------- 8,456,645 7,292,758 23,822,412 19,743,839 -------------------------- ---------------------------- Income before income taxes 1,953,979 1,054,501 4,719,914 2,438,046 Income tax expense 692,550 369,176 1,687,524 803,212 -------------------------- ---------------------------- Net income $ 1,261,429 $ 685,325 $ 3,032,390 $1,634,834 ========================== ============================ Earnings per share of common stock $ 0.13 $ 0.07 $ 0.31 $ 0.17 ========================== ============================= Weighted average common and common equivalent shares outstanding 9,924,796 9,655,742 9,894,014 9,534,584 ========================== =============================
See accompanying notes to summary consolidated financial statements. Item 1. Financial Statements
CRYOLIFE, INC. AND SUBSIDIARIES SUMMARY CONSOLIDATED BALANCE SHEETS September 30, December 31, 1996 1995 ---- ---- (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 97,145 $ 166,931 Marketable securities 2,145,688 6,015,158 Receivables (net) 7,707,504 5,369,205 Deferred preservation costs (net) 6,374,252 5,996,201 Inventories (net) 353,427 424,200 Prepaid expenses 583,489 369,594 Deferred income taxes 184,821 -- ----------------------------------- Total current assets 17,446,326 18,341,289 ----------------------------------- Property and equipment (net) 9,651,735 3,279,168 Patents and other intangibles (net) 4,510,903 1,728,262 Other assets 500,288 240,897 ----------------------------------- TOTAL ASSETS $ 32,109,252 $ 23,589,616 =================================== LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,681,788 $ 1,372,862 Accrued expenses 1,986,771 1,474,365 Accrued compensation 393,998 260,709 Current portion of long term debt 477,859 -- ----------------------------------- Total current liabilities 4,540,416 3,107,936 ----------------------------------- Deferred income taxes -- 16,486 Other long term liabilities 3,582,559 -- ----------------------------------- Total liabilities 8,122,975 3,124,422 ----------------------------------- Shareholders' Equity: Preferred stock -- -- Common stock (issued 10,105,987 shares in 1996 and 9,974,332 shares in 1995) 101,060 99,744 Additional paid-in capital 17,098,584 16,568,312 Retained earnings 7,006,928 3,974,538 Less: Treasury stock (543,000 shares) (179,625) (179,625) Unrealized (loss) gain on investments (19,803) 28,092 Notes receivable from shareholders (20,867) (25,867) ----------------------------------- Total shareholders' equity 23,986,277 20,465,194 ----------------------------------- TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 32,109,252 $ 23,589,616 ===================================
See accompanying notes to summary consolidated financial statements. Item 1. Financial Statements
CRYOLIFE, INC. AND SUBSIDIARIES SUMMARY CONSOLIDATED STATEMENTS OF CASH FLOWS Nine Months Ended September 30, 1996 1995 ---- ---- (Unaudited) Net cash from operating activities: Net income $ 3,032,390 $ 1,634,834 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 1,006,429 695,661 Provision for doubtful accounts (81,600) 289,026 Deferred income taxes (201,307) 128,866 Increase in receivables (1,782,824) (1,528,178) (Increase) decrease in deferred preservation costs and inventories (176,058) 733,422 Increase in prepaid expenses (213,895) (303,610) Increase in accounts payable and accrued expenses 661,637 850,478 ----------------------------------- Net cash provided by operating activities 2,244,772 2,500,499 ----------------------------------- Net cash used in investing activities: Capital expenditures (7,097,566) (1,138,170) Cash paid for acquisition, net of cash acquired (721,721) -- Proceeds from the sale of marketable securities 5,799,569 409,111 Purchase of marketable securities (1,930,099) (2,881,723) Increase in other assets (1,663,852) (640,365) ----------------------------------- Net cash used in investing activities (5,613,669) (4,251,147) ----------------------------------- Net cash provided by financing activities: Proceeds from other long term liabilities 2,810,418 -- Proceeds from issuance of common stock and from notes receivable from shareholders 488,693 252,370 ----------------------------------- Net cash provided by financing activities 3,299,111 252,370 ----------------------------------- Decrease in cash (69,786) (1,498,278) Cash and cash equivalents at beginning of period 166,931 2,592,799 ----------------------------------- Cash and cash equivalents at end of period $ 97,145 $ 1,094,521 =================================== Supplemental cash flow information Non-cash investing and financing activities: Fair values of assets acquired $ 645,095 -- Cost in excess of assets acquired 1,619,610 -- Liabilities assumed (292,984) -- Notes issued for assets acquired (1,250,000) -- ----------------------------------- Total cash paid for acquisition $ 721,721 -- ===================================
See accompanying notes to summary consolidated financial statements. CRYOLIFE, INC. AND SUBSIDIARIES NOTES TO SUMMARY CONSOLIDATED FINANCIAL STATEMENTS Note 1 - Basis of Presentation The accompanying unaudited summary consolidated financial statements have been prepared in accordance with (i) generally accepted accounting principles for interim financial information, and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. Operating results for the three and nine months ended September 30, 1996 are not necessarily indicative of the results that may be expected for the year ended December 31, 1996. Notes 2,3 and 4 below cover certain events occurring after the latest fiscal year end. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Form 10-K for the year ended December 31, 1995. Note 2 - Shareholders' equity On May 16, 1996 the Board of Directors declared a two for one stock split, effected in the form of a stock dividend, payable on June 28, 1996 to shareholders of record on June 7, 1996. All share and per share information in the accompanying financial statements have been adjusted to reflect such split. Note 3 - Revolver/Term Loan Agreement On August 30, 1996 the Company executed a revolving term loan agreement with a bank which permits the Company to borrow up to $10,000,000 at either the bank's prime rate of interest or adjusted Libor, as defined, plus an applicable Libor margin. This credit agreement contains certain restrictive convenants including, but not limited to, maintenance of certain financial ratios and a minimum tangible net worth requirement. The credit agreement is secured by substantially all of the Company's assets, excluding intellectual property. Note 4 - Acquisition On September 12, 1996 the Company acquired the assets of United Cryopreservation Foundation, Inc. ("UCFI"), a processor and distributor of cryopreserved human heart valves and saphenous vein for transplant. Under the terms of the acquisition, the Company will pay $2,000,000 over a five year period and assumed certain obligations of UCFI. The impact of the acquisition on operations for the three months ended September 30, 1996 was not significant. PART I - FINANCIAL INFORMATION Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Results of Operations Revenues were $10.4 million and $28.5 million for the three and nine months ended September 30, 1996, respectively, compared to $8.3 million and $22.2 million for the corresponding periods in 1995. Revenues increased 25% and 29% for the three and nine months ended September 30, 1996, respectively, compared to the corresponding periods in 1995. These revenue increases were primarily due to greater allograft shipments resulting from increased demand. Revenues from human heart valve preservation increased 25% to $7.1 million for the three months ended September 30, 1996 from $5.7 million for the three months ended September 30, 1995, representing 68% and 69% of total revenues, respectively. For the nine months ended September 30, revenues from human heart valve preservation increased 26% to $19.2 million for 1996 from $15.2 million for 1995, representing 67% and 68% of total revenues, respectively. Third quarter revenues increased due to a 31% increase in tissue shipments resulting from an increase in demand in the third quarter of 1996 compared to the third quarter of 1995. Nine month revenues increased due to a 31% increase in tissue shipments resulting from an increase in demand in the first nine months of 1996 compared to 1995. Revenues from the sale of porcine valves increased 109% to $71,000 for the three months ended September 30, 1996 from $34,000 for the three months ended September 30, 1995, representing 1% and less than 1% of total revenues, respectively. For the nine months ended September 30, revenues from the sale of porcine valves increased 77% to $302,000 for 1996 from $171,000 for 1995, representing 1% of total revenues for both periods. Three month revenues increased due to a 6% increase in shipments resulting from an increase in demand in the first three months of 1996 compared to 1995. Nine month revenues increased due to a 50% increase in shipments resulting from an increase in demand in the first nine months of 1996 compared to 1995. Revenues from vein preservation increased 22% to $2.2 million for the three months ended September 30, 1996 from $1.8 million for the three months ended September 30, 1995, representing 21% and 22% of total revenues, respectively. For the nine months ended September 30, revenues from vein preservation increased 20% to $6.1 million for 1996 from $5.1 million for 1995, representing 21% and 23% of total revenues, respectively. Third quarter revenues increased due to a 27% increase in tissue shipments resulting from an increase in demand in the third quarter of 1996 compared to the third quarter of 1995. Nine month revenues increased due to a 20% increase in tissue shipments resulting from an increase in demand in the first nine months of 1996 compared to 1995. Revenues from orthopaedic tissue preservation increased 133% to $775,000 for the three months ended September 30, 1996 from $332,000 for the three months ended September 30, 1995, representing 7% and 4% of total revenues, respectively. For the nine months ended September 30, revenues from orthopaedic tissue preservation increased 147% to $2.4 million for 1996 from $970,000 for 1995, representing 8% and 4% of total revenues, respectively. Third quarter revenues increased due to a 218% increase in tissue shipments resulting from an increase in demand in the third quarter of 1996 compared to the third quarter of 1995. Nine month revenues increased due to a 233% increase in tissue shipments resulting from an increase in demand in the first nine months of 1996 compared to 1995. Other revenues were $273,000 for the three months ended September 30, 1996 compared to $469,000 for the three months ended September 30, 1995, representing 3% and 6% of total revenues, respectively. For the nine months ended September 30, other revenues were $526,000 for 1996 compared to $735,000 for 1995, representing 2% and 3% of total revenue, respectively. Other revenues consist primarily of research grant award revenues and interest income. Research grant award revenues in 1996 are primarily related to the bioadhesive and synergraft projects. Interest income decreased for the third quarter of 1996 compared to third quarter of 1995 due to a decrease in investments. Income from the termination of the option agreement with Bayer Corporation totaled $88,000, net of related expenses. Preservation costs aggregated $3.6 million and $9.7 million, respectively, for the three and nine months ended September 30, 1996, representing 35% of total revenues for both periods, compared to $3.2 million and $8.3 million, respectively, for the three and nine months ended September 30, 1995, representing 38% and 37% of total revenues, respectively. Preservation costs increased 13% for third quarter 1996 compared to third quarter 1995 and increased 18% for the first nine months of 1996 compared to the first nine months of 1995 due to increased shipments of human allografts. General, administrative, and marketing expenses aggregated $4.2 million and $12.0 million, respectively, for the three and nine months ended September 30, 1996, representing 40% and 42% of total revenues respectively, compared to $3.5 million and $9.5 million, respectively, for the three and nine months ended September 30, 1995, representing 42% and 43% of total revenues, respectively. This increase reflects the general overhead growth trends, including increased marketing expenses associated with the increase in revenues and the switch from a predominantly independent sales force to a predominantly direct sales force. Research and development expenses aggregated $615,000 and $2.0 million, respectively, for the three and nine months ended September 30, 1996, representing 6% and 7% of total revenues, respectively, compared to $651,000 and $2.0 million, respectively, for the three and nine months ended September 30, 1995, representing 8% and 9% of total revenues, respectively. R & D spending relates principally to the Company's focus on bioadhesives and the synergraft technology. Seasonality The demand for the Company's human heart valve tissue preservation services is seasonal, with peak demand generally occurring in the second and third quarters. Management believes this demand trend for human heart valves is primarily due to the high number of pediatric surgeries scheduled during the summer months. Liquidity and Capital Resources At September 30, 1996 net working capital was $12.9 million, compared to $15.1 million at December 31, 1995, with a current ratio of 3.8 to 1 at September 30, 1996. Shareholders' equity at September 30, 1996 was $24.0 million. The Company's primary capital requirements arise out of working capital needs, including receivables and deferred preservation costs, and capital expenditures for facilities and equipment, primarily the new corporate headquarters. The increase in receivables relates to the increase in revenue and to receivables acquired from UCFI. The increase in prepaid expenses relates primarily to prepaid lab supplies for the bioadhesives facility. The increase in other assets relates primarily to the purchase of the Bioglue technology and intangibles assets recorded in connection with the purchase of the assets of UCFI The increase in accounts payable and accrued expenses is due to increased procurement fees pursuant to an increase in tissue procured, and the increase in overhead to support the increased revenues. Other long term liabilities relate to the acquisition of the Bioglue technology, the acquisition of the assets of UCFI, and draws on the Company's line of credit. Fixed asset additions of $7.1 million during the first nine months of 1996 related principally to the construction of the new corporate headquarters. The Company does not expect to incur significant additional costs relating to the completion of the construction of the new corporate headquarters. The Company believes that available cash, cash equivalents, and marketable securities, along with cash generated from operations and the Company's $10 million credit facility, will be sufficient to meet its operating and development needs for the foreseeable future. Forward-Looking Statements Statements made in this Form 10-Q for the quarter ended September 30, 1996 that state the Company's or management's intentions, hopes, beliefs, expectations or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the Company's actual results could differ materially from those contained in such forward-looking statements as a result of adverse changes in any of a number of factors that affect this Company's business, including without limitation, changes in (1) government regulation of the Company's business, (2) the Company's competitive position, (3) the availability of tissue for implant, (4) the status of the Company's products under development, (5) the protection of the Company's proprietary technology and (6) the reimbursement of health care costs by third-party payors. Part II - OTHER INFORMATION Item 1. Legal Proceedings. None Item 2. Changes in Securities. None Item 3. Defaults Upon Senior Securities. Not Applicable Item 4. Submission of Matters to a Vote of Security Holders. None Item 5. Other information. None Item 6. Exhibits and Reports on Form 8-K (a) The exhibit index can be found below. Exhibit Number Description - ------ ----------- 2.1* Sale Agreement dated August 16, 1996 between the Company and Donald Nixon Ross. 2.2 Asset Purchase Agreement among the Company and United Cryopreservation Foundation, Inc., United Transplant Foundation, Inc. and QV, Inc. dated September 11, 1996. 3.1 Restated Certificate of Incorporation of the Company, as amended. (Incorporated by reference to Exhibit 3.1 to the Registrant's Registration Statement on Form S-1 (No. 33-56388).) 3.2 Amendment to Articles of Incorporation of the Company dated November 29, 1995. (Incorporated by reference to Exhibit 3.2 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 1995.) 3.3 Amendment to the Company's Articles of Incorporation to increase the number of authorized shares of common stock from 20 million to 50 million shares and to delete the requirement that all preferred shares have one vote per share. (Incorporated by Reference to Exhibit 3.3 to the Registrant's Quarterly Report on Form 10-Q for the quarter ended June 30, 1996.) 3.4 ByLaws of the Company, as amended. (Incorporated by reference to Exhibit 3.2 to the Registrant's Annual Report of Form 10-K for the fiscal year ended December 31, 1993.) 10.1 Noncompetition Agreement between the Company and United Cryopreservation Foundation, Inc. dated September 11, 1996. 10.2 Noncompetition Agreement between the Company and United Transplant Foundation, Inc. dated September 11, 1996. 10.3 Noncompetition Agreement between the Company and QV, Inc. dated September 11, 1996. 10.4 Revolving\Term Loan Facility between the Company and NationsBank N.A., dated August 30, 1996. 11.1 Statement re: computation of earnings per share 27.1 Financial Data Schedule - -------- * The Company has applied for confidential treatment of portions of this Agreement. Accordingly, portions thereof have been omitted and filed separately with the Securities and Exchange Commission. (b) Current Reports on Form 8-K. None SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its benine months by the undersigned thereunto duly authorized. CRYOLIFE, INC. (Registrant) November 13, 1996 /s/ Edwin B. Cordell, Jr. - ------------------ ------------------------- DATE EDWIN B. CORDELL, JR. Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
                                   EXHIBIT 2.1


                        CONFIDENTIAL TREATMENT REQUESTED

Confidential Portions of this Agreement which have been redacted are marked with
brackets  ("[ ]").  The  omitted  material  has been filed  separately  with the
Securities and Exchange Commission.

372890.1








                                 Dated: 8/15/96



                                 SALE AGREEMENT



                              (1) DONALD NIXON ROSS
                              (2) CRYOLIFE INC.


                              Trevor Robinson & Co.
                                  Howard House
                                 70 Baker Street
                                    Weybridge
                                     Surrey
                                    KT13 8AL
                               Tel: (01932) 859655
                               Fax: (01932) 847469


372890.1





THIS AGREEMENT is made the 15th day of August, 1996.

BETWEEN:

     (1)  MR.  DONALD  NIXON ROSS of 25 Upper  Wimpole  Street,  London W1M 7TA,
          England ("Mr. Ross"); and

     (2)  CRYOLIFE,  INC.  of 2211 New  Market  Parkway,  Suite  142,  Marietta,
          Georgia 30067, USA, a corporation  incorporated  under the laws of the
          State of Florida ("Cryolife")

WHEREAS

A.        By three  assignments  each dated 18 July 1995 Mr. Ross  acquired  the
          Patents (as defined below) and/or the then pending  application(s) for
          the Patents from Promedica International Inc.

B.        Cryolife  wishes to  purchase  and Mr. Ross wishes to sell to CryoLife
          his right  title and  interest  in the  Patents,  together  with other
          assets and intellectual property rights on the terms and conditions of
          this agreement (the "Agreement").

IT IS AGREED:

1.       Interpretation

         1.1  The following words shall have the following  meanings unless they
              are  inconsistent  with the  context  and except  where  expressly
              provided:

              Assignments             the Assignments of the Patents and the IPR
                                      by Mr.  Ross  to  CryoLife  in  the  forms
                                      attached as Schedule 3

              Completion              completion  of the matters  referred to in
                                      clause 4

              Completion              Date August 30, 1996

              Consulting              Agreement  the  Agreement  under which Mr.
                                      Ross  is  to  provide   his   services  to
                                      CryoLife, in the form attached as Schedule
                                      4

              CryoLife's              Solicitors Trevor Robinson & Co. of Howard
                                      House, 70 Baker Street, Weybridge, Surrey,
                                      KT13 8AL

372890.1



                                      -2-

              IPR                     all industrial and  intellectual  property
                                      rights  of  Mr.  Ross  in  respect  of the
                                      Valves  including  but without  limitation
                                      the Patents,  trade marks,  service  marks
                                      (whether   registered   or   unregistered)
                                      design  rights and  copyrights in any part
                                      of the world

              Know-How                all information  (including that comprised
                                      in or derived from  formulae,  techniques,
                                      designs,   specifications   and  drawings)
                                      relating  to  the  Valves,  their  design,
                                      construction and/or use

              Mr. Ross's Solicitor    Mr. Edward J.C. Album of Exchange Tower,
                                      1 Harbour Exchange Square, London B14
                                      9GE

              Net sales               being the gross selling price of the
                                      Valves  received  directly  by CryoLife or
                                      its  associate   companies  by  CryoLife's
                                      distributors   or   customer,   less   the
                                      commission   paid  by  CryoLife   (or  its
                                      associate companies) to representatives in
                                      connection with the sale of the Valves

              Patent                  those  patents  and  patent   applications
                                      registered   in  the  name  of  Mr.   Ross
                                      relating  to the  Valves  and their use as
                                      are   more   particularly   described   in
                                      Schedule 1

              Purchased Assets        collectively,  the IPR, Patents and
                                      Stock

              Shares                  fully  paid  shares  of  Common  Stock  of
                                      CryoLife

              Stock                   those  Valves held by Mr. Ross as are more
                                      particularly described in Schedule 2

              Valves                  stented  or  unstented  porcine  pulmonary
                                      heart valves


372890.1


                                       -3-


                                         [  ] - CONFIDENTIAL TREATMENT REQUESTED


         1.2      Unless otherwise  stated,  references to clauses and schedules
                  shall  be   references   to  clauses  and  schedules  to  this
                  Agreement.

2.       Sale and Purchase

         Subject to the terms of this  Agreement  Mr.  Ross shall sell with full
         title  guarantee  and  CryoLife  shall  purchase  free from all  liens,
         charges and  encumbrances  as at the  Completion  Date,  the  Purchased
         Assets.

3.       Purchase Consideration

         3.1      The  consideration  for the  Purchased  Assets  and the rights
                  granted hereunder shall be:

                  3.1.1    Cash

                           CryoLife shall pay to Mr. Ross US$[  ] in cash at 
                           Completion.

                  3.1.2    Shares

                           3.1.2.1          CryoLife  shall  issue  to Mr.  Ross
                                            Shares  having a value of US$[   ]
                                            based on an average of the mid point
                                            bid and ask prices on the NASDAQ/NMS
                                            Quotation  Service during the 30 day
                                            period   ending  two  business  days
                                            immediately prior to Completion.

                           3.1.2.2          The  allotment and  registration  of
                                            the Shares hereunder,  the filing of
                                            a  registration  statement  and  the
                                            taking  by  CryoLife  of  action  in
                                            respect  of  the  Shares   shall  be
                                            unconditional  obligations and shall
                                            not be  subject  to any  set-off  or
                                            counterclaim.

                  3.1.3    Royalty

                           CryoLife  shall pay Mr. Ross a royalty for five years
                           after gaining  approval by the United States Food and
                           Drug  Administration  to start clinical trials on the
                           Valves.   Such  royalty  being  the  greater  of  the
                           following  in  each  of  the  years   following  such
                           approval being received:

                           3.1.3.1          [  ]% of the Net Sales; and

                           3.1.3.2          Year 1 - US$ [  ]

372890.1


                                       -4-


                                         [  ] - CONFIDENTIAL TREATMENT REQUESTED


                                            Year 2 - US$          [  ]
                                            Year 3 - US$          [  ]
                                            Year 4 - US$          [  ]
                                            Year 5 - US$          [  ]

                           CryoLife shall be entitled to withhold any taxes from
                           the  royalty  payments it may be required to withhold
                           by the US or UK tax  authorities.  CryoLife  shall be
                           deemed to have fully satisfied its obligations  under
                           this clause by paying the net amount of the royalties
                           to Mr. Ross.

         3.2      The  considerations  payable  under  this  clause  3 shall  be
                  allocated among the Purchased Assets as reasonably  determined
                  by CryoLife after consultation.

4.       Completion

         4.1      The sale and purchase shall be completed at the offices of Mr.
                  Ross's  Solicitor on the Completion  Date when all the matters
                  set out in this clause 4 shall be effected.

         4.2      Mr. Ross shall deliver to CryoLife or CryoLife's Solicitors;

                  4.2.1    the Assignments each duly executed by Mr. Ross;

                  4.2.2    the Consulting Agreement duly executed by Mr. Ross;

                  4.2.3    such additional documents, duly signed by Mr. Ross as
                           shall  be  required  by   CryoLife's   solicitors  to
                           complete  the  sale  and  purchase  of the  Purchased
                           Assets;

                  4.2.4    all  documents  held by Mr. Ross that may be required
                           by CryoLife to fully utilise the IPR and Know-How.

                  4.2.5    the Stock.

         4.3      Upon completion of the matters referred to above:

                  4.3.1    CryoLife   shall  pay  US$  [   ]  to  Mr.   Ross's
                           solicitor's  client  account  by way  of  telegraphic
                           transfer.

                  4.3.2    CryoLife  shall  deliver  to  Mr.  Ross's   solicitor
                           certificates  representing  the Shares as detailed in
                           clause 3.3, the shares to be  registered  in the name
                           of Mr. Ross or his nominees.

372890.1


                                       -5-






                  4.3.3    CryoLife shall accept full responsibility for all and
                           any  fee,  costs  or  charges  that  may  be  due  on
                           Completion  to  maintain  the Patents and to transfer
                           the  European  Patent into  patents  satisfactory  to
                           comply  with  the  patent   requirements  of  France,
                           Germany and the United  Kingdom and to reimburse  Mr.
                           Ross for any costs he has reasonably  incurred (up to
                           a maximum of US$10,790) in connection  with the same,
                           prior to Completion on Mr. Ross producing documentary
                           evidence.

                  4.3.4    To  provide  Mr.  Ross with the  ability  to sell the
                           Shares detailed in Clause 3.1.2 within the U.S. or to
                           a U.S.  person during the year following the issuance
                           of the  Shares to Mr.  Ross,  CryoLife  agrees at Mr.
                           Ross'  written  direction  to register the Shares for
                           resale under the U.S. Securities laws on one occasion
                           and to keep the registration open for three months or
                           the  anniversary of the issuance of the Shares to Mr.
                           Ross.  Mr. Ross' written  direction must be delivered
                           to  CryoLife  at  least  45 days in  advance  and may
                           request  registration  to occur at any time after the
                           3rd month or before the 11th month after the issuance
                           of the Shares to Mr. Ross.

5.       License

         5.1      Mr. Ross hereby  grants to  CryoLife  an  exclusive  perpetual
                  license  with the right to  sublicense  to use the name "Ross"
                  for the purpose of  identifying  and  promoting the Valves and
                  Mr. Ross hereby waives any right he may have to apply his name
                  to any other  xenograft  valve and shall not  permit any third
                  party to apply the name "Ross" to such valves.

         5.2      Mr. Ross warrants that he has not permitted any third party to
                  use the name  Ross in  connection  with  xenograft  valves  or
                  authorised such use.

         5.3      Mr. Ross agrees to support any  application  that CryoLife may
                  make  to  register  "Ross"  as a  trade  mark  as  applied  to
                  xenograft  valves  based on or derived  from the Valves in any
                  jurisdiction it sees fit.

6.       Warranties and Representations

         Mr. Ross represents and warrants to CryoLife as follows:

         6.1      that Mr. Ross has good and  marketable  title to the Purchased
                  Assets free and clear of all  encumbrances,  claims,  security
                  interests, liens and charges or restrictions of any kind.


372890.1


                                      -6-





         6.2      Mr. Ross owns or has  exclusive  right to make,  use, sell and
                  commercialise  all of the IPR and to the knowledge of Mr. Ross
                  no  third  party  has  been  granted  a  license  or has  been
                  permitted to use and/or commercialise the IPR.

         6.3      No royalties,  honorariums  or fees are payable by Mr. Ross to
                  third parties by reason of the ownership or use of the IPR.

         6.4      Apart  from  matters  disclosed  by Mr.  Ross's  solicitor  to
                  CryoLife's  solicitor  in  correspondence  dated 7 August 1996
                  there  is no  litigation,  pending  or  threatened,  or  claim
                  against  Mr.  Ross in  connection  with  the IPR or any of the
                  other  Purchased  Assets and Mr. Ross has not  received and is
                  not aware of any claim which contests the validity of or right
                  to use any of the IPR nor has Mr.  Ross  received  any  notice
                  that any of the IPR conflicts or will conflict with any of the
                  asserted rights of others.

         6.5      Mr.  Ross  will use his best  efforts  to  prevent  any of his
                  warranties or representations  contained in this Agreement not
                  being true and correct at Completion.

         6.6      Mr. Ross represents and warrants that:

                  6.6.1    he is not a U.S.  person (as  defined  under the U.S.
                           Securities  Act of 1933  and  rules  and  regulations
                           promulgated thereunder  (collectively the "Securities
                           Act");

                  6.6.2    the  securities  being  acquired  by Mr. Ross are not
                           being acquired on behalf of or for the benefit of any
                           U.S. person and will not be held in the United States
                           for a one year period;

                  6.6.3    none of the  securities  being  acquired  by Mr. Ross
                           will  be  transferred  by  him  in  violation  of the
                           Securities Act; and

                  6.6.4    he understands  that none of the securities have been
                           registered  under the  Securities Act and they cannot
                           be sold within the United States or to a U.S.  person
                           for one year unless they are subsequently  registered
                           under the  Securities Act or unless an exemption from
                           such registration is obtained.

7.       Indemnification

         7.1      Mr.  Ross  hereby  indemnifies  CryoLife  and  shall  keep  it
                  indemnified  and  hold it  harmless  from and  against  claims
                  liabilities  damages losses and expenses  incurred or suffered
                  by any of them and arising out of:

372890.1


                                       -7-






                  7.1.1    any material breach of any warranty or representation
                           of  Mr.  Ross  contained  in  this  Agreement  or any
                           inaccurate  schedule or any  instrument  or agreement
                           entered into pursuant to this Agreement;

                  7.1.2    any  action  claim  suit or  proceeding  brought by a
                           third party  arising out of actual or alleged acts or
                           omissions of Mr. Ross in  connection  with the Valves
                           produced  and/or  used prior to  Completion  save for
                           those Valves included in the Stock;

                  7.1.3    any breach of the Consulting Agreement.

         7.2      CryoLife  hereby  indemnifies  Mr.  Ross  and  shall  keep him
                  indemnified and hold him harmless from and against all claims,
                  liabilities,  damages,  losses, costs and expenses incurred or
                  suffered by Mr. Ross and arising out of any action  claim suit
                  or  proceeding  brought  by a third  party  against  Mr.  Ross
                  arising out of actual or alleged acts or omissions of CryoLife
                  in  connection  with  the  use of the  Valves  and  IPR  after
                  Completion.

         7.3      CryoLife  shall have a right but not the obligation to set-off
                  against  amounts  otherwise due or coming due under clause 3.3
                  for the amounts which are indemnifiable pursuant to clause 7.1
                  The right of set off is not  exclusive  to any other  right or
                  remedy  CryoLife  may have  with  respect  to the  indemnified
                  claims,  the right of set off shall in no way limit CryoLife's
                  indemnification  rights or the amounts, if any, which CryoLife
                  becomes entitled to receive thereunder.

8.       Enquiries

         Mr. Ross agrees to promptly refer to CryoLife all enquiries relating to
         the IPR and/or Valves which Mr. Ross may receive after Completion.

9.       Announcements

         No  announcement  or disclosure  concerning  the terms of  transactions
         contemplated  by or any  matter  ancillary  to this  Agreement,  or its
         existence  shall  (save  as  required  by  law)  be  made  by Mr.  Ross
         whatsoever   except  with  the  prior  written  approval  of  CryoLife.
         CryoLife's  announcement  of its  acquisition  (if any)  shall be shown
         beforehand to Mr. Ross.

10.      Mr.  Ross agrees  that he will not take or  threaten  any legal  action
         against  Tissuemed  Limited of Astley Lane  Industrial  Estate,  Astley
         Lane,  Swillington,  Leeds,  LS26  8XT  at any  time  either  prior  to
         Completion or thereafter without first obtaining the written consent of
         CryoLife,   which  consent   CryoLife  may  withhold  at  its  absolute
         discretion.

372890.1


                                       -8-






11.      General Provisions

         11.1     Notices

                  Any  and all  notices  or  other  communications  required  or
                  permitted  to be given  under  any of the  provisions  of this
                  Agreement shall be in writing and shall be deemed to have been
                  duly given when (i) personally  delivered or sent by overnight
                  or express delivery service;  or (ii) sent by facsimile with a
                  transmission report to support the sending of the facsimile to
                  the parties at the addresses set forth below:

                  To Mr. Ross:                       25 Upper Wimpole Street
                                                     London W1M 7TA

                                                     Fax No: +44 (0)171 935 0190

                  With a Copy to:                    Edward Album, Esq.
                                                     Exchange Tower
                                                     1 Harbour Exchange Square
                                                     London E14 9GE

                                                     Fax No: +44 (0)171 971 5668

                  To CryoLife:                       CryoLife, Inc.
                                                     2211 New Market Parkway
                                                     Suite 142
                                                     Marietta, Georgia  30067
                                                     USA

                                                     Fax No: 001 770 612 7889

                  With a Copy to:                    Robinson Services Limited
                                                     Howard House
                                                     70 Baker Street
                                                     Weybridge
                                                     Surrey KT13 8AL
                                                     England

                                                     Fax No:  +44 (0)1932 847469

                  All notice shall be deemed  received when  received,  provided
                  that  refusal  to accept  delivery  shall be  deemed  receipt.
                  Either party may change its address for the

372890.1


                                       -9-





                  purposes  of this  Section  by giving  written  notice of such
                  change  to the  other  party in the  manner  provided  in this
                  clause.

         11.2     Assignment

                  This  Agreement  may not be assigned by any party  without the
                  prior written consent of the other party.

         11.3     Waiver

                  No  waiver  of  any  breach  or  default  hereunder  shall  be
                  considered  valid or effective unless in writing and signed by
                  the party  giving such  waiver,  and no such  waiver  shall be
                  deemed a waiver of any  subsequent  breach or  default  of the
                  same or similar nature or otherwise.

         11.4     Binding Effect; No Third Party Beneficiary

                  This  Agreement is entered into for, and shall be binding upon
                  and inure to the  exclusive  benefit of, each party hereto and
                  their respective  successors and any permitted assign,  and no
                  other party shall derive any rights or benefits hereunder.

         11.5     Counterparts

                  This  Agreement  may be executed in one or more  counterparts,
                  all of which taken together shall be deemed one original.

         11.6     Expenses

                  CryoLife and Mr. Ross shall each be responsible  for their own
                  fees and expenses  incurred in connection with the transaction
                  contemplated herein.

         11.7     Survival

                  Indemnification  obligations and CryoLife's obligations to pay
                  the  royalties  under clause 3.13  pursuant to this  Agreement
                  shall survive Completion.

         11.8     Further Documents

                  Each  party  will,  whenever  and  as  often  as it  shall  be
                  requested by the other party, execute, acknowledge and deliver
                  or cause to be  executed,  acknowledged  and  delivered,  such
                  further instruments and documents as may be necessary in order
                  to carry out the terms and conditions of this Agreement and to
                  complete the sale

372890.1


                                      -10-





                  and  transfer  herein  contemplated  and  shall do any and all
                  other acts as may be  reasonably  requested  in order to carry
                  out the intent and purposes of this Agreement.

         11.9     Severability

                  Should any term or provision of this Agreement or any document
                  required  herein to be executed or delivered at the Completion
                  be declared  invalid,  void, or  unenforceable,  all remaining
                  terms and  provisions  hereof  shall  remain in full force and
                  effect  and  shall  in no  way  be  invalidated,  impaired  or
                  affected thereby.

         11.10    Integration; Amendment

                  This Agreement  (including  Schedules)  constitutes the entire
                  agreement of the parties  with  respect to the subject  matter
                  hereof and may not be modified,  amended or terminated  except
                  by  a  written  agreement   specifically   referring  to  this
                  Agreement  signed  by  the  parties  hereto.   This  Agreement
                  supersedes any and all prior agreements and/or  understandings
                  between the parties.

         11.11    Governing Law

                  This  Agreement  shall be governed and construed in accordance
                  with the laws of England.




372890.1


                                      -11-





IN WITNESS  WHEREOF,  the parties  hereto have caused this  Agreement to be duly
executed as of the date set forth above.

For and on behalf of CRYOLIFE, INC.


Signed by:        /s/ Steven E. Anderson
- ----------        ----------------------

Name:             Steven E. Anderson
- -----             ------------------

Position:         President/CEO
- ---------         -------------




/s/ Donald Nixon Ross   Witness                /s/ E. J. C. Album
- ---------------------                          ------------------
DONALD NIXON ROSS                              E. J. C. Album
                                               Solicitor
                                               Exchange Tower
                                               1 Harbour Exchange Square
                                               Tel: 0171-971-5887



372890.1


                                      -12-




                                    SCHEDULES




*Schedule 1                 Patents

*Schedule 2                 Stock

*Schedule 3                 Assignment

*Schedule 4                 Consulting Agreement


* Indicates  Schedules which have been omitted from this filing.  The Registrant
hereby agrees to furnish to the Commission a copy of any omitted Schedule listed
above supplementally upon request.

372890.1


                                      -13-
                                  EXHIBIT 2.2


                            ASSET PURCHASE AGREEMENT


         THIS ASSET PURCHASE  AGREEMENT (the  "Agreement") is made this 11th day
of  September,  1996,  by  and  among  CryoLife,  Inc.,  a  Florida  corporation
("CryoLife");  United Cryopreservation  Foundation,  Inc., a non-profit Illinois
corporation ("UCFI"); United Transplant Foundation, Inc., an Illinois non-profit
corporation,  which is a corporate  member of UCFI  ("UTF");  and QV,  Inc.,  an
Illinois  non-profit  corporation,  which is a corporate  member of UCFI ("QV").
(UTF and QV are  hereinafter  referred  to  collectively  as the  "Members"  and
individually as a "Member").

                              W I T N E S S E T H:

         WHEREAS,  CryoLife is in the business of developing and commercializing
technology   for  the  ultralow   temperature   preservation   of  viable  human
cardiovascular and orthopedic tissues for transplant;

         WHEREAS,   UCFI  is  a  non-profit   organization   organized  for  the
cryopreservation of human tissue for transplant;

         WHEREAS,  UCFI  desires to sell to CryoLife,  and  CryoLife  desires to
purchase  from UCFI,  substantially  all of the assets of UCFI  pursuant  to the
terms of this Agreement;

         WHEREAS,  the  parties  desire  to set forth  certain  representations,
warranties  and  covenants  made by each to the  other as an  inducement  to the
consummation of the sale and certain additional agreements related thereto;

         NOW,  THEREFORE,  in  consideration of $10.00 paid by CryoLife to UCFI,
the mutual representations, warranties and covenants herein contained, and other
good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereby agree as follows:

                                    ARTICLE 1
                           PURCHASE AND SALE OF ASSETS

         1.1 PURCHASED ASSETS.  Subject to and upon the terms and conditions set
forth herein and except for those assets  described in Section 1.2 hereof,  UCFI
agrees to sell to CryoLife,  and CryoLife  agrees to purchase  from UCFI, at the
Closing (as hereinafter  defined),  all of the tangible and intangible assets of
UCFI (collectively, the "Assets"), including but not limited to:

             (a) All of UCFI's interest in and the rights and benefits  accruing
to UCFI as sublessee under that certain Sublease (collectively,  with the letter
amendments hereinafter referenced,  the "Sublease") dated November, 1995 between
Regional Organ Bank of Illinois,


378486.1





Inc.  ("ROBI") and UCFI, as amended by that certain letter dated November,  1995
from ROBI to UCFI and countersigned by UCFI and submitted for  countersigning by
American National Bank and Trust Company of Chicago,  as Trustee under Trust No.
59097,  (the  "Landlord")  and that certain letter dated December 21, 1995, from
Winthrop  Management,  as agent for the Landlord and  countersigned  by ROBI and
UCFI, for certain real property as described in such Sublease and located at 800
South Wells, Chicago, Illinois 60607 (the "Subleased Property");

             (b)  All of  UCFI's  machinery,  appliances,  equipment,  including
UCFI's computer hardware and software, tools, supplies,  leasehold improvements,
construction  in  progress,  furniture  and  fixtures  owned  by  UCFI as of the
Closing,  including,  without limitation,  those items listed on Schedule 1.1(b)
attached  hereto  ("Fixed  Assets")  and all other  tangible  personal  property
located  at the  Subleased  Property  and  relating  to the  business  conducted
thereat;

             (c)  All   intellectual   property  of  UCFI,   including   without
limitation,  all  proprietary  processes,   methods,   formulas,   devices,  and
techniques  related  to  the  procurement,   processing,   and  distribution  of
cryopreserved tissue;  trademarks;  service marks; goodwill and other intangible
assets  but  excluding  those  items  listed  on  Schedule  1.2   (collectively,
"Intellectual Property");

             (d) All of UCFI's right, title and interest in and to its telephone
numbers and the directory  advertising for such telephone numbers, to the extent
assignable;

             (e) All claims, security and other deposits,  prepayments,  prepaid
expenses,  refunds,  causes of  action,  choses in action,  rights of  recovery,
warranty rights,  rights of set off, rights to receive insurance  proceeds,  and
rights of recoupment of UCFI ("Deposits");

             (f)  All  of  UCFI's  licenses,   consents,   permits,   variances,
certifications and approvals of governmental agencies to the extent transferable
and requested by CryoLife;

             (g) Business books, records,  ledgers, files,  documents,  business
plans,   budgets,   financial   statements,   correspondence,   customer  lists,
advertising and promotional materials of UCFI ("Books and Records");

             (h) Cash on hand,  cash in UCFI's bank accounts and escrow accounts
and cash equivalents; and

             (i) All accounts  and notes  receivable  and deferred  preservation
costs of UCFI as of Closing ("Accounts Receivable").

         EACH PARTY  ACKNOWLEDGES  THAT  CRYOLIFE  SHALL NOT OBTAIN TITLE TO ANY
HUMAN TISSUE OR ORGANS UNDER THE AGREEMENT.



378486.1

                                       -2-





         1.2  EXCLUDED  ASSETS.  Anything to the  contrary in Section 1.1 hereof
notwithstanding, the Assets shall exclude the following ("Excluded Assets"):

             (a) any real property owned by UCFI; and

             (b) those items set forth on Schedule 1.2 attached hereto.

         1.3 NO LIENS OR  ENCUMBRANCES.  The Assets will be transferred and sold
to  CryoLife  free  and  clear  of all  claims,  liens,  encumbrances,  security
interests, and similar interests of any kind or nature whatsoever.

                                    ARTICLE 2
                    PURCHASE PRICE; ASSUMPTION OF LIABILITIES

         2.1 PURCHASE PRICE. The consideration for the Assets (collectively, the
"Asset  Consideration")  will  be an  amount  equal  to  $2,000,000  (the  "Cash
Consideration"),  plus  the  aggregate  amount  of the  Assumed  Liabilities  as
described in and subject to the provisions of Section 2.3.

         2.2 PAYMENT. The Asset Consideration shall be paid to UCFI as follows:

             (a)  $750,000  shall  be paid in  immediately  available  funds  at
Closing;

             (b) the  balance of the Cash  Consideration  will be  evidenced  by
delivery  of a  promissory  note  from  CryoLife  in favor of UCFI,  in the form
attached hereto as Exhibit 2.2 (the "Promissory Note"); and

             (c) the Assumed  Liabilities  shall be assumed by CryoLife pursuant
to the  Assignment  and  Assumption  Agreement and  Assignment and Assumption of
Sublease (as defined in Section 2.3).

         2.3 ASSUMED LIABILITIES.

             (a) At the Closing,  CryoLife  agrees to assume only the  following
(collectively,  the "Assumed  Liabilities"):  (i) obligations and liabilities of
UCFI  arising  from and  after the  Closing  with  respect  to the  Sublease  as
contemplated  in the Assignment and  Assumption of Sublease  attached  hereto as
Exhibit  2.3(a)(i) (the  "Assignment  and  Assumption of Sublease");  (ii) trade
payables,  accrued expenses and other current liabilities incurred by UCFI prior
to Closing and payable in the ordinary course of business as contemplated by the
Assignment and Assumption  Agreement  attached hereto as Exhibit 2.3(a)(ii) (the
"Assignment  and Assumption  Agreement").  CryoLife  shall not assume,  and UCFI
shall remain  responsible  for, the payment of the $750,000 loan payable by UCFI
to the Members. Notwithstanding the foregoing, in no event shall the aggregate


378486.1

                                       -3-





amount  of  liabilities  and  obligations  assumed  by  CryoLife  under  Section
2.3(a)(ii) exceed $500,000.

             (b) Except for the Assumed  Liabilities set forth in Section 2.3(a)
above,  it is expressly  understood and agreed that CryoLife shall not be liable
for any obligations,  liabilities,  contracts,  debts, claims, costs,  expenses,
agreements or understandings of any kind or nature whatsoever  related to UCFI's
operation  of its  business or its  ownership  or use of the Assets,  including,
without limitation,  (i) any debts or liabilities of UCFI arising from events or
occurrences  prior to the Closing,  (ii) any liability of UCFI for any period of
time for  federal,  state or local  taxes,  and (iii) any  liability of UCFI for
expenses, debts or obligations incurred within or outside the ordinary course of
business.  Anything to the contrary contained herein  notwithstanding,  CryoLife
shall not assume or have any obligations or liabilities whatsoever in respect of
severance, Worker Adjustment and Retraining Act, income tax withholding, payroll
and/or unemployment tax, workers' compensation, pension, profit-sharing,  health
insurance,  Part 6 of Subtitle B of Title I of the  Employee  Retirement  Income
Security  Act of 1974,  as  amended  ("ERISA")  or any other  employee  or other
benefit liabilities,  including, without limitation any contribution, tax, lien,
penalty,  cost,  interest,  claim, loss, action,  suit, damage, cost assessment,
withdrawal liability, liability to the Pension Benefit Guaranty Corporation (the
"PBGC"),  liability  under Section 412 of the Internal  Revenue Code of 1986, as
amended (the "Code") or Section 302(a)(2) of ERISA or other similar liability or
expense of UCFI or any ERISA  Affiliate,  in respect of any Employee to be Hired
(as defined in Section  3.1),  for the period of time prior to  Closing,  and in
respect of any Leased  Employees,  for any  period of time  before,  on or after
Closing.  ERISA  Affiliate  shall  mean any trade or  business,  whether  or not
incorporated,  which  has  employees  who  are  or  have  been  at any  date  of
determination  occurring  within the  preceding six years,  treated  pursuant to
Section  4001(a)(14)  of ERISA and/or  Section 414 of the Code as employees of a
single employer.

         2.4  ALLOCATION  OF THE  CONSIDERATION  AMONG  THE  ASSETS.  The  Asset
Consideration received by UCFI shall be allocated,  for tax purposes, among each
item or class of the Assets of UCFI  pursuant to Schedule  2.4 hereof.  UCFI and
CryoLife  each agrees that it will prepare and file any notice or other  filings
required  pursuant  to Section  1060 of the Code,  and that any such  notices or
filings  will  be  prepared   based  on  such  tax   allocation   of  the  Asset
Consideration. CryoLife agrees to send to UCFI a completed copy of its Form 8594
("Asset  Acquisition  Statement  under  Section  1060")  with  respect  to  this
transaction prior to filing such form with the Internal Revenue Service.

         2.5 CLOSING.  The closing of the transactions  contemplated herein (the
"Closing")  shall take place on or before  September 15, 1996, at the offices of
CryoLife's counsel upon compliance with the terms,  conditions and contingencies
contained herein or on such other date as is mutually agreed upon by the parties
hereto  (such  date  to be  herein  referred  to as  the  "Closing  Date").  All
computations,  adjustments,  and  transfers  for the  purposes  hereof  shall be
effective  as of the close of business on the Closing  Date on terms  reasonably
acceptable to CryoLife.


378486.1

                                       -4-






                                    ARTICLE 3
                         OTHER COVENANTS AND AGREEMENTS

         3.1 EMPLOYEE MATTERS.  UCFI currently  receives the services of certain
individuals who are employees of QV, pursuant to a management  agreement between
UCFI  and QV.  A true,  correct  and  complete  list of such  persons  (the  "QV
Employees") is attached hereto as Schedule 3.1.  CryoLife  intends to hire three
of these  employees as of Closing,  each of whom are  identified on Schedule 3.1
(the "Employees to be Hired").  With respect to the Employees to be Hired,  from
Closing forward, CryoLife shall be solely responsible and exclusively liable for
compensating  the  Employees  to be Hired  and  complying  with  all  applicable
federal,  state and local laws with respect to the  employment  of such persons,
including  without  limitation,  liability  for FICA,  FUTA,  unemployment  tax,
pension  and  profit-sharing  plan  contributions,   employee  fringe  benefits;
provided,  however, that in no event shall CryoLife have any responsibility with
respect to any Employees to be Hired for liabilities  attributable to periods on
or  prior  to  Closing  (including  without  limitation  any  severance  pay  or
liabilities  arising under  continuation of group healthcare  coverage  benefits
pursuant  to  Section  4980B of the Code and Part 6 of  Subtitle B of Title I of
ERISA  ("COBRA")  attributable  to their  termination  of  employment  with QV).
CryoLife  shall offer to obtain the services of the QV Employees  other than the
Employees to be Hired (the "Leased Employees")  pursuant to an agreement between
CryoLife  and QV,  the form of which is  attached  hereto  as  Exhibit  3.1 (the
"Employee Leasing Agreement"). In no event shall CryoLife have any obligation or
liability  whatsoever  to provide any benefits or  compensation  directly to the
Leased  Employees,  it being  acknowledged  and  agreed  that QV shall  have the
exclusive liability and responsibility for compensating the Leased Employees and
complying with all applicable federal,  state and local laws with respect to the
employment of such persons,  including without  limitation,  liability for FICA,
FUTA, unemployment tax, pension and profit-sharing plan contributions,  employee
fringe benefits, and that QV shall indemnify and hold harmless CryoLife from any
liability  whatsoever with respect thereto whether arising before,  on, or after
the  Closing  Date.  In the event of  termination  of the  relationship  between
CryoLife and QV described herein with respect to the Leased Employees,  CryoLife
shall have no liability whatsoever to provide any severance or other benefits of
any nature  whatsoever to any Leased Employees or their  dependents  (including,
without  limitation,  severance pay or liabilities arising under COBRA, it being
acknowledged and agreed that the exclusive  responsibility  for all such matters
shall be with QV. QV shall be  responsible  for all vacation of the Employees to
be Hired prior to Closing,  and QV shall be responsible  for all vacation of all
Leased Employees accruing prior to or after Closing; provided, however, CryoLife
acknowledges and agrees that amounts accrued by UCFI in connection with vacation
of QV  Employees  and payable to QV in the  ordinary  course of UCFI's  business
shall be an "Assumed  Liability" of CryoLife  under  Section  2.3(a)(ii) of this
Agreement.

         3.2 CONSENTS.  Promptly after  execution of this  Agreement,  UCFI will
promptly apply for or otherwise seek, and use their best efforts to obtain,  all
consents  and  approvals   required  for   consummation   of  the   transactions
contemplated hereby, including without


378486.1

                                       -5-





limitation,  those consents listed in Schedule 3.2 hereof  (including  estoppels
and  consents  from  the  lessors  and  sublessors  under  the  Sublease  to the
assignment  thereof to  CryoLife  in form  substantially  similar to Exhibit 3.2
attached  hereto).  Any charges  imposed by the lessors for such  estoppels  and
consents  shall be borne by UCFI,  and UCFI and the  Members  shall  jointly and
severally  indemnify  CryoLife  against  any  action  brought  against  CryoLife
resulting  from  UCFI's  failure  to  pay  such  charges.   Notwithstanding  the
foregoing, the parties agree that CryoLife shall bear all charges imposed by the
lessor of the  Subleased  Property  in  connection  with  establishing  a direct
landlord-tenant relationship between CryoLife and said lessor to the extent such
charges exceed $1,500,  and that ROBI shall bear such charges to the extent such
charges are less than or equal to $1,500. The parties acknowledge that it may be
difficult  to obtain,  prior to  Closing,  the consent of the  Landlord  and the
mortgagee of the Subleased  Property (the  "Mortgagee") to the assignment of the
Sublease.  In the event UCFI uses its best efforts to obtain such consent  prior
to Closing but is unable to obtain such consent by such date, CryoLife agrees to
waive the  receipt  of such  consent as a  condition  to close.  CryoLife  shall
cooperate with UCFI in all reasonable  respects in UCFI's efforts to obtain such
consent, whether before or after Closing. Notwithstanding any waiver by CryoLife
of the receipt of the Landlord's and Mortgagee's Consents prior to Closing, UCFI
and its Members shall jointly and severally  indemnify  CryoLife for any damages
incurred by it as a result of the failure to obtain the Landlord and Mortgagee's
consent,  including,   without  limitation,  any  moving  expenses  incurred  by
CryoLife.  To the extent the Landlord and Mortgagee  refuse to give such consent
and require  CryoLife to vacate the Subleased  Property,  the assignment and the
assumption of the Sublease shall become null, void, and ineffective and CryoLife
shall have no rights  under or liability  for payment of any rental  obligations
thereunder  after  the  date  it  vacates  such  premises.  Notwithstanding  the
foregoing,  CryoLife shall be responsible for the payment and performance of all
of UCFI's  obligations  under the  Sublease  for all  periods  up to the date it
vacates  the  premises  following  the  Landlord  or  Mortgagee's  denial of its
consent.  To the extent the consent of the Landlord  and  Mortgagee is obtained,
CryoLife  agrees to use  reasonable  efforts  to obtain  from the  Landlord  and
Mortgagee  the  release  of UCFI  and  ROBI  from any  obligation  or  liability
subsequent to the Closing in connection with the Subleased Property.

         3.3 DUE DILIGENCE REVIEW.

             (a) UCFI currently conducts its business at the Subleased Property.
Upon the  execution  and delivery  hereof,  UCFI shall  concurrently  deliver to
CryoLife all Schedules  required to be attached  hereto.  Prior to the execution
and delivery hereof,  UCFI shall deliver to CryoLife true,  correct and complete
copies of the Sublease, insurance policies, the Historical Financials and UCFI's
tax returns  (pursuant to Section 4.11  hereof),  together  with all  amendments
thereto through the date of execution  hereof.  UCFI, its employees,  agents and
representatives  shall provide to CryoLife and its employees,  agents,  counsel,
accountants,  financial consultants and other representatives full access to all
information  regarding the Assets and business of UCFI and shall fully cooperate
with  CryoLife as  reasonably  needed to verify the accuracy of the  information
prepared by UCFI. UCFI shall


378486.1

                                       -6-





afford  CryoLife,  its employees,  agents,  counsel,  accountants  and financial
consultants  full  access,  during  normal  business  hours and upon  reasonable
notice, any reasonably necessary hours thereafter,  to the offices,  properties,
records,  files and other  documents  and  information  of or relating to UCFI's
business and the Assets as CryoLife, its employees, agents, counsel, accountants
or financial consultants may reasonably request. UCFI shall allow CryoLife,  its
employees,  agents,  counsel,  accountants and financial consultants access to a
work area  within such  business  office and shall allow the copying of any such
records as requested by such party.  However,  CryoLife's  due diligence  review
shall at all  times be  conducted  in a manner  which is not  disruptive  to the
business of UCFI. UCFI reserves the right to require  CryoLife's agents to enter
into confidentiality agreements covering information acquired in connection with
such due diligence reviews in form reasonably satisfactory to UCFI.

             (b) Prior to Closing, UCFI shall prepare and deliver to CryoLife an
unaudited balance sheet as of July 31, 1996 (or such later date as designated by
CryoLife) and an unaudited income statement for the one-month period then ended,
in accordance with generally accepted accounting principles consistently applied
throughout the period  involved  (except that such interim  statements  need not
include footnotes or normal year-end  adjustments)  (collectively,  the "Interim
Financials").  The Interim  Financials  shall be  accompanied  by a  certificate
signed by the  President  that such  Interim  Financials  have been  prepared in
accordance with generally accepted accounting  principles  consistently  applied
throughout  the period  involved  (except for the absence of footnotes or normal
year-end  adjustments) and fairly present the financial  condition of UCFI as of
the date  thereof and the results of  operations  for the period then ended.  As
soon as is reasonably  practicable  after the execution of this Agreement,  UCFI
will provide  CryoLife with such  financial  statements  and  information as are
reasonably necessary to permit KPMG Peat Marwick to prepare financial statements
of UCFI in accordance with generally accepted accounting principles consistently
applied  and  Regulation  S-X as  promulgated  by the  Securities  and  Exchange
Commission  ("SEC").  UCFI  acknowledges  that such  financial  information  and
statements must be provided to the Accountants in a manner which will enable the
Accountants  to complete the Audit within 60 days  following the Closing of this
Agreement in order to comply with SEC filing requirements.  All costs associated
with  the  Audit  (other  than  UCFI's  personnel  costs,  if any)  shall be the
responsibility of CryoLife.

             (c)  CryoLife   shall  cause  its   employees,   agents,   counsel,
accountants,  financial  consultants and other representatives to hold in strict
confidence  any and all  information  obtained from UCFI and to not disclose any
such  information  (unless such  information  is or becomes  ascertainable  from
public  sources or public  disclosure of such  information  is in the good faith
judgment of CryoLife required by law); provided, however, that nothing contained
herein  shall  limit  the  right  of any  such  persons  to  disclose  any  such
information  to CryoLife or its  employees,  agents,  representatives,  counsel,
accountants,  financial  advisors,  underwriters  and sources of financing  (and
their counsel and  accountants) for the purpose of facilitating the consummation
of the transactions  contemplated  hereby.  Should the transaction  contemplated
herein not be consummated for any reason whatsoever,


378486.1

                                       -7-





CryoLife agrees to keep information  obtained from UCFI confidential and not use
it for any purpose adverse to the interests of UCFI (unless such  information is
or  becomes  ascertainable  from  public  sources or public  disclosure  of such
information  is in the good faith  judgment of CryoLife  required by law).  Upon
termination of this Agreement  pursuant to Section 9.1, CryoLife shall return to
UCFI all documents  obtained by or provided to CryoLife pursuant to this Section
3.3.

             (d) CryoLife's due diligence  review and any  inspections  pursuant
thereto  shall  not  waive  or  release  UCFI or the  Members  from any of their
representations or warranties under this Agreement.

         3.4 NONCOMPETITION AGREEMENTS. Concurrently with the Closing, UCFI, QV,
and UTF, shall each enter into a Noncompetition  Agreement with CryoLife, in the
form of Exhibit 3.4 attached hereto.

         3.5 UCFI'S ACCESS TO BOOKS AND RECORDS. CryoLife agrees to preserve all
of the records and books, customer records, and any other records which UCFI may
turn over to CryoLife  pursuant to this Agreement until the fifth anniversary of
the Closing Date,  and, until such time, to make them  available,  during normal
business  hours, to UCFI or the Members,  their counsel,  accountants and others
authorized by them for inspection and the making of extracts therefrom, provided
such  inspection  and making of  extracts  do not  unreasonably  interfere  with
CryoLife's operations and business.

         3.6 CONDUCT OF BUSINESS BY UCFI PENDING THE CLOSING. UCFI covenants and
agrees that,  unless  CryoLife shall otherwise  consent in writing,  between the
date hereof and the Closing,  the  business of UCFI shall be conducted  only in,
and UCFI shall not take any action  except in, the  ordinary  course of business
and in a manner  consistent  with  past  practice;  and  UCFI  will use its best
efforts to preserve  substantially intact the business  organization of UCFI, to
keep available the services of its present  officers and the QV Employees and to
preserve the present  relationships of UCFI with customers,  suppliers and other
persons with which UCFI has significant  business relations except that UCFI may
take steps to terminate any agreements  which are not to be assigned.  By way of
amplification  and not  limitation,  except as  expressly  provided  for in this
Agreement,  UCFI shall not, between the date hereof and the Closing, directly or
indirectly,  take any of the following actions without the prior written consent
of CryoLife:

             (a) (i) issue, sell, pledge,  dispose of, encumber,  authorize,  or
propose the issuance, sale, pledge, disposition, encumbrance or authorization of
any  membership  interests  or  rights  of any kind to  acquire  any  membership
interests of UCFI; (ii) amend or propose to amend the Articles of  Incorporation
or By-Laws of UCFI;  (iii)  redeem,  purchase or  otherwise  acquire or offer to
redeem,  purchase  or  otherwise  acquire  any  membership  interests;  or  (iv)
authorize  or propose  or enter  into any  contract,  agreement,  commitment  or
arrangement with respect to any of the matters set forth in this Section 3.6(a);



378486.1

                                       -8-





             (b) (i) acquire (by merger, consolidation,  or acquisition of stock
or assets)  any  interest  in any  corporation,  partnership  or other  business
organization  or  division  thereof;  (ii)  except  in the  ordinary  course  of
business,  sell,  pledge,  dispose of, or encumber or  authorize  or propose the
sale, pledge,  disposition or encumbrance of any assets of UCFI; (iii) incur any
indebtedness  for  borrowed  money  or  enter  into  any  material  contract  or
agreement,  except in the ordinary course of business; (iv) authorize any single
capital expenditure in excess of $1,000 or capital expenditures in the aggregate
in  excess  of  $5,000;  or (v) enter  into or amend  any  contract,  agreement,
commitment or  arrangement  with respect to any of the matters set forth in this
Section 3.6(b);

             (c) take any action other than in the  ordinary  course of business
and in a manner  consistent  with past practice  (none of which actions shall be
unreasonable or unusual) with respect to increasing compensation of any officer,
director,  or any of the QV  Employees  or  with  respect  to the  grant  of any
severance or  termination  pay  (otherwise  than pursuant to policies of UCFI in
effect on the date  hereof and fully  disclosed  to  CryoLife  prior to the date
hereof) or with respect to any increase of benefits  payable under its severance
or  termination  pay policies in effect on the date hereof;  provided,  however,
CryoLife's  consent shall not be required with respect to grants or increases of
severance pay provided,  if made prior to Closing,  such payments are made by or
reimbursed  by the  Members  or, if made  following  the  Closing,  are the sole
responsibility of the Members;

             (d) except as  permitted by (c),  make any  payments  except in the
ordinary course of business and in amounts and in a manner  consistent with past
practice  (none of which  payments  shall be  unreasonable  or unusual),  to any
employee of, or independent  contractor or consultant  to, UCFI,  enter into any
employee  benefit  plan,  any  employment  or  consulting  agreement,  grant  or
establish any new awards under any employee benefit plan or agreement,  or adopt
or otherwise amend any of the foregoing;

             (e) take any action  except in the ordinary  course of business and
in a manner  consistent  with past practice or make any change in its methods of
procurement,  management,  distribution,  marketing, accounting or operating (or
practices relating to payment of trade accounts or to other payments);

             (f) except in the  ordinary  course of business or as  specifically
permitted  herein,  take any action to incur or  increase  prior to Closing  any
indebtedness  for borrowed money from banks or other  financial  institutions or
cancel without  payment in full, any notes,  loans or receivables  except in the
ordinary course of business;

             (g) loan or  advance  monies to any person  under any  circumstance
whatsoever,   except  travel  advances,   salary  advances  in  connection  with
vacations,  or other  reasonable  expense  advances to QV Employees  made in the
ordinary course of business consistent with past practices; or



378486.1

                                       -9-





             (h) do any act or omit to do any act which  would cause a breach of
any  contract,  commitment  or obligation of UCFI except where such breach would
not cause a Material Adverse Effect (as defined in Section 3.9).

         3.7 NO  NEGOTIATIONS.  UCFI covenants that subject to Section 9.2, from
and after the date hereof, neither UCFI, nor its officers, members or directors,
nor  anyone  acting  on  behalf  of UCFI or such  persons,  shall,  directly  or
indirectly,  solicit, engage in discussions or negotiations with, or provide any
information  to, any person,  firm or other entity or group (other than CryoLife
or its  representatives)  concerning  any merger,  sale of  substantial  assets,
purchase or sale of membership interests or similar transaction involving UCFI.

         3.8 CLOSING COSTS.

             (a) All of the expenses incurred by CryoLife in connection with the
authorization,  negotiation,  preparation,  execution  and  performance  of this
Agreement and other  agreements  referred to herein and the  consummation of the
transactions  contemplated hereby, including,  without limitation,  all fees and
expenses  of agents,  representatives,  brokers,  counsel  and  accountants  for
CryoLife, shall be paid by CryoLife.

             (b) All  expenses  incurred by the  Members and UCFI in  connection
with the authorization,  negotiation,  preparation, execution and performance of
this Agreement and the other agreements  referred to herein and the consummation
of the transactions contemplated hereby, including without limitation,  all fees
and expenses of agents, representatives, brokers, counsel and accountants, shall
be paid by the  Members  and  UCFI.  Prior to the  Closing,  the  Members  shall
reimburse UCFI in full for any and all such expenses  (excluding  expenses which
would  otherwise have been incurred by UCFI in the ordinary  course of business)
incurred  on behalf of the  Members  or UCFI  which have been or will be paid by
UCFI prior to the Closing.  After the Closing, UCFI and the Members shall remain
responsible  for and shall pay all such expenses  incurred on behalf of UCFI and
the Members.

         3.9      NOTIFICATION OF CERTAIN MATTERS.

             (a) UCFI shall give  prompt  notice to CryoLife in the event any of
the following events occur prior to the Closing:

                           (i) the  occurrence  or  nonoccurrence  of any  event
                  whose  occurrence  or  nonoccurrence  would be likely to cause
                  either  (A)  any  representation  or  warranty  of UCFI or the
                  Members contained in this Agreement to be untrue or inaccurate
                  in any  material  respect at any time from the date  hereof to
                  the  Closing,  or (B)  directly or  indirectly,  any  Material
                  Adverse Effect for UCFI. The term  "Material  Adverse  Effect"
                  means any change in or effect on the business of the specified
                  entity that is or will be materially  adverse to the business,
                  operations,   properties  (including  intangible  properties),
                  condition


378486.1

                                      -10-





                  (financial or  otherwise),  assets,  liabilities or regulatory
                  status of such entity by virtue of the fact that it would have
                  an  adverse  effect of in  excess  of $5,000 on the  financial
                  condition  of  such  entity,   would   represent  a  potential
                  liability or claim in excess of $5,000,  or would constitute a
                  criminal act; or

                           (ii) Any material  failure of UCFI or any Member,  or
                  any officer,  director,  or agent  thereof,  to comply with or
                  satisfy any  covenant,  condition  or agreement to be complied
                  with or satisfied by it hereunder.

             (b) CryoLife  shall give prompt  notice to UCFI in the event any of
the following events occur prior to the Closing:

                           (i) the  occurrence  or  nonoccurrence  of any  event
                  whose  occurrence  or  nonoccurrence  would be likely to cause
                  either  (A)  any   representation   or  warranty  of  CryoLife
                  contained in this  Agreement to be untrue or inaccurate in any
                  material  respect  at any time  from the  date  hereof  to the
                  Closing,  or (B) an event, the disclosure of which is required
                  by the Securities Exchange Act of 1934, as amended; or

                           (ii)  any  material  failure  of  CryoLife,   or  any
                  officer,  director,  employee or agent thereof, to comply with
                  or satisfy any covenant, condition or agreement to be complied
                  with or satisfied by it hereunder.

             (c)  Notwithstanding  the  foregoing,  the  delivery  of any notice
pursuant to this  Section 3.9 shall not limit or  otherwise  affect the remedies
available hereunder to the party receiving such notice.

         3.10 PUBLIC ANNOUNCEMENTS.

             (a) Except as may be required by law or as provided in this Section
3.10,  each of UCFI and  CryoLife  agrees that it will not,  and will direct its
directors, officers, employees, representatives and agents who have knowledge of
the transactions  between UCFI, the Members,  and CryoLife  contemplated by this
Agreement not to, disclose to any person who is not a participant in discussions
concerning such  transactions  (other than any persons whose consent is required
to be  obtained  hereunder),  any of the terms,  conditions  or other facts with
respect to any such transactions.

             (b) Attached  hereto as Exhibit  3.10 is the form of press  release
that has been approved by CryoLife and UCFI for issuance upon the Closing. After
the Closing, each of CryoLife and UCFI shall obtain the prior written consent of
the other  before  issuing  any press  release  or  otherwise  making any public
statements with respect to the  transactions  contemplated by this Agreement and
shall not issue any such press release or make any such public  statement  prior
to such consent;  provided,  however,  notwithstanding  the foregoing,  CryoLife
shall be  entitled  to make any  disclosure  that it  believes in its good faith
judgment,


378486.1

                                      -11-





after consultation with its legal counsel, is required by law to be made. In the
event  CryoLife  determines  that a  disclosure  is  required by law to be made,
CryoLife  shall use  reasonable  efforts to  provide a copy of any  contemplated
press  release to UCFI prior to the issuance  thereof and to include any changes
requested by UCFI with respect thereto.

         3.11 BULK SALES.  CryoLife  hereby  waives  compliance by UCFI with the
provisions  of any  applicable  state bulk transfer  statutes,  and UCFI and the
Members, jointly and severally, covenant and agree to pay and discharge when due
all claims of creditors  asserted  against  CryoLife by reason of any failure of
UCFI and/or the Members to so comply, and to indemnify CryoLife fully in respect
thereof, which indemnity shall survive the Closing.

         3.12 PROCUREMENT AGREEMENTS. At the Closing,  Procurement Agreements in
the form attached hereto as Exhibit 3.12 (the "Procurement Agreements") shall be
entered into between  CryoLife and ROBI and CryoLife and Mid-America  Transplant
Services ("MTS"), respectively.

         3.13  PREPAYMENT OF SUBLEASE.  To the extent rent under the Sublease is
prepaid and such  prepayments  do not extend for more than six months  following
Closing,  CryoLife shall reimburse the existing  tenant,  ROBI, for its pro rata
portion  of such  prepayments  on a monthly  basis as such  payments  would have
otherwise become due under the Sublease.

         3.14 DISTRIBUTION  AGREEMENT.  At the Closing,  CryoLife and UCFI shall
enter into a Distribution  Agreement in the form attached hereto as Exhibit 3.14
(the "Distribution Agreement").

         3.15 FURNITURE.  The parties hereby  acknowledge that the furniture and
certain other equipment (the  "Furniture")  used by UCFI in the operation of its
business is leased pursuant to that certain Master Lease Agreement dated October
11, 1995 between UCFI and First American Bank of Dundee (the "Furniture Lease").
The parties have agreed that, prior to Closing, UCFI shall exercise its right to
purchase  the  Furniture  pursuant  to the terms of the  Furniture  Lease.  UCFI
represents  and  warrants to CryoLife  that the cost to exercise  such  purchase
option shall not exceed $32,000.

         3.16 TRANSITIONAL  AGREEMENTS.  At the Closing, ROBI and CryoLife shall
enter  into (a) a License  Agreement  in the form  attached  hereto  as  Exhibit
3.16(a), and (b) an Agreement Regarding Services and Related Matters in the form
attached   hereto  as   Exhibit   3.16(b)   (collectively,   the   "Transitional
Agreements").

         3.17 INSURANCE.  UCFI has submitted to its insurance company a claim in
the aggregate amount of $141,309.14 (the "Insured Amount") for the water damages
incurred in connection  with the events  described on Schedule 4.24. UCFI agrees
it shall provide reasonable cooperation and assistance to CryoLife following the
Closing in the collection of the Insured Amount, and to the extent the insurance
company  refuses or fails to pay the Insured  Amount  within 120 days  following
Closing, UCFI shall pay to CryoLife the Insured


378486.1

                                      -12-





Amount,  and thereafter  UCFI shall be entitled to pursue payment thereof and to
receipt of the Insured Amount upon any payment by the insurance company.

                                    ARTICLE 4
             REPRESENTATIONS AND WARRANTIES OF UCFI AND THE MEMBERS

         In order to induce CryoLife to enter into this Agreement and consummate
the transactions  contemplated hereby, UCFI and each Member hereby,  jointly and
severally,  makes the following representations and warranties to CryoLife, each
of which  warranties  and  representations  is material to and is relied upon by
CryoLife.

         4.1  ORGANIZATION  AND AUTHORITY OF UCFI.  UCFI is a  corporation  duly
organized,  validly existing and in good standing under the laws of the State of
Illinois.  UCFI and each Member is a non-profit  organization under Illinois law
and is an organization  described in Section  501(c)(3) of the Code and is not a
"Private  Foundation,"  within the meaning of Section 509 of the Code.  UCFI has
received a  determination  letter from the Internal  Revenue Service (the "IRS")
that it is  described  in  Section  501(c)(3)  of the  Code and that it is not a
Private  Foundation.  UCFI is duly  qualified  as a foreign  corporation  in all
jurisdictions  in which the  conduct of its  business  or the  ownership  of its
properties  requires  such  qualification  and Schedule 4.1 lists all the states
where UCFI is so qualified. UCFI has all necessary corporate power and authority
to own,  lease and operate  its  properties  and  conduct its  business as it is
currently being conducted. UCFI does not own, directly or indirectly, any equity
interest in any corporation, partnership, joint venture or other entity and does
not have any  "subsidiaries,"  which for  purposes of this  Agreement  means any
corporation  or other legal entity of which UCFI owns,  directly or  indirectly,
more than 50% of the stock or other  equity  interests  the holders of which are
generally  entitled to vote for the  election of the board of directors or other
governing body of such corporation or other legal entity.

         4.2 CORPORATE  POWER AND AUTHORITY;  DUE  AUTHORIZATION.  UCFI and each
Member has full  corporate  power and  authority  to execute  and  deliver  this
Agreement and to consummate  the  transactions  contemplated  hereby.  UCFI, the
Members,  ROBI, and MTS each have full corporate  power and authority to execute
and deliver each of the Asset Purchase  Transaction  Documents to which it is or
will be a party and to consummate the transactions  contemplated thereby. "Asset
Purchase   Transaction   Documents"   means  all  Exhibits  and  all   officer's
certificates  to be delivered at the Closing and  referenced in Sections 7 and 8
excluding  Exhibits 3.10, 7.4(g) and 8.4(i).  All of the members of UCFI are set
forth on Schedule 4.2 attached  hereto.  The duly elected officers and directors
of UCFI are set forth on Schedule 4.2 attached  hereto.  The  directors  and the
Members of UCFI have duly approved and  authorized the execution and delivery of
this Agreement and each of the Asset Purchase Transaction  Documents to which it
is a party and the  consummation  of the  transactions  contemplated  hereby and
thereby,  and no other corporate  proceedings are necessary.  Assuming that this
Agreement and each of the Asset Purchase Transaction Documents to which CryoLife
is a party constitutes a valid and binding


378486.1

                                      -13-





agreement of  CryoLife,  as  applicable,  this  Agreement  and each of the Asset
Purchase  Transaction  Documents to which UCFI, QV, UTF,  ROBI,  and/or MTS is a
party, constitutes,  or will constitute when executed and delivered, a valid and
binding agreement of such party, in each case enforceable in accordance with its
terms subject to applicable bankruptcy, insolvency, reorganization,  moratorium,
or similar laws  affecting  the rights of  creditors  generally  and  principles
governing the availability of equitable remedies.

         4.3  TITLE TO  ASSETS.  UCFI has  good  and  valid  title to all of its
Assets, free and clear of any liens,  pledges,  encumbrances,  claims or similar
rights of third parties. At the Closing, UCFI will transfer to CryoLife good and
valid title to all of its Assets, free and clear of any liens, pledges, charges,
encumbrances, claims, or similar rights of third parties.

         4.4 NO CONFLICT; REQUIRED CONSENTS.  Assuming all consents,  approvals,
authorizations  and  other  actions  listed on  Schedule  3.2  hereto  have been
obtained or taken with  respect to items (a) and (b) below,  the  execution  and
delivery by UCFI of this  Agreement  and the  execution and delivery by UCFI and
the  Members  of each  Asset  Purchase  Transaction  Document  to  which it is a
signatory  and the  consummation  by UCFI and the  Members  of the  transactions
contemplated hereby and thereby do not and will not, to the knowledge of UCFI or
the Members,  (a) require the  consent,  approval or action of, or any filing or
notice  to,  any  corporation,  firm,  person  or other  entity  or any  public,
governmental  or judicial  authority;  (b) violate the terms of any  instrument,
document or agreement  to which UCFI or any Member is a party,  or by which UCFI
or any Member or the property of UCFI  (including the Assets) is bound, or be in
conflict with, result in a breach of or constitute (upon the giving of notice or
lapse  of time or  both) a  default  under  any  such  instrument,  document  or
agreement of UCFI or any Member,  or result in the creation of any lien upon any
of the property or assets of UCFI (including the Assets); (c) violate any order,
writ,  injunction,  decree,  judgment,  ruling,  law,  rule or regulation of any
federal,  state, county,  municipal,  or foreign court or governmental authority
applicable  to UCFI  or any  Member  or  relating  to the  Assets  or to  UCFI's
business; or (d) violate the Articles of Incorporation or Bylaws of UCFI.

         4.5  COMPLIANCE  WITH  LAWS.  To the best of UCFI's  and each  Member's
knowledge,  UCFI is in compliance with all applicable  laws,  orders,  rules and
regulations of all governmental bodies and agencies.

         4.6  LICENSES  AND PERMITS.  UCFI holds and is in  compliance  with all
licenses, permits, concessions, grants, franchises, approvals and authorizations
listed on  Schedule  4.6  attached  hereto,  and to the best of UCFI's  and each
Member's  knowledge,  such  list  constitutes  all  of  the  licenses,  permits,
concessions,  grants,  franchises,  approvals  and  authorizations  necessary or
required  for the use or  ownership  of the Assets and the  operation  of UCFI's
business.  Except as previously  disclosed to CryoLife in writing,  neither UCFI
nor any  Member has  received  notice of any  violations  in respect of any such
licenses, permits, concessions, grants, franchises, approvals or authorizations.
No  proceeding  is  pending  or,  to the  knowledge  of  UCFI  or a  Member,  is
threatened, which seeks revocation


378486.1

                                      -14-





or limitation of any such licenses,  permits,  concessions,  grants, franchises,
approvals or authorizations.

         4.7 FINANCIAL INFORMATION.

             (a) Prior to the date hereof,  UCFI has delivered to CryoLife true,
correct and complete copies of the audited balance sheets of UCFI as of June 30,
1996 and June 30, 1995, and audited income  statements for the fiscal years then
ended  (collectively,   the  "Historical   Financials").   All  such  Historical
Financials  (including  any related notes and  schedules)  have been prepared in
accordance with generally accepted accounting  principles  consistently  applied
throughout the periods  involved and fairly  present the financial  condition of
UCFI at the  respective  dates thereof and the results of its operations for the
periods then ended.

             (b) The Interim Financials, when delivered, will have been prepared
in accordance with generally accepted accounting principles consistently applied
throughout the periods  involved (except for the absence of footnotes and normal
year-end adjustments) and will show all liabilities,  direct and contingent,  of
UCFI required at the time of  preparation  to be shown in  accordance  with such
principles.  The  balance  sheet  included  in  the  Interim  Financials,   when
delivered,  will fairly  present the financial  condition of UCFI as of the date
thereof,  and the income  statement  included  in the Interim  Financials,  when
delivered,  will fairly  present the results of the  operations  of UCFI for the
period indicated. The income statement included in the Interim Financials,  when
delivered,  will not  contain  any  material  items of special or  non-recurring
income or any other income not earned in the ordinary course of UCFI's business.

             (c) On the date hereof,  there are no liabilities or obligations of
UCFI  of  any  nature,  whether  liquidated,  unliquidated,  accrued,  absolute,
contingent or otherwise except for those (i) that will be specifically reflected
or  reserved  against  as to  amount  in the  balance  sheets  contained  in the
Historical  Financials,  (ii) that arise  thereafter  in the ordinary  course of
business,  and (iii) that are  specifically  set forth on Schedule  4.7 attached
hereto; and at the Closing,  there will be no liabilities or obligations of UCFI
of any nature, whether liquidated,  unliquidated,  accrued, absolute, contingent
or  otherwise  except  for  those  (A) that will be  specifically  reflected  or
reserved  against as to amount in the  balance  sheet  contained  in the Interim
Financials,  (B) that arise after the date of such balance sheet in the ordinary
course of business or (C) that are specifically set forth on Schedule 4.7.

             (d) UCFI has not been  during the 12 months  immediately  preceding
the  execution  of this  Agreement,  insolvent  within the  meaning of 11 U.S.C.
Section 101(31). UCFI has and is paying its debts as they become due.

         4.8 SUFFICIENCY OF ASSETS. The Assets and the assets excluded therefrom
pursuant to Section 1.2 hereof  constitute all the material assets of any nature
with which UCFI has conducted its business for the 12-month  period prior to the
Closing Date, subject only to


378486.1

                                      -15-





additions and deletions in the ordinary course of business.  All material assets
and  rights  relating  to  UCFI's  business  are  held  only  by  UCFI,  and all
agreements,  obligations,  expenses and transactions  related to UCFI's business
have  been  entered  into,  incurred  and  conducted  only by UCFI or one of its
Members.  To the extent any agreements or transactions have been entered into by
a Member, such agreement or transaction has or will be assigned to UCFI prior to
Closing  or, to the  extent  not  assigned,  has been  previously  disclosed  to
CryoLife in writing.

         4.9 DEPOSITS.  Attached as Schedule 4.9 is a true, correct and complete
list of Deposits of UCFI, setting forth the amount of each Deposit.

         4.10 TRADE PAYABLES; ACCRUED EXPENSES.

             (a) Schedule  4.10(a) is a true,  correct and complete  list of the
trade payables and accrued  expenses of UCFI  outstanding as of the date of this
Agreement,  which  list  indicates  the number of days such  payables  have been
outstanding.  All such trade payables and accrued expenses have been incurred in
the ordinary course of business.

             (b) At the Closing,  UCFI shall deliver to CryoLife an updated list
of trade payables and accrued  expenses of UCFI (the "Closing Trade Payables and
Accrued  Expenses List") listing all trade payables and accrued expenses of UCFI
as of the Closing.  The Closing Trade Payables and Accrued Expenses List will be
true, correct and complete as of the Closing.

             (c)  Schedule  4.10(c)  attached  hereto  is a  true,  correct  and
complete list of all  obligations for  indebtedness  owed by UCFI as of the date
hereof (other than trade  payables) and all  obligations  of UCFI as of the date
hereof  incurred  other than in the  ordinary  course of  business,  stating the
origin of the obligation and the amount owed.

         4.11 TAX RETURNS AND  PAYMENTS.  All federal,  state and local  income,
franchise,  sales,  use,  payroll,  excise,  business,  license and  information
(including,  without  limitation,  IRS Form 990) tax returns of UCFI required by
law to be filed for all periods to and  including  the Closing Date have been or
will be timely filed and were or will be accurate  and correct  when filed,  and
UCFI has paid or will pay all taxes,  including federal,  state or local income,
franchise,  sales,  use,  payroll,  excise,  business and license  taxes and any
penalties and interest or other charges applicable thereto ("Taxes") due for all
periods prior to and including the Closing Date. No state,  federal or local tax
liens exist with respect to UCFI or any of its assets (including the Assets). No
audit of the Taxes of UCFI is  currently  in  progress  or has, to UCFI's or any
Member's  knowledge,   been  scheduled.  The  full  amount  of  any  unpaid  tax
liabilities  which have accrued  through  June 30, 1996 has been  reflected as a
liability in the books and in the financial statements of UCFI as of the date of
their  accrual.  UCFI has paid all taxes which would not  otherwise  require the
filing of returns and which are required to be paid and which otherwise would be
delinquent.  Prior to the  execution  of this  Agreement,  UCFI has  provided to
CryoLife true, correct and complete


378486.1

                                      -16-





copies of UCFI's  federal  income tax  returns on Form 990 for 1995,  1994,  and
1993,  which  returns  were  properly  signed by UCFI and timely  filed with the
Internal Revenue Service.

         4.12 FIXED  ASSETS.  The Fixed  Assets owned by UCFI include all of the
furniture, fixtures and equipment owned and used by UCFI in the operation of its
business.  Each of the Fixed Assets is in good  operating  condition and repair,
normal wear and tear excepted, for all present uses by UCFI. A true, correct and
complete list of the Fixed Assets is attached as Schedule  1.1(b),  and all such
Fixed Assets are located at the Subleased  Property unless a different  location
is noted on Schedule 1.1(b).

         4.13 PROCESSED  TISSUE.  UCFI's  inventory of processed tissue held for
distribution  pursuant to the  Distribution  Agreement  consists,  and as of the
close of business  on the last  business  day  preceding  the Closing  Date will
consist, only of human cryopreserved  cardiovascular,  vascular,  and orthopedic
tissue which has been preserved using UCFI's protocols  required for and used in
the recovery, processing,  packing, storage and distribution of human tissue and
organs and has been processed in accordance with UCFI's protocols. True, correct
and complete copies of all such protocols have been supplied to CryoLife. UCFI's
inventory of processed tissue held for distribution pursuant to the Distribution
Agreement  is in full  compliance  with all  requirements  of Title 21,  Code of
Federal  Regulations Part 1270 except where failure to so comply would not cause
a Material Adverse Effect.  Schedule 4.13 attached hereto is a true, correct and
complete list of the processed tissue held by UCFI by type and size.

         4.14 INTELLECTUAL PROPERTY.  Schedule 4.14 hereto lists all trademarks,
service  marks,  and  copyrights  of UCFI used by UCFI in the  operation  of its
business.  UCFI owns and/or has the sole and  exclusive  right to use all of the
Intellectual  Property.  Upon the consummation of the transactions  contemplated
hereby,  to the  knowledge of UCFI and the Members,  CryoLife will have the sole
and exclusive  right to own and use the  Intellectual  Property.  No claims have
been asserted and no claims are pending or, to UCFI's or any Member's  knowledge
threatened by any person or entity, to the use of any such Intellectual Property
or  challenging  or questioning  the validity or  effectiveness  of any state or
federal  registration  of the  Intellectual  Property  and neither  UCFI nor any
Member knows of any valid basis for such claim.  UCFI's use of the  Intellectual
Property,  and, to the knowledge of UCFI and the Members,  CryoLife's  continued
use of the  Intellectual  Property  following  the Closing in the same manner as
heretofore used by UCFI, does not and will not infringe the rights of any person
or entity.

         4.15  CONTRACTS.  Schedule  4.15 sets forth a true and complete list of
all written or oral contracts, agreements and other instruments to which UCFI or
its Assets are subject or bound,  including without  limitation  agreements with
organ procurement agencies and other procurement sources, sales representatives,
distributors,  suppliers and independent  contractors in the operation of UCFI's
business, except any contract, agreement or understanding involving an aggregate
annual expenditure of less than $10,000 (collectively,  the "Contracts").  Prior
to execution of this Agreement, UCFI has provided to CryoLife


378486.1

                                      -17-





true,  correct  and  complete  copies of the  Contracts,  including  any and all
amendments  and waivers  thereto.  Except as otherwise  disclosed to CryoLife in
writing,  such Contracts are valid,  legally binding and enforceable against the
parties thereto.  Except as otherwise disclosed to CryoLife in writing,  neither
UCFI nor, to the best of UCFI's and any Member's  knowledge,  any other party to
any of the Contracts is in breach of, or in default under,  any of the Contracts
and no event has  occurred  which,  with the  notice or lapse of time,  or both,
would  constitute a default by UCFI or any other party to any of the  Contracts.
The  assignment  of any of the  Contracts  to CryoLife in  accordance  with this
Agreement will not constitute a breach or violation of such Contract.

         4.16 HAZARDOUS  SUBSTANCE.  For purposes of this paragraph,  "hazardous
substance"  means any substance or material (a) identified in Section 101(14) of
the  Comprehensive  Environmental  Response,  Compensation and Liability Act, 42
U.S.C.  Section  9601(14)  and as  set  forth  in  Title  40,  Code  of  Federal
Regulations,  Part  302,  as the  same may be  amended  from  time to time,  (b)
determined to be toxic,  a pollutant or  contaminant,  under  federal,  state or
local statute, law, ordinance, rule, or regulation or judicial or administrative
order or decision,  as same may be amended from time to time,  (c) petroleum and
petroleum products and distillates, (d) asbestos, (e) radon, (f) polychlorinated
biphenyls  and  (g)  such  other  materials,  substances  or  waste  subject  to
regulation  under any applicable law. There are no violations of federal,  state
or local laws  relating to health,  safety and the  environment  relating to the
operations  of UCFI's  business  or the  current  or former  state of the Assets
(excluding violations which would not have a Material Adverse Effect). To UCFI's
and the Members' knowledge,  either there are no "hazardous  substances" located
on,  in or under  the  Subleased  Property  or used in the  operation  of UCFI's
business;  or UCFI has fully  disclosed  to CryoLife  in writing the  existence,
extent and nature of any "hazardous substances" which UCFI is legally authorized
to maintain on, in, or under the  Subleased  Property or the Assets as to use in
connection therewith and UCFI has obtained all licenses,  permits, and approvals
required with respect  thereto and is in full  compliance with all of the terms,
conditions and  requirements of such licenses,  permits and approvals.  UCFI has
not caused or permitted to exist, as a result of an intentional or unintentional
act or  omission  on its part,  a  releasing,  discharging,  spilling,  leaking,
pumping,  emitting,  pouring,  emptying,  or dumping of "hazardous  substances."
Except as  otherwise  disclosed  to CryoLife in  writing,  neither  UCFI nor any
Member has received any written notice, summons,  citation, notice of violation,
letter or other  communication  concerning  any pending or  threatened  claim or
litigation in which any person or entity alleges the presence,  release,  threat
of release,  placement  on or at the  Subleased  Property or the Assets,  or the
generation,  transportation,  storage, treatment, or disposal at, on or from the
Subleased  Property or the Assets, of any hazardous  substance,  or in which any
person  alleges a  violation  of any law  governing  or imposing  any  liability
arising out of any matter relating to health, safety or the environment.

         4.17 LITIGATION;  JUDGMENTS.  Except as otherwise  disclosed by UCFI to
CryoLife in writing, there is no action, proceeding or investigation pending, or
to UCFI's or any Member's knowledge, threatened against or involving UCFI or any
Member relating to any of the Assets or the operation of UCFI's business, nor is
there any action or proceeding


378486.1

                                      -18-





pending or threatened before any court, tribunal or governmental body seeking to
restrain or prohibit or to obtain damages or other relief in connection with the
consummation  of transactions  contemplated  by this  Agreement,  or which might
adversely affect UCFI's business or Assets, or UCFI's or any Member's ability to
consummate  the  transactions  contemplated  by this  Agreement  and  the  Asset
Purchase  Transaction  Documents.  Neither UCFI nor any Member is the subject of
any judgment,  order or decree entered in any lawsuit or proceeding  relating to
the Assets or the operation of UCFI's business.

         4.18  SUBLEASE.  UCFI has  delivered  to  CryoLife a true,  correct and
complete  copy of the  Sublease,  together  with  all  amendments,  addenda  and
supplements thereto with respect to the Sublease:

             (a) The Sublease is legal, valid, binding, enforceable, and in full
force and effect;

             (b) Subject to obtaining  any  necessary  consent from the Landlord
and  Mortgagee  in  respect  of the  transactions  contemplated  hereunder,  the
Sublease  will continue to be legal,  valid,  binding,  enforceable  and in full
force and effect on identical terms following the Closing;

             (c) No party to the Sublease is in breach or default,  and no event
has occurred which,  with notice or lapse of time,  would constitute a breach or
default or permit termination, modification or acceleration thereunder;

             (d) No other party to the Sublease  has  repudiated  any  provision
thereof;

             (e) There have not been and there are no disputes,  oral agreements
or forebearances in effect as to the Sublease;

             (f  UCFI  has  good  title  to the  leasehold  interest  under  the
Sublease;

             (g) UCFI has not assigned, transferred, conveyed, mortgaged, deeded
in trust or  encumbered  any interest in the  leasehold and neither UCFI nor any
Member is aware of any such assignment,  transfer, conveyance, mortgage, deed in
trust or encumbrance of any interest in the leasehold; and

             (h) All  facilities  leased or subleased  under the  Sublease  have
received  or  have  applied  for  all  approvals  of  governmental   authorities
(including  licenses  and permits)  required in  connection  with the  operation
thereof and have been  operated and  maintained in  accordance  with  applicable
laws,  rules and  regulations  with respect to the  activities of UCFI conducted
thereat.

         4.19 INSURANCE.  UCFI maintains  property,  fire,  casualty,  workman's
compensation,  general liability insurance and other forms of insurance relating
to its Assets and the


378486.1

                                      -19-





operation  of UCFI's  business  against  risks of the kind  customarily  insured
against and in amounts customarily  insured (and, where appropriate,  in amounts
not less  than the  replacement  cost of the  Assets).  UCFI will  maintain  its
insurance  policies in full force and effect through the Closing Date.  Schedule
4.19 lists all of the  insurance  policies  maintained by UCFI,  which  schedule
includes the name of the insurance company,  the policy number, a description of
the type of insurance  covered by such  policy,  the dollar limit of the policy,
and the annual premiums for such policy.

         4.20  UNION;  LABOR.  UCFI does not engage any  person  directly  as an
employee,  and the QV Employees  constitute  all of the  individuals  performing
full-time  services for UCFI and  participating in the day-to-day  operations of
UCFI. Neither UCFI nor QV is a party to any collective  bargaining  agreement or
any other contract,  written or oral, with any trade or labor union,  employees'
association or similar organization with respect to the QV Employees.  There are
no strikes or labor disputes pending or threatened, or to UCFI's or any Member's
knowledge,  any attempts at union organization of the QV Employees. All salaries
and  wages  paid and  withheld  by QV are and have been in  compliance  with all
applicable federal, state and local laws.

         4.21     BENEFIT PLANS AND ERISA.

             (a) UCFI does not  maintain,  contribute  to or otherwise  have any
liability  whatsoever  with respect to any  "employee  benefit plan" (within the
meaning of Section 3(3) of ERISA) or any other bonus,  profit sharing,  pension,
compensation,  deferred  compensation,  stock  option,  stock  purchase,  fringe
benefit,  severance,  post-retirement,   scholarship,  disability,  sick  leave,
vacation, individual employment, commission, bonus, payroll practice, retention,
or other plan,  agreement,  policy,  trust fund or arrangement for any of the QV
Employees or other personnel providing services to UCFI.

             (b)   CryoLife   shall  not,  as  a  result  of  the   transactions
contemplated  by this  Agreement  (including  without  limitation the receipt of
services of the QV  Employees):  (i) become  liable for any  contribution,  tax,
lien,  penalty,  cost,  interest,   claim,  loss,  action,  suit,  damage,  cost
assessment  or other  similar  type of liability or expense of UCFI or any ERISA
Affiliate (including  predecessors thereof) with regard to any "employee benefit
plan"  (within  the meaning of Section  3(3) of ERISA) of UCFI,  QV or any other
ERISA Affiliate.

         4.22 IMMIGRATION MATTERS.  (Intentionally deleted.)

         4.23 BROKERS  FEES  AND  EXPENSES.  Neither  UCFI nor any  Member  has
retained or utilized the services of any broker, finder or intermediary, or paid
or agreed to pay any fee or commission to any person or entity for or on account
of the transactions  contemplated  hereby,  or had any  communications  with any
person  or  entity  which  would  obligate  CryoLife  to pay  any  such  fees or
commissions.



378486.1

                                      -20-





         4.24 ABSENCE OF MATERIAL CHANGES.  Except as set forth in Schedule 4.24
attached hereto or otherwise reflected in the Interim Financials,  from June 30,
1996 to the date of this Agreement:

             (a) there has not been any Material Adverse Effect in the condition
(financial or otherwise) of the business, the liabilities or the assets of UCFI;

             (b) there has been no Material  Adverse Effect in UCFI's  relations
with,  nor has UCFI lost (or received  written  notice that it is about to lose)
any distributors or suppliers with which UCFI has significant business relations
(except if as a result of UCFI's efforts to terminate  agreements which will not
be assigned);

             (c) UCFI has operated  its business in the ordinary  course and has
not sold,  assigned,  or transferred  any of its assets,  except in the ordinary
course of its business;

             (d) except as disclosed on Schedule  4.24,  UCFI has not mortgaged,
pledged  or  subjected  to  any  lien,  pledge,  mortgage,   security  interest,
conditional sales contract,  or other encumbrance of any nature whatsoever,  any
of UCFI's assets (including the Assets);

             (e)  there  has been no  amendment,  termination,  or waiver of any
right of UCFI under any contract, governmental license or permit that would have
a Material Adverse Effect on its Assets or its business;

             (f) UCFI has not:

                 (i) paid any  judgment  resulting  from any  suit,  proceeding,
arbitration, claim or counterclaim in respect of Assets or business in excess of
$10,000  (provided that all such excluded payments do not aggregate to more than
$50,000);

                 (ii) made any such  payment to any party in  settlement  of any
such suit, proceeding,  arbitration,  claim or counterclaim in excess of $10,000
(provided  that  all  such  excluded  payments  do not  aggregate  to more  than
$50,000);

                 (iii) written down or failed to write down (in accordance  with
generally  accepted  accounting  principles),  or  written  up the  value of any
inventory or assets of UCFI;

                 (iv) made any  material  changes  in the  customary  methods of
operation of UCFI's  business,  including  practices  and  policies  relating to
accounting, purchasing, marketing or selling;

                 (v) (except in respect of ordinary trade payables) incurred any
indebtedness  or  guaranteed  any  indebtedness,  except  for  borrowings  under
existing loans or lines of credit in the ordinary course of business; or


378486.1

                                      -21-






                 (vi) agreed,  whether in writing or  otherwise,  to take any of
the actions specified in this Section 4.24.

         4.25 BANK ACCOUNTS. Schedule 4.25 contains a true, complete and correct
list  showing the name and location of each bank or other  institution  in which
UCFI has any deposit  account or safe  deposit box,  together  with a listing of
account  numbers and names of all  persons  authorized  to draw  thereon or have
access thereto.

         4.26 FULL DISCLOSURE.  The statements,  representations  and warranties
made by UCFI and the Members in this  Agreement,  in the  Schedules and Exhibits
attached hereto, and in the Asset Purchase Transaction  Documents do not contain
any  untrue  statement  of a  material  fact or omit to  state a  material  fact
necessary to make the statements  contained  herein or therein,  in light of the
circumstances under which they were made, not misleading.

                                    ARTICLE 5
                   REPRESENTATIONS AND WARRANTIES OF CRYOLIFE

         In order to induce  UCFI and the  Members to enter into this  Agreement
and to consummate the transactions  contemplated hereby, CryoLife represents and
warrants to UCFI and the Members as follows:

         5.1 ORGANIZATION OF CRYOLIFE.  CryoLife is a corporation duly organized
and validly existing and in good standing under the laws of the State of Florida
and has the corporate power to own, lease, and operate its property and to carry
on its business as now being conducted by it.

         5.2 CORPORATE POWER AND AUTHORITY; DUE AUTHORIZATION. CryoLife has full
corporate  power and authority to execute and deliver this Agreement and each of
the Asset Purchase Transaction Documents to which CryoLife is or will be a party
and to consummate the transactions contemplated hereby and thereby. The Board of
Directors  of CryoLife  have duly  approved and  authorized  the  execution  and
delivery of this Agreement and each of the Asset Purchase Transaction  Documents
to  which  it is or will be a party  and the  consummation  of the  transactions
contemplated hereby and thereby, and no other corporate  proceedings on the part
of CryoLife are necessary to approve and authorize the execution and delivery of
this   Agreement  and  such  Asset  Purchase   Transaction   Documents  and  the
consummation of the transactions  contemplated hereby and thereby. Assuming that
this  Agreement and each of the Asset  Purchase  Transaction  Documents to which
CryoLife is a party  constitutes a valid and binding  agreement of UCFI and/or a
UCFI  Affiliate,  as the  case may be,  this  Agreement  and  each of the  Asset
Purchase Transaction Documents to which CryoLife is a party constitutes, or will
constitute  when  executed  and  delivered,  a valid and  binding  agreement  of
CryoLife, as applicable, in each case enforceable against CryoLife in accordance
with its terms, subject to applicable  bankruptcy,  insolvency,  reorganization,
moratorium,  or similar laws  affecting  the rights of creditors  generally  and
principles governing the availability of equitable remedies.


378486.1

                                      -22-






         5.3 NO CONFLICT;  CONSENTS.  The  execution and delivery by CryoLife of
this Agreement,  the Asset Purchase Transaction Documents to which it is or will
be a party and the  consummation  by CryoLife of the  transactions  contemplated
hereby and thereby do not and will not, to CryoLife's knowledge, (a) require the
consent,  approval  or action of, or any  filing or notice to, any  corporation,
firm, person or other entity or any public,  governmental or judicial authority;
(b) violate the terms of any instrument, document or agreement to which CryoLife
is a party,  or by which CryoLife or the property of CryoLife is bound, or be in
conflict with, resulting in a breach of or constitute (upon the giving of notice
or lapse of time,  or both) a default  under any such  instrument,  document  or
agreement; (c) violate any order, writ, injunction,  decree,  judgment,  ruling,
law or regulation of any federal, state, county,  municipal, or foreign court or
governmental  authority  applicable  to CryoLife and relating to the purchase of
UCFI's  business;  or (d) violate the  Articles  of  Incorporation  or Bylaws of
CryoLife.

         5.4 BROKERS  FEES AND  EXPENSES.  CryoLife has not retained or utilized
the services of any broker,  finder,  or intermediary,  or paid or agreed to pay
any  fee or  commission  to any  person  or  entity  for  or on  account  of the
transactions  contemplated  hereby, or had any communications with any person or
entity  which  would  obligate  UCFI  or any  Member  to pay  any  such  fees or
commissions.

         5.5 FULL  DISCLOSURE.  The statements,  representations  and warranties
made by CryoLife in this  Agreement and in the Exhibits  attached  hereto do not
contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements  contained  herein or therein,  in light of the
circumstances under which they were made, not misleading.

                                    ARTICLE 6
                                 INDEMNIFICATION

         6.1  INDEMNIFICATION  BY UCFI AND  MEMBERS.  In  addition  to any other
indemnification  obligations  of UCFI or the Members  under any other  provision
hereof,  UCFI,  and the  Members,  jointly  and  severally  indemnify  and  hold
CryoLife,  and  its  affiliates,  directors,  officers,  employees  and  agents,
harmless from and against all claims,  liabilities,  lawsuits, costs, damages or
expenses (including, without limitation, reasonable attorneys' fees and expenses
incurred in litigation or otherwise) arising out of and sustained by any of them
due to (a) any  misrepresentation  or  breach of any  representation,  warranty,
covenant or agreement of UCFI or the Members  contained in this Agreement or any
Asset Purchase Transaction Document; (b) any liability or obligation relating to
the operation of UCFI's  business or the ownership or use of the Assets  through
the  Closing  Date,  other  than the  Assumed  Liabilities,  including,  without
limitation,   any  and  all  claims,   liabilities,   Taxes,  debts,  contracts,
agreements, obligations, damages, costs and expenses, known or unknown, fixed or
contingent, claimed or demanded by third parties against CryoLife arising out of
the operation of UCFI's business,  including, without limitation, the processing
and  distribution of human tissue,  the Sublease and the use or occupancy of the
Subleased Property, or the


378486.1

                                      -23-





ownership or use of the Assets,  prior to and through the Closing Date;  (c) the
failure of the parties to this  Agreement to comply with the  provisions  of the
bulk sales law in any state having  jurisdiction over Assets or the transactions
contemplated  herein;  (d) breach by ROBI or MTS of the Procurement  Agreements;
(e) the  occurrence  of events  which,  had  Sections  4.4  and/or  4.5 not been
qualified to the  knowledge of UCFI and the Members,  would have  constituted  a
breach of such Sections,  or (f) claims  resulting from the correct  application
and conduct by  CryoLife  under the  Distribution  Agreement  of UCFI's  written
protocols for the distribution of processed tissue, which protocols are provided
to CryoLife in writing at the Closing (the "UCFI Protocols").

         6.2 INDEMNIFICATION BY CRYOLIFE.  CryoLife hereby indemnifies and holds
UCFI  and the  Members,  and  each  of  UCFI's  and  each  Member's  affiliates,
directors,  officers, employees and agents (including,  without limitation, ROBI
and MTS in  their  capacities  as  contracting  parties  to the  Asset  Purchase
Transaction  Documents  and  otherwise),  harmless  from and against all claims,
liabilities,  lawsuits, costs, damages or expenses (including without limitation
reasonable  attorneys  fees and expenses  incurred in  litigation  or otherwise)
arising out of and sustained by any of them due to (a) any  misrepresentation or
breach of any  representation,  warranty,  covenant or  agreement of CryoLife in
this  Agreement  or any Asset  Purchase  Transaction  Document;  (b) any Assumed
Liabilities;  (c) the use or  occupancy  of the  Subleased  Property  after  the
Closing Date,  except as contemplated by Section 3.2; (d) except with respect to
claims  arising  from or  described in Section 6.1 or with respect to which UCFI
and/or the Members have specifically  agreed to be responsible  pursuant to this
Agreement or any Asset Purchase Document,  any liability or obligation  relating
to the operation, use, or ownership of the Assets after the Closing Date and the
employment  after the  Closing  Date of the  Employees  to be Hired;  or (e) the
occurrence  of events which had Section 5.3 not been  qualified to the knowledge
of CryoLife, would have constituted a violation of such Section.

         In addition, the parties specifically acknowledge that claims may arise
with respect to tissue that has been processed by UCFI prior to the Closing, but
which is distributed by CryoLife, on behalf of UCFI after the Closing,  pursuant
to the Distribution Agreement. With respect thereto, in the event a claim arises
or  results  from the  processing  of the tissue by UCFI prior to Closing or the
correct application and conduct by CryoLife under the Distribution  Agreement of
the UCFI  Protocols,  UCFI and the Members  shall  indemnify  and hold  CryoLife
harmless from such claims in accordance  with the  provisions of Section 6.1; in
the event a claim  arises or  results  from the  distribution  of the  tissue by
CryoLife in violation of the terms of the Distribution  Agreement or as a result
of  CryoLife's   negligence  or  willful   misconduct  in  connection  with  the
distribution  of the tissue under the  Distribution  Agreement,  CryoLife  shall
indemnify and defend UCFI and the Members in accordance  with the  provisions of
Section 6.2.

         6.3 PROVISIONS  REGARDING  INDEMNIFICATION.  The indemnified  party (or
parties) shall promptly notify the indemnifying party (or parties) of any claim,
demand,  action or  proceeding  for which  indemnification  will be sought under
Section 6.1 or 6.2 of this


378486.1

                                      -24-





Agreement  and, if such claim,  demand,  action or  proceeding  is being made or
prosecuted by a third party, the indemnifying  party will have the right, at its
expense,  to  assume  the  defense  thereof  using  counsel  acceptable  to  the
indemnified  party,  whose  consent  shall  not be  withheld  unreasonably.  The
indemnified party shall have the right to participate in at its own expense, but
not  control,  the  defense of any such third  party  claim,  demand,  action or
proceeding.  In connection  with any such third party claim,  demand,  action or
proceeding,  UCFI, the Members, and CryoLife shall cooperate with each other. No
such third party claim,  demand,  action or proceeding  shall be settled without
the prior written consent of the indemnified party provided,  however, that if a
firm, written offer is made to settle any such third party claim, demand, action
or proceeding and the indemnifying  party proposes to accept such settlement and
the  indemnified  party  refuses to consent to such  settlement,  then:  (i) the
indemnifying  party shall be excused from,  and the  indemnified  party shall be
solely  responsible for, all further defense of such third party claim,  demand,
action or proceeding;  and (ii) the maximum liability of the indemnifying  party
relating to such third party claim,  demand,  action or proceeding  shall be the
amount of the proposed  settlement if the amount  thereafter  recovered from the
indemnified  party on such third party claim,  demand,  action or  proceeding is
greater than the amount of the proposed settlement.

         6.4 SURVIVAL.  The  representations  and  warranties  contained in this
Agreement  and in the Asset  Purchase  Transaction  Documents  delivered  at the
Closing shall  survive the Closing for a period ending on the fifth  anniversary
date of the  Closing and shall  thereafter  cease to be of any force and effect,
except  for (a) claims  for  indemnification  resulting  from  breaches  of such
representations  and  warranties as to which notice has been given in accordance
with  Section  6.3 hereof  prior to such date and which are pending on such date
and (b)  representations  and  warranties  relating  to: (i) title to the Assets
(Section 4.3 hereof), (ii) Taxes (Sections 4.11 and 6.1 hereof), (iii) financial
statements  (Sections 3.3 and 4.7 hereof);  (iv)  compliance  with bulk transfer
laws  (Section  3.11 hereof) and (v) employee  benefits  (Sections  2.3, 3.1 and
4.21),  each of which shall survive until the end of the statute of  limitations
applicable to the underlying claim for which indemnification is sought.  Neither
such  survival  nor the  liability  of any party  with  respect  to the  party's
representations and warranties shall be reduced by any investigation made at any
time by or on behalf of any party.

         6.5 RIGHT OF SET-OFF.

             (a) CryoLife  shall have the limited  right to set-off  against the
Promissory  Note in accordance with the procedures set forth in this Section 6.5
if an event has occurred that entitles CryoLife to indemnification under Article
6 of this  Agreement,  which Event has not been satisfied by UCFI or the Members
(a  "Set-Off  Event").  In the event of a Set-Off  Event,  CryoLife  shall  send
written  notice to UCFI and the Members of its intent to  exercise  its right of
set-off hereunder,  which notice shall contain (i) a specific description of the
reasons why  CryoLife  believes it is  entitled to  indemnification  and set-off
under the  Agreement,  including  a  specific  description  of the nature of the
claim, liability,  lawsuit, cost, damage or expense arising out of and sustained
by CryoLife, its affiliates, directors, officers,


378486.1

                                      -25-





employees and agents,  as well as a specific  description  of the Set-Off Event;
(ii) the amount of the proposed set-off (which amount shall equal the amount due
and payable by UCFI or the Members to CryoLife  pursuant to the  indemnification
provisions  of this  Article 6) (the  "Proposed  Set-Off  Amount");  and (iii) a
specific description of how such amount was determined.

             (b) In the event UCFI disputes CryoLife's  assertion that a Set-Off
Event has occurred or disputes the Proposed Set-Off Amount,  UCFI shall have ten
business  days in which  to  notify  CryoLife  in  writing  that  such  claim is
disputed,  which  notice  shall  specify (i) the reasons  UCFI  believes no such
Set-Off Event has occurred, and (ii) why UCFI believes that the Proposed Set-Off
Amount is in error.  In the event  UCFI  fails to notify  CryoLife  within  such
ten-day  period,  UCFI and the  Members  shall be deemed to have  accepted  such
set-off,  with respect to the amount and event  described in the notice.  In the
event of a dispute,  the parties  shall  negotiate  in good faith to resolve the
dispute.

             (c) In the event the  parties  are  unable to resolve  the  dispute
within 30 days  following the  expiration of the ten-day  response  period,  the
matter shall be submitted to arbitration in accordance  with Section 10. Pending
resolution  of a dispute  under this Section 6.5, all amounts  payable or coming
due under the Promissory Note, up to the Proposed Set-Off Amount,  shall be paid
by CryoLife into a separate, joint order,  interest-bearing account (the "Escrow
Account").

             (d) In the event it is  determined  by the arbiters that no Set-Off
Event has occurred, CryoLife shall forthwith release its interest in said Escrow
Account,  including accrued interest thereon, or pay forthwith the amount of the
Proposed Set-Off Amount plus the amount of interest accrued thereon, to UCFI, at
CryoLife's  option.  In addition,  CryoLife shall reimburse UCFI and the Members
for all reasonable  costs,  including  attorney's fees,  incurred by UCFI or the
Members in connection with resolving the dispute.

             (e) In the event it is  determined  by the arbiters  that a Set-Off
Event has occurred in an amount equal to the Proposed Set-Off Amount,  then UCFI
shall release its interest in said Escrow Account and CryoLife shall be entitled
to the funds held in such Escrow Account,  plus any interest accrued thereon. To
the  extent  that the funds  held in such  Account  are less  than the  Proposed
Set-Off  Amount,  UCFI and the Members shall promptly pay to CryoLife the amount
of the  deficit,  or, at  CryoLife's  option,  CryoLife  may off-set such amount
against amounts coming due under the Promissory Note in the future. In addition,
UCFI or the Members shall forthwith pay an amount equal to the reasonable costs,
including attorney's fees, incurred by CryoLife in resolving the dispute.

             (f) In the event it is  determined  by the arbiters  that a Set-Off
Event has occurred but the  Proposed  Set-Off  Amount is greater than the amount
which is  determined  to be the  correct  amount due and  payable by UCFI or the
Members to CryoLife pursuant to the indemnification provisions of this Article 6
(the "Actual Set-Off Amount"), then UCFI shall forthwith release its interest in
said Escrow Account in an amount equal to the lower


378486.1

                                      -26-





of the amount of funds held in the Escrow  Account or the Actual  Set-Off Amount
plus any  interest  accrued  thereon.  If the amount of funds held in the Escrow
Account is less than the  Actual  Set-Off  Amount,  UCFI and the  Members  shall
promptly pay to CryoLife the amount of the deficit,  or, at  CryoLife's  option,
CryoLife may off-set such amount against amounts coming due under the Promissory
Note in the future.  The difference  between the Proposed Set-Off Amount and the
Actual Set-Off Amount is hereinafter referred to as the "Set-Off  Differential."
To the  extent  that the funds  held in the  Escrow  Account  exceed  the Actual
Set-Off  Amount,  plus  interest,  such excess  shall be released to UCFI or the
Members  forthwith,  together with the amount of any interest accrued thereon in
accordance with the written instructions of UCFI.

             (g) In the event it is  determined  by the arbiters  that a Set-Off
Event has  occurred  but the  Proposed  Set-Off  Amount is less than the  Actual
Set-Off Amount,  then UCFI shall release its interest in said Escrow Account and
CryoLife  shall be entitled  to the funds held in such  Account,  plus  interest
accrued on said amount. In addition, UCFI or the Members shall pay forthwith the
Set-Off Differential.

             (h) In either of the  events  described  in 6.5(f) or  6.5(g),  the
arbitrator  shall  have the  authority  to  award  reasonable  costs,  including
attorneys' fees, as the arbitrator deems appropriate.

             (i) In the event  CryoLife  fails to comply  with the terms of this
Section  6.5, in  addition to any other  rights to which UCFI may be entitled at
law or in equity, ROBI and MTS shall have the right to terminate the Procurement
Agreements.

             (j) In the event  that UCFI or the  Members  fail to pay or release
amounts due under this Section  6.5,  then in addition to any other rights which
CryoLife  may be  entitled  at law or in equity,  CryoLife  shall be entitled to
set-off  additional amounts due under the Promissory Note, but only in an amount
equal to the amount due hereunder.

             (k) The  foregoing  rights of set-off shall not be exclusive of any
other right or remedy CryoLife may have with respect to the indemnified  claims,
whether by  contract,  at law or in  equity;  provided,  however,  that under no
circumstance  shall CryoLife be entitled to set-off any amounts  against amounts
due under the  Promissory  Note except as provided  herein.  Except as otherwise
provided,  this  Section 6.5 shall not be deemed to limit  CryoLife's  rights to
indemnification, at law, in equity, or under this Agreement.

         6.6 LIMITATION OF LIABILITY.  Notwithstanding anything contained herein
to the contrary,  in no event shall either  party's  liability  pursuant to this
Article 6 for breach of any  representation,  warranty,  or agreement exceed the
aggregate amount of the Asset  Consideration;  provided,  however, the foregoing
shall not be applicable to claims with respect to (i) Taxes  (Sections  4.11 and
6.1);   (ii)  employee   benefits   (Sections  2.3,  3.1,  and  4.21,  or  (iii)
environmental  matters (Section 4.16). The foregoing  limitation shall not apply
with respect to claims arising under Section 6.1(b) or 6.2(c).


378486.1

                                      -27-






                                    ARTICLE 7
                          CONDITIONS TO OBLIGATIONS OF
                                CRYOLIFE TO CLOSE

         Each and every  obligation of the CryoLife  under this  Agreement to be
performed on or prior to the Closing shall be subject to the fulfillment,  on or
prior to the Closing, of each of the following conditions:

         7.1 REPRESENTATIONS AND WARRANTIES TRUE AT CLOSING. The representations
and warranties made by UCFI and the Members in or pursuant to this Agreement and
the Asset Purchase  Transaction  Documents or given on their behalf hereunder or
thereunder shall be true and correct on and as of the Closing Date with the same
effect as though such  representations  and warranties had been made or given on
and as of the Closing Date.

         7.2 OBLIGATIONS  PERFORMED.  UCFI and the Members shall have performed
and complied with all agreements  and conditions  required by this Agreement and
the Asset  Purchase  Transaction  Documents to be performed or complied  with by
them prior to or at the Closing.

         7.3 CONSENTS.  Except for the consent of the Landlord and Mortgagee to
the assignment of Sublease,  with respect to which the provisions of Section 3.2
shall apply, UCFI shall have obtained and delivered to CryoLife written consents
of all  persons  or  entities  whose  consent  is  required  to  consummate  the
transactions  contemplated herein, if any, and all of such consents shall remain
in full force and effect at and as of the Closing.

         7.4 CLOSING  DELIVERIES.  UCFI shall have delivered to CryoLife each of
the following,  together with any additional items which CryoLife may reasonably
request to effect the transactions contemplated herein:

             (a) possession of the Assets;

             (b) a Bill of Sale in the form of Exhibit 7.4(b)  attached  hereto,
the  Assignment  and  Assumption  Agreement,  the  Assignment  and Assumption of
Sublease,  and such additional  instruments of sale, transfer,  conveyance,  and
assignment  duly  executed by UCFI as of the Closing Date as counsel to CryoLife
shall deem necessary or appropriate;

             (c) a certified  copy of the corporate  resolutions of UCFI and the
Members  of  UCFI  authorizing  the  transactions  contemplated  hereby  and the
execution,  delivery and  performance  by UCFI of this  Agreement  and the other
agreements  and  instruments  contemplated  hereby,  together with an incumbency
certificate with respect to officers of UCFI executing  documents or instruments
on behalf of UCFI;



378486.1

                                      -28-





             (d) a certificate of the President of UCFI and a certificate of the
President of each Member  certifying as to the matters set forth in Sections 7.1
and 7.2 hereof and as to the  satisfaction of all other  conditions set forth in
this Article 7;

             (e) the Noncompetition Agreements referred to in Section 3.4 hereof
duly executed by UCFI and each Member;

             (f) a Closing Trade Payables and Accrued  Expenses List pursuant to
Section 4.10(b);

             (g) an  opinion of  counsel  to UCFI  substantially  in the form of
Exhibit 7.4(g);

             (h) written consents from all parties to the Sublease whose consent
to the transactions  contemplated  hereby is required (subject to the provisions
of Section 3.2);

             (i) the  Procurement  Agreements  referred to in Section  3.12 duly
executed by ROBI and MTS;

             (j) the Employee Leasing Agreement  referred to in Section 3.1 duly
executed by QV;

             (k) the  Distribution  Agreement  referred to in Section  3.14 duly
executed by UCFI;

             (l) the  Transitional  Agreements  referenced  in Section 3.16 duly
executed by ROBI; and

             (m) any other  documents or agreements  contemplated  hereby and/or
necessary or appropriate to consummate the transactions contemplated hereby.

         7.5 NO CHALLENGE.  There shall not be pending or threatened any action,
proceeding or  investigation  before any court or  administrative  agency by any
government  agency or any pending  action by any other person,  challenging,  or
seeking  material damages in connection with, the acquisition by CryoLife of the
Assets  pursuant  to the  transactions  contemplated  by this  Agreement  or the
ability of  CryoLife or any of its  affiliates  to own and operate the Assets or
otherwise  materially  adversely  affecting  the  business,  assets,  prospects,
financial condition or results of operations of UCFI.

         7.6 NO  INVESTIGATIONS  OF UCFI OR  BUSINESS.  As of the Closing  Date,
there shall be no, and neither UCFI nor any Member  shall have any  knowledge of
or reason to know of any, pending or threatened  investigation by any municipal,
state or federal government agency or regulatory body with respect to the Assets
or UCFI's business.



378486.1

                                      -29-





         7.7 NO MATERIAL  ADVERSE EFFECT.  Since June 30, 1996, there shall have
been no Material Adverse Effect in the business, financial condition, results of
operations  and/or  Assets  (without  giving effect to the  consequences  of the
transactions  contemplated  by this  Agreement)  of UCFI,  whether  reflected in
financial  statements,  the schedules  hereto or  otherwise,  which has not been
waived by CryoLife in writing.

         7.8 REVISED  SCHEDULES.  UCFI shall have provided CryoLife with revised
Schedules  dated as of the  Closing  Date (the  "Revised  Schedules"),  with all
material changes through such date duly noted thereon, and the Revised Schedules
will not contain any disclosures which set forth changes which in the opinion of
CryoLife,  individually  or in the  aggregate,  have  or may  have a  Materially
Adverse  Effect on UCFI  and/or its  operations,  unless  such  disclosures  are
approved in writing by CryoLife.

         7.9 LEGALITY. No federal or state statute, rule, regulation,  executive
order,  decree or injunction  shall have been enacted,  entered,  promulgated or
enforced by any court or  governmental  authority which is in effect and has the
effect of making the  transactions  contemplated  hereby  illegal  or  otherwise
prohibiting the consummation of the transactions contemplated hereby.

         7.10  REGULATORY  MATTERS.  All  filings  shall  have been made and all
approvals  shall have been  obtained  as may be  legally  required  pursuant  to
federal  and  state  laws  prior  to  the   consummation  of  the   transactions
contemplated by this Agreement and all actions,  by or in respect of, or filings
with,  any  governmental  body,  agency or  official or any other  person  which
require action on the part of or the cooperation  and/or  participation  of UCFI
and  which  are  required  to  permit  the   consummation  of  the  transactions
contemplated  by this  Agreement so that  CryoLife  shall be able to continue to
carry on the business of UCFI  substantially in the manner now conducted by UCFI
shall have been taken or made.

         7.11 BLUE SKY. All blue sky permits or approvals  required to carry out
the transactions contemplated hereby shall have been received.

         7.12 REPAYMENT OF DEBTS. At the Closing, all officers,  directors,  and
Members  of UCFI  and the QV  Employees  shall  repay  in full  any  outstanding
indebtedness owed to UCFI by them.

         7.13 FURNITURE. UCFI shall have acquired all right, title, and interest
in and to the Furniture as contemplated by Section 3.15.



378486.1

                                      -30-





                                    ARTICLE 8
                        CONDITIONS TO UCFI'S OBLIGATIONS

         Each and every  obligation of UCFI under this Agreement to be performed
on or prior to the Closing shall be subject to the  fulfillment,  on or prior to
the Closing, of each of the following conditions:

         8.1 REPRESENTATIONS AND WARRANTIES TRUE AT CLOSING. The representations
and warranties made by CryoLife in or pursuant to this Agreement or given on its
behalf  hereunder  shall be true and correct on and as of the Closing  Date with
the same effect as though such  representations  and warranties had been made or
given on and as of the Closing Date.

         8.2 OBLIGATIONS  PERFORMED.  CryoLife shall have performed and complied
with all of its  respective  obligations  under this  Agreement  which are to be
performed or complied with by it prior to or at the Closing.

         8.3 CLOSING DELIVERIES.  CryoLife shall have delivered to UCFI, each of
the  following,  together with any  additional  items which UCFI may  reasonably
request to effect the transactions contemplated herein:

             (a) the  cash and  Promissory  Note,  duly  executed  by  CryoLife,
representing the Cash Consideration due to UCFI;

             (b)  certified  copies of the  corporate  resolutions  of  CryoLife
authorizing the transactions contemplated hereby and the execution, delivery and
performance of this Agreement and the Asset  Purchase  Transaction  Documents to
which  CryoLife is a signatory by CryoLife,  and  incumbency  certificates  with
respect to the officers of CryoLife executing documents or instruments on behalf
of CryoLife;

             (c) a certificate of the President of CryoLife certifying as to the
matters set forth in Sections 8.1 and 8.2 hereof and as to the  satisfaction  of
all other conditions set forth in this Article 8;

             (d) the  Assignment  and  Assumption  Agreement and  Assignment and
Assumption of Sublease duly executed by CryoLife and such additional instruments
of sale, transfer, conveyance, and assignment as counsel to CryoLife and counsel
to UCFI shall mutually deem necessary or appropriate;

             (e) the  Procurement  Agreements  referred to in Section  3.12 duly
executed by CryoLife;

             (f) the Employee Leasing Agreement  referred to in Section 3.1 duly
executed by CryoLife;


378486.1

                                      -31-






             (g) the  Distribution  Agreement  referred to in Section  3.14 duly
executed by CryoLife;

             (h) any other  documents or agreements  contemplated  hereby and/or
necessary or appropriate to consummate the transactions contemplated hereby; and

             (i) an opinion of counsel of CryoLife  substantially in the form of
Exhibit 8.3(i).

         8.4 NO CHALLENGE.  There shall not be pending or threatened any action,
proceeding or  investigation  before any court or  administrative  agency by any
government  agency or any pending  action by any other person,  challenging,  or
seeking  material damages in connection with, the acquisition by CryoLife of the
Assets  pursuant  to this  Agreement  or the  ability of  CryoLife or any of its
affiliates  to own and  operate  the Assets or  otherwise  materially  adversely
affecting the business,  assets,  prospects,  financial  condition or results of
operations of CryoLife.

         8.5 NO MATERIAL  ADVERSE EFFECT.  Since June 30, 1996, there shall have
been no Material Adverse Effect in the business, financial condition, results of
operations and/or assets of CryoLife, whether reflected in financial statements,
the schedules hereto or otherwise.

         8.6 LEGALITY. No federal or state statute, rule, regulation,  executive
order,  decree or injunction  shall have been enacted,  entered,  promulgated or
enforced by any court or  governmental  authority which is in effect and has the
effect of making the  transactions  contemplated  hereby  illegal  or  otherwise
prohibiting the consummation of the transactions contemplated hereby.

         8.7  REGULATORY  MATTERS.  All  filings  shall  have  been made and all
approvals  shall have been  obtained  as may be  legally  required  pursuant  to
federal  and  state  laws  prior  to  the   consummation  of  the   transactions
contemplated by this Agreement and all actions,  by or in respect of, or filings
with,  any  governmental  body,  agency or  official or any other  person  which
require  action  on the  part  of or the  cooperation  and/or  participation  of
CryoLife and which are required to permit the  consummation of the  transactions
contemplated  by this  Agreement so that  CryoLife  shall be able to continue to
carry on the business of UCFI  substantially in the manner now conducted by UCFI
shall have been taken or made.

         8.8 BLUE SKY. All blue sky permits or  approvals  required to carry out
the transactions contemplated hereby shall have been received.



378486.1

                                      -32-





                                    ARTICLE 9
                                   TERMINATION

         9.1  TERMINATION.  This  Agreement may be terminated at any time before
the Closing Date:

             (a) by mutual written consent of CryoLife and UCFI;

             (b) by  CryoLife  if there  occurs a  substantial  loss,  damage or
diminution of Assets or other Material Adverse Effect on the business of UCFI or
arising  from any  cause  including  theft,  fire,  flood or act of God prior to
Closing;

             (c) by any  nonbreaching  party hereto if there has been a material
breach of any representation,  warranty, covenant or agreement contained in this
Agreement on the part of any nonterminating party hereto; or

             (d) by either CryoLife or UCFI if the Closing is not consummated on
or before September 15, 1996.

         9.2 EFFECTS OF  TERMINATION.  In the event this Agreement is terminated
pursuant to Section 9.1(a) or 9.1(d) above,  no party shall have any obligations
to  the  others   hereunder   except  for  those   obligations   in  respect  to
confidentiality and the return of confidential  information set forth in Section
3.3 hereof.  If this  Agreement  is  terminated  pursuant  to Section  9.1(b) or
9.1(c),  the  obligations  in  respect  to  confidentiality  and the  return  of
confidential  information set forth in Section 3.3 hereof shall remain in effect
and each party  hereto may  exercise  all  remedies  available  to it under this
Agreement, at law or in equity.

                                   ARTICLE 10
                            MISCELLANEOUS PROVISIONS

         10.1 RISK OF LOSS.  The risk of loss prior to the Closing Date shall be
with UCFI.  In the event a material  portion of the Assets or the  operations of
the business of UCFI shall have been materially  damaged or otherwise  adversely
affected as a result of any strike,  accident or other casualty or act of God or
the public enemy, or any judicial,  administrative or governmental proceeding at
such time as UCFI  proposed to close,  then  CryoLife  shall have the options of
either (a)  proceeding to close with an  assignment  of any  insurance  proceeds
which  may be paid to  reflect  such loss or  damage,  or (b)  terminating  this
Agreement without further liability to UCFI.



378486.1

                                      -33-





         10.2  SEVERABILITY  AND  OPERATIONS  OF LAW. If any  provision  of this
Agreement is prohibited by the laws of any  jurisdiction  as those laws apply to
this  Agreement,  that  provision  shall be  ineffective  to the  extent of such
prohibition  and/or  shall be  modified  to  conform  with  such  laws,  without
invalidating the remaining provisions hereto.

         10.3 MODIFICATION. This Agreement may not be changed or modified except
in writing  specifically  referring to this  Agreement and signed by each of the
parties hereto.

         10.4 ASSIGNMENT, SURVIVAL AND BINDING AGREEMENT. This Agreement and the
Asset Purchase Transaction Documents may not be assigned (a) by CryoLife, except
to a wholly  owned  subsidiary  of  CryoLife,  in  which  event  CryoLife  shall
guarantee the payment and  performance of such  subsidiary  under the Promissory
Note on terms  acceptable  to UCFI,  or (b) by UCFI or the Members,  without the
prior written consent of CryoLife, provided UCFI may assign its rights under the
Promissory Note to any of its Members by providing notice thereof to CryoLife in
writing.  The terms and conditions  hereof shall survive the Closing as provided
herein and shall inure to the benefit of and be binding upon the parties  hereto
and their respective successors and assigns.

         10.5  COUNTERPARTS.  This  Agreement  may be  executed  in one or  more
counterparts,  each of  which  shall be  deemed  an  original,  but all of which
together shall constitute one and the same instrument.

         10.6  NOTICES.  All  notices,  requests,   demands,  claims  and  other
communications  hereunder  will be in writing  and shall be deemed duly given if
personally  delivered,  sent by telefax, sent by a recognized overnight delivery
service which guarantees next day delivery  ("Overnight  Delivery") or mailed by
registered or certified  mail,  return receipt  requested,  postage  prepaid and
addressed to the intended recipient as set forth below.

             If to UCFI, UTF or QV:             QV, Inc.
                                                322 South Green Street
                                                Suite 500
                                                Chicago, Illinois 60607
                                                Attention:  President
                                                Telefax: (312) 697-8477

             with a copy to:                    Katten Muchin & Zavis
                                                525 West Monroe Street
                                                Suite 1600
                                                Chicago, Illinois 60661
                                                Attention:  Mr. Steven R. Olsen
                                                Telefax: (312) 902-1061



378486.1

                                      -34-





             If to CryoLife:                    Mr. Steven G. Anderson
                                                Chairman of the Board, 
                                                Chief Executive Officer
                                                and President
                                                CryoLife, Inc.
                                                2211 New Market Parkway 
                                                Suite 142
                                                Marietta, Georgia 30067
                                                Telefax:  (770) 850-0762

             with a copy to:                    Arnall Golden & Gregory
                                                2800 One Atlantic Center
                                                1201 West Peachtree Street
                                                Atlanta, Georgia  30309-3400
                                                Attention:  Ms. M. Nan King
                                                Telefax:  (404) 873-8775

or at such other address as any party hereto  notifies the other parties  hereof
in writing.  The parties hereto agree that notices or other  communications that
are sent in  accordance  herewith (i) by personal  delivery or telefax,  will be
deemed  received on the business day sent, (ii) by Overnight  Delivery,  will be
deemed received the business day immediately  following the date sent, and (iii)
by U.S. mail, will be deemed received three business days immediately  following
the date sent.  For  purposes of this  Agreement,  a "business  day" is a day on
which  CryoLife is open for  business and shall not include a Saturday or Sunday
or legal holiday. Notwithstanding anything to the contrary in this Agreement, no
action  shall be required of CryoLife or UCFI except on a business  day,  and in
the event an action is  required  on a day  which is not a  business  day,  such
action shall be required to be performed on the next  succeeding  day which is a
business day.

         10.7 ENTIRE AGREEMENT;  NO THIRD PARTY  BENEFICIARIES.  This Agreement,
together with the Exhibits and Schedules attached hereto, constitutes the entire
agreement and  supersedes any and all other prior  agreements and  undertakings,
both written and oral,  among the parties,  or any of them,  with respect to the
subject matter hereof and, except as otherwise expressly provided herein, is not
intended to confer upon any person other than  CryoLife and UCFI,  any rights or
remedies hereunder.

         10.8 FURTHER ASSURANCES. The parties to this Agreement agree to execute
and/or  deliver,  either  before or after  Closing,  any  further  documents  or
agreements contemplated hereby and/or necessary or appropriate to effectuate and
consummate  the  transactions  contemplated  hereby.  UCFI  agrees to provide to
CryoLife,  both before and after the Closing,  such  information as CryoLife may
reasonably request in order to consummate the transactions  contemplated  hereby
and to effect an orderly transition following Closing.



378486.1

                                      -35-





         10.9 ARBITRATION.

             (a) SUBMISSION TO ARBITRATION.  If any dispute or difference  shall
arise between the parties to this Agreement,  as to the  interpretation  of this
Agreement or any covenants or conditions of this  Agreement or as to the rights,
duties,  or liabilities of any party under this Agreement as to any act, matter,
or thing arising out of or under or relating to this  Agreement,  the same shall
be finally  settled by arbitration  conducted in accordance  with the Commercial
Arbitration  Rules (the "Rules") and  Supplementary  Procedures  for  Commercial
Arbitration  (the  "Supplementary   Procedures")  of  the  American  Arbitration
Association,  in effect the date  hereof.  Whenever  any  dispute,  controversy,
claim,  or difference  which may be submitted to arbitration  under this Section
10.9 arises  between the  parties,  either party hereby may give the other party
notice  of  its  intention  to  submit  such  dispute,  controversy,  claim,  or
difference  to  arbitration.  Such  arbitration  shall  take  place in  Atlanta,
Georgia,  before three arbitrators,  with one arbitrator  selected by each party
and the third arbitrator  mutually agreed upon by the parties.  In the event the
parties  cannot  agree  upon the  third  arbitrator  within  20 days  after  the
effective date of receipt, as provided in Section 10.6, of either party's notice
to  arbitrate,   the  third  arbitrator  shall  be  appointed  by  the  American
Arbitration   Association  in  accordance  with  the  Rules  and   Supplementary
Procedures.  It is expressly  agreed between the parties that whether or not the
Rules of the  American  Arbitration  Association  shall  provide for a discovery
procedure,  such discovery procedure is hereby granted and permitted in the said
arbitration  proceedings,  the  parties  may  apply to the  arbitrators  for the
enforcement  of any form of  discovery  which would be  permitted by the laws of
Georgia, and their award or decision in respect of such discovery shall be final
and binding.

             (b)  COSTS;  BINDING.  The  parties  agree  that each  party to the
arbitration  is to pay an  equal  part  of the  deposit  fixed  by the  American
Arbitration   Association  or  the  arbitrators.   The  determinations  of  such
arbitrators will be final and binding upon the parties to the  arbitration,  and
judgment upon the award rendered by the  arbitrators may be entered in any court
having  jurisdiction,  or  application  may be made to such court for a judicial
acceptance  of the award and an order of  enforcement,  as the case may be.  The
arbitrators shall set forth the grounds for their decision in the award.

             (c)  CONDITION   PRECEDENT.   The  parties  hereto  stipulate  that
submission  of disputes to  arbitration  as  provided in this  Section  10.9 and
arbitration pursuant thereto shall be a condition precedent to any suit, action,
or proceeding instituted in any court or before any administrative tribunal with
respect  to  this  Agreement  or  disputes  arising  out  of or  regarding  this
Agreement;  provided,  however,  notwithstanding  the foregoing,  a party hereto
shall  not be  required  to  satisfy  such  condition  precedent  requiring  the
submission  of all  disputes  between the parties to  arbitration  if such party
seeks,  a  restraining  order,  injunction,  or similar  remedy to  specifically
enforce the confidentiality,  non-competition, or non-solicitation provisions of
this Agreement or any Asset Purchase Transaction Document.



378486.1

                                      -36-





         IN WITNESS WHEREOF,  the parties have executed this Agreement as of the
day and year set forth above.

                                       "CryoLife":

                                       CryoLife, Inc.


                                        By:/s/ Steven G. Anderson
                                           ------------------------------------
                                           Steven G. Anderson
                                           Chairman of the Board,
                                           Chief Executive Officer and President

                                        "UCFI":

                                        UNITED CRYOPRESERVATION
                                        FOUNDATION, INC.


                                        By:/s/ Daniel Woods
                                           ------------------------------------
                                           Daniel Woods
                                           Title: Vice President/General Manager


                                        "UTF":

                                        UNITED TRANSPLANT FOUNDATION,
                                        INC.


                                        By:/s/ Jerold Anderson
                                           ------------------------------------
                                           Jerold Anderson
                                           Title:  President

  
                                        "QV":

                                        QV, INC.


                                         By:/s/ Daniel Woods
                                            -----------------------------------
                                            Daniel Woods
                                            Title:  Vice President



378486.1

                                      -37-




                         LIST OF SCHEDULES AND EXHIBITS


*Schedule 1.1(b)        Fixed Assets
*Schedule 1.2           Excluded Items
*Schedule 2.4           Allocation of Asset Consideration
*Schedule 3.1           List of Employees Subleased from QV, Inc.
*Schedule 3.2           Consents
*Schedule 4.1           States in which UCFI is Qualified to do business
*Schedule 4.2           List of Members, Officers and Directors
*Schedule 4.6           Licenses and Permits
*Schedule 4.7           Certain Liabilities and Obligations
*Schedule 4.9           List of Deposits
*Schedule 4.10(a)       Trade Payables as of Date of Agreement
*Schedule 4.10(c)       Indebtedness
*Schedule 4.13          Processed Tissue
*Schedule 4.14          Intellectual Property
*Schedule 4.15          Contracts
*Schedule 4.19          Insurance
*Schedule 4.24          Material Changes since 6/30/95
*Schedule 4.25          Bank Accounts

*Exhibit 2.2            Form of Promissory Note
*Exhibit 2.3(a)(i)      Form of Assignment and Assumption of Sublease 
*Exhibit 2.3(a)(ii)     Form of Assignment and Assumption  Agreement 
*Exhibit 3.1            Form of Employee  Leasing  Agreement  
*Exhibit 3.2            Form of Consent  
*Exhibit 3.4            Form of Noncompetition Agreement 
*Exhibit 3.10           Form of Press Release 
*Exhibit 3.12           Form of Procurement  Agreements  
*Exhibit  3.14          Form of Distribution  Agreement  
*Exhibit 3.16(a)        Form of License  Agreement  
*Exhibit 3.16(b)        Form of Agreement Regarding Services 
                        and Related Matters 
*Exhibit 7.4(b)         Form of Bill of Sale 
*Exhibit 7.4(g)         Form of Opinion of UCFI's  Counsel  
*Exhibit 8.3(i)         Form of Opinion of CryoLife's Counsel

* Indicates Schedules and Exhibits which have been omitted from this filing. The
Registrant  hereby  agrees to furnish to the  Commission  a copy of any  omitted
Schedules and Exhibits listed above supplementally upon request.

                                   EXHIBIT 10.1

                            NONCOMPETITION AGREEMENT

                        
         This  NONCOMPETITION  AGREEMENT (the  "Agreement") is entered into this
11th day of September, 1996, by and between United Cryopreservation  Foundation,
Inc., a non-profit Illinois corporation ("UCFI"), and CryoLife,  Inc., a Florida
corporation ("CryoLife").

                              W I T N E S S E T H:

         WHEREAS,  pursuant  to  that  certain  Asset  Purchase  Agreement  (the
"Purchase  Agreement") dated as of September 11, 1996, by and among CryoLife and
UCFI, CryoLife has agreed to purchase and UCFI has agreed to sell, substantially
all of the assets of UCFI;

         WHEREAS, United Transplant Foundation, Inc. ("UTF") and QV, Inc. ("QV")
are the sole members of UCFI;

         WHEREAS,  in order to induce  CryoLife to enter into and consummate the
Purchase  Agreement,  UCFI,  UTF,  and QV have each  agreed  to  accept  certain
restrictions as set forth herein and in those certain Non-Competition Agreements
of even date herewith between CryoLife and UTF and between CryoLife and QV.

         NOW, THEREFORE, in consideration of the mutual covenants and agreements
of the parties herein contained, and other good and valuable consideration,  the
receipt and  sufficiency  of which are hereby  acknowledged,  the parties hereto
agree as follows:

         1.  DEFINITIONS.   The  following   definitions  shall  apply  to  this
Agreement:

             (a)  "Company   Business"   means  the   business  of   processing,
preserving,  and/or distributing cryopreserved heart valves, saphenous veins, or
femoral veins for implantation in humans. Company Business shall not include any
other  business  activities,  including,  without  limitation,  the  processing,
procuring  and/or  distributing  of bone  or any  tissue  or  organ  other  than
cryopreserved  heart valves,  saphenous veins, or femoral veins for implantation
in humans.

             (b) "Competing Business" means any person,  concern, or entity that
is engaged  in or  conducts a  business  substantially  the same as the  Company
Business.

             (c)  "Territory"  means Arizona,  Arkansas,  California,  Colorado,
Illinois,  Indiana,  Kentucky,  Louisiana,  Missouri,  New York, North Carolina,
Pennsylvania,   Tennessee,   Texas,  and  Virginia,  which  the  parties  hereby
acknowledge  to be the  geographic  area in  which  UCFI  conducts  the  Company
Business on the date of this Agreement.


378489.1






             (d) "Trade Secrets" means  information  including,  but not limited
to, technical and nontechnical data, formulas, patterns, compilations, programs,
devices, methods,  techniques,  drawings,  processes,  financial data, financial
plans, product plans, pricing information,  marketing information,  and lists of
actual or potential  customers or suppliers  which (1) derives  economic  value,
actual or potential,  from not being generally known to or readily ascertainable
by  proper  means  by other  persons  who can  obtain  economic  value  from its
disclosure or use; and (2) is the subject of efforts that are  reasonable  under
the circumstances to maintain its secrecy.

         2. COVENANTS OF THE SELLER.  UCFI  acknowledges  that, by virtue of the
special knowledge of the affairs, business, customers, suppliers and vendors and
the  operations  of the Company  Business that UCFI has,  CryoLife  would suffer
substantial  damage  if UCFI  breaches  or  violates  any of the  covenants  and
agreements  set  forth in this  Section  2.  Therefore,  UCFI has  agreed to the
following covenants and agreements:

             (a) UCFI  covenants  that it shall not,  for a period of five years
from and  after the date  hereof  (the  "Noncompetition  Period"),  directly  or
indirectly,  in the  Territory,  for its own  account  or as an owner,  partner,
member, stockholder, joint venturer, investor, lender, or in any other capacity,
own,  engage in,  conduct,  manage,  operate  or  participate  in any  Competing
Business.

             (b) During the  Noncompetition  Period,  UCFI  covenants and agrees
that it will not, directly or indirectly, on its own behalf or in the service or
on behalf of others,  solicit, divert or appropriate to a Competing Business, or
attempt to solicit,  divert or appropriate to or for any Competing Business, any
persons and/or  entities who were customers of UCFI in the Territory on the date
immediately preceding the date of this Agreement, or any person and/or entity in
the Territory to whom UCFI has sold or provided any products or services  during
the 12 month period immediately preceding the date of this Agreement.

             (c) During the  Noncompetition  Period,  UCFI  covenants and agrees
that it will not, directly or indirectly, on its own behalf or in the service or
on behalf of others,  hire or attempt to hire any  employee of  CryoLife,  or to
cause any such  employee  to leave his or her  employment,  in order to  perform
services in the Territory for a Competing Business.

         3. SEVERABILITY.  Each provision of this Agreement is severable, and if
any one of such  provisions  shall be reformed or declared  unenforceable,  such
reformation or declaration  shall not affect the  enforceability  or validity of
any other  provision  thereof.  Each  provision  thereof shall be enforceable by
CryoLife or any  successor  thereof  against UCFI  notwithstanding  any claim or
cause of action asserted by UCFI against CryoLife or any successor thereof.  The
existence  of any  claim,  demand,  action,  or cause of action of UCFI  against
CryoLife shall not constitute a defense to the enforcement by CryoLife of any of
the covenants contained herein.



378489.1

                                                      -2-





         4.   REFORMATION  BY  COURT.  In  the  event  any  court  of  competent
jurisdiction  should  determine  that  any of the  terms of this  Agreement  are
unreasonable  or  unenforceable  in  scope,  UCFI and  CryoLife  consent  to the
exercise  by such court of its  equitable  jurisdiction  to reform such terms in
accordance with applicable law.

         5.  REMEDIES.  UCFI agrees that if it breaches  any  provision  of this
Agreement,  the damage to CryoLife  would be difficult to  ascertain,  and money
damages would not afford CryoLife an adequate remedy.  Therefore,  if UCFI is in
breach of this Agreement, the parties hereto agree that CryoLife is entitled, in
addition  to any and all rights and  remedies  as would be  provided  by law, to
specific  performance,  injunctive,  and other  equitable  relief to  prevent or
restrain a breach of this  Agreement.  In addition,  the parties agree that this
Agreement  constitutes  an Asset Purchase  Transaction  Document as such term is
defined in the Purchase  Agreement.  The rights of CryoLife under this Agreement
shall survive the  expiration of the  Noncompetition  Period and are in addition
to, and not in lieu of, any and all rights CryoLife may have at law or in equity
to protect  its  business  interests.  UCFI  agrees to be liable for any and all
costs and expenses,  including attorneys fees, resulting from the breach by UCFI
of any provision of this Agreement.

         6.  CONFIDENTIAL  INFORMATION.  UCFI  covenants  and  agrees  that  all
confidential and proprietary  information  developed,  utilized,  or received by
UCFI  relating to the  operation  of the  Company  Business by UCFI prior to the
Closing of the Purchase  Agreement,  including,  without  limitation,  all Trade
Secrets and all  information  which has been  disclosed to UCFI by a third party
and  which  UCFI  has  treated  as  confidential  (collectively,   "Confidential
Information"),  and all physical  embodiments  thereof,  has been transferred to
CryoLife  pursuant to the Purchase  Agreement.  UCFI will hold such Confidential
Information  in trust and  strictest  confidence,  and will not use,  reproduce,
distribute,  disclose or otherwise disseminate the Confidential Information. The
confidentiality  requirements and use  restrictions  contained in this Section 6
shall survive any  termination  of this Agreement but shall not apply (i) to any
Confidential  Information  that falls into the public domain through no fault of
UCFI or (ii) to any Confidential  Information which is not a Trade Secret when a
period of five years has expired following the execution of this Agreement.

         All records, notes, files, memoranda,  reports,  marketing information,
price lists, supplier lists and information,  documents, and all copies and like
items  relating to the Trade  Secrets which shall be disclosed to or which shall
come into the  possession of UCFI during or prior to the  Noncompetition  Period
shall be the sole and exclusive  property of CryoLife.  UCFI agrees that, at any
time upon request,  it will  promptly  deliver to CryoLife the originals and all
copies of any of the foregoing that are in its possession, custody or control.

         7. AMENDMENTS.  No amendment or modification of this Agreement shall be
valid or binding  upon  CryoLife  unless  made in  writing  and signed by a duly
authorized officer of CryoLife,  or upon UCFI, unless made in writing and signed
by UCFI.



378489.1

                                       -3-





         8. ASSIGNMENT.  This Agreement may not be assigned by any party without
the prior written consent of the other party hereto,  provided that CryoLife may
assign  this  Agreement  in whole or in part to one or more  affiliates  thereof
without the consent of UCFI.

         9.       NOTICES.

                  (a) Any and all  notices or other  communications  required or
permitted to be given under any of the provisions of this Agreement  shall be in
writing  and  shall be  deemed  to have  been  duly  given  when (i)  personally
delivered or sent by a recognized  overnight  delivery  service which guarantees
next  day  delivery  ("Overnight  Delivery"),   (ii)  transmitted  by  facsimile
transmission  (with a copy sent first class registered or certified mail, return
receipt requested and postage prepaid or by Overnight Delivery), or (iii) mailed
by first class registered or certified mail, return receipt  requested,  postage
prepaid,  transmitted  or  addressed to the parties at the  addresses  set forth
below:

                  If to UCFI:              QV, Inc.
                                           322 South Green Street
                                           Suite 500
                                           Chicago, Illinois 60607
                                           Attention:  President
                                           Telefax: (312) 697-8477

                  with a copy to:          Katten Muchin & Zavis
                                           525 West Monroe Street
                                           Suite 1600
                                           Chicago, Illinois 60661
                                           Attention:  Mr. Steven R. Olsen
                                           Telefax: (312) 902-1061

                  If to CryoLife:          Mr. Steven G. Anderson
                                           Chairman of the Board, Chief 
                                           Executive Officer and President
                                           CryoLife, Inc.
                                           2211 New Market Parkway, Suite 142
                                           Marietta, Georgia 30067
                                           Telefax:  (770) 850-0762

                  with a copy to:          Arnall Golden & Gregory
                                           2800 One Atlantic Center
                                           1201 West Peachtree Street
                                           Atlanta, Georgia  30309-3400
                                           Attention:  Ms. M. Nan King
                                           Telefax:  (404) 873-8775



378489.1

                                       -4-




             (b)  All  notices  shall  be  deemed  received  (i)  if  personally
delivered or transmitted by facsimile,  on the business day when so delivered or
transmitted or if not transmitted at a time which concludes  during the business
day of the  recipient,  on the next  succeeding  business  day,  (ii) if sent by
Overnight  Delivery,  one business day after it is sent and (iii) if mailed,  48
hours after  deposit in the United  States mail,  as first class  registered  or
certified mail, return receipt  requested,  postage  pre-paid.  Either party may
change its address for the  purposes of this Section by giving not less than ten
days  prior  written  notice of such  change to the  other  party in the  manner
provided in this Section.

         10.  COUNTERPARTS.  This  Agreement  may be  executed  in  two or  more
counterparts,  each of  which  shall be  deemed  an  original,  but all of which
together shall constitute one and the same instrument.

         IN WITNESS WHEREOF, the parties hereto,  intending to be legally bound,
have executed and delivered this Agreement as of the date set forth above.

                                        UCFI:

                                        UNITED CRYOPRESERVATION
                                        FOUNDATION, INC.


                                         By:/s/ Daniel Woods
                                         -------------------
                                                Daniel Woods
                                         Title: Vice President/General Manager


                                         CRYOLIFE, INC.


                                          By:/s/ Steven G. Anderson
                                          -------------------------
                                                 Steven G. Anderson
                                                 Chairman of the Board
                                                 Chief Executive Officer 
                                                 and President





378489.1




                                      -5-
                                  EXHIBIT 10.2


                            NONCOMPETITION AGREEMENT


         This  NONCOMPETITION  AGREEMENT (the  "Agreement") is entered into this
11th day of September, 1996, by and between United Transplant Foundation,  Inc.,
a  non-profit  Illinois  corporation  ("UTF"),  and  CryoLife,  Inc.,  a Florida
corporation ("CryoLife").

                              W I T N E S S E T H:

         WHEREAS,  pursuant  to  that  certain  Asset  Purchase  Agreement  (the
"Purchase  Agreement") dated as of September 11, 1996, by and among CryoLife and
United  Cryopreservation  Foundation,  Inc.  ("UCFI"),  CryoLife  has  agreed to
purchase and UCFI has agreed to sell, substantially all of the assets of UCFI;

         WHEREAS, UTF and QV, Inc. ("QV") are the sole members of UTF;

         WHEREAS,  in order to induce  CryoLife to enter into and consummate the
Purchase  Agreement,  UCFI,  UTF,  and QV have each  agreed  to  accept  certain
restrictions as set forth herein and in those certain Non-Competition Agreements
of even date herewith between CryoLife and UCFI and between CryoLife and QV.

         NOW, THEREFORE, in consideration of the mutual covenants and agreements
of the parties herein contained, and other good and valuable consideration,  the
receipt and  sufficiency  of which are hereby  acknowledged,  the parties hereto
agree as follows:

         1.  DEFINITIONS.   The  following   definitions  shall  apply  to  this
Agreement:

             (a)  "Company   Business"   means  the   business  of   processing,
preserving,  and/or distributing cryopreserved heart valves, saphenous veins, or
femoral veins for implantation in humans. Company Business shall not include any
other  business  activities,  including,  without  limitation,  the  processing,
procuring  and/or  distributing  of bone  or any  tissue  or  organ  other  than
cryopreserved  heart valves,  saphenous veins, or femoral veins for implantation
in humans.

             (b) "Competing Business" means any person,  concern, or entity that
is engaged  in or  conducts a  business  substantially  the same as the  Company
Business.

             (c)  "Territory"  means Arizona,  Arkansas,  California,  Colorado,
Illinois,  Indiana,  Kentucky,  Louisiana,  Missouri,  New York, North Carolina,
Pennsylvania,   Tennessee,   Texas,  and  Virginia,  which  the  parties  hereby
acknowledge  to be the  geographic  area in  which  UCFI  conducts  the  Company
Business on the date of this Agreement.



378497.1





             (d) "Trade Secrets" means  information  including,  but not limited
to, technical and nontechnical data, formulas, patterns, compilations, programs,
devices, methods,  techniques,  drawings,  processes,  financial data, financial
plans, product plans, pricing information,  marketing information,  and lists of
actual or potential  customers or suppliers  which (1) derives  economic  value,
actual or potential,  from not being generally known to or readily ascertainable
by  proper  means  by other  persons  who can  obtain  economic  value  from its
disclosure or use; and (2) is the subject of efforts that are  reasonable  under
the circumstances to maintain its secrecy.

         2.  COVENANTS OF THE SELLER.  UTF  acknowledges  that, by virtue of the
special knowledge of the affairs, business, customers, suppliers and vendors and
the  operations  of the Company  Business  that UTF has,  CryoLife  would suffer
substantial  damage  if UTF  breaches  or  violates  any of  the  covenants  and
agreements  set  forth in this  Section  2.  Therefore,  UTF has  agreed  to the
following covenants and agreements:

             (a) UTF  covenants  that it shall  not,  for a period of five years
from and  after the date  hereof  (the  "Noncompetition  Period"),  directly  or
indirectly,  in the  Territory,  for its own  account  or as an owner,  partner,
member, stockholder, joint venturer, investor, lender, or in any other capacity,
own,  engage in,  conduct,  manage,  operate  or  participate  in any  Competing
Business.

             (b) During the Noncompetition Period, UTF covenants and agrees that
it will not,  directly or indirectly,  on its own behalf or in the service or on
behalf of others,  solicit,  divert or appropriate to a Competing  Business,  or
attempt to solicit,  divert or appropriate to or for any Competing Business, any
persons and/or  entities who were customers of UCFI in the Territory on the date
immediately preceding the date of this Agreement, or any person and/or entity in
the Territory to whom UCFI has sold or provided any products or services  during
the 12 month period immediately preceding the date of this Agreement.

             (c) During the Noncompetition Period, UTF covenants and agrees that
it will not,  directly or indirectly,  on its own behalf or in the service or on
behalf of others, hire or attempt to hire any employee of CryoLife,  or to cause
any such employee to leave his or her employment,  in order to perform  services
in the Territory for a Competing Business.

         3. SEVERABILITY.  Each provision of this Agreement is severable, and if
any one of such  provisions  shall be reformed or declared  unenforceable,  such
reformation or declaration  shall not affect the  enforceability  or validity of
any other  provision  thereof.  Each  provision  thereof shall be enforceable by
CryoLife or any successor thereof against UTF notwithstanding any claim or cause
of action  asserted  by UTF  against  CryoLife  or any  successor  thereof.  The
existence  of any  claim,  demand,  action,  or cause of action  of UTF  against
CryoLife shall not constitute a defense to the enforcement by CryoLife of any of
the covenants contained herein.



378497.1

                                       -2-





         4.   REFORMATION  BY  COURT.  In  the  event  any  court  of  competent
jurisdiction  should  determine  that  any of the  terms of this  Agreement  are
unreasonable or unenforceable in scope, UTF and CryoLife consent to the exercise
by such court of its equitable  jurisdiction  to reform such terms in accordance
with applicable law.

         5.  REMEDIES.  UTF agrees that if it  breaches  any  provision  of this
Agreement,  the damage to CryoLife  would be difficult to  ascertain,  and money
damages would not afford CryoLife an adequate  remedy.  Therefore,  if UTF is in
breach of this Agreement, the parties hereto agree that CryoLife is entitled, in
addition  to any and all rights and  remedies  as would be  provided  by law, to
specific  performance,  injunctive,  and other  equitable  relief to  prevent or
restrain a breach of this  Agreement.  In addition,  the parties agree that this
Agreement  constitutes  an Asset Purchase  Transaction  Document as such term is
defined in the Purchase  Agreement.  The rights of CryoLife under this Agreement
shall survive the  expiration of the  Noncompetition  Period and are in addition
to, and not in lieu of, any and all rights CryoLife may have at law or in equity
to protect its business interests. UTF agrees to be liable for any and all costs
and expenses,  including attorneys fees, resulting from the breach by UTF of any
provision of this Agreement.

         6.  CONFIDENTIAL  INFORMATION.   UTF  covenants  and  agrees  that  all
confidential and proprietary information developed, utilized, or received by UTF
relating to the  operation of the Company  Business by UCFI prior to the Closing
of the Purchase Agreement,  including, without limitation, all Trade Secrets and
all information which has been disclosed to UCFI by a third party and which UCFI
has treated as confidential (collectively,  "Confidential Information"), and all
physical  embodiments  thereof, has been transferred to CryoLife pursuant to the
Purchase  Agreement.  UTF will hold such  Confidential  Information in trust and
strictest  confidence,  and will not use,  reproduce,  distribute,  disclose  or
otherwise   disseminate  the  Confidential   Information.   The  confidentiality
requirements and use restrictions  contained in this Section 6 shall survive any
termination  of this  Agreement  but shall  not  apply  (i) to any  Confidential
Information that falls into the public domain through no fault of UTF or (ii) to
any Confidential  Information  which is not a Trade Secret when a period of five
years has expired following the execution of this Agreement.

         All records, notes, files, memoranda,  reports,  marketing information,
price lists, supplier lists and information,  documents, and all copies and like
items  relating to the Trade  Secrets which shall be disclosed to or which shall
come into the  possession  of UTF during or prior to the  Noncompetition  Period
shall be the sole and  exclusive  property of CryoLife.  UTF agrees that, at any
time upon request,  it will  promptly  deliver to CryoLife the originals and all
copies of any of the foregoing that are in its possession, custody or control.

         7. AMENDMENTS.  No amendment or modification of this Agreement shall be
valid or binding  upon  CryoLife  unless  made in  writing  and signed by a duly
authorized  officer of CryoLife,  or upon UTF, unless made in writing and signed
by UTF.



378497.1

                                       -3-





         8. ASSIGNMENT.  This Agreement may not be assigned by any party without
the prior written consent of the other party hereto,  provided that CryoLife may
assign  this  Agreement  in whole or in part to one or more  affiliates  thereof
without the consent of UTF.

         9.       NOTICES.

                  (a) Any and all  notices or other  communications  required or
permitted to be given under any of the provisions of this Agreement  shall be in
writing  and  shall be  deemed  to have  been  duly  given  when (i)  personally
delivered or sent by a recognized  overnight  delivery  service which guarantees
next  day  delivery  ("Overnight  Delivery"),   (ii)  transmitted  by  facsimile
transmission  (with a copy sent first class registered or certified mail, return
receipt requested and postage prepaid or by Overnight Delivery), or (iii) mailed
by first class registered or certified mail, return receipt  requested,  postage
prepaid,  transmitted  or  addressed to the parties at the  addresses  set forth
below:

                  If to UTF:             United Transplant Foundation, Inc.
                                         c/o Regional Organ Bank of
                                         Illinois, Inc.
                                         800 South Wells Street, Suite 190
                                         Chicago, Illinois 60607
                                         Telefax:  (312) 803-7643

                  with a copy to:        Katten Muchin & Zavis
                                         525 West Monroe Street
                                         Suite 1600
                                         Chicago, Illinois 60661
                                         Attention:  Mr. Steven R. Olsen
                                         Telefax: (312) 902-1061

                  If to CryoLife:        Mr. Steven G. Anderson
                                         Chairman of the Board, Chief 
                                         Executive Officer and President
                                         CryoLife, Inc.
                                         2211 New Market Parkway, Suite 142
                                         Marietta, Georgia 30067
                                         Telefax:  (770) 850-0762

                  with a copy to:        Arnall Golden & Gregory
                                         2800 One Atlantic Center
                                         1201 West Peachtree Street
                                         Atlanta, Georgia  30309-3400
                                         Attention:  Ms. M. Nan King
                                         Telefax:  (404) 873-8775



378497.1

                                       -4-




                  (b) All notices  shall be deemed  received  (i) if  personally
delivered or transmitted by facsimile,  on the business day when so delivered or
transmitted or if not transmitted at a time which concludes  during the business
day of the  recipient,  on the next  succeeding  business  day,  (ii) if sent by
Overnight  Delivery,  one business day after it is sent and (iii) if mailed,  48
hours after  deposit in the United  States mail,  as first class  registered  or
certified mail, return receipt  requested,  postage  pre-paid.  Either party may
change its address for the  purposes of this Section by giving not less than ten
days  prior  written  notice of such  change to the  other  party in the  manner
provided in this Section.

         10.  COUNTERPARTS.  This  Agreement  may be  executed  in  two or  more
counterparts,  each of  which  shall be  deemed  an  original,  but all of which
together shall constitute one and the same instrument.

         IN WITNESS WHEREOF, the parties hereto,  intending to be legally bound,
have executed and delivered this Agreement as of the date set forth above.

                                    UTF:

                                    UNITED TRANSPLANT FOUNDATION, INC.
                                                              


                                    By:/s/ Jerold Anderson
                                       ----------------------
                                           Jerold Anderson
                                    Title: President


                                    CRYOLIFE, INC.


                                    By:/s/ Steven G. Anderson
                                       ------------------------
                                           Steven G. Anderson
                                           Chairman of the Board
                                           Chief Executive Officer and President


378497.1

                                      -5-

                                  EXHIBIT 10.3

                            NONCOMPETITION AGREEMENT


         This  NONCOMPETITION  AGREEMENT (the  "Agreement") is entered into this
11th day of  September,  1996,  by and between QV, Inc.,  a non-profit  Illinois
corporation ("QV"), and CryoLife, Inc., a Florida corporation ("CryoLife").

                              W I T N E S S E T H:

         WHEREAS,  pursuant  to  that  certain  Asset  Purchase  Agreement  (the
"Purchase  Agreement") dated as of September 11, 1996, by and among CryoLife and
United  Cryopreservation  Foundation,  Inc.  ("UCFI"),  CryoLife  has  agreed to
purchase and UCFI has agreed to sell, substantially all of the assets of UCFI;

         WHEREAS, United Transplant Foundation, Inc. ("UTF") and QV are the sole
members of UCFI;

         WHEREAS,  in order to induce  CryoLife to enter into and consummate the
Purchase  Agreement,  UCFI,  UTF,  and QV have each  agreed  to  accept  certain
restrictions as set forth herein and in those certain Non-Competition Agreements
of even date herewith between CryoLife and UTF and between CryoLife and UCFI.

         NOW, THEREFORE, in consideration of the mutual covenants and agreements
of the parties herein contained, and other good and valuable consideration,  the
receipt and  sufficiency  of which are hereby  acknowledged,  the parties hereto
agree as follows:

         1.  DEFINITIONS.   The  following   definitions  shall  apply  to  this
Agreement:

             (a)  "Company   Business"   means  the   business  of   processing,
preserving,  and/or distributing cryopreserved heart valves, saphenous veins, or
femoral veins for implantation in humans. Company Business shall not include any
other  business  activities,  including,  without  limitation,  the  processing,
procuring  and/or  distributing  of bone  or any  tissue  or  organ  other  than
cryopreserved  heart valves,  saphenous veins, or femoral veins for implantation
in humans.

             (b) "Competing Business" means any person,  concern, or entity that
is engaged  in or  conducts a  business  substantially  the same as the  Company
Business.

             (c)  "Territory"  means Arizona,  Arkansas,  California,  Colorado,
Illinois,  Indiana,  Kentucky,  Louisiana,  Missouri,  New York, North Carolina,
Pennsylvania,   Tennessee,   Texas,  and  Virginia,  which  the  parties  hereby
acknowledge  to be the  geographic  area in  which  UCFI  conducts  the  Company
Business on the date of this Agreement.



3784931





             (d) "Trade Secrets" means  information  including,  but not limited
to, technical and nontechnical data, formulas, patterns, compilations, programs,
devices, methods,  techniques,  drawings,  processes,  financial data, financial
plans, product plans, pricing information,  marketing information,  and lists of
actual or potential  customers or suppliers  which (1) derives  economic  value,
actual or potential,  from not being generally known to or readily ascertainable
by  proper  means  by other  persons  who can  obtain  economic  value  from its
disclosure or use; and (2) is the subject of efforts that are  reasonable  under
the circumstances to maintain its secrecy.

         2.  COVENANTS OF THE SELLER.  QV  acknowledges  that,  by virtue of the
special knowledge of the affairs, business, customers, suppliers and vendors and
the  operations  of the Company  Business  that QV has,  CryoLife  would  suffer
substantial  damage  if QV  breaches  or  violates  any  of  the  covenants  and
agreements  set  forth  in this  Section  2.  Therefore,  QV has  agreed  to the
following covenants and agreements:

             (a) QV covenants that it shall not, for a period of five years from
and after the date hereof (the "Noncompetition Period"), directly or indirectly,
in  the  Territory,  for  its  own  account  or as an  owner,  partner,  member,
stockholder,  joint venturer,  investor,  lender, or in any other capacity, own,
engage in, conduct, manage, operate or participate in any Competing Business.

             (b) During the Noncompetition  Period, QV covenants and agrees that
it will not,  directly or indirectly,  on its own behalf or in the service or on
behalf of others,  solicit,  divert or appropriate to a Competing  Business,  or
attempt to solicit,  divert or appropriate to or for any Competing Business, any
persons and/or  entities who were customers of UCFI in the Territory on the date
immediately preceding the date of this Agreement, or any person and/or entity in
the Territory to whom UCFI has sold or provided any products or services  during
the 12 month period immediately preceding the date of this Agreement.

             (c) During the Noncompetition  Period, QV covenants and agrees that
it will not,  directly or indirectly,  on its own behalf or in the service or on
behalf of others, hire or attempt to hire any employee of CryoLife,  or to cause
any such employee to leave his or her employment,  in order to perform  services
in the Territory for a Competing Business.

         3. SEVERABILITY.  Each provision of this Agreement is severable, and if
any one of such  provisions  shall be reformed or declared  unenforceable,  such
reformation or declaration  shall not affect the  enforceability  or validity of
any other  provision  thereof.  Each  provision  thereof shall be enforceable by
CryoLife or any successor thereof against QV notwithstanding  any claim or cause
of  action  asserted  by QV  against  CryoLife  or any  successor  thereof.  The
existence  of any  claim,  demand,  action,  or cause of  action  of QV  against
CryoLife shall not constitute a defense to the enforcement by CryoLife of any of
the covenants contained herein.



3784931

                                       -2-





         4.   REFORMATION  BY  COURT.  In  the  event  any  court  of  competent
jurisdiction  should  determine  that  any of the  terms of this  Agreement  are
unreasonable or  unenforceable in scope, QV and CryoLife consent to the exercise
by such court of its equitable  jurisdiction  to reform such terms in accordance
with applicable law.

         5.  REMEDIES.  QV agrees  that if it  breaches  any  provision  of this
Agreement,  the damage to CryoLife  would be difficult to  ascertain,  and money
damages would not afford  CryoLife an adequate  remedy.  Therefore,  if QV is in
breach of this Agreement, the parties hereto agree that CryoLife is entitled, in
addition  to any and all rights and  remedies  as would be  provided  by law, to
specific  performance,  injunctive,  and other  equitable  relief to  prevent or
restrain a breach of this  Agreement.  In addition,  the parties agree that this
Agreement  constitutes  an Asset Purchase  Transaction  Document as such term is
defined in the Purchase  Agreement.  The rights of CryoLife under this Agreement
shall survive the  expiration of the  Noncompetition  Period and are in addition
to, and not in lieu of, any and all rights CryoLife may have at law or in equity
to protect its business interests.  QV agrees to be liable for any and all costs
and expenses,  including attorneys fees,  resulting from the breach by QV of any
provision of this Agreement.

         6.  CONFIDENTIAL   INFORMATION.   QV  covenants  and  agrees  that  all
confidential and proprietary information developed,  utilized, or received by QV
relating to the  operation of the Company  Business by UCFI prior to the Closing
of the Purchase Agreement,  including, without limitation, all Trade Secrets and
all information which has been disclosed to UCFI by a third party and which UCFI
has treated as confidential (collectively,  "Confidential Information"), and all
physical  embodiments  thereof, has been transferred to CryoLife pursuant to the
Purchase  Agreement.  QV will hold such  Confidential  Information  in trust and
strictest  confidence,  and will not use,  reproduce,  distribute,  disclose  or
otherwise   disseminate  the  Confidential   Information.   The  confidentiality
requirements and use restrictions  contained in this Section 6 shall survive any
termination  of this  Agreement  but shall  not  apply  (i) to any  Confidential
Information  that falls into the public domain through no fault of QV or (ii) to
any Confidential  Information  which is not a Trade Secret when a period of five
years has expired following the execution of this Agreement.

         All records, notes, files, memoranda,  reports,  marketing information,
price lists, supplier lists and information,  documents, and all copies and like
items  relating to the Trade  Secrets which shall be disclosed to or which shall
come into the  possession  of QV during  or prior to the  Noncompetition  Period
shall be the sole and  exclusive  property of CryoLife.  QV agrees that,  at any
time upon request,  it will  promptly  deliver to CryoLife the originals and all
copies of any of the foregoing that are in its possession, custody or control.

         7. AMENDMENTS.  No amendment or modification of this Agreement shall be
valid or binding  upon  CryoLife  unless  made in  writing  and signed by a duly
authorized officer of CryoLife, or upon QV, unless made in writing and signed by
QV.



3784931

                                       -3-





         8. ASSIGNMENT.  This Agreement may not be assigned by any party without
the prior written consent of the other party hereto,  provided that CryoLife may
assign  this  Agreement  in whole or in part to one or more  affiliates  thereof
without the consent of QV.

         9.       NOTICES.

                  (a) Any and all  notices or other  communications  required or
permitted to be given under any of the provisions of this Agreement  shall be in
writing  and  shall be  deemed  to have  been  duly  given  when (i)  personally
delivered or sent by a recognized  overnight  delivery  service which guarantees
next  day  delivery  ("Overnight  Delivery"),   (ii)  transmitted  by  facsimile
transmission  (with a copy sent first class registered or certified mail, return
receipt requested and postage prepaid or by Overnight Delivery), or (iii) mailed
by first class registered or certified mail, return receipt  requested,  postage
prepaid,  transmitted  or  addressed to the parties at the  addresses  set forth
below:

                  If to QV:            QV, Inc.
                                       322 South Green Street
                                       Suite 500
                                       Chicago, Illinois 60607
                                       Attention:  President
                                       Telefax: (312) 697-8477

                  with a copy to:      Katten Muchin & Zavis
                                       525 West Monroe Street
                                       Suite 1600
                                       Chicago, Illinois 60661
                                       Attention:  Mr. Steven R. Olsen
                                       Telefax: (312) 902-1061

                  If to CryoLife:      Mr. Steven G. Anderson
                                       Chairman of the Board, Chief Executive 
                                       Officer and President
                                       CryoLife, Inc.
                                       2211 New Market Parkway, Suite 142
                                       Marietta, Georgia 30067
                                       Telefax:  (770) 850-0762

                  with a copy to:      Arnall Golden & Gregory
                                       2800 One Atlantic Center
                                       1201 West Peachtree Street
                                       Atlanta, Georgia  30309-3400
                                       Attention:  Ms. M. Nan King
                                       Telefax:  (404) 873-8775



3784931

                                       -4-




             (b)  All  notices  shall  be  deemed  received  (i)  if  personally
delivered or transmitted by facsimile,  on the business day when so delivered or
transmitted or if not transmitted at a time which concludes  during the business
day of the  recipient,  on the next  succeeding  business  day,  (ii) if sent by
Overnight  Delivery,  one business day after it is sent and (iii) if mailed,  48
hours after  deposit in the United  States mail,  as first class  registered  or
certified mail, return receipt  requested,  postage  pre-paid.  Either party may
change its address for the  purposes of this Section by giving not less than ten
days  prior  written  notice of such  change to the  other  party in the  manner
provided in this Section.

         10.  COUNTERPARTS.  This  Agreement  may be  executed  in  two or  more
counterparts,  each of  which  shall be  deemed  an  original,  but all of which
together shall constitute one and the same instrument.

         IN WITNESS WHEREOF, the parties hereto,  intending to be legally bound,
have executed and delivered this Agreement as of the date set forth above.

                                     QV:

                                     QV, INC.


                                     By: /s/ Daniel Woods
                                     --------------------
                                     Title:   President


                                     CRYOLIFE, INC.


                                     By:/s/ Steven G. Anderson
                                     -------------------------
                                        Steven G. Anderson
                                        Chairman of the Board
                                        Chief Executive Officer and President



3784931
                                      -5-
                                  EXHIBIT 10.4


                    THIRD AMENDED AND RESTATED LOAN AGREEMENT


                                     BETWEEN


                            NATIONSBANK, N.A. (SOUTH)


                                       AND


                                 CRYOLIFE, INC.




                           DATED AS OF AUGUST 30, 1996









                                TABLE OF CONTENTS

                                                                            Page

ARTICLE I - DEFINITIONS AND RULES OF CONSTRUCTION.............................1
               SECTION 101.  Specific Definitions.............................1
               SECTION 102.  Accounting Terms.................................8
               SECTION 103.  Titles...........................................8
               SECTION 104.  Number and Gender................................8

ARTICLE II - THE LOANS........................................................8
               SECTION 201.  The Loans........................................8
               SECTION 202.  Collateral and Guaranties........................9
               SECTION 203.  Agreements Regarding Interest and Other
                             Charges..........................................10
               SECTION 204.  Indemnity........................................11
               SECTION 205.  Capital Adequacy.................................11

ARTICLE III - REPRESENTATIONS AND WARRANTIES..................................12
               SECTION 301.  Organization and Existence; Subsidiaries.........12
               SECTION 302.  Financial Statements.............................12
               SECTION 303.  Borrower Authority and Power.....................12
               SECTION 304.  No Defaults......................................12
               SECTION 305.  No Pending Claims................................13
               SECTION 306.  No Outstanding Judgments.........................13
               SECTION 307.  Outstanding Securities...........................13
               SECTION 308.  Tax Returns......................................13
               SECTION 309.  Franchises, Licenses, Permits, Etc...............13
               SECTION 310.  No Governmental Consents Required................13
               SECTION 311.  ERISA Matters....................................14
               SECTION 312.  Regulation U and Other Securities Law Matters....14
               SECTION 313.  Environmental Representations....................14
               SECTION 314.  Reaffirmation....................................14

ARTICLE IV - AFFIRMATIVE COVENANTS............................................15
               SECTION 401.  Inspection and Examination.......................15
               SECTION 402.  Books and Records................................15
               SECTION 403.  Financial Statements and Other Information.......15
               SECTION 404.  Maintenance of Assets............................16
               SECTION 405.  Maintenance of Insurance.........................16
               SECTION 406.  Payment of Taxes.................................16
               SECTION 407.  Environmental Matters............................17
               SECTION 408.  Primary Depository Relationships.................17

ARTICLE V - NEGATIVE COVENANTS................................................17
               SECTION 501.  Type of Business.................................18
               SECTION 502.  Transactions with Affiliates.....................18



379000.1


                                       -i-





               SECTION 503.  Merger, Consolidation, Acquisitions, Etc.........18
               SECTION 504.  ERISA Matters....................................18
               SECTION 506.  Guaranties.......................................19
               SECTION 507.  Financial Covenants..............................19
               SECTION 508.  Funded Debt......................................20

ARTICLE VI - CONDITIONS TO LENDING............................................20
               SECTION 601.  Representations and Warranties...................20
               SECTION 602.  Performance of Covenants.........................20
               SECTION 603.  No Violation of Negative Covenants...............20
               SECTION 604.  No Material Adverse Changes......................20
               SECTION 605.  Delivery of Loan Documents.......................20
               SECTION 606.  No Default or Event of Default...................21
               SECTION 607.  Incidental Matters...............................21

ARTICLE VII - EVENTS OF DEFAULT...............................................22
               SECTION 701.  Failure to Pay Liabilities.......................22
               SECTION 702.  Representations and Warranties...................22
               SECTION 703.  Negative Covenant Breach.........................22
               SECTION 704.  Other Covenant Breach............................22
               SECTION 705.  Other Agreements with Lender.....................22
               SECTION 706.  Voluntary Bankruptcy.............................22
               SECTION 707.  Involuntary Bankruptcy...........................23
               SECTION 708.  Other Indebtedness...............................23
               SECTION 709.  Material Adverse Change..........................23
               SECTION 710.  Change in Control................................23

ARTICLE VIII - REMEDIES UPON DEFAULT..........................................24
               SECTION 801.  Acceleration and Other Remedies..................24
               SECTION 802.  Application of Proceeds; Collection Costs........24

ARTICLE IX - MISCELLANEOUS....................................................25
               SECTION 901.  Time of Essence..................................25
               SECTION 902.  Entire Agreement.................................25
               SECTION 903.  Several Counterparts.............................25
               SECTION 904.  Survival of Warranties...........................25
               SECTION 905.  Rights Cumulative................................25
               SECTION 906.  No Release; Term of Agreement....................25
               SECTION 907.  Waivers and Modifications........................26
               SECTION 908.  Waiver of Presentment, Etc.......................26
               SECTION 909.  Notices..........................................26
               SECTION 910.  No Assignment by Borrower........................26
               SECTION 911.  Lender's Expenses................................26
               SECTION 912.  Payment of Taxes.................................27
               SECTION 913.  Demand Liabilities...............................27
               SECTION 914.  Set-Offs Against Deposits........................27



379000.1


                                      -ii-





               SECTION 915.  Participant Set-Off..............................27
               SECTION 916.  Confidentiality..................................27
               SECTION 917.  Governing Law; Severability......................28
               SECTION 918.  Successors and Assigns...........................28
               SECTION 919.  Jury Trial Waiver and Consent to Jurisdiction 
                             and Venue........................................28



Exhibit A                    -              Promissory Note Form
Exhibit B                    -              Security Agreement Form
Exhibit C-1                  -              Stock Pledge Agreement Form
Exhibit C-2                  -              Stock Power Form
Exhibit D                    -              Subsidiary Guaranty Agreement Form
Exhibit E                    -              Subsidiary Security Agreement Form
Exhibit F                    -              Borrower's Closing Certificate Form
Exhibit G                    -              Guarantor's Closing Certificate Form
Exhibit H                    -              Opinion Letter Form
Exhibit I                    -              Waiver and Consent Form
Exhibit J                    -              Compliance Certificate Form

Schedule 301                 -              Subsidiaries
Schedule 304                 -              Existing Defaults
Schedule 305                 -              Pending Claims
Schedule 505                 -              Permitted Liens
Schedule 508                 -              Permitted Funded Debt





379000.1


                                      -iii-






                    THIRD AMENDED AND RESTATED LOAN AGREEMENT


         THIS  AGREEMENT  made and  entered  into as of the 30th day of  August,
1996, by and between  NATIONSBANK,  N.A. (SOUTH) ("Lender"),  a national banking
association  which is the successor by merger to Bank South,  a Georgia  banking
corporation formerly known as Bank South, N.A., and CRYOLIFE, INC. ("Borrower"),
a Florida corporation.

                              W I T N E S S E T H:

         Pursuant to a Loan Agreement, dated as of July 12, 1989, between Lender
and Borrower, as amended and restated by an Amended and Restated Loan Agreement,
dated as of February  20,  1992,  between  Lender and  Borrower,  and as further
amended and restated by a Second Amended and Restated Loan  Agreement,  dated as
of August 4, 1994,  between Lender and Borrower  (collectively,  the "Prior Loan
Agreements"),  Lender has agreed to make  certain  loans  available to Borrower.
Borrower and Lender desire to again amend and restate the Prior Loan  Agreements
and are entering into this Agreement for such purpose.

         NOW, THEREFORE, for and in consideration of the premises and the mutual
agreements,  warranties  and  representations  herein made,  Lender and Borrower
agree to amend and restate the Prior Loan Agreements as follows:


                ARTICLE I - DEFINITIONS AND RULES OF CONSTRUCTION

         SECTION 101. SPECIFIC DEFINITIONS.  As used herein, the following terms
shall have the following meanings:

         "Affiliate"  means any Person  directly or  indirectly  controlling  or
controlled by or under direct or indirect common control with Borrower.  For the
purposes of this  definition,  "control" when used with respect to any specified
Person  means the power to direct the  management  and  policies of such Person,
directly or indirectly,  whether through the ownership of voting securities,  by
contract  or  otherwise;  and the  terms  "controlling"  and  "controlled"  have
meanings correlative to the foregoing.

         "This Agreement"  means this agreement as originally  executed or as it
may  from  time  to  time  be  amended  by one or  more  written  amendments  or
modification  agreements  entered  into  pursuant to the  applicable  provisions
hereof.

         "Borrower"  shall have the meaning  given that term in the  preamble to
this  Agreement,  and such term also shall  include  Borrower's  successors  and
assigns.

         "Capital  Expenditures"  shall mean  expenditures  of over $10,000 each
made or



379000.1





liabilities  incurred by Borrower  for the  acquisition  of any fixed  assets or
improvements  (and any replacements,  substitutions or additions  thereto) which
have a useful life of more than one (1) year,  including  the direct or indirect
acquisition  of such  assets by way of  increased  product or  service  changes,
off-set items or otherwise,  and payments made during the relevant fiscal period
with  respect  to  Capitalized  Lease  Obligations,   all  as  determined  on  a
consolidated  basis;  provided,   however,  that  for  purposes  of  determining
compliance with Section 507(b),  capital expenditures for leasehold improvements
and equipment made by Borrower for its new corporate headquarters building shall
be excluded.

         "Capitalized Lease Obligations" shall mean any indebtedness of Borrower
represented by obligations  under a lease that is required to be capitalized for
financial  reporting purposes in accordance with generally  accepted  accounting
principles  in effect  from time to time,  and the  amount of such  indebtedness
shall be the capitalized amount of such obligations determined on a consolidated
basis in accordance with generally accepted accounting  principles  consistently
applied.

         "Collateral"  means and includes  all  property  assigned or pledged to
Lender or in which  Lender  has been  granted a  security  interest  or to which
Lender  has been  granted  security  title  under  this  Agreement  or the other
Financing Documents and the proceeds thereof.

         "Contractual  Obligation" of any Person shall mean any provision of any
agreement,  instrument, security, or undertaking to which such Person is a party
or by which it or any of the property owned by it is bound.

         "Credit Expiration Date" shall mean September 1, 1998, as such date may
be extended, accelerated or amended pursuant to this Agreement.

         "Credit   Parties"   shall  mean,   collectively,   Borrower   and  its
Subsidiaries.

         "CryoLife  International"  shall mean CryoLife  International,  Inc., a
Florida  corporation  which is a Subsidiary of Borrower,  and its successors and
assigns.

         "Current  Assets" shall mean, at any date,  the amount which all of the
current  assets of Borrower  would be shown on a  consolidated  balance sheet of
Borrower at such date prepared in accordance with generally accepted  accounting
principles consistently applied.

         "Current  Liabilities" shall mean, at any date, the amount at which all
of the current liabilities of Borrower would be shown on a consolidated  balance
sheet of Borrower at such date prepared in accordance  with  generally  accepted
accounting principles consistently applied.

         "Current  Maturities  of Funded  Debt" shall mean,  with respect to any
particular period, the sum of all principal payments scheduled to be made during
such period in respect of the Funded Debt of Borrower (which for purposes hereof
shall include the



379000.1


                                       -2-





allocated  principal portion of payments due on Capitalized  Lease  Obligations,
and also shall include the current portion of any other Funded Debt).

         "Current  Ratio"  shall  mean,  at any date,  the  ratio of  Borrower's
Current Assets to its Current Liabilities at such time.

         "Debt Coverage Ratio" shall mean, with respect to any particular fiscal
period of  Borrower,  the ratio of (a)  Borrower's  EBITDAR for the  consecutive
4-quarter  period ending  therewith to (b) the sum (without  duplication) of (i)
Borrower's  Current  Maturities  of Funded Debt for the  immediately  succeeding
consecutive  4-quarter  period  plus (ii)  Borrower's  Interest  Expense for the
consecutive  4-quarter  period ending  therewith  plus (iii)  Borrower's  Rental
Expense for the immediately  succeeding  consecutive  4-quarter  period,  all as
determined on a consolidated basis.

         "Default"  shall  mean any event  which,  with the  giving of notice or
lapse of time (or both), would become an Event of Default.

         "EBIT" shall mean,  for any fiscal period of Borrower,  an amount equal
to the sum of  Borrower's  Net Income (Loss) for such period plus, to the extent
subtracted in determining such Net Income (Loss),  (i) Borrower's taxes based on
income and (ii) Borrower's Interest Expense, all as determined on a consolidated
basis.

         "EBITDAR"  shall mean,  for any fiscal  period of  Borrower,  an amount
equal to  Borrower's  EBIT for such  period  plus,  to the  extent  deducted  in
determining such EBIT,  Borrower's  depreciation  and amortization  expenses and
Rental Expense, all as determined on a consolidated basis.

         "Environmental  Laws" shall mean all federal,  state, local and foreign
laws  relating to pollution or  protection of the  environment,  including  laws
relating  to  emissions,   discharges,   releases  or  threatened   releases  of
pollutants,   contaminants,   chemicals,  or  industrial,   toxic  or  hazardous
substances or wastes into the environment  (including without limitation ambient
air,  surface  water,  ground  water,  or land),  or  otherwise  relating to the
manufacture,   processing,  distribution,  use,  treatment,  storage,  disposal,
transport,  or handling of pollutants,  contaminants,  chemicals, or industrial,
toxic or hazardous  substances or wastes,  and any and all  regulations,  codes,
plans,  orders,  decrees,  judgments,  injunctions,  notices  or demand  letters
issued, entered, promulgated or approved thereunder.

         "ERISA" shall mean the Employee Retirement Income Security Act of 1974,
P.L. 93-406, as amended.

         "Event of Default"  shall mean any of the events  specified  in Article
VII of this Agreement,  provided that any express requirement therein for notice
or lapse of time shall have been satisfied.

         "Final Maturity Date" shall mean September 1, 2003, as such date may be



379000.1


                                       -3-





extended, accelerated or amended pursuant to this Agreement.

         "Financing Documents" means and includes this Agreement,  the Note, the
Security Agreement,  each Stock Pledge Agreement, each Subsidiary Guaranty, each
Subsidiary Security Agreement,  and any extensions,  renewals,  modifications or
substitutions thereof or therefor,  and all other associated loan and collateral
documents including, without limitation, all guaranties,  suretyship agreements,
security   agreements,   pledge   agreements,   security  deeds,   subordination
agreements,  exhibits, schedules,  attachments,  financing statements,  notices,
consents,  waivers, opinions,  letters, reports, records, title certificates and
applications  therefor,  assignments,  stock  powers  or  transfers,  documents,
instruments, information and other writings related thereto, or furnished by any
Credit Party to Lender in connection  therewith or in connection with any of the
Collateral,  including  without  limitation  any  such  documents  executed  and
delivered  pursuant  to Section 202 hereof;  provided,  however,  that this term
shall not include the Prior Loan Agreements or the Prior Security Agreements.

         "Funded Debt" shall mean, for any particular  Person,  all Indebtedness
for money borrowed,  Indebtedness  secured by purchase money liens,  Capitalized
Lease Obligations,  conditional sales contracts and similar title retention debt
instruments,  all as determined  for such Person on a  consolidated  basis.  The
calculation  of Funded Debt for any  particular  Person shall include all Funded
Debt of such  Person  plus  all  Funded  Debt of  other  Persons  to the  extent
guaranteed by such Person,  to the extent  secured by any assets of such Person,
or to the extent  supported by a letter of credit issued for the account of such
Person.

         "Governmental Authority" means any applicable nation or government, any
state, local or other political  subdivision  thereof,  any court, and any other
entity   exercising   executive,    legislative,    judicial,   regulatory,   or
administrative functions of or pertaining to government.

         "Guaranty"  shall  mean  any  contractual  obligation,   contingent  or
otherwise,  of a Person with respect to any  Indebtedness or other obligation or
liability  of  another   Person,   including   without   limitation,   any  such
Indebtedness,   obligation  or  liability  directly  or  indirectly  guaranteed,
endorsed,  co-made or  discounted  or sold with  recourse by that Person,  or in
respect  of which  that  Person is  otherwise  directly  or  indirectly  liable,
including Contractual  Obligations (contingent or otherwise) arising through any
agreement  to purchase,  repurchase,  or  otherwise  acquire such  Indebtedness,
obligation  or liability or any security  therefor,  or any agreement to provide
funds  for the  payment  or  discharge  thereof  (whether  in the form of loans,
advances, stock purchases,  capital contributions or otherwise),  or to maintain
solvency,  assets, level of income, or other financial condition, or to make any
payment other than for value received.

         "Herein",  "hereof",  and "hereunder" and other words of similar import
refer to this Agreement as a whole and not to any particular article, paragraph,
section or other subdivision.




379000.1


                                       -4-





         "Indebtedness" of any Person shall mean, without  duplication:  (i) all
obligations  of  such  Person  which  in  accordance  with  generally   accepted
accounting  principles  consistently  applied  would be shown on a  consolidated
balance  sheet of such Person as a  liability  (including,  without  limitation,
obligations  for borrowed money and for the deferred  purchase price of property
or services,  and  obligations  evidenced by bonds,  debentures,  notes or other
similar  instruments);  (ii) all rental  obligations under leases required to be
capitalized under generally accepted accounting principles consistently applied;
(iii)  all  Guaranties  of  such  Person  (including  contingent   reimbursement
obligations  under undrawn letters of credit);  and (iv)  Indebtedness of others
secured by any Lien upon property owned by such Person, whether or not assumed.

         "Intellectual   Property  Rights"  shall  mean,  with  respect  to  any
particular Person, all patents,  patent applications,  continuation,  refile and
reissue patent applications,  trademarks,  service marks,  trademark and service
mark applications, trade names, copyrights,  copyright registrations,  copyright
applications,   trade   secrets  and  other  similar   proprietary   information
(including,  but not by way of limitation,  inventions,  technical  information,
processes, algorithms, procedures, specifications, designs, knowledge, know-how,
data and databases) now owned or hereafter acquired by such Person.

         "Interest  Expense" shall mean, for any fiscal period of Borrower,  the
total interest  expense of Borrower,  as determined on a  consolidated  basis in
accordance with generally accepted accounting principles consistently applied.

         "Lender" shall have the meaning given that term in the preamble to this
Agreement, and such term also shall include Lender's successors and assigns.

         "Leverage Ratio" shall mean, at any date, the ratio of Borrower's Total
Liabilities to its Net Worth at such time.

         "Liabilities" means all indebtedness,  liabilities,  and obligations of
Borrower of any nature whatsoever which Lender may now or hereafter have, own or
hold,  and which now or hereafter  arise under or on account of this  Agreement,
the Note or any of the other Financing  Documents and any extensions,  renewals,
modifications or substitutions thereof or therefor.

         "Lien" shall mean any mortgage, pledge, collateral assignment, security
interest, security deposit,  encumbrance,  lien or charge of any kind (including
any agreement to give any of the foregoing,  any conditional sale or other title
retention  agreement,  any lease in the  nature  thereof,  and the  filing of or
agreement to give any financing  statement under the Uniform  Commercial Code of
any jurisdiction,  but excluding  licenses granted in the ordinary course of the
grantor's business).

         "Loans"  shall  mean  any and all  Loans  made by  Lender  to  Borrower
pursuant to Section 201 hereof.




379000.1


                                       -5-





         "Maximum  Availability"  shall mean $10,000,000,  as such amount may be
reduced or amended pursuant to this Agreement.

         "Net Income (Loss)" shall mean, for any fiscal period of Borrower,  the
net income (or loss) of Borrower on a consolidated  basis for such period (taken
as a single accounting  period) determined in conformity with generally accepted
accounting  principles  consistently  applied,  but excluding  therefrom (to the
extent  otherwise  included  therein and without  duplication)  (i) any gains or
losses,  together with any related  provisions  for taxes,  realized by Borrower
upon any sale of its assets other than in the ordinary course of business,  (ii)
any other  non-recurring  gains or  losses,  and (iii) any income or loss of any
other Person  acquired  prior to the date such other Person becomes a Subsidiary
of  Borrower  or is  merged  into  or  consolidated  with  Borrower  or  all  or
substantially all of such other Person's assets are acquired by Borrower.

         "Net Worth" shall mean, as of any  particular  date,  Borrower's  total
shareholder's  equity (including capital stock,  additional paid-in capital, and
retained earnings after deducting  treasury stock) which would appear as such on
a consolidated  balance sheet of Borrower  prepared in accordance with generally
accepted accounting principles as then in effect.

         "Note"  shall mean the  Promissory  Note  substantially  in the form of
Exhibit A  attached  hereto to be  executed  by  Borrower  in favor of Lender to
evidence the Loans, and all renewals, extensions,  modifications or replacements
thereof.

         "Person" means any individual, corporation, partnership, joint venture,
association,   joint-stock  company,  trust,   unincorporated   organization  or
government or any agency or political subdivision thereof.

         "Prior Loan  Agreements"  shall have the meaning given such term in the
preamble to this Agreement.

         "Prior  Security   Agreements"   shall  mean  the  Security   Agreement
(Equipment)  and the  Security  Agreement  (Receivables/Inventory),  both  dated
December 31, 1986, executed by Borrower in favor of Lender, as amended,  and the
Equipment Security  Agreement,  dated as of August 4, 1994, executed by Borrower
in favor of Lender.

         "Purchase  Money  Indebtedness"  shall  mean (i)  Indebtedness  for the
payment of all or any part of the purchase  price of any fixed assets,  (ii) any
Indebtedness  incurred for the sole purpose of financing or  refinancing  all or
any part of the purchase  price of any fixed  assets,  (iii)  Capitalized  Lease
Obligations, and (iv) any renewals,  extensions or refinancings thereof (but not
any increases in the principal amounts thereof outstanding at that time).

         "Purchase Money Lien" shall mean a Lien upon fixed assets which secures
the Purchase Money Indebtedness  relating thereto but only if such Lien shall at
all times be confined solely to the fixed assets the purchase price of which was
financed or refinanced



379000.1


                                       -6-





through the incurrence of the Purchase Money  Indebtedness  secured by such Lien
and only if such Lien secures solely such Purchase Money Indebtedness.

         "Rental  Expense"  shall mean,  for any fiscal period of Borrower,  the
total  rental  expense  of  Borrower  for  such  period,   as  determined  on  a
consolidated basis in accordance with generally accepted  accounting  principles
consistently  applied, and which shall include without limitation rental expense
under operating leases.

         "Revolving  Loan Period" shall mean the period which runs from the date
of this Agreement until the Credit Expiration Date.

         "Security  Agreement"  shall mean the  Amended  and  Restated  Security
Agreement,  substantially in the form of Exhibit B attached hereto,  executed or
to be executed by Borrower in favor of Lender pursuant to this Agreement and any
modification or replacement thereof or therefor.

         "Stock  Pledge  Agreement"  shall  mean any and all  Stock  Pledge  and
Security  Agreements,  substantially in the form of Exhibit C-1 attached hereto,
executed  or to be  executed  by  Borrower  in favor of Lender  pursuant to this
Agreement and any modification or replacement thereof or therefor.

         "Subsidiary"  means,  as applied to Borrower,  (i) any  corporation  of
which 50% or more of the  outstanding  stock (other than  directors'  qualifying
shares)  having  ordinary  voting  power to  elect a  majority  of its  board of
directors (or other governing body),  regardless of the existence at the time of
a  right  of the  holders  of any  class  or  classes  (however  designated)  of
securities  of such  corporation  to exercise such voting power by reason of the
happening of any  contingency,  or any  partnership  of which 50% or more of the
outstanding  partnership interests is, at the time, directly or indirectly owned
by  Borrower  or by one or more  Subsidiaries  of  Borrower,  and (ii) any other
entity which is directly or indirectly controlled or capable of being controlled
by Borrower or by one or more Subsidiaries of Borrower.

         "Subsidiary  Guaranty"  shall  mean  any and all  Guaranty  Agreements,
substantially  in the form of  Exhibit  D  attached  hereto,  executed  or to be
executed by a Subsidiary of Borrower in favor of Lender and any modifications or
replacements thereof or therefor.

         "Subsidiary  Security  Agreement"  shall  mean  any  and  all  Security
Agreements,  substantially in the form of Exhibit E attached hereto, executed or
to be  executed  by a  Subsidiary  of  Borrower  in  favor  of  Lender  and  any
modifications or replacements thereof or therefor.

         "Term Loan  Period"  shall  mean the period  which runs from the Credit
Expiration Date through the Final Maturity Date.




379000.1


                                       -7-





         "Tissue Freezers" shall mean, collectively,  the tissue freezers leased
or loaned by  Borrower to third  parties in the  ordinary  course of  Borrower's
business.

         "Total  Liabilities"  shall mean, as of any particular date, the amount
which all liabilities of Borrower would be shown on a consolidated balance sheet
of  Borrower  at such  date  prepared  in  accordance  with  generally  accepted
accounting principles consistently applied.

         "Voting  Stock" shall mean the  securities of any class or classes of a
corporation   the   holders  of  which  are   ordinarily,   in  the  absence  of
contingencies,  entitled to elect a majority of the corporate  directors of such
corporation (or Persons performing similar functions).

         SECTION 102.  ACCOUNTING  TERMS.  All  accounting  terms not  otherwise
defined herein have the meanings  assigned to them in accordance  with generally
accepted accounting principles consistently applied.

         SECTION 103.  TITLES.  The titles of the  Articles and Sections  herein
appear as a matter of convenience  only and shall not affect the  interpretation
hereof.

         SECTION 104.  NUMBER AND GENDER.  Words  importing the singular  number
hereunder  shall include the plural number and vice versa,  and any pronoun used
herein shall be deemed to cover all genders.


                             ARTICLE II - THE LOANS

         SECTION 201. THE LOANS. (a) From time to time upon Borrower's  request,
and subject to the terms and  conditions  of this  Agreement,  Lender  agrees to
advance to Borrower  prior to the Credit  Expiration  Date amounts  which do not
exceed the Maximum Availability in aggregate outstanding principal amount at any
one time.  Advances  made by Lender  to  Borrower  under  this  Section  201 are
hereinafter  collectively called the "Loans".  Notwithstanding  anything in this
Agreement to the contrary,  the Lender shall not be obligated  hereunder to make
any Loans on or after the  earlier  of (i) the  Credit  Expiration  Date or such
later  date to which  such  expiration  date may be  extended  by  Lender in its
discretion or (ii) the date Lender pursuant to Section 801(a) hereof  terminates
its obligation to make any further Loans to Borrower  hereunder.  Subject to the
terms and conditions hereof, prior to the Credit Expiration Date,  Borrower,  at
its option, from time to time may borrow,  repay and reborrow all or any portion
of the Loans,  except that  Borrower's  right to prepay Loans  bearing  interest
based on the  Adjusted  LIBOR (as such  term is  defined  in the Note)  shall be
subject to the breakage  provisions of the Note and any such prepayment shall be
applied as provided in the Note.

         (b) The  proceeds of the Loans may be used by Borrower  only to finance
acquisitions  by the Borrower and to finance  Borrower's  and its  Subsidiaries'
working capital



379000.1


                                       -8-





and other general corporate needs (including  without  limitation to finance the
cost of the leasehold improvements and equipment purchases made or to be made by
Borrower for its new corporate headquarters building in Marietta, Georgia).

         (c) The Loans are to be  evidenced  by the Note.  Interest on the Loans
will accrue at the rate or rates per annum set forth in the Note,  and principal
and interest on the Loans will be payable in the manner prescribed in the Note.

         (d)  Borrower  shall  pay to  Lender  an  origination  fee for the Loan
facility  provided by Lender to Borrower under this Section 201, which fee shall
be in the amount of $5,000 (and Lender shall credit  against such sum the $5,000
commitment  letter fee previously  paid by Borrower to Lender in connection with
such  facility)  and such fee shall be deemed  fully  earned by Lender  upon the
parties' execution and delivery of this Agreement from the Borrower and shall be
non-refundable.

         (e) Borrower  shall pay to Lender unused  facility fees for  Borrower's
Loan facility  hereunder  during the Revolving Loan Period computed on the daily
average  unused  portion  of the  Maximum  Availability  at a rate per  annum of
three-eighths of one percent (.375%). Such unused facility fees shall be payable
by Borrower to Lender quarterly in arrears, commencing on November 30, 1996, and
continuing to be due on the last day of each February,  May, August and November
thereafter  during the Revolving Loan Period as well as on the Credit Expiration
Date.  Notwithstanding  anything in this Section to the contrary,  however,  the
total unused  facility  fees payable by Borrower to Lender under clauses (x) and
(y) above shall not exceed the sum of $6,250 and $25,000,  respectively,  during
each of the  following two periods:  the period from the date of this  Agreement
though August 31, 1997, and the period from September 1, 1997 through the Credit
Expiration Date.

         (f) All of the Loans shall  constitute  one loan by Lender to Borrower.
Lender shall maintain a loan account on its books in which shall be recorded all
Loans,  all  payments  made by Borrower  on the Loans and all other  appropriate
debits and  credits as  provided  in this  Agreement  and the Note with  respect
thereto,  including without limitation all charges,  expenses and interests. All
entries in such account shall be made in accordance with the Lender's  customary
accounting  practices  as in effect from time to time.  Lender  shall  render to
Borrower  a  monthly  statement  setting  forth  the  balance  of such  account,
including principal, interest, expenses and fees, and each such statement shall,
absence  manifest  error or  omissions,  be presumed  correct  and binding  upon
Borrower and shall constitute an account stated unless,  within thirty (30) days
after  receipt of any such  statement  from Lender,  Borrower  shall  deliver to
Lender a written objection thereto specifying the error or errors or omission or
omissions, if any, contained in such statement.

         (g) All  interest  and fees owing by  Borrower to Lender  hereunder  or
under the other Financing  Documents shall be computed on the basis of a 360-day
year and the actual days elapsed




379000.1


                                       -9-





         SECTION 202.  COLLATERAL AND  GUARANTIES.  (a) All of the Loans and the
other  Liabilities  shall be secured  pursuant to the Security  Agreement  which
shall be duly executed and  delivered by Borrower to Lender in  connection  with
this  Agreement  and pursuant to which Lender shall be granted a  first-priority
security  interest in all of  Borrower's  present or future  accounts,  contract
rights,  chattel paper, general intangibles (excluding its Intellectual Property
Rights but including the proceeds thereof),  instruments,  documents, inventory,
equipment,  fixtures, leasehold improvements,  and other assets and all proceeds
thereof  (excluding its Intellectual  Property Rights but including the proceeds
thereof). In addition,  all of the Loans and the other Liabilities shall also be
secured pursuant to a Stock Pledge Agreement which (together with an irrevocable
stock power in the form of Exhibit C-2 attached  hereto)  shall be duly executed
and  delivered  by  Borrower to Lender in  connection  with this  Agreement  and
pursuant to which Lender shall be granted a first-priority  security interest in
all of the capital stock of CryoLife International and all proceeds thereof.

         (b)  All  of the  Loans  and  the  other  Liabilities  shall  be  fully
guaranteed by CryoLife  International  pursuant to a Subsidiary  Guaranty  which
shall be duly  executed  and  delivered by CryoLife  International  to Lender in
connection  with this  Agreement.  In  addition,  the  obligations  of  CryoLife
International  under such  Subsidiary  Guaranty  shall be secured  pursuant to a
Subsidiary  Security  Agreement  which shall be duly  executed and  delivered by
CryoLife International to Lender in connection with this Agreement, and pursuant
to which Lender shall be granted a  first-priority  security  interest in all of
CryoLife  International's  present or future accounts,  contract rights, chattel
paper,  general  intangibles  (excluding its  Intellectual  Property  Rights but
including the proceeds thereof),  instruments,  documents, inventory, equipment,
fixtures, leasehold improvements, and other assets and all proceed thereof.

         (c) Within ten (10) days after  Borrower's  creation or  acquisition of
any  Subsidiary,  Borrower  shall  pledge  all  of the  capital  stock  of  such
Subsidiary to the Lender as additional collateral for the Liabilities,  Borrower
shall cause such  Subsidiary  to guaranty the  repayment of the  Liabilities  to
Lender,  and  Borrower  shall  cause  such  Subsidiary  to grant to the Lender a
first-priority  perfected  security  interest  in and lien on all of its  assets
(excluding its Intellectual Property Rights, but including the proceeds thereof)
as additional  collateral for the  Liabilities,  all pursuant to such Subsidiary
Guaranties,  Subsidiary Security  Agreements,  Stock Pledge Agreements and other
collateral  documents as are acceptable in all respects to the Lender.  Borrower
also shall  provide  Lender  with any and all  closing  certificates,  financing
statement filings,  opinions of counsel and other closing documents of the types
described  in Section 605 hereof as the Lender may request  with respect to such
pledge, guaranty and collateral documents.

         (d)  Borrower  shall  execute  (or  cause to be  executed)  any and all
financing  statements,  fixture  filings,  certificate  of  title  applications,
collateral assignments,  stock powers or transfers, or other documents as Lender
may  reasonably  request  from time to time in order to perfect or maintain  the
perfection and priority of Lender's  security  interest in the Collateral now or
hereafter covered by the Security  Agreement,  any Stock Pledge Agreement or any
Subsidiary Security Agreement or any additional collateral documents executed by



379000.1


                                      -10-





Borrower or any Subsidiary pursuant to this Section 202.

         (e) If any of the Collateral  will be located on any premises which are
leased by  Borrower  or any of its  Subsidiaries  from a third party or, if such
premises are owned by Borrower or one of its Subsidiaries, on which any creditor
(other than Lender) holds a security deed, mortgage, or deed of trust granted by
Borrower or one of its Subsidiaries,  Borrower shall cause each such third party
lessor or  creditor  to  execute  in favor of  Lender a Waiver  and  Consent  in
substantially  the form of Exhibit I  attached  hereto (or in such other form as
may be acceptable to Lender).

         SECTION 203. AGREEMENTS REGARDING INTEREST AND OTHER CHARGES.  Pursuant
to the Official Code of Georgia  Annotated  Section  7-4-2,  Lender and Borrower
hereby  agree that the only  charge  imposed  or to be  imposed  by Lender  upon
Borrower  for the use of money in  connection  with the Loans is and will be the
interest  required under the Note, which interest will be at the rates which are
or will be expressed in simple interest terms in the Note as of the date of such
Note.  Borrower hereby acknowledges and agrees that Lender has not imposed on it
any minimum borrowing requirements,  reserve or escrow balances, or compensating
balances  related in any way to this Agreement.  In no event shall the amount of
interest  due and  payable  under this  Agreement,  the Note or any of the other
Financing  Documents  exceed the maximum rate of interest  allowed by applicable
law (including,  without limitation,  Official Code of Georgia Annotated Section
7-4-18) and, in the event any such payment is inadvertently  made by Borrower or
inadvertently received by Lender, such excess sum shall be credited as a payment
of principal.  It is the express  intent hereof that Borrower not pay and Lender
not receive, directly or indirectly or in any manner, interest in excess of that
which may be lawfully paid under applicable law.

         SECTION 204. INDEMNITY.  Borrower agrees to indemnify and hold harmless
the Lender from and against any and all claims,  liabilities,  losses,  damages,
actions and demands by any party  against the Lender  arising out of the making,
holding or  administration  of the Loans or the  Collateral,  allegations of any
participation  by the Lender in the affairs of any or all of the Credit  Parties
or  allegations  that the Lender has any joint  liability with any or all of the
Credit  Parties  for  any  reason,  or any  claims  against  the  Lender  by any
shareholder of the Borrower,  unless,  with respect to the above,  the Lender is
finally  and  judicially  determined  to have  acted or failed to act with gross
negligence or to have engaged in willful misconduct.

         SECTION 205. CAPITAL ADEQUACY. Without limiting any other provisions of
this Agreement,  in the event that the Lender  determines  after the date hereof
that the  introduction  or change  after the date of this  Agreement of any law,
treaty,  governmental (or  quasi-governmental)  rule,  regulation,  guideline or
order regarding capital adequacy, or any change therein or in the interpretation
or application  thereof after the date of this  Agreement,  or compliance by the
Lender with any request or directive  regarding capital adequacy (whether or not
having the force of law and whether or not failure to comply  therewith would be
unlawful)  from  a  central  bank  or  governmental  authority  or  body  having
jurisdiction  which is introduced  or changed after the date of this  Agreement,
does or shall



379000.1


                                      -11-





have the  effect of  reducing  the rate of return on the  Lender's  capital as a
consequence of its obligations  hereunder to a level below that which the Lender
could have achieved but for such law,  treaty,  rule,  regulation,  guideline or
order or such change or  compliance  (taking  into  consideration  the  Lender's
policies with respect to capital  adequacy and assuming the full  utilization of
the Lender's capital immediately before such adoption,  change or compliance) by
an amount reasonably deemed by the Lender to be material,  then the Lender shall
promptly after its determination of such occurrence notify the Borrower thereof.
The Borrower agrees to pay to the Lender as an additional fee from time to time,
within ten (10) days after written notice and demand by the Lender,  such amount
as the  Lender  certifies  to be the  amount  that will  compensate  it for such
reduction in connection  with its  obligations  hereunder.  A certificate of the
Lender  claiming  compensation  under this Section  shall be  conclusive  in the
absence  of  manifest  error or fraud and  shall  set  forth  the  nature of the
occurrence giving rise to such compensation, the additional amount or amounts to
be paid to it hereunder and the method by which such amounts were determined. In
determining such amount, the Lender may use reasonable averaging and attribution
methods.

                  ARTICLE III - REPRESENTATIONS AND WARRANTIES

         Borrower  represents  and warrants to Lender that each of the following
is true, correct, complete and accurate in all respects:

         SECTION 301. ORGANIZATION AND EXISTENCE;  SUBSIDIARIES. (a) Borrower is
a corporation  duly organized,  validly  existing and in good standing under the
laws of the State of  Florida,  and is  qualified  to do  business  as a foreign
corporation  in the State of Georgia.  CryoLife  International  is a corporation
duly  organized,  validly  existing and in good  standing  under the laws of the
State of Florida,  and is qualified to do business as a foreign  corporation  in
the State of Georgia.

         (b)  Borrower  has no  Subsidiaries  as of the date of this  Agreement,
except for the  Subsidiaries  identified  on Schedule 301 attached  hereto,  and
Borrower  agrees  that it will not  hereafter  acquire or form any  Subsidiaries
without  giving Lender at least thirty (30) days' prior written  notice  thereof
and complying with any applicable  requirements  of Sections 202 and 503 hereof.
In the event Borrower so acquires or forms any Subsidiaries,  each Subsidiary of
Borrower  will be a corporation  duly  organized,  validly  existing and in good
standing with the laws of the state of its incorporation.

         SECTION 302.  FINANCIAL  STATEMENTS.  Each  financial  statement of any
Credit Party which has been  delivered to Lender  presents  fairly the financial
condition of such Credit Party as of the date indicated  therein and the results
of its  operations for the period(s)  shown therein.  There has been no material
adverse  change in the financial  condition or operations of the Credit  Parties
taken as a whole since the date of said financial statement,  nor has any Credit
Party mortgaged,  pledged or granted a security interest in or encumbered any of
its assets since such date.

         SECTION 303. BORROWER AUTHORITY AND POWER. Each Credit Party has full



379000.1


                                      -12-





power  and  authority  to make,  execute  and  perform  in  accordance  with the
respective  terms  thereof each of the Financing  Documents  executed by it. The
execution  and  performance  by each  Credit  Party  of each  and  every  of the
Financing  Documents  executed by it have been duly  authorized by all requisite
action,  and each and every one of them constitutes the legal, valid and binding
obligation of such Credit Party  enforceable  in accordance  with its respective
terms.

         SECTION 304. NO DEFAULTS.  Except as set forth on Schedule 304 attached
hereto,  none  of  the  Credit  Parties  is  in  default  under  any  contracts,
agreements, licenses, franchises, leases, security agreements, deeds, mortgages,
promissory notes, documents, instruments or chattel paper to which it is a party
or by  which  it or any of its  properties  or  assets  is  bound  or  affected.
Execution, delivery and performance by any Credit Party of each and every of the
Financing  Documents  executed  by it do not  violate  any  provision  of law or
regulations and does not result in a breach of or constitute a default under any
agreement, indenture or other instrument to which any Credit Party is a party or
by which any Credit Party is bound.

         SECTION  305. NO PENDING  CLAIMS.  Except as  disclosed on Schedule 305
attached hereto, there is no claim, action,  suit,  arbitration,  investigation,
condemnation  or other  proceeding  at law or in  equity,  or by or  before  any
federal,  state, local or other  governmental  agency, or by or before any other
agency or  arbitrator,  nor is there any judgment,  order,  writ,  injunction or
decree of any court pending, anticipated or (to Borrower's knowledge) threatened
against any Credit Party or against any of its  properties or assets which might
have a material  adverse  effect on the Credit Parties taken as a whole or their
respective  properties or assets, or which might call into question the validity
or enforceability of any of the Financing Documents,  or which might involve the
alleged violation by any Credit Party of any federal, state, local or other law,
rule or regulation;  provided,  however,  that no representation is made in this
Section 305 with respect to Environmental Laws.

         SECTION 306. NO  OUTSTANDING  JUDGMENTS.  There are no  outstanding  or
unpaid judgments against any Credit Party.

         SECTION  307.  OUTSTANDING  SECURITIES.  All  of  Borrower's  and  each
Subsidiary's  outstanding capital stock has been validly issued,  fully paid and
is  non-assessable.  Borrower is not in  violation  of any  applicable  federal,
state,  local,  or other  securities  laws and  regulations  with respect to the
issuance of any of its capital stock or any other of its securities.

         SECTION 308.  TAX RETURNS.  Each Credit Party has filed or caused to be
filed all required federal,  state, local, or other tax returns when due and has
paid  (except as  otherwise  permitted  by Section 406 hereof) all  governmental
taxes and other charges  imposed upon it or on any of its  properties or assets.
Borrower does not know of any proposed  additional  tax  assessment  against any
Credit Party.




379000.1


                                      -13-





         SECTION 309. FRANCHISES,  LICENSES, PERMITS, ETC. Each Credit Party has
all material franchises,  licenses,  permits, patents,  copyrights,  trademarks,
trade names, and other authority  necessary to enable it to conduct its business
as presently  conducted;  provided,  however,  that no representation is made in
this Section 309 with respect to Environmental Laws.

         SECTION 310. NO GOVERNMENTAL CONSENTS REQUIRED.  No consent,  approval,
order, authorization,  designation, registration, declaration, or filing (except
the filing of financing  statements  or notations  of liens on  certificates  of
title) with or of any federal,  state, local, or other governmental authority or
public body on the part of any Credit Party is required in  connection  with any
Credit  Party's  execution,  delivery  or  performance  of any of the  Financing
Documents; or if required, all such prerequisites have been fully satisfied.

         SECTION 311. ERISA MATTERS. None of the Credit Parties has incurred any
material  accumulated  funding  deficiency  within the meaning of the ERISA, and
none of the Credit  Parties has incurred  any material  liability to the Pension
Benefit Guaranty  Corporation  established under ERISA (or any successor thereto
under such Act) in  connection  with any employee  benefit plan  established  or
maintained by any of the Credit Parties.

         SECTION 312. REGULATION U AND OTHER SECURITIES LAW MATTERS. None of the
transactions contemplated in this Agreement (including,  without limitation, the
use of the  proceeds  from the Loans) will  violate or result in a violation  of
Section 7 of the Securities Exchange Act of 1934, as amended, or any regulations
issued pursuant thereto, including,  without limitation,  Regulations U and X of
the Board of Governors of the Federal  Reserve  System,  12 C.F.R.,  Chapter II.
Borrower  does not own or intend to carry or purchase any "margin  stock" within
the meaning of said Regulation U, including  margin stock  originally  issued by
it.  None of the  proceeds  of the Loans will be used to  purchase  or carry (or
refinance  any  borrowing  the proceeds of which were used to purchase or carry)
any  "security"  within the meaning of the  Securities  Exchange Act of 1934, as
amended.

         SECTION 313. ENVIRONMENTAL  REPRESENTATIONS.  (a) Each Credit Party has
obtained all permits, licenses and other authorizations which are required under
Environmental  Laws,  and each Credit  Party is in  compliance  in all  material
respects  with all terms and  conditions of the required  permits,  licenses and
authorizations and is also in compliance in all material respects with all other
limitations,  restrictions,  conditions, standards, prohibitions,  requirements,
obligations,  schedules and timetables contained in any applicable Environmental
Laws;

         (b) Borrower is not aware of, and has not received notice of, any past,
present or future  events,  conditions,  circumstances,  activities,  practices,
incidents,  actions  or plans  which,  with  respect to any  Credit  Party,  may
interfere with or prevent such Credit Party's compliance or continued compliance
in any  material  respect  with  Environmental  Laws,  or may  give  rise to any
material common law or legal liability, or otherwise form the



379000.1


                                      -14-





basis of any material claim, action, demand, suit, proceeding, hearing, study or
investigation against such Credit Party, based on or related to the manufacture,
processing,  distribution,  use,  treatment,  storage,  disposal,  transport  or
handling,  or the emission,  discharge,  release or threatened  release into the
environment, of any pollutant,  contaminant,  chemical, or industrial,  toxic or
hazardous substance or waste; and

         (c) There is no civil, criminal or administrative action, suit, demand,
claim, hearing,  notice or demand letter, notice of violation,  investigation or
proceeding pending or threatened against any Credit Party relating in any way to
Environmental Laws.

         SECTION  314.  REAFFIRMATION.  Each request for a Loan made by Borrower
pursuant to this  Agreement  shall  constitute an automatic  representation  and
warranty  by  Borrower  to Lender  that there does not then exist any Default or
Event of Default as well as a  reaffirmation  as of the date of such  request of
all of the  representations  and warranties of the Credit  Parties  contained in
this  Agreement and the other  Financing  Documents  (except as to those changes
otherwise consented to by Lender or contemplated herein).

                       ARTICLE IV - AFFIRMATIVE COVENANTS

         For so long as this Agreement is in effect, and unless Lender expressly
consents in writing  otherwise or to the contrary  (which  consent  shall not be
unreasonably  withheld),  Borrower  hereby  expressly  covenants  and  agrees as
follows:

         SECTION 401.  INSPECTION AND  EXAMINATION.  Upon reasonable  request of
Lender,  each Credit Party shall permit during regular business hours any person
designated by Lender to inspect and examine such Credit Party's  financial books
and  records,  its  minute  books and other  business  memoranda  and  writings;
provided,  however, that so long as no Event of Default has occurred and is then
continuing  Borrower may condition  Lender's (or its  designee's)  access to any
Credit Party's  business  memoranda and writings (other than its financial books
and records) on Lender's (or such  designee's)  entering into a suitable written
confidentiality  agreement.  Each Credit Party shall make available its officers
and employees to Lender to discuss the financial affairs of such Credit Party at
such reasonable times and intervals as Lender may request, and each Credit Party
shall  promptly  confirm or furnish in reasonable  detail  whatever  information
relative to such Credit Party as Lender's authorized representative,  auditor or
counsel may reasonably request.

         SECTION 402. BOOKS AND RECORDS. Each Credit Party shall keep its books,
records and accounts in accordance with generally accepted accounting principles
and practices applied on a basis consistent with preceding years.

         SECTION 403. FINANCIAL STATEMENTS AND OTHER INFORMATION. Borrower shall
promptly  furnish to  Lender:  (1) Not later than 120 days after the end of each
subsequent fiscal year,  consolidated and consolidating  financial statements of
the  Borrower,   to  include   balance  sheets  and  statements  of  income  and
stockholders'  equity,  all in reasonable  detail,  prepared in accordance  with
generally accepted accounting principles and



379000.1


                                      -15-





certified by an independent accounting firm acceptable to Lender and accompanied
by a duly  completed  Compliance  Certificate  in the form of Exhibit J attached
hereto  executed on behalf of Borrower by its chief financial  officer;  (2) Not
later than 30 days after and as of the end of each month  (other  than the final
month of each fiscal year),  consolidated  financial statements of Borrower,  to
include balance sheets and statements of income and stockholders' equity, all in
reasonable  detail,  prepared in accordance with generally  accepted  accounting
principles  (subject  to  changes  resulting  from  year-end  adjustments),  and
certified by the chief  financial  officer of Borrower and accompanied by a duly
completed  Compliance  Certificate  in the form of  Exhibit  J  attached  hereto
executed on behalf of Borrower by its chief financial officer; (3) Promptly upon
becoming  aware of the  existence of any Default or Event of Default,  a written
notice  specifying  the nature and period of  existence  thereof and what action
Borrower is taking or proposes to take with respect  thereto;  (4) Promptly upon
becoming aware that the holder of any other evidence of indebtedness or security
of any Credit Party has given notice or taken any other action with respect to a
claimed default or event of default or event which, with the giving of notice or
passage  of time,  or  both,  would  constitute  a  default,  a  written  notice
specifying the notice given or action taken by such holder and the nature of the
claimed  default or event and what action Borrower is taking or proposes to take
with respect  thereto;  (5) Promptly upon  transmission  thereof,  copies of all
financial  statements,  proxy statements,  notices and reports as Borrower shall
send  to its  public  shareholders,  if  any,  and  copies  of all  registration
statements  and all other reports which Borrower may file from time to time with
the  Securities  and Exchange  Commission  or any  comparable  state  securities
regulatory agency; and (6) From time to time upon request of Lender,  such other
information relating to the operations, business, and financial condition of any
Credit Party as Lender may reasonably request.

         SECTION 404.  MAINTENANCE  OF ASSETS.  Each Credit Party shall maintain
and keep all of its  property  and assets  (other than Tissue  Freezers) in good
repair, working order and condition and shall from time to time make all needful
and proper repairs, renewals and replacements thereto subject to reasonable wear
and tear.

         SECTION 405. MAINTENANCE OF INSURANCE. Each Credit Party shall maintain
with  financially  sound and  reputable  insurers  acceptable to Lender (i) with
reference  to its property  other than the  Collateral,  insurance  against such
risks and in such amounts as is customary in the case of Persons of  established
reputations engaged in the same or similar business and similarly situated,  and
(ii)  liability  and  worker's  compensation  insurance  in such  amounts  as is
customary in the case of Persons of established  reputations engaged in the same
or similar  business and  similarly  situated  (except that the dollar amount of
each Credit Party's liability  insurance coverage must be acceptable to Lender),
and, upon request by Lender,  shall furnish  Lender copies of the policies under
which such  insurance is carried.  The Credit  Parties'  obligations  concerning
insurance of the Collateral are governed by the applicable  Financing Documents.
The Credit  Parties  shall not be  required to maintain  property  insurance  on
Tissue Freezers.

         SECTION 406.  PAYMENT OF TAXES.  Each Credit Party shall punctually pay
and discharge all taxes,  assessments and governmental charges or levies imposed
upon it or



379000.1


                                      -16-





upon its income or upon any of its  property,  as well as all claims of any kind
which,  if unpaid,  might by law become a Lien upon its property,  except taxes,
assessments,  charges,  levies or claims  which are in good faith  being  timely
litigated or otherwise  properly contested by such Credit Party and which cannot
become a Lien  upon  any of the  Collateral  with  priority  over  the  security
interest of Lender or as to which such  Credit  Party has  established  reserves
satisfactory  to Lender.  Upon any Credit Party's failure to make prompt payment
of any such obligation of such Credit Party not excepted above,  Lender may, but
is  under  no  obligation  to,  pay all or any  part of the  same  or  effect  a
settlement  or  compromise  thereof in the name of such  Credit  Party;  and all
amounts so paid by Lender as well as the  expenses  incurred in  negotiating  or
attempting to negotiate a compromise or settlement will  automatically  become a
part of the  Liabilities of Borrower under this Agreement and will bear interest
from the date of such  payment at the lower of (i) the highest  rate of interest
which  Borrower  has  contracted  to pay on any of the  Liabilities  or (ii) the
highest rate permissible under applicable law.

         SECTION 407.  ENVIRONMENTAL  MATTERS.  Borrower  shall notify Lender in
writing, promptly upon learning thereof, of:

         (i) any  notice  that  any  Credit  Party is not in  compliance  in any
material  respect with all terms and  conditions  of all  permits,  licenses and
authorizations  which are required under  Environmental Laws, or that any Credit
Party is not in compliance in any material  respect with all other  limitations,
restrictions,  conditions, standards, prohibitions,  requirements,  obligations,
schedules and timetables contained in any applicable Environmental Laws;

         (ii) any  notice of any past,  present  or future  events,  conditions,
circumstances,  activities,  practices,  incidents, actions or plans which, with
respect to any Credit  Party,  may interfere  with or prevent its  compliance or
continued  compliance in any material  respect with  Environmental  Laws, or may
give  rise to any  material  common  law or  legal  liability  on its  part,  or
otherwise  form  the  basis  of  any  material  claim,  action,   demand,  suit,
proceeding,  hearing,  study or investigation against it, based on or related to
the manufacture,  processing,  distribution,  use, treatment, storage, disposal,
transport,  or  handling,  or the  emission,  discharge,  release or  threatened
release  into the  environment,  of any  pollutant,  contaminant,  chemical,  or
industrial, toxic or hazardous substance or waste; and

         (iii) any  notice or claim of any  civil,  criminal  or  administrative
action,  suit,  demand,  claim,  hearing,  notice  or demand  letter,  notice of
violation, investigation, or proceeding pending or threatened against any Credit
Party relating in any way to Environmental Laws.

         SECTION 408. PRIMARY  DEPOSITORY  RELATIONSHIPS.  To the maximum extent
permitted by applicable  law, the Credit  Parties shall  maintain  their primary
depository relationships with Lender.




379000.1


                                      -17-






                         ARTICLE V - NEGATIVE COVENANTS

         For so long as this Agreement is in effect, and unless Lender expressly
consents in writing  otherwise or to the contrary  (which  consent  shall not be
unreasonably  withheld),  Borrower hereby expressly  covenants and agrees to the
following negative covenants:

         SECTION 501. TYPE OF BUSINESS.  Borrower and its Subsidiaries shall not
engage in any type of business other than the  development,  sale,  licensing or
use of medical products,  bio-technology  or tissue  engineering or any activity
reasonably incidental thereto.

         SECTION 502.  TRANSACTIONS WITH AFFILIATES.  None of the Credit Parties
shall  engage in any  transactions  with an  Affiliate,  except on terms no less
favorable  to  such  Credit   Party  than  could  be  obtained  in   arms-length
transactions with others.

         SECTION 503.  MERGER,  CONSOLIDATION,  ACQUISITIONS,  ETC.  None of the
Credit Parties shall:  (i) transfer all or  substantially  all of its assets to,
consolidate  with  or  merge  with  any  other  Person;   (ii)  acquire  all  or
substantially  all of the  properties or capital  stock of any other Person;  or
(iii) create or acquire any  Subsidiary or enter into any  partnership  or joint
venture;  provided,  however,  that (a) any  Subsidiary of Borrower may merge or
consolidate  with, or convey all or substantially all of its assets to, Borrower
or  another   Subsidiary  of  Borrower  (but  Borrower  must  be  the  surviving
corporation  for any such  merger  or  consolidation  involving  Borrower),  (b)
Borrower may acquire all or substantially all of the properties or capital stock
of another  Person (or Borrower may form a Subsidiary to make such  acquisition)
so long as such  transaction  does not cause a violation of Section 501 above or
503(iii)(e)  below,  Borrower  complies with any and all requirements of Section
202(c)  applicable  thereto  and no other  Default or Event of Default  would be
caused  thereby,  (c)  Borrower  may  form a new  Subsidiary  so  long  as  such
transaction  does  not  cause a  violation  of  Section  501  above  or  Section
503(iii)(e) below and Borrower complies with any and all requirements of Section
202(c)  applicable  thereto  and no other  Default or Event of Default  would be
caused thereby, (d) any Credit Party may enter into a merger or consolidation in
connection with any acquisition  transaction permitted under clause (b) above so
long as such Credit Party is the  surviving  corporation  therefrom and no other
Default  or Event of  Default  would be caused  thereby,  and (e)  Borrower  may
acquire all or  substantially  all of the properties or capital stock of another
Person or create or acquire  Subsidiaries  or enter into  partnerships  or joint
ventures  so long as  Borrower's  total  investment  in all  such  acquisitions,
Subsidiaries, partnerships or joint ventures (whether in the form of cash, loans
or other property but exclusive of  contributions  or transfers of  Intellectual
Property  Rights)  does not  exceed  $7,000,000  in the  aggregate  and no other
Default or Event of Default would be caused  thereby.  Lender agrees that,  upon
request of  Borrower  from time to time (but not more  frequently  than once per
fiscal  year),  Lender  may  in  its  sole  discretion  increase  the  aforesaid
limitation on investment  set forth in clause (e) above,  which  increase  shall
become effective upon Lender's written notice to Borrower thereof.

         SECTION 504. ERISA MATTERS. None of the Credit Parties shall incur or



379000.1


                                      -18-





suffer to exist any material  accumulated  funding deficiency within the meaning
of ERISA  or incur  any  material  liability  to the  Pension  Benefit  Guaranty
Corporation established under ERISA (or any successor thereto under ERISA).

         SECTION 505.  LIENS.  None of the Credit  Parties shall create,  incur,
assume  or suffer  to exist  any Lien of any kind  upon any of its  property  or
assets now owned or hereafter acquired,  excluding,  however, from the operation
of this  covenant:  (1) liens in  connection  with  worker's  compensation;  (2)
deposits or pledges to secure the performance of bids, tenders, contracts (other
than contracts for the payment of money), leases, statutory obligations,  surety
and appeal bonds,  and other  obligations of a like nature arising in the normal
and ordinary course of business; (3) mechanics',  workmen's,  materialmen's, and
other like  liens  arising in the normal  and  ordinary  course of  business  in
respect of  obligations  which are not overdue or which are being  contested  in
good  faith  by  such  Credit  Party  and as to  which  such  Credit  Party  has
established reserves  satisfactory to the Lender; (4) tax or other nonconsensual
liens,  encumbrances or charges which are being litigated or otherwise  properly
contested  in good faith by such Credit  Party and as to which such Credit Party
has established reserves satisfactory to the Lender; (5) the security interests,
security  titles  and  liens  conveyed  to  Lender  under  any of the  Financing
Documents;  (6) Purchase Money Liens securing Purchase Money Indebtedness to the
extent  permitted  under  Section  508;  and (7) any other  Liens  disclosed  on
Schedule 505 attached hereto.

         SECTION  506.  GUARANTIES.  None of the  Credit  Parties  shall  in any
manner,  directly or indirectly,  become a guarantor of any obligation of, or an
endorser of, or otherwise  assume or become liable upon any obligations or other
indebtedness of any other Person except (i) pursuant to the Financing  Documents
or (ii) in connection  with the  depositing of checks in the normal and ordinary
course of business.

         SECTION 507. FINANCIAL COVENANTS. Borrower shall not violate any of the
following financial covenants.

         (a) Borrower shall not change its fiscal year without Lender's consent;

         (b) Borrower shall not make Capital Expenditures in any one fiscal year
ending on or after  December 31, 1996,  which exceed  $2,000,000 in total amount
for such fiscal year;

         (c) Borrower shall not permit its Current Ratio at any time on or after
the date of this Agreement to be less than 2.0 to 1.0;

         (d) Borrower  shall not permit its Leverage  Ratio to exceed 1.0 to 1.0
at any time on or after the date of this Agreement;

         (e) Borrower shall not permit its Net Worth to be less than $18,000,000
at any time during the period from the date of this Agreement  through  December
31, 1996,  and  Borrower  shall not permit its Net Worth at any time during each
fiscal year of Borrower



379000.1


                                      -19-





ending  thereafter to be less than its minimum  required Net Worth hereunder for
its immediately preceding fiscal year plus $500,000; and

         (f) Borrower  shall not permit its Debt  Coverage  Ratio for any fiscal
quarter or year to be less than 1.3 to 1.0.

         SECTION  508.  FUNDED  DEBT.  None of the Credit  Parties  shall incur,
assume,  or suffer to exist any Funded  Debt of such  Credit  Party,  except (i)
Funded  Debt  arising  under  this  Agreement  or  any of  the  other  Financing
Documents,  (ii) Purchase  Money  Indebtedness  not to exceed  $250,000 in total
amount for all the Credit  Parties  incurred in any fiscal  year,  and (iii) any
other Funded Debt described on Schedule 508 attached hereto.


                       ARTICLE VI - CONDITIONS TO LENDING

         All of Lender's  obligations  under this Agreement,  including  without
limitation any obligation to lend or advance moneys to Borrower,  are subject to
the fulfillment of each of the following conditions at or before the date hereof
as well as at the time each Loan is requested or made hereunder:

         SECTION 601.  REPRESENTATIONS  AND WARRANTIES.  All representations and
warranties  of the Credit  Parties  contained in this  Agreement and in each and
every of the other Financing Documents are true, correct,  complete and accurate
in all material respects.

         SECTION 602.  PERFORMANCE  OF COVENANTS.  The Credit Parties shall have
duly and  properly  performed in all respects  all  covenants,  agreements,  and
obligations  required  by the  terms  of  this  Agreement  or  any of the  other
Financing Documents to be performed by them.

         SECTION  603. NO VIOLATION  OF NEGATIVE  COVENANTS.  None of the Credit
Parties has taken or permitted to be taken any actions which would conflict with
any of the provisions of Article V of this Agreement.

         SECTION  604.  NO  MATERIAL  ADVERSE  CHANGES.  Since  the date of this
Agreement,  no material  adverse  change  shall have  occurred in the  business,
operations,  financial  condition  or assets of the  Credit  Parties  taken as a
whole.

         SECTION 605.  DELIVERY OF LOAN  DOCUMENTS.  Borrower  has  delivered to
Lender, or caused to be delivered to the Lender,  duly executed  counterparts of
this  Agreement,  the Note,  and the other  Financing  Documents  required under
Sections  202(a) and 202(b),  together with the following  described  additional
documents:

         (a)  Certificates  from the Secretaries of State of Florida and Georgia
issued as of the date of this Agreement (or within 45 days thereof) stating that
each of the Borrower and CryoLife  International is a corporation duly organized
(or, in the case of Georgia, is a



379000.1


                                      -20-





     foreign corporation qualified to do business) and is in good standing under
the laws of such states;

         (b) A copy  (certified by the  Secretary of State of Florida  within 45
days  of the  date of  this  Agreement)  of  each  of  Borrower's  and  CryoLife
International's certificate of incorporation;

         (c) A  Certificate  of the  Borrower  in the form of Exhibit F attached
hereto, duly completed and executed;

         (d) A Certificate  of CryoLife  International  in the form of Exhibit G
attached hereto;

         (e) An  opinion  of  counsel  for  Borrower  in the form of  Exhibit  H
attached hereto;

         (f) Satisfactory  evidence of the recording of such Uniform  Commercial
Code financing  statements and other  documents in such filing offices as Lender
may deem  necessary or  appropriate to perfect or maintain the perfection of the
Lender's  security  interests  under the Security  Agreement and the  Subsidiary
Security  Agreement,  as well as written  reports of  examinations of the public
records of such filing  office as the Lender may deem  necessary or  appropriate
indicating  that  there  are  no  other  Liens  of  record  covering  any of the
Collateral  covered  by  the  Security  Agreement  or  the  Subsidiary  Security
Agreement (except Liens permitted under Section 505 hereof);

         (g) Any Waivers and  Consents  required  from any  landlord or creditor
under Section 202 hereof.

         (g)  Such  other  documents,  instruments  and  agreements  as  may  be
reasonably required by Lender or Lender's counsel in connection with any loan or
advance hereunder.

         SECTION  606.  NO DEFAULT OR EVENT OF  DEFAULT.  No Default or Event of
Default shall have occurred.

         SECTION 607. INCIDENTAL MATTERS. All matters incidental to each advance
hereunder shall be reasonably satisfactory to Lender.


                         ARTICLE VII - EVENTS OF DEFAULT

         The  occurrence  of  any  one or  more  of the  following  events  will
constitute an event of default (herein called an "Event of Default") by Borrower
under this Agreement.

         SECTION 701. FAILURE TO PAY LIABILITIES. Failure of Borrower punctually



379000.1


                                      -21-





to make payment of any amount payable to Lender,  whether principal or interest,
on any of the Liabilities  within five (5) days of the date the same becomes due
and  payable,  whether at  maturity,  or at a date fixed for any  prepayment  or
partial prepayment, or by acceleration or otherwise.

         SECTION  702.   REPRESENTATIONS  AND  WARRANTIES.   If  any  statement,
representation, or warranty of any Credit Party made in this Agreement or in any
of the other  Financing  Documents at any time  furnished by or on behalf of any
Credit Party to Lender  proves to have been untrue,  incorrect,  misleading,  or
incomplete in any material respect as of the date made.

         SECTION  703.  NEGATIVE  COVENANT  BREACH.  Failure of any Credit Party
punctually  and fully to perform,  observe,  discharge or comply with any of the
covenants set forth in Article V of this Agreement.

         SECTION  704.  OTHER  COVENANT  BREACH.  Failure  of any  Credit  Party
punctually  and fully to perform,  observe,  discharge or comply with any of the
covenants set forth in this  Agreement  (other than Article V), which failure is
not cured within thirty (30) days after notice from Lender to Borrower.

         SECTION 705. OTHER AGREEMENTS WITH LENDER. The occurrence of a default,
an event of  default  or an Event of  Default  under any of the other  Financing
Documents or under any other  agreement to which any Credit Party and Lender are
parties or under any other  instrument  executed by any Credit Party in favor of
Lender, including any loan agreements, notes, leases, deeds or other documents.

         SECTION  706.  VOLUNTARY  BANKRUPTCY.   If  any  Credit  Party  becomes
insolvent  as  defined  in the  Georgia  Uniform  Commercial  Code or  makes  an
assignment  for the  benefit  of  creditors;  or if any action is brought by any
Credit Party  seeking  dissolution  of such Credit Party or  liquidation  of its
assets or seeking the appointment of a trustee,  interim trustee,  receiver,  or
other  custodian  for any of its  property;  or if any Credit Party  commences a
voluntary case under the Federal  Bankruptcy Code; or if any  reorganization  or
arrangement  proceeding is  instituted  by any Credit Party for the  settlement,
readjustment, composition or extension of any of its debts upon any terms; or if
any action or petition is otherwise  brought by any Credit Party seeking similar
relief  or  alleging  that it is  insolvent  or  unable to pay its debts as they
mature.

         SECTION 707. INVOLUNTARY  BANKRUPTCY.  If any action is brought against
any Credit Party seeking  dissolution of such Credit Party or liquidation of any
of its assets or seeking the appointment of a trustee, interim trustee, receiver
or other  custodian for any of its property,  and such action is consented to or
acquiesced in by such Credit Party or is not dismissed within sixty (60) days of
the date upon which it was  instituted;  or if any proceeding  under the Federal
Bankruptcy  Code is  instituted  against  such Credit Party and (i) an order for
relief is entered in such  proceeding or (ii) such proceeding is consented to or
acquiesced in by such Credit Party or is not dismissed within sixty (60) days of
the date upon



379000.1


                                      -22-





which it was instituted;  or if any reorganization or arrangement  proceeding is
instituted   against  any  Credit  Party  for  the   settlement,   readjustment,
composition,  or  extension  of  any of its  debts  upon  any  terms,  and  such
proceeding  is  consented  to or  acquiesced  in by such Credit  Party or is not
dismissed within sixty (60) days of the date upon which it was instituted; or if
any action or petition is otherwise  brought  against any Credit  Party  seeking
similar relief or alleging that it is insolvent, unable to pay its debts as they
mature, or generally not paying its debts as they become due, and such action or
petition  is  consented  to or  acquiesced  in by such  Credit  Party  or is not
dismissed within sixty (60) days of the date upon which it was brought.

         SECTION 708. OTHER  INDEBTEDNESS.  If any Credit Party is in default on
indebtedness  to another  Person having any  outstanding  balance of $100,000 or
more or an event has  occurred  which,  with the  giving of notice or passage of
time,  or both,  will  cause  such  Credit  Party to be in  default  on any such
indebtedness to another Person.

         SECTION 709.  MATERIAL  ADVERSE CHANGE.  Any material adverse change in
the  Credit  Parties'  financial  condition  or  means  or  ability  to pay  the
Liabilities.

         SECTION 710. CHANGE IN CONTROL.  The acquisition after the date of this
Agreement by any Person (or by any two or more Persons acting in concert) except
Steven G. Anderson of beneficial  ownership (within the meaning of Rule 13d-3 of
the Securities and Exchange Commission) of either (i) a sufficient number of the
Voting  Stock of Borrower so that the total  number of such shares  beneficially
owned by such Person (or group of Persons  acting in concert)  equals or exceeds
twenty-five  percent (25%) of the  outstanding  Voting Stock of Borrower or (ii)
the power to direct or cause the  direction  of the  management  and policies of
Borrower  (whether  through  ownership  of voting  securities,  by  contract  or
otherwise).


                      ARTICLE VIII - REMEDIES UPON DEFAULT

         SECTION 801. ACCELERATION AND OTHER REMEDIES. Upon the occurrence of an
Event of Default:

         (a) Lender  may, at its option and without  prior  notice to  Borrower,
terminate  its  remaining  obligations  hereunder  to make any further  Loans to
Borrower;

         (b)  Any  of  the  Liabilities  may   (notwithstanding  any  provisions
contained  therein  or  herein to the  contrary),  at the  option of Lender  and
without  presentment,  demand,  notice or  protest of any kind (all of which are
expressly  waived by Borrower in this  Agreement),  be declared due and payable,
whereupon they immediately will become due and payable;

         (c) Lender may also, at its option, and without notice or demand of any
kind, exercise from time to time any and all rights and remedies available to it
under this



379000.1


                                      -23-





Agreement  or under any of the other  Financing  Documents,  as well as exercise
from time to time any and all rights and remedies  available to a secured  party
when a debtor is in  default  under a  security  agreement  as  provided  in the
Uniform  Commercial  Code of Georgia,  or  available  to Lender  under any other
applicable  law or in  equity,  including  without  limitation  the right to any
deficiency remaining after disposition of the Collateral; and

         (d)  Borrower  shall  pay  all of the  reasonable  costs  and  expenses
actually incurred by Lender in enforcing its rights under this Agreement and the
other Financing Documents.  In the event any claim under this Agreement or under
any of the other Financing  Documents is referred to an attorney for collection,
or collected by or through an attorney at law, Borrower will be liable to Lender
for all reasonable  expenses  actually  incurred by it in seeking to collect the
Liabilities or to enforce its rights hereunder, in the other Financing Documents
or in  the  Collateral,  including  without  limitation  actual  and  reasonable
attorneys' fees.

         SECTION 802.  APPLICATION OF PROCEEDS;  COLLECTION  COSTS. Any proceeds
from  disposition of any of the Collateral may be applied by Lender first to the
payment of all  reasonable  expenses  and costs  actually  incurred by Lender in
collecting  such  Liabilities,  in enforcing the rights of Lender under each and
every of the  Financing  Documents  and in  collecting,  retaking,  holding  and
preparing the Collateral for and  advertising  the sale or other  disposition of
and realizing upon the Collateral,  including without  limitation the reasonable
expenses of  liquidating  any liens or claims upon the Collateral and reasonable
attorneys'  fees (but not to exceed  actual fees  incurred) as well as all other
legal  expenses and court costs.  Any balance of such proceeds may be applied by
Lender  toward  the  payment  of such of the  Liabilities  and in such  order of
application  as the Lender  may from time to time  elect.  Lender  shall pay the
surplus,  if any, to Borrower.  Borrower  shall pay the  deficiency,  if any, to
Lender.

                           ARTICLE IX - MISCELLANEOUS

         SECTION 901. TIME OF ESSENCE. Time is of the essence of this Agreement.

         SECTION 902. ENTIRE AGREEMENT.  This Agreement,  together with the Note
and all of the other Financing Documents, supersedes and replaces the Prior Loan
Agreements,  the Prior Security Agreements,  and all other prior discussions and
agreements  by and between any of the Credit  Parties and Lender with respect to
the Loans or the  Collateral,  and together they  constitute the sole and entire
agreement  between the parties with  respect  thereto.  No promises,  covenants,
representations,  or  agreements  other  than  as  expressly  set  forth  in the
Financing  Documents  have been made to or with any Credit  Party,  and Borrower
represents  and  warrants  that it is not  relying on any  promises,  covenants,
representations  or  agreements,  other  than as  expressly  set  forth  in such
documents in entering into this Agreement.

         SECTION 903.  SEVERAL  COUNTERPARTS.  This Agreement may be executed in
any number of counterparts each of which shall be deemed an original, and all of
such



379000.1


                                      -24-





counterparts together shall constitute one and the same instrument.

         SECTION 904. SURVIVAL OF WARRANTIES.  All  representations,  covenants,
and  warranties  made  in  this  Agreement,  or in any of  the  other  Financing
Documents are cumulative and in addition to those imposed by law or equity,  and
are to survive the execution  hereof,  the making of the Loans, and the delivery
hereof and of all the other Financing Documents.

         SECTION  905.  RIGHTS  CUMULATIVE.  All rights and  remedies of Lender,
whether  provided  for  herein or in any of the  other  Financing  Documents  or
conferred by law or in equity or by statute or otherwise, are cumulative and not
alternative,  and may be enforced successively or concurrently.  The collection,
repossession,  sale or retention of any of the Collateral by Lender will not bar
an action by Lender for the  recovery of any of the  Liabilities  of Borrower to
Lender  (Borrower  having expressly agreed herein to remain fully liable for any
deficiency), nor will Lender's bringing of an action against Borrower to recover
moneys  owing  under any of the  Liabilities  bar  Lender's  right to collect or
repossess any of the Collateral.

         SECTION  906.  NO  RELEASE;  TERM OF  AGREEMENT.  No sale,  assignment,
transfer,   renewal,   addition,    extension,    consolidation,    subdivision,
modification,  or  substitution  of  any of  the  Liabilities,  or of any of the
Financing  Documents,  or of any  interest  thereunder,  nor any  loss,  damage,
injury,  theft,  or destruction of any of the Collateral  will release  Borrower
from its  obligations  hereunder.  The Liabilities may from time to time be paid
and Liabilities thereafter incurred, and neither this Agreement nor the security
interests and security titles conveyed under the Financing Documents shall lapse
or terminate because no Liabilities are outstanding. This Agreement shall remain
in full force and effect until such time as (i) no Liabilities  are  outstanding
and (ii) Lender is under no obligation to make any Loans hereunder to Borrower.

         SECTION 907. WAIVERS AND MODIFICATIONS.  Lender will not be deemed as a
consequence of any act,  delay,  failure,  omission,  or forbearance  (including
without limitation failure to exercise its right of accelerating the maturity of
any of the Liabilities or other indulgences granted from time to time by Lender)
or for any other reason:  (1) to have waived, or to be estopped from exercising,
any of its rights or  remedies  under this  Agreement  or under any of the other
Financing  Documents,  or (2) to have modified,  changed,  amended,  terminated,
rescinded,  or  superseded  any of the terms of this  Agreement or of any of the
other Financing Documents, unless such waiver, modification,  amendment, change,
termination,  rescission, or supersession is express, in writing and signed by a
duly authorized  officer of Lender.  No single or partial  exercise by Lender of
any right or remedy will preclude other or further  exercise thereof or preclude
the  exercise  of any other  right or  remedy,  and a waiver  expressly  made in
writing on one occasion  will be effective  only in that  specific  instance and
only for the precise  purpose for which  given,  and will not be  construed as a
consent to or a waiver of any right or remedy on any future occasion.  No notice
to or demand on Borrower in any instance  will entitle  Borrower to any other or
future notice or demand in similar or other circumstances.



379000.1


                                      -25-






         SECTION 908. WAIVER OF  PRESENTMENT,  ETC.  Borrower  hereby  expressly
waives presentment,  demand,  dishonor,  protest,  notice for payment, notice of
non-payment,  notice of dishonor,  notice of default,  notice of  compromises or
surrender  and any other  demand or notice  whatsoever  in  connection  with the
Financing Documents.

         SECTION 909. NOTICES.  Except as provided  otherwise in this Agreement,
all notices and other  communications  under this Agreement are to be in writing
and are to be deemed to have been duly given and to be effective  upon  delivery
to the party to whom  they are  directed.  If sent by U.S.  mail,  first  class,
certified, return receipt requested, postage prepaid, and addressed to Lender or
to Borrower at their  respective  addresses set forth  beneath their  respective
signatures  below,  such  notices,  demands and other  communications  are to be
deemed to have been delivered on the second  business day after being so posted.
Either  Lender or  Borrower  may by  written  notice to the  other  designate  a
different address for receiving notices under this Agreement; provided, however,
that no such change of address will be effective until written notice thereof is
actually received by the party to whom such change of address is sent.

         SECTION 910. NO ASSIGNMENT BY BORROWER.  Borrower may not,  without the
consent of Lender,  assign any of its rights or duties hereunder or under any of
the other Financing Documents.

         SECTION 911. LENDER'S EXPENSES. All statements,  reports, certificates,
opinions,  and other  documents  or  information  furnished  to Lender under the
Financing  Documents  shall be  supplied  by  Borrower  without  cost to Lender.
Further,   Borrower  shall  reimburse   Lender  on  demand  for  all  reasonable
out-of-pocket  costs and expenses  (including  actual and reasonable legal fees)
incurred by the Lender or its  participants in connection with the  preparation,
establishment,   operation,   enforcement,  and  termination  of  the  Financing
Documents or the protection or  preservation of any right or claim of the Lender
with respect to the Financing  Documents;  provided,  however,  that  Borrower's
obligation to reimburse Lender for its attorney's fees and expenses  relating to
the  initial  preparation  and  establishment  of this  Agreement  and the other
Financing Documents shall not exceed $10,000.

         SECTION 912. PAYMENT OF TAXES.  Borrower will pay all taxes (if any) in
connection with this Agreement,  any of the other Financing Documents, any loans
made in connection with this  Agreement,  or the issuance or ownership of any of
the Financing  Documents and in connection with any  modification of said loans,
this Agreement, or any of the other Financing Documents (excluding, however, any
taxes  imposed upon or measured by the net income of the Lender),  and will save
the  Lender  harmless  without  limitation  as  to  time  against  any  and  all
liabilities  with respect to all such taxes.  The  obligations of Borrower under
this section shall survive the payment of the Liabilities and the termination of
this Agreement.

         SECTION 913. DEMAND LIABILITIES. If any of the Liabilities are by their
terms demand  obligations,  nothing  contained  herein shall  affect,  impair or
modify the



379000.1


                                      -26-





demand nature of such  obligations,  and the occurrence of a Default or an Event
of Default shall not be a prerequisite  for Lender's  requiring  payment of such
obligations.

         SECTION 914. SET-OFFS AGAINST DEPOSITS. Upon the occurrence of an Event
of Default hereunder, Lender, without notice or demand of any kind, may hold and
set off against such of the Liabilities (whether matured or unmatured) as Lender
may  elect,  any  balance or amount to the credit of  Borrower  in any  deposit,
agency,  reserve,  holdback or other account of any nature whatsoever maintained
by or on behalf of Borrower  with Lender at any of its  offices,  regardless  of
whether  such  accounts  are general or special and  regardless  of whether such
accounts are individual or joint.

         SECTION 915.  PARTICIPANT SET-OFF. Any Person purchasing an interest in
debt obligations  under this Agreement held by Lender may exercise all rights of
offset with respect to such interest as fully as if such Person were a holder of
debt obligations hereunder in the amount of such interest.

         SECTION  916.  CONFIDENTIALITY.  Each of the parties to this  Agreement
shall use  reasonable,  good  faith  efforts to  maintain  as  confidential,  in
accordance with such Person's  normal  practices and policies for protecting its
own confidential  information,  this Agreement and the other Financing Documents
and the terms and conditions  thereof,  and all other  information  delivered to
such party in  connection  with the  transactions  contemplated  by or otherwise
pursuant to this  Agreement  that is  proprietary in nature and that was clearly
marked or labeled or otherwise  identified  as being  confidential  information;
provided, however, that each such Person may disclose information concerning the
aforesaid  Financing  Documents  or their  terms and  conditions  or such  other
confidential  information  described  above  (i) as  required  in its  counsel's
opinion  pursuant to the lawful  requirements  or  requests of any  Governmental
Authority,  (ii) as required in its  counsel's  opinion by any  governmental  or
administrative  rule,  judicial  process or subpoena,  (iii) to their respective
attorneys,  accountants,  advisers or  consultants  (but only on a  confidential
basis as provided below),  (iv) to the extent necessary in its counsel's opinion
to enforce such Person's rights or remedies or perform such Person's obligations
under any of the  Financing  Documents  or  applicable  law,  (v) to the  extent
necessary or  appropriate  in the opinion of its counsel in connection  with any
litigation  or other  proceeding  having it or any of its  Affiliates as a party
thereto,  and (vi)  Lender  may  disclose  such  information  to any  actual  or
prospective  assignee or  participant  of Lender.  If Lender or any Credit Party
discloses any  information  covered by this  subsection to any of its attorneys,
accountants,  advisers or consultants,  such Person shall advise such attorneys,
accountants,  advisers or consultants of the provisions of this Section but such
Person  shall  not  be  liable  for  any  misappropriation  or  misuse  of  such
information by such attorneys,  accountants,  consultants or advisers other than
occasioned by such  Person's own gross  negligence  or willful  misconduct.  The
obligations  of the parties  under this Section 916 shall survive until one year
after the date of any termination of this Agreement. Lender agrees, upon request
of Borrower  following any  termination  of this  Agreement,  to use  reasonable
efforts to return to Borrower any  confidential  or  proprietary  information of
Borrower  delivered  to  Lender  pursuant  to  this  Agreement  and in  Lender's
possession.




379000.1


                                      -27-





         SECTION 917. GOVERNING LAW; SEVERABILITY. This Agreement and all of the
other Financing  Documents have been made and delivered in the State of Georgia,
and the terms, provisions and performance thereof are in all respects, including
without  limitation  all  matters  of  construction,  interpretation,  validity,
enforcement, and performance, to be construed in accordance with and governed by
the  internal  laws of that  State,  including  without  limitation  the Uniform
Commercial  Code of  Georgia,  as  amended  and in  effect  on the  date of this
Agreement.  Wherever possible,  each provision of this Agreement and of each and
every of the other Financing Documents is to be interpreted in such manner as to
be effective and valid under  applicable  law, but if any  provision  thereof is
prohibited or invalid under such law, such provision is to be  ineffective  only
to the  extent of such  prohibition  or  invalidity,  without  invalidating  the
remainder of such provision or the remaining  provisions of this Agreement or of
any of the other Financing Documents.

         SECTION 918.  SUCCESSORS  AND  ASSIGNS.  All rights of Lender under the
Financing  Documents  shall inure to the benefit of its  successors and assigns.
All  obligations  of  Borrower  under the  Financing  Documents  shall  bind its
successors and permitted assigns.

         SECTION 919. JURY TRIAL WAIVER AND CONSENT TO  JURISDICTION  AND VENUE.
EACH PARTY TO THIS  AGREEMENT  HEREBY WAIVES ANY RIGHT SUCH PARTY MAY HAVE UNDER
ANY  APPLICABLE  LAW TO A TRIAL BY JURY WITH RESPECT TO ANY SUIT OR LEGAL ACTION
WHICH MAY BE COMMENCED BY OR AGAINST SUCH PERSON OR THE OTHER PARTIES CONCERNING
THE INTERPRETATION,  CONSTRUCTION,  VALIDITY, ENFORCEMENT OR PERFORMANCE OF THIS
AGREEMENT OR ANY OF THE OTHER FINANCING DOCUMENTS.  EACH PARTY TO THIS AGREEMENT
FURTHER AGREES AND CONSENTS TO THE  JURISDICTION OF ANY FEDERAL COURT SITTING IN
FULTON COUNTY,  GEORGIA WITH RESPECT TO ANY SUCH SUIT OR LEGAL ACTION,  AND EACH
PARTY TO THIS  AGREEMENT  FURTHER  AGREES AND  CONSENTS  TO VENUE OF ANY FEDERAL
COURT  SITTING IN FULTON  COUNTY,  GEORGIA WITH REGARD TO ANY SUCH SUIT OR LEGAL
ACTION.






379000.1


                                      -28-




         IN WITNESS  WHEREOF,  Lender has executed this Agreement,  and Borrower
has executed this  Agreement  and placed its seal hereon,  all as of the day and
year first above written.

                                 BORROWER:

                                 CRYOLIFE, INC.


                                 By:/s/ Steven G. Anderson
                                    -------------------------
                                         President

                                      Address:  2211 New Market Parkway
                                                Suite 142
                                                Marietta, Georgia  30067

                                           (CORPORATE SEAL)

                                  LENDER:

                                  NATIONSBANK, N.A. (SOUTH)



                                   By:/s/ Christopher L. Jones
                                      ---------------------------
                                          Senior Vice President

                                      Address:  600 Peachtree Street, N.E.
                                                18th Floor
                                                Atlanta, Georgia  30308
                                      Attn:     Christopher L. Jones
                                                Senior Vice President



379000.1


                                      -29-






                                    EXHIBIT A

                                 PROMISSORY NOTE


AUGUST 30, 1996                                                      $10,000,000

     FOR VALUE RECEIVED, the undersigned (hereinafter referred to as "Borrower")
promises to pay to the order of NATIONSBANK,  N.A. (SOUTH) (hereinafter referred
to as  "Lender")  at Lender's  office  located at 600  Peachtree  Street,  N.E.,
Atlanta,  Georgia  30308,  or at such  other  place  as the  holder  hereof  may
designate,  the principal sum of TEN MILLION DOLLARS  ($10,000,000),  or so much
thereof  as shall  have been  advanced  hereagainst  and  shall be  outstanding,
together with  interest on so much of the principal  balance of this Note as may
be  outstanding  and  unpaid  from  time to time,  calculated  on the basis of a
360-day year and actual days  elapsed,  at the rate or rates per annum  provided
below.

     The unpaid principal balance of this Note shall bear interest at a rate per
annum equal to the Prime Rate (as defined below) plus (i) zero basis points (0%)
during the period from the date of this Note through  August 31, 2001,  and (ii)
twenty-five  basis points  (0.25%) from and after  September 1, 2001;  provided,
however,  that  Borrower  may,  by a written  notice  (or by  telephonic  notice
promptly confirmed in writing) delivered to the Lender not later than 10:00 a.m.
(Atlanta  time) on the  second  Business  Day prior to any  Interest  Period (as
defined below)  designated by the Borrower in such notice,  direct that interest
accrue on the  unpaid  principal  balance of this Note (or any  portion  thereof
which is in an amount of not less than $100,000 or any greater integral multiple
thereof) outstanding from time to time during such Interest Period at a rate per
annum  equal  to the sum of the  Adjusted  LIBOR  (as  defined  below)  for such
Interest Period plus the Applicable  LIBOR Margin (as defined below);  provided,
further,  however,  that upon the occurrence and during the  continuation of any
Event of  Default  (as  defined  below),  the  Lender  may,  upon  notice to the
Borrower,  suspend  Borrower's right to use the aforesaid Adjusted LIBOR option.
Each such designation by the Borrower of an interest rate for this Note based on
the  Adjusted  LIBOR  and of an  Interest  Period  applicable  thereto  shall be
irrevocable  and shall remain in effect  throughout such Interest  Period.  Upon
determining any interest rate based on the Adjusted LIBOR for an Interest Period
requested  by the  Borrower,  the Lender shall  promptly  notify the Borrower by
telephone  (which shall be promptly  confirmed in writing by the Lender) of such
determination,  and such determination  shall, in the absence of manifest error,
be final, conclusive and binding for all purposes.  Notwithstanding  anything in
this Note to the contrary,  a prepayment of any portion of the principal balance
of this Note which is then bearing  interest  based on the Adjusted LIBOR may be
made without penalty by the Borrower only on the last day of the Interest Period
applicable  thereto and, if any such prepayment is made on a day that is not the
last day of the  applicable  Interest  Period,  the  Borrower  shall  pay to the
Lender,  upon the  Lender's  written  request to the  Borrower  therefor  (which
request  shall set forth the basis for the request of such payment in reasonable
detail and, in the absence of manifest  error,  shall be final,  conclusive  and
binding on the Lender and the Borrower),  an amount equal to any and all losses,
expenses and liabilities  (including,  without limitation,  any interest paid by
the Lender to the  extent not  recovered  by the Lender in  connection  with its
re-employment  of the  prepaid  funds  and  including  any  loss of  anticipated
profits)  which the  Lender  may  sustain  as a result of such  prepayment.  The
calculation  of any and all amounts  payable to the Lender  with  respect to any
portion of the  principal  balance of this Note  bearing  interest  based on the
Adjusted  LIBOR  shall be made as though  the Lender had  actually  funded  such
portion  through  the  purchase  of  deposits  in the London  interbank  market;
provided,  however,  that the Lender  may fund such  portion of this Note in any
manner  it  sees  fit and the  foregoing  assumptions  shall  be used  only  for
calculation of amounts which may be payable under this Note.

     As used in  this  Note,  the  following  terms  shall  have  the  following
meanings: (a) "Adjusted LIBOR" shall mean, for any Interest Period, the rate per
annum  (rounded  upwards  to the  nearest  1/16th  of one  percentage  point (if
necessary))  equal to the quotient obtained by dividing (x) the offered rate for
United States dollar  deposits for a period  comparable to such Interest  Period
appearing  on the  Telerate  Screen Page 3750 (or as quoted or published by such
other recognized independent quote service as may be selected by the Lender from
time to time)  as of  11:00  a.m.  (Atlanta  time)  on the date  that is two (2)
Business Days prior to the  beginning of such  Interest  Period (but if at least
two such rates appear on such screen or are so quoted at such time,  the offered
rate for such Interest Period shall be the arithmetic mean of such rates) by (y)
a  percentage  equal to one (1) minus the then  average  stated  maximum  amount
(stated as a decimal) of all reserve  requirements  applicable  to any member of
the Federal Reserve System in respect of Eurocurrency  liabilities as defined in
Regulation  D of the Board of Governors  of the Federal  Reserve  System (or any
successor  categories  for  such  liabilities  under  such  Regulation  D);  (b)
"Applicable LIBOR Margin" shall mean (i) one hundred  seventy-five  basis points
(1.75%)  during the period from the date of this Note  through  August 31, 2000,
(ii) two hundred basis points  (2.0%)  during the period from  September 1, 2000
through August 31, 2001, and (iii) two hundred  twenty-five basis points (2.25%)
during the period from and after  September 1, 2001;  (c)  "Business  Day" shall
mean any day  excluding  a  Saturday,  Sunday,  any other day on which banks are
required or permitted to be closed in the city in which  Lender's  address shown
in this Note is located, and any other day on which trading is not carried on by
and between banks in United States dollars in the London interbank  market;  (d)
"Interest  Period" shall mean, in the case of the  determination of any Adjusted
LIBOR,  a one, two,  three,  four, six or twelve month period as selected by the
Borrower  but (i) in the event any  Interest  Period would end on a day which is
not a  Business  Day,  such  Interest  Period  shall  be  deemed  to  end on the
immediately  succeeding  Business  Day unless  such  extension  would cause such
Interest  Period to end on the next  calendar  month in which case such Interest
Period shall be deemed to end on the  immediately  preceding  Business Day, (ii)
any  Interest  Period  which  begins on a day for which there is no  numerically
corresponding day in the calendar month in which such Interest Period ends shall
expire on the immediately  preceding  Business Day, and (iii) the Borrower shall
not be entitled to select any  Interest  Period which  extends  beyond the final
maturity  date of this  Note;  (e)  "LIBOR  Advance"  means any  portion  of the
principal  balance of this Note which bears interest based on Adjusted LIBOR for
a particular  Interest Period;  (f) "Prime Rate" shall mean the rate of interest
announced by Lender from time to time as its "prime rate," "prime lending rate,"
"base rate" or similar  reference  rate (any such rate  announced by Lender is a
reference rate only and does not  necessarily  represent the best or lowest rate
actually charged by it to any customer and the Lender may make loans at rates of
interest which are at, above or below such reference rate) and the Prime Rate in
effect at the close of business  on each  business  day of Lender  shall for the
purposes  of this  Note be the  Prime  Rate  for  that  day and any  immediately
succeeding  non-business day or days of Lender,  and in the event the Prime Rate
is  discontinued  as a standard,  the holder hereof shall designate a comparable
reference rate as a substitute therefor; and (g) "Prime Rate Advances" means any
and all portions of the principal balance of this Note which bear interest based
on the Prime Rate.

     This Note shall be payable as follows:

                  (a) Accrued interest on this Note shall be payable as follows:
         (i)  during the period  from the date of this Note  through  August 31,
         1998, accrued interest shall be payable quarterly in arrears on so much
         of the  principal  balance of this Note as then  consists of Prime Rate
         Advances,  which payments shall be due commencing on November 30, 1996,
         and shall continue to be on the last day of each February,  May, August
         and November  thereafter up to and through August 31, 1998, and accrued
         interest  shall  be  payable  in  arrears  on so much of the  principal
         balance of this Note as then  consists of LIBOR  Advances at the end of
         each Interest Period applicable  thereto (and, in the case of any LIBOR
         Advance  having an Interest  Period in excess of three months,  accrued
         interest  thereon  shall be due on each day which  occurs  every  three
         months after the initial date of such Interest Period), and (ii) during
         the period from and after September 1, 1998,  accrued interest shall be
         payable in arrears on each date on which a payment of  principal is due
         on this Note pursuant to paragraph (b) below; and

                  (b) The  principal  balance of this Note shall be repayable in
         sixty (60) consecutive monthly  installments each in an amount equal to
         one-sixtieth (1/60th) of the outstanding principal balance of this Note
         as of the opening of the Lender's  business on September 1, 1998, which
         installments  shall be due  commencing  on October  1, 1998,  and shall
         continue to be due on the same day of each succeeding  month thereafter
         up to and through September 1, 2003, except that in all cases the final
         installment  of principal  due  hereunder on such final  maturity  date
         shall be in an amount equal to the entire  remaining  unpaid  principal
         balance of this Note.

     This Note is the "Note"  referred to in the Third Amended and Restated Loan
Agreement of even date between Borrower and Lender (said agreement,  as the same
may be hereafter  amended,  supplemented,  or restated,  being herein called the
"Loan  Agreement")  and this Note  evidences  any and all Loans now or hereafter
made by Lender to Borrower thereunder.

     Borrower  shall pay a late charge of five percent  (5%) of any  installment
payment  hereunder  which is not paid within ten (10) days after such payment is
due.  During the existence of any Event of Default  under this Note,  the unpaid
principal and accrued  interest balance of this Note shall bear interest on each
day  until  paid  at the  Prime  Rate  (as  defined  above)  plus,  in  Lender's
discretion,  up to an  additional  (i) two  percentage  points (2.0%) during the
period  from the  date of this  Note  through  August  31,  2001 or (ii) two and
one-quarter  percentage  points (2.25%) from and after September 1, 2001, but in
each such  period  only to the  extent  that  payment of such  interest  on such
principal  or interest is  enforceable  under  applicable  law.  All payments or
prepayments on this Note shall be applied,  first,  to interest  accrued on this
Note through the date of such payment or prepayment  and then to principal  (and
any  partial  principal  prepayments  on this Note made  prior to the date shown
above on which the  initial  principal  installment  is due  hereunder  shall be
applied to such installments in the inverse order of their maturity).

     Borrower may, upon thirty (30) days' prior written notice to Lender, prepay
the  principal  balance  of this  Note in whole or in part  without  premium  or
penalty but any  prepayment  of any portion of this Note then  bearing  interest
based on Adjusted  LIBOR will be subject to certain  additional  provisions  set
forth  above and any  partial  prepayment  of this Note shall be applied as also
provided above. In addition, in the event Borrower sells, transfers,  assigns or
otherwise  conveys any of its property to another person,  Borrower shall make a
mandatory principal prepayment on this Note, without premium or penalty,  within
five (5) business days after the closing of such  transaction,  which prepayment
shall be in an amount  equal to one hundred  percent  (100%) of the  proceeds of
such transaction (net of the cost of such transaction,  including any reasonable
sales  commissions  paid to persons who are not affiliated with the Borrower and
also net of any taxes  payable by the Borrower on account of such  transaction),
except that this  principal  prepayment  requirement  shall not apply to (i) any
sale by Borrower of its inventory in the ordinary  course of its business,  (ii)
any sale or other  disposition by Borrower of any of its obsolete or unnecessary
equipment  so long as the net  proceeds  of each  such  disposition  are used by
Borrower to replace such  equipment or purchase  other  equipment,  or (iii) any
other sale or  disposition  of any  property  by  Borrower  which the Lender has
expressly  agreed in writing  will be exempt from this  prepayment  requirement.
Notwithstanding the foregoing, however, no prepayment pursuant to this paragraph
shall be due in any  particular  fiscal  year of  Borrower  unless and until the
total amount of such net proceeds for all such sales or other  conveyances  made
during such fiscal year exceeds $500,000.

     Upon the  occurrence  of an Event of  Default  under  (and as such  term is
defined in) the Loan Agreement,  Lender, at its option, without demand or notice
of any kind,  may declare this Note  immediately  due and payable.  In case this
Note is collected by or through an attorney-at-law, all costs of such collection
incurred by the Lender,  including reasonable  attorney's fees, shall be paid by
Borrower (but not to exceed actual fees and expenses incurred).

     Time is of the essence of this Note. Demand, presentment, notice, notice of
demand, notice for payment,  protest and notice of dishonor are hereby waived by
each and every maker, guarantor,  surety and other person or entity primarily or
secondarily  liable on this Note. Lender shall not be deemed to waive any of its
rights under this Note unless such waiver be in writing and signed by Lender. No
delay or  omission  by Lender in  exercising  any of its rights  under this Note
shall operate as a waiver of such rights and a waiver in writing on one occasion
shall not be construed as a consent to or a waiver of any right or remedy on any
future occasion.

     This Note shall be governed by and  construed  and  enforced in  accordance
with the laws of the State of Georgia (without giving effect to its conflicts of
law rules).  Whenever possible, each provision of this Note shall be interpreted
in such manner as to be  effective  and valid under  applicable  law, but if any
provision of this Note shall be prohibited by or invalid under  applicable  law,
such provision  shall be ineffective  only to the extent of such  prohibition or
invalidity,  without  invalidating  the  remainder  of  such  provision  or  the
remaining provisions of this Note.

     Words  importing  the singular  number  hereunder  shall include the plural
number and vice versa,  and any pronoun used herein shall be deemed to cover all
genders. "Person" as used herein means any individual, corporation, partnership,
joint  venture,   association,   joint  stock  company,  trust,   unincorporated
association or government or any agency or political  subdivision  thereof.  The
word "Lender" as used herein shall include  transferees,  successors and assigns
of Lender,  and all rights of Lender hereunder shall inure to the benefit of its
transferees, successors and assigns. All obligations of Borrower hereunder shall
bind such Person's successors and assigns.

     SIGNED,  SEALED AND DELIVERED by the undersigned Borrower as of the day and
year first above set forth.

                               CRYOLIFE, INC.



                               By:__________________________
                                  Title:____________________

                                        (CORPORATE SEAL)



                                      



                                    EXHIBIT B

                     AMENDED AND RESTATED SECURITY AGREEMENT


     THIS  AGREEMENT  is made and entered  into as of August 30,  1996,  between
NATIONSBANK, N.A. (SOUTH), a national banking association which is the successor
by merger to Bank South, a Georgia  banking  corporation  formerly known as Bank
South,  N.A.,  having its main office at 600 Peachtree  Street,  N.E.,  Atlanta,
Georgia  30308  ("Secured  Party"),  and CRYOLIFE,  INC., a Florida  corporation
having its chief executive  office and principal place of business at 2211 North
Market Parkway, Suite 142, Marietta, Cobb County, Georgia 30067 ("Debtor").

                               STATEMENT OF FACTS

     Secured Party holds certain liens on certain of Debtor's equipment pursuant
to an  Equipment  Security  Agreement,  dated as of August 4, 1994,  executed by
Debtor in favor of Secured Party (the "Prior Security  Agreement"),  which liens
secured  certain of the loans made by Secured  Party to Debtor  under the Second
Amended and Restated Loan  Agreement,  also dated as of August 4, 1994,  between
Secured Party and Debtor (the "Prior Loan Agreement").

     Secured  Party and Debtor  have  agreed to amend and restate the Prior Loan
Agreement by entering into a Third Amended and Restated Loan Agreement, dated as
of the date hereof, between Secured Party and the Debtor (said agreement, as the
same may be  amended,  supplemented  or  restated,  is herein  called the "Third
Restated  Loan  Agreement").  It is a  condition  precedent  to Secured  Party's
obligation to make loans to Debtor under the Third  Restated Loan Agreement that
the Prior  Security  Agreement  be amended  and  restated  as  provided  in this
Agreement, and that parties are entering into this Agreement for such purpose.

     In  consideration  of any and all loans or other extensions of credit which
may be now or hereafter  made from time to time by Secured Party to Debtor under
the  Third  Restated  Loan  Agreement,  as well as for other  good and  valuable
consideration, the receipt and adequacy of which are hereby acknowledged, Debtor
and  Secured  Party do hereby  agree to amend  and  restate  the Prior  Security
Agreement as follows:

                               STATEMENT OF FACTS

     1. SECURITY  INTEREST.  (a) Debtor hereby grants to Secured Party a present
and continuing security interest in and lien on all of the Collateral  described
in Sections l(b) and l(c) below to secure the payment and  performance of all of
the Obligations described in Section 2 below.

     (b) The term  "Collateral"  as used  herein  shall mean and include all now
existing or hereafter  arising rights,  titles and interests of Debtor in, to or
under the following  types or items of property of Debtor,  whether now owned or
hereafter  existing or hereafter  created,  acquired or arising and  wheresoever
located, and all cash and non-cash proceeds thereof:

         (i)      ALL ACCOUNTS RECEIVABLE, ETC. - All accounts, contract rights,
                  chattel paper, instruments,  documents and general intangibles
                  of Debtor,  including without limitation all causes of action,
                  corporate  or  other  records,   deposit  accounts,   patents,
                  trademarks, service marks, trade names, copyrights, good will,
                  customer  lists,  tax refund claims,  computer  programs,  and
                  software, and all claims under guaranties,  letters of credit,
                  security  interests  or other  security  held by or granted to
                  Debtor  to secure  payment  of any of its  accounts,  contract
                  rights, chattel paper, instruments or general intangibles, and
                  all  rights  to  indemnification   and  all  other  intangible
                  property of any kind and nature of Debtor  (collectively,  the
                  "Accounts Receivable");

         (ii)     ALL  INVENTORY,  ETC. - All of Debtor's  inventory,  including
                  without  limitation  all goods  intended  for sale or lease by
                  Debtor or for display or  demonstration,  all work in process,
                  all raw materials, all finished goods, and all other materials
                  and supplies of every nature and description  used or intended
                  for use in connection with the manufacture, printing, packing,
                  shipping, advertising,  selling, leasing or furnishing of such
                  goods or otherwise  used or consumed in Debtor's  business and
                  all  documents  evidencing  and all warranty  rights and other
                  general   intangibles   relating  to  any  of  the   foregoing
                  (collectively,  the "Inventory");  provided, however, that the
                  inventory shall not include any human tissue; and

         (iii)    ALL  EQUIPMENT,  ETC. - All machinery,  apparatus,  equipment,
                  furniture,  fixtures,  leasehold improvements,  motor vehicles
                  and other tangible  personal property (other than Inventory as
                  defined above) of Debtor of every kind and description used in
                  Debtor's operations or business or owned by Debtor or in which
                  Debtor  has  an  interest,  and  all  parts,  accessories  and
                  accessions   thereto  and   substitutions   and   replacements
                  therefor, and all documents evidencing and all warranty rights
                  and other general intangibles of Debtor relating to any of the
                  foregoing (collectively, the "Equipment").

         Notwithstanding  anything herein to the contrary,  the Collateral shall
not  include  any of Debtor's  Intellectual  Property  Rights (as defined in the
Third Restated Loan  Agreement)  but the  Collateral  shall include the proceeds
thereof.

         (c)  Unless  otherwise  defined  herein,  all terms  contained  in this
Agreement shall have the meanings provided for by the Uniform Commercial Code as
in effect in the State of  Georgia  to the  extent  the same are used or defined
therein.  In addition,  the term "proceeds" as used herein includes  whatever is
receivable  or received  when any  Collateral  or any proceeds  thereof is sold,
collected,  exchanged or  otherwise  disposed of,  whether such  disposition  is
voluntary or  involuntary,  and also includes  without  limitation all rights to
payment (including  returned premiums) with respect to any insurance relating to
such Collateral. In addition, all references herein to a particular type or item
of Collateral shall be deemed to include all now existing or hereafter  acquired
books and records of Debtor  relating  to such  Collateral  (including,  without
limitation, all computer materials and records). The Collateral also includes in
all cases all monies and other property of Debtor of any other kind which may be
now or hereafter in the  possession of or under the control of Secured Party and
all deposit or other  accounts of Debtor with Secured  Party and all balances or
other property now or hereafter held or on deposit therein.

         2. OBLIGATIONS  SECURED.  This Agreement and the security  interest and
lien granted hereunder to Secured Party secures all obligations which may be now
or hereafter  owing by Debtor to Secured  Party under this  Agreement as well as
any and all  indebtedness,  obligations or other liabilities which may be now or
hereafter  owing by the Debtor to Secured Party under or on account of the Third
Restated  Loan  Agreement  or any of the other  Financing  Documents  as defined
therein, and including without limitation any interest which, but for the filing
by or against  Debtor of a petition in  bankruptcy,  would  accrue on any of the
foregoing  indebtedness,  obligations  or  liabilities.  All  of  the  foregoing
indebtedness,  obligations or other liabilities are herein  collectively  called
the "Obligations".

         3.  REPRESENTATIONS  AND  WARRANTIES.   Debtor  hereby  represents  and
warrants to Secured Party that:

         (a)  Debtor  has  full  power  and  authority,  and has  completed  all
proceedings  and obtained all  approvals  and  consents  necessary,  to execute,
deliver and perform this Agreement and the transactions contemplated hereby.

         (b) Such  execution,  delivery,  and performance  will not violate,  or
cause a default under or result in a lien (other than Secured  Party's  security
interest  and lien  hereunder)  upon any  property  of Debtor  pursuant  to, any
applicable law, rule or regulation or any agreement, indenture, judgment, order,
decree, or instrument binding upon or affecting Debtor or any of the Collateral.

         (c) This Agreement constitutes the legal, valid, and binding obligation
of Debtor,  enforceable  against Debtor in accordance  with its terms (except as
such enforceability may be limited by bankruptcy,  insolvency,  or other similar
laws  affecting the  enforcement  of creditor's  rights or by general  equitable
principles),  and this Agreement grants to Secured Party a valid and enforceable
security interest in or other lien on the Collateral.

         (d) Debtor's chief executive office and principal place of business are
located at Debtor's address shown above.

         (e) Debtor has good and marketable  title to the Collateral (or, in the
case of any  after-acquired  Collateral,  Debtor  will have good and  marketable
title to the Collateral at the time Debtor acquires rights in such Collateral).

         (f) Except for the  security  interest  and lien  granted  hereunder in
favor of Secured  Party,  no person has (or,  in the case of any  after-acquired
Collateral,  at the time Debtor acquires  rights therein,  will have) any right,
title,  claim, or other interest (whether in the nature of a security  interest,
other lien or charge,  or  otherwise)  in,  against or to any  Collateral or any
interest therein.

         (g) All information heretofore, herein or hereafter supplied to Secured
Party by or on behalf of Debtor with respect to any of the Collateral is or will
be true and correct in all material respects at the time so supplied.

         (h) Debtor has delivered to Secured Party all  instruments,  documents,
chattel paper,  and other items of Collateral in which Secured Party's  security
interest or lien hereunder  must be perfected by possession and the  certificate
of title with respect to each motor vehicle, if any, included in the Collateral,
together with such additional  writings,  including,  without  limitation,  duly
executed blank and undated assignments and stock powers, with respect thereto as
Secured Party shall request.

         All of the foregoing  representations  and warranties shall survive the
execution, delivery and acceptance of this Agreement by Secured Party and Debtor
and the closing of the transactions contemplated hereby.

         4.  COVENANTS  AND  AGREEMENTS OF DEBTOR.  Debtor hereby  covenants and
agrees with Lender as follows:

         (a)  Debtor  shall  do all  acts  that may be  necessary  to  maintain,
preserve, and protect the Collateral.

         (b)  Debtor  shall  not  use or  permit  any  Collateral  to be used in
violation of any applicable  law, rule or  regulation,  or any provision of this
Agreement or any other  agreement  with Secured  Party related  thereto,  or any
policy of insurance covering such Collateral.

         (c) Debtor shall pay promptly when due all taxes, assessments, charges,
encumbrances and liens now or hereafter imposed upon or affecting any Collateral
or Secured  Party's  security  interest or other lien  hereunder  (including all
property, excise, intangible, use, sales, stamp and other such taxes), except to
the extent expressly permitted in the Third Restated Loan Agreement.

         (d) Debtor shall appear in and defend any action or proceeding that may
adversely affect its title to or Secured Party's interests in the Collateral.

         (e)  Except  to  the  extent  permitted  in  the  Third  Restated  Loan
Agreement,  Debtor shall not sell, encumber, lease, rent or otherwise dispose of
or transfer  any  Collateral  or any right or interest  therein and Debtor shall
keep the  Collateral  free of all levies,  security  interests  or other  liens,
charges or encumbrances.

         (f) Debtor shall comply in all material  respects with all laws,  rules
and regulations  (including those governing  environmental  matters) relating to
the possession,  operation, storage,  maintenance,  disposal, and control of the
Collateral.

         (g)  Debtor  agrees  that  such  care as  Secured  Party  gives  to the
safekeeping of its own property of like kind shall constitute reasonable care of
such Collateral when it may be in Secured Party's possession.

         (h) If and to the extent  requested  by  Secured  Party,  Debtor  shall
account fully for and promptly  deliver to Secured Party,  in the form received,
all  documents,   chattel  paper,   instruments,   and  agreements  constituting
Collateral hereunder and all proceeds of the Collateral  received,  all endorsed
to Secured Party or in blank.

         (i) Debtor shall keep accurate,  and complete records of the Collateral
and shall  provide  Secured  Party with such records and such other  reports and
information relating to the Collateral as Secured Party may request from time to
time.

         (j) Debtor shall keep, procure,  execute, and deliver from time to time
any and all, indorsements, notifications,  registrations, assignments, financing
statements,  fixture  filings,  certificate  of title  applications,  and  other
writings deemed necessary or appropriate by Secured Party to perfect,  maintain,
and protect its security  interest in or other lien on the Collateral  hereunder
and the priority  thereof,  and Debtor shall take such other  actions as Secured
Party may request to protect the value of the Collateral and of Secured  Party's
security interest in the Collateral,  including,  without limitation,  obtaining
such landlord waivers, mortgagee waivers and other assurances from third parties
regarding  Secured  Party's  access  to and  right to  foreclose  on or sell the
Collateral  and right to realize the practical  benefits of such  foreclosure or
sale as Secured Party may request.  Unless  prohibited by applicable law, Debtor
hereby authorizes  Secured Party to execute and file any financing  statement or
fixture  filing on  Debtor's  behalf,  and the  parties  further  agree that any
carbon,  photographic,   or  other  reproduction  of  this  Agreement  shall  be
sufficient as a financing  statement and may be filed in any appropriate  office
in lieu thereof.

         (k) Debtor shall reimburse  Secured Party upon demand for all costs and
expenses,  including, without limitation,  actual and reasonable attorney's fees
and disbursements,  Secured Party may now or hereafter incur while exercising or
enforcing any right, power, or remedy provided to Secured Party by this Security
Agreement or by law, all of which costs and expenses  shall  constitute  part of
the Obligations secured hereunder.

         (l) Debtor  shall give  Secured  Party not less than  thirty  (30) days
prior  written  notice  of any  change in  Debtor's  chief  executive  office or
principal  place of business or Debtor's legal name or trade name(s) or style(s)
from that set forth in this Agreement.

         (m) Debtor shall keep its records concerning the Collateral at Debtor's
address set forth above or at Debtor's other  location(s)  (if any) set forth on
Schedule 1 attached to this  Agreement  and shall not remove such  records  from
such location(s) without the prior written consent of Secured Party.

         (n) Debtor shall keep all  Collateral  consisting  of goods (other than
Inventory in transit and mobile goods) at the address for Debtor set forth above
or at Debtor's other locations (if any) set forth on Schedule 1 attached to this
Agreement,  and Debtor shall not,  without the prior written approval of Secured
Party,  remove any  Collateral  therefrom  except for sales of  Inventory in the
ordinary  course  of  business  and the  disposition  of  obsolete  or  worn-out
Equipment in accordance  with this Agreement and except for the storage of goods
at  locations  other than those shown above or on Schedule 1 attached  hereto if
(i) Debtor gives  Secured Party  written  notice of the new storage  location at
least thirty (30) days prior to storing such  Collateral at such location,  (ii)
Secured Party's security interest in such Collateral  hereunder is and continues
to be duly  perfected,  (iii) all documents and other receipts in respect of any
Collateral  maintained at such premises are promptly delivered to Secured Party,
and (iv) the owner (and, if requested by Secured  Party,  any mortgagee) of such
premises  agrees in writing with Secured Party not to assert any lien in respect
of such  Collateral  and to permit Secured Party to have the right to enter upon
and use such premises in order to inspect,  store,  process,  assemble or remove
the Collateral therefrom after the occurrence of an Event of Default.

         (o) Debtor shall furnish Secured Party with such information  regarding
the Collateral (and any account  debtors  thereunder) as Secured Party from time
to time may request.

         (p) Debtor shall keep the  Collateral in good  condition and repair and
shall not cause or permit any waste of any of the Collateral.

         (q) Debtor shall  insure the  Collateral,  with Secured  Party named as
loss payee under all property  coverages and as an additional  insured under all
liability  coverages,  in form and amount, with insurers,  and against risks and
liabilities which are satisfactory to Secured Party in all respects,  and Debtor
hereby assigns all such policies and all proceeds  thereof  (including  returned
premiums) to Secured Party, to secure the Obligations, agrees to deliver them to
Secured  Party at its request,  and agrees that Secured Party may make any claim
thereunder,  cancel the  insurance  on default by Debtor,  collect  and  receive
payment and indorse any instrument in payment of loss or return premium or other
refund or return, and apply such amounts received,  at Secured Party's election,
to replacement of the Collateral or to the Obligations.  Debtor shall not use or
permit  the  use of any of the  Collateral  in  any  manner  which  will  render
inapplicable or invalid any insurance  coverage  therefor.  Debtor shall deliver
the  originals of all property  insurance  policies  covering the  Collateral to
Secured  Party  together  with loss  payable  endorsements  thereon  in form and
substance satisfactory to Secured Party and in the name of Secured Party as loss
payee  thereunder.  Each  policy of  insurance  or each such  endorsement  shall
contain a clause  requiring  the  insurer to give not less than thirty (30) days
prior written notice to Secured Party in the event of cancellation of the policy
for  nonpayment  of premium  and a clause to the effect  that the  interests  of
Secured  Party  thereunder  shall not be impaired or  invalidated  by any act or
neglect of Debtor nor by the  occupation  of the  premises  covered  thereby for
purposes more hazardous than are permitted by said policy.

         (r) Debtor agrees that all risk of loss of the Collateral  shall at all
times be and remain upon Debtor  irrespective of whether such Collateral is then
in Debtor's or Secured Party's possession.

         (s) Debtor  agrees that any of the  Collateral  consisting of Equipment
shall be and remain personal property and shall not, by reason of its attachment
or other  connection  to any real  property,  either become or be deemed to be a
fixture or  appurtenance  to such real property and shall at all times be deemed
severable therefrom.

         (t) Debtor  shall permit  Secured  Party (or any person  designated  by
Secured Party) from time to time to inspect the Collateral and to inspect, audit
and make copies of or extracts  from all books and records  maintained  by or on
behalf of Debtor pertaining to the Collateral (including computer records),  all
at such times and places as Secured Party may request from time to time.

         5. POWER OF  ATTORNEY.  Debtor  hereby  agrees  that from time to time,
without presentment, notice or demand, and without affecting or impairing in any
way the rights of Secured Party with respect to the Collateral,  the obligations
of Debtor hereunder or the other  Obligations,  Secured Party may, but shall not
be  obligated  to and shall incur no  liability to Debtor or any third party for
failing to, take any action which Debtor is obligated by this  Agreement to take
but which the Debtor  fails to take,  and Debtor  also  hereby  appoints  (which
appointment is coupled with an interest and shall be irrevocable so long as this
Agreement is in effect)  Secured Party as its  attorney-in-fact  with full power
and  authority  at any  time to take any of the  following  actions  during  the
existence  of any Event of  Default  hereunder  in either  Debtor's  or  Secured
Party's name (but Secured  Party shall have no  obligation to and shall incur no
liability to Debtor or any third party for failing to exercise any such power or
authority):  (a) to collect  by legal  proceedings  or  otherwise  and  indorse,
receive and receipt for all dividends,  interest,  payments, proceeds, and other
sums and  property  now or  hereafter  payable  on or on  account  of any of the
Collateral;  (b) to enter into any extension,  reorganization,  deposit, merger,
consolidation,  or other agreement pertaining to, or deposit, surrender, accept,
hold or apply other  property in exchange  for,  any of the  Collateral;  (c) to
insure,  process, and preserve any of the Collateral or to take any other action
which Debtor is obligated by this  Agreement to take; (d) to transfer any of the
Collateral  to its own or its  nominee's  name;  (e) to make any  compromise  or
settlement,  and take any action it deems advisable,  with respect to any of the
Collateral; (f) to prepare, file and sign Debtor's name to any proof of claim in
bankruptcy  (or any similar  document)  against any account debtor on any of the
Collateral;  (g) to receive, open and dispose of Debtor's mail pertaining to any
of  the  Collateral   consisting  of  Accounts  Receivables  and  notify  postal
authorities to deliver such mail to such address as Secured Party may designate;
(h) to indorse Debtor's name upon any checks or other proceeds of any Collateral
and deposit same to any account of Secured Party;  (i) to indorse  Debtor's name
on any other  document,  instrument  or other  agreement  relating to any of the
Collateral;  (j) to send verifications of Accounts Receivable to account debtors
thereunder;  (k) to use the  information  recorded on or  contained  in any data
processing  equipment,  other computer  hardware or any software relating to any
Collateral;  (l) to make,  adjust or enforce  claims under any insurance  policy
relating to any Collateral;  (m) to do all other acts and things  necessary,  in
Secured Party's judgment,  to fulfill Debtor's obligations under this Agreement;
and (n) to pay any and all taxes,  assessments,  charges,  encumbrances or liens
now or hereafter imposed upon or affecting any of the Collateral.  The foregoing
power of attorney may be exercised by Secured  Party in its  discretion,  in its
name or Debtor's name, and without prior notice to or demand upon Debtor. Debtor
agrees to reimburse  Secured  Party on demand for any sums  advanced or expenses
incurred by Secured Party in exercising  any of the foregoing  rights and powers
together  with  interest  accruing  thereon daily at the highest rate Debtor has
contracted to pay on any of the Obligations.  Debtor's reimbursement obligations
under this Section shall constitute part of the Obligations secured hereunder.

         6. EVENTS OF DEFAULT. An event of default under this Agreement shall be
deemed to exist upon the  occurrence  of any of the  following  event (each such
event being herein called an "Event of Default"):

         (a) If any representation, or warranty of Debtor made in this Agreement
proves to have been untrue, incorrect,  misleading or incomplete in any material
respect as of the date made or deemed made;

         (b) Failure of Debtor to perform, observe, discharge or comply with any
of the covenants set forth in Section 4 (other than  subsection  (e), (k) or (l)
thereof) of this  Agreement,  which failure is not cured within thirty (30) days
of the giving by Secured Party to Debtor of written notice of same;

         (c)  Failure  of  Debtor  punctually  and  fully to  perform,  observe,
discharge or comply with any of the other covenants set forth in this Agreement;

         (d) The  occurrence  of any other  Event of Default  under (and as such
term is defined in) the Third Restated Loan Agreement.

         7.  SECURED  PARTY'S  REMEDIES.  Upon the  occurrence  and  during  the
continuation  of any one or more of the  foregoing  Events of  Default,  Secured
Party  may,  at its  option,  and  without  notice to or demand on Debtor and in
addition to all rights and remedies  available to Secured  Party under the Third
Restated Loan Agreement or any of the other Financing  Documents,  or at law, in
equity, or otherwise, do any one or more of the following:

         (a)  Secured  Party may  declare  any or all of the  Obligations  to be
immediately  due and payable and foreclose or otherwise  enforce Secured Party's
security  interest in or other lien hereunder on any or all of the Collateral in
any manner permitted by law or provided for in this Agreement.

         (b)  Secured  Party may  recover  from  Debtor all costs and  expenses,
including,  without limitation,  actual and reasonable attorney's fees, incurred
or paid by Secured Party in exercising or enforcing any right,  power, or remedy
with respect to any or all of the Collateral provided to it by this Agreement or
by applicable law. Notwithstanding anything herein to the contrary, the Debtor's
liability under this Agreement for the Secured Party's attorney's fees shall not
exceed the attorney's fees actually incurred by the Secured Party.

         (c)  Secured  Party may require  Debtor to  assemble  any or all of the
Collateral and make it available to Secured Party at such place or places as may
be designated by Secured Party.

         (d) Secured Party may enter onto any property  where any  Collateral is
located and take possession thereof with or without judicial process.

         (e) Prior to Lender's disposition of any Collateral,  Secured Party may
store, process,  complete,  repair or recondition it or otherwise prepare it for
disposition in any manner and to the extent Secured Party deems appropriate (but
Secured Party shall not be obligated to do so).

         (f) Secured  Party may  transfer any of the  Collateral  into its name,
notify any account  debtor under or other person  obligated on any Collateral to
make payments  thereunder  directly to Secured Party,  and otherwise  collect or
enforce  payment  of any of the  Collateral  (but  Secured  Party  shall have no
obligation to do any of the foregoing).

         (g)  Secured  Party  may  sell  or  otherwise  dispose  of  any  of the
Collateral at one or more public or private sales at Debtor's or Secured Party's
place of business or any other place or places,  including without limitation at
any  brokers  board or  security  exchange,  in lots or in bulk,  for cash or on
credit,  all as Secured Party,  in its discretion,  may deem  advisable.  Debtor
agrees that seven (7) days' prior written notice from Secured Party to Debtor of
any public sale of any  Collateral  or the date after which any private  sale of
any Collateral will be held shall constitute  reasonable notice thereof and such
sale may be held at such  locations as Secured  Party may designate in each said
notice.  Secured Party shall have the right to conduct any such sale on Debtor's
premises,  without any charge therefor, and any such sales may be adjourned from
time to time in accordance with  applicable law.  Secured Party may purchase all
or any part of the  Collateral  at any public sale or, if  permitted by law, any
private  sale and, in lieu of actual  payment of such  purchase  price,  Secured
Party may set-off the amount of such price against the Obligations.

         (h) Secured Party is hereby  granted by Debtor a license or other right
to use during the term of this Agreement, without charge, any or all of Debtor's
labels, patents,  software,  copyrights,  trade secrets, trade names, trademarks
and advertising  materials,  or any other property of any similar nature,  as it
pertains  to any of the  Collateral,  in  advertising  for sale and  selling any
Collateral or in completing  Debtor's  performance  under or collecting any sums
owing in respect of any  Collateral,  and Debtor's rights under all licenses and
all  franchise  agreements  relating  to any of the  Collateral  shall  inure to
Secured  Party's  benefit to the extent of Secured  Party's  rights,  titles and
interests in or to the Collateral under this Agreement.

         (i) Secured Party also may, without prior notice or demand of any kind,
hold and set-off against such of the Obligations  (whether matured or unmatured)
as Secured  Party may elect any balance of amount to the credit of Debtor in any
deposit,  agency,  reserve,  holdback or other account of any nature  whatsoever
which may be now or hereafter  maintained by or on behalf of Debtor with Secured
Party in any of its offices,  regardless  of whether any such account is general
or special and regardless of whether any such account is individual or joint.

         8. APPLICATION OF PROCEEDS.  (a) All monies and other proceeds received
by  Secured  Party  upon  any  collection,  sale  or  other  disposition  of any
Collateral,  together  with all other  monies  and other  proceeds  received  by
Secured Party hereunder, shall be applied as follows:

                           First,  to the  payment of the  reasonable  costs and
                  expenses of such sale,  collection or other  disposition which
                  may have been  incurred by Secured  Party,  including  without
                  limitation  actual and reasonable  attorney's fees as provided
                  in  Section  7(b)  above  and all other  reasonable  expenses,
                  liabilities  and advances made or incurred by Secured Party in
                  connection therewith;

                           Second,  to the payment of all other Obligations then
                  due in such order as Secured Party may elect; and

                           Third,  after payment in full of all Obligations then
                  due, any surplus then  remaining  from such proceeds  shall be
                  paid to Debtor; and

         (b) Debtor  shall  remain  liable to Secured  Party for any  deficiency
owing on the Obligations after the application of the proceeds of the Collateral
as provided above.

         9. INDEMNITY.  Debtor hereby agrees to indemnity Secured Party and hold
Secured Party  harmless  from and against any claim,  liability,  loss,  damage,
expense,  suit,  action or proceeding  which may now or hereafter be suffered or
incurred by Secured Party as a result of Debtor's failure to observe, perform or
discharge Debtor's duties or obligations hereunder or Secured Party's holding or
administering this Agreement or any Collateral unless with respect to any of the
above Secured Party is finally determined to have acted with gross negligence or
to have engaged in willful  misconduct.  Without  limiting the generality of the
foregoing,  this indemnity shall extend to any claims  asserted  against Secured
Party by any person under any environmental,  occupational safety and hazard, or
other  similar  laws,  rules or  regulations  by reason of Debtor's or any other
person's  failure  to  comply  with any such  laws,  rules or  regulations.  The
indemnity  obligations  of Debtor under this Section shall  constitute a part of
the  Obligations  secured  hereunder and shall survive the  termination  of this
Agreement.

         10. MISCELLANEOUS.  (a) Any waiver,  forbearance or failure or delay by
Secured Party in exercising  any of its rights,  powers,  or remedies  hereunder
shall not preclude the further  exercise  thereof,  and every right,  power,  or
remedy of Secured Party  hereunder shall continue in full force and effect until
such  right,  power or remedy is  specifically  waived in a writing  executed by
Secured  Party.  Debtor  waives  any right to require  Secured  Party to proceed
against  any  person or to  exhaust  any  Collateral  or to pursue any remedy in
Secured Party's power.

         (b)  This   Agreement   may  be  executed  in  any  number  of  several
counterparts,  each of which when so executed  shall be deemed to be an original
and all of which  counterparts  taken together shall constitute one and the same
instrument.

         (c) This Agreement  contains the entire agreement between Secured Party
and Debtor with respect to the  Collateral and supersedes and replaces the Prior
Security  Agreement as well as any and all other prior agreements,  commitments,
understandings,   negotiations  or  correspondence  between  them  with  respect
thereto.  If any provision of this Agreement shall be held invalid or prohibited
under applicable law, this Agreement shall be invalid or ineffective only to the
extent of such invalidity or prohibition,  without invalidating the remainder of
this Agreement.

         (d) The  rights,  powers,  and  remedies  of Secured  Party  under this
Agreement shall be in addition to all other rights, powers, or remedies given to
Secured Party by applicable law or by any other agreement,  all of which rights,
powers and remedies  shall be  cumulative  and may be exercise  successively  or
concurrently  without  impairing  Secured Party's security  interest in or other
lien on any of the Collateral.

         (e) All singular  terms used herein  shall  include the plural and vice
versa.  All  pronouns  used  herein  shall be deemed to cover all  genders.  All
headings  used  herein  are for  convenience  of  reference  only and  shall not
constitute a substantive part of this Agreement.

         (f) This  Agreement may not be amended or modified  except by a writing
signed by each of the parties hereto.

         (g) Except as may be otherwise  expressly provided herein, all notices,
requests and demands to or upon any party  hereto  shall be given in  accordance
with the notice provisions of the Third Restated Loan Agreement.

         (h) All rights of Secured Party under this Agreement shall inure to the
benefit of its successors and assigns,  and all obligations of Debtor  hereunder
shall bind its successors, and assigns.

         (i) This  Agreement and all security  interests and other liens granted
or  conveyed  hereunder  shall  remain  in full  force and  effect  and shall be
irrevocable  until such time as (x) no Obligations  are  outstanding and (y) the
Third Restated Loan  Agreement is no longer in effect.  Debtor hereby waives any
right Debtor may have upon payment in full of the Obligations to require Secured
Party to terminate  its security  interest in the  Collateral  or any  financing
statement relating thereto until this Agreement is terminated in accordance with
the foregoing terms.

         (j) This Agreement  shall be construed in accordance  with and governed
by the laws of the State of Georgia  without  giving effect to its choice of law
rules.

         (k) Time is of the essence of this Agreement.

         IN  WITNESS  WHEREOF,  Debtor  and  Secured  Party  have  executed  and
delivered this Agreement,  and Debtor has affixed its seal hereto, as of the day
and year first above set forth.

                                     DEBTOR:

                                     CRYOLIFE, INC.



                                     By:______________________________
                                     Title:___________________________

                                               (CORPORATE SEAL)



                                     SECURED PARTY:

                                     NATIONSBANK, N.A. (SOUTH)



                                     By:______________________________
                                     Title:___________________________







      

                                  SCHEDULE 1 TO
                               SECURITY AGREEMENT
                              DATED AUGUST 30, 1996
                       BETWEEN CRYOLIFE, INC., AS DEBTOR,
                 AND NATIONSBANK, N.A. (SOUTH), AS SECURED PARTY


Additional Locations for Debtor:

                                      None.








                                 ---------------------------------
                                 DEBTOR'S INITIALS:


                                 ---------------------------------
                                 SECURED PARTY'S INITIALS:


                                 ---------------------------------



                                      





                                   EXHIBIT C-1

                       STOCK PLEDGE AND SECURITY AGREEMENT


         THIS STOCK PLEDGE AND SECURITY AGREEMENT (this  "Agreement"),  dated as
of  August  30,  1996,  made by  CRYOLIFE,  INC.,  a  Florida  corporation  (the
"Pledgor"),  to NATIONSBANK,  N.A. (SOUTH), a national banking  association (the
"Pledgee").

                              W I T N E S S E T H:

         WHEREAS, the Pledgor and the Pledgee are parties to a Third Amended and
Restated Loan Agreement,  dated as of August 30, 1996 (as the same may hereafter
be amended, restated,  supplemented or otherwise modified from time to time, the
"Loan  Agreement";  the terms defined  therein and not otherwise  defined herein
being  used  herein as  therein  defined),  pursuant  to which the  Pledgee  has
committed to loan certain amounts to the Pledgor;

         WHEREAS,  the Pledgor owns the  outstanding  shares of capital stock of
the corporation identified on Schedule 1 attached hereto (the "Subsidiary");

         WHEREAS,  it is a condition  precedent to the Pledgee's  obligations to
make the Loans under the Loan Agreement that the Pledgor  execute and deliver to
the Pledgee this Agreement;

         WHEREAS,  the Pledgor  desires to execute this Agreement to satisfy the
conditions described in the preceding paragraph;

         NOW,  THEREFORE,  in  consideration  of the  benefits  accruing  to the
Pledgor,  the receipt and sufficiency of which are hereby  acknowledged,  and in
order to  induce  the  Pledgee  to make  Loans  to the  Pledgor  under  the Loan
Agreement, the Pledgor hereby makes the following representations and warranties
to the Pledgee and hereby covenants and agrees with the Pledgee as follows:

         1. SECURITY FOR  OBLIGATIONS  ETC. This Agreement is for the benefit of
the  Pledgee to secure the  prompt  payment in full when due,  whether at stated
maturity,  by  acceleration  or  otherwise,  of  (i)  the  Note  and  all  other
Liabilities (whether for principal,  interest,  fees, expenses or otherwise) and
(ii) all costs and  expenses  incurred  by the  Pledgee in  connection  with the
exercise of its rights and remedies hereunder (including  reasonable  attorneys'
fees actually  incurred) (all such obligations  collectively  being the "Secured
Obligations").

         2. PLEDGED STOCK.  As used herein,  the term "Pledged Stock" shall mean
all of the shares of capital stock of the Subsidiary set forth on Schedule 1 and
all  other  shares of such  stock  which  may be now or  hereafter  owned by the
Pledgor.  The Pledgor  represents  and warrants  that on the date hereof (a) the
Pledged Stock  consists of the number and type of shares of the capital stock of
the  Subsidiary as described on Schedule 1 attached  hereto;  (b) the Pledgor is
the holder of record and sole  beneficial  owner of such Pledged Stock;  and (c)
the Pledged  Stock  constitutes  the  percentage  of the issued and  outstanding
capital stock of the Subsidiary as set forth on Schedule 1.

         3. PLEDGE OF SECURITIES, ETC.

            3.1 PLEDGE.  To secure the Secured  Obligations and for the purposes
set forth in Section 1, the  Pledgor  hereby  pledges to the Pledgee the Pledged
Stock,  together  with (i) the  certificates  representing  such  Pledged  Stock
accompanied by stock powers duly executed in blank by the Pledgor,  and (ii) all
dividends  (whether in cash, stock,  warrants,  options,  or other  securities),
cash,  instruments or other  property from time to time received,  receivable or
otherwise  distributed  in  respect  of or in  exchange  for  any and all of the
Pledged Stock; and hereby assigns, transfers,  hypothecates and sets over to the
Pledgee all of the  Pledgor's  right,  title and  interest in and to the Pledged
Stock  (and in and to the  certificates  or  instruments  evidencing  the  items
described  in clauses  (i) and (ii) above) to be held by the  Pledgee,  upon the
terms and conditions set forth in this Agreement.  The Pledgor agrees to deliver
to the Pledgee all certificates  and instruments  evidencing the items described
in clause (ii) above promptly upon the Pledgor's receipt thereof.

            3.2  DEFINITION OF PLEDGED  SECURITIES AND  COLLATERAL.  The Pledged
Stock and all items  described  in clause  (ii) of Section  3.1 are  hereinafter
called the "Pledged  Securities," and the Pledged Securities,  together with all
other  securities  and  moneys  received  and at the  time  held by the  Pledgee
hereunder and any proceeds of any of the foregoing,  are hereinafter  called the
"Collateral."

         4. APPOINTMENT OF SUB-AGENTS; ENDORSEMENTS, ETC. The Pledgee shall have
the right to appoint one or more agents for the  purpose of  retaining  physical
possession  of the  Collateral,  which  may be held  (if  applicable  and in the
discretion  of the Pledgee) in the name of the Pledgor,  endorsed or assigned in
blank or in favor of the Pledgee or any nominee or nominees of the Pledgee or an
agent appointed by the Pledgee.

         5. VOTING, ETC. Unless and until an Event of Default (such term to mean
an Event of Default as defined  herein) shall have occurred and be continuing or
would be caused  thereby,  the  Pledgor  shall be  entitled  to vote any and all
Pledged Stock and to give consents, waivers or ratifications in respect thereof;
provided that no vote shall be cast or any consent, waiver or ratification given
or any action taken which would violate or be inconsistent with any of the terms
of this Agreement,  the Loan Agreement,  or any instrument or agreement relating
to the Secured  Obligations.  All such rights of the Pledgor to vote and to give
consents,  waivers  and  ratifications  shall  cease in case an Event of Default
shall occur and be continuing, and Section 7 hereof shall become applicable.

         6. DIVIDENDS AND OTHER DISTRIBUTIONS.  Unless an Event of Default shall
have occurred and be continuing or would be caused  thereby,  all cash dividends
payable in respect of the Pledged  Securities shall be paid to the Pledgor,  but
only to the extent (if any) permitted by the Loan  Agreement.  The Pledgee shall
also be entitled to receive directly, and to retain as part of the Collateral:

            (a) all other or additional  stock or securities or property  (other
         than cash) paid or  distributed  by way of  dividend  in respect of the
         Pledged Securities;

            (b) all other or  additional  stock or other  securities or property
         (including  cash)  paid  or  distributed  in  respect  of  the  Pledged
         Securities by way of stock-split, spin-off, split-up, reclassification,
         combination of shares or similar rearrangement; and

            (c) all other or  additional  stock or other  securities or property
         which may be paid in respect of the Pledged Securities by reason of any
         consolidation,   merger,  exchange  of  stock,  conveyance  of  assets,
         liquidation or similar corporate reorganization.

         6.1  ADDITIONAL  SHARES.  The Pledgor agrees and covenants that it will
cause the Subsidiary  not to issue any stock or other  securities in addition to
or in substitution  for the Pledged  Securities  except to the Pledgor,  and any
such additional or substitute stock as securities shall be delivered directly to
the  Pledgee  by the  Subsidiary  and shall  constitute  part of the  Collateral
pledged hereunder.

         7. EVENTS OF DEFAULT.

         7.1  DEFINITION OF EVENTS OF DEFAULT.  The following  specified  events
shall constitute Events of Default under this Agreement:

            (a) the  existence or  occurrence  of any Event of Default under the
         Loan Agreement;

            (b) any  representation,  warranty or statement made or deemed to be
         made by the Pledgor or any of its officers under or in connection  with
         this  Agreement  shall have been false or  misleading  in any  material
         respect when made or deemed to be made;

            (c) the  Pledgor  shall fail to observe or perform  any  covenant or
         agreement  set forth in  Section  5, 6  (including  Section  6.1) or 15
         hereof; and

            (d) the  Pledgor  shall fail to observe or perform  any  covenant or
         agreement set forth in this Agreement,  other than those referred to in
         paragraph (c) above,  which failure shall continue for thirty (30) days
         after the Pledgee gives the Pledgor notice of same.

         7.2  REMEDIES.  In case an Event of Default  shall have occurred and be
continuing,  the Pledgee shall be entitled to exercise all of the rights, powers
and  remedies  (whether  vested in it by this  Agreement,  any  other  Financing
Document or by law and including, without limitation, all rights and remedies of
a secured  party of a debtor in default under the Uniform  Commercial  Code (the
"Code") in effect in the State of Georgia at that time) for the  protection  and
enforcement of its rights in respect of the Collateral, and the Pledgee shall be
entitled,  without  limitation,  to exercise  the  following  rights,  which the
Pledgor hereby agrees to be commercially reasonable:

            (i) to receive  all  amounts  payable  in respect of the  Collateral
         otherwise  payable  under  Section 6 to the  Pledgor and to enforce the
         payment of the Pledged  Securities  and to exercise  all of the rights,
         powers, and remedies of the Pledgor thereunder;

            (ii)  to  transfer  all  or any  part  of the  Collateral  into  the
         Pledgee's name or the name of its nominee or nominees;

            (iii)  to vote  all or any part of the  Collateral  (whether  or not
         transferred  into the  name of the  Pledgee)  and  give  all  consents,
         waivers and  ratifications  in respect of the  Collateral and otherwise
         act with respect thereto as though it were the outright owner thereof;

            (iv) at any time or from time to time to sell,  assign and  deliver,
         or grant options to purchase,  all or any part of the Collateral in one
         or more parcels, or any interest therein, at any public or private sale
         at any exchange,  broker's board or at any of the Pledgee's  offices or
         elsewhere,  without demand of performance,  advertisement  or notice of
         intention  to  sell  or of the  time or  place  of sale or  adjournment
         thereof or to redeem or  otherwise  (all of which are hereby  expressly
         and  irrevocably  waived by the  Pledgor),  for cash,  on credit or for
         other property, for immediate or future delivery without any assumption
         of credit  risk,  and for such price or prices and on such terms as the
         Pledgee in its sole  discretion may determine;  the Pledgor agrees that
         to the  extent  that  notice of sale shall be  required  by law that at
         least ten (10) days  notice to the Pledgor of the time and place of any
         public  sale or the time  after  which any  private  sale is to be made
         shall  constitute  reasonable  notification;  the Pledgee  shall not be
         obligated to make any sale of  Collateral  regardless of notice of sale
         having been given;  the Pledgee may adjourn any public or private  sale
         from time to time by announcement at the time and place fixed therefor,
         and any such sale may, without further notice,  be made at the time and
         place to which it was so  adjourned;  the  Pledgor  hereby  waives  and
         releases to the fullest extent  permitted by law any right or equity of
         redemption with respect to the Collateral, whether before or after sale
         hereunder,  and all rights,  if any, of marshalling  the Collateral and
         any other  security for the Secured  Obligations  or otherwise;  at any
         such sale, unless prohibited by applicable law, the Pledgee may bid for
         and  purchase all or any part of the  Collateral  so sold free from any
         such right or equity of redemption; and the Pledgee shall not be liable
         for failure to collect or realize upon any or all of the  Collateral or
         for any delay in so doing nor shall any of them be under any obligation
         to take any action whatsoever with regard thereto;

            (v)  to  settle,  adjust,   compromise  and  arrange  all  accounts,
         controversies,  questions, claims and demands whatsoever in relation to
         all or any part of the Collateral;

            (vi) to execute all such contracts, agreements, deeds, documents and
         instruments;  to bring, defend and abandon all such actions,  suits and
         proceedings;  and to take all actions in relation to all or any part of
         the Collateral as the Pledgee in its sole discretion may determine;

            (vii) to appoint managers,  agents, officers and servants for any of
         the purposes  mentioned in the  foregoing  provisions of this Section 7
         and to dismiss the same, all as the Pledgee in its sole  discretion may
         determine; and

            (viii)  generally,  to take all such other  action as the Pledgee in
         its sole  discretion may determine as incidental or conducive to any of
         the matters or powers  mentioned in the  foregoing  provisions  of this
         Section 7 and which the Pledgee  may or can do lawfully  and to use the
         name of the Pledgor for the purposes  aforesaid and in any  proceedings
         arising therefrom.

         8.  REMEDIES,  ETC.,  CUMULATIVE.  Each right,  power and remedy of the
Pledgee provided for in this Agreement or any other Financing Document or now or
hereafter  existing at law or in equity or by statute  shall be  cumulative  and
concurrent and shall be in addition to every other such right,  power or remedy.
The  exercise or  beginning of the exercise by the Pledgee of any one or more of
the  rights,  powers or remedies  provided  for in this  Agreement  or any other
Financing  Document  or now or  hereafter  existing  at law or in  equity  or by
statute or otherwise  shall not preclude the  simultaneous  or later exercise by
the  Pledgee of all such other  rights,  powers or  remedies,  and no failure or
delay on the part of the  Pledgee to exercise  any such  right,  power or remedy
shall operate as a waiver thereof.

         9.  APPLICATION OF PROCEEDS.  All moneys  collected by the Pledgee upon
any sale or other disposition of the Collateral,  together with all other moneys
received by the Pledgee hereunder, shall be applied as follows:

                  First,  to the payment of the costs and expenses of such sale,
         collection  or  other  realization,   including,   without  limitation,
         reasonable  attorneys'  fees actually  incurred and all other expenses,
         liabilities  and  advances  actually  made or actually  incurred by the
         Pledgee in connection therewith;

                  Second,  to the payment of the Secured  Obligations  then due;
         and

                  Third,  after payment in full of all Secured  Obligations then
         due, to the Pledgor, or its successors or assigns, or to whomsoever may
         be lawfully  entitled  to receive  the same or as a court of  competent
         jurisdiction may direct any surplus then remaining from such proceeds.

         10.  PURCHASERS OF  COLLATERAL.  Upon any sale of any of the Collateral
hereunder  (whether by virtue of the power of sale herein  granted,  pursuant to
judicial process or otherwise), the receipt of the Pledgee or the officer making
the sale shall be a sufficient  discharge to the  purchaser or purchasers of the
Collateral so sold, and such  purchaser or purchasers  shall not be obligated to
see to the  application  of any  part of the  purchase  money  paid  over to the
Pledgee or such officer or be  answerable in any way for the  misapplication  or
nonapplication thereof.

         11. PAYMENT OF EXPENSES;  INDEMNITY.  The Pledgor shall: (i) whether or
not the transactions  hereby  contemplated  are consummated,  pay all reasonable
out-of-pocket  costs and expenses of the Pledgee actually incurred in connection
with the  administration  (both  before  and  after  the  execution  hereof  and
including  advice of counsel as to the  rights  and duties of the  Pledgee  with
respect  thereto) of the Pledgee incurred in connection with the preservation of
rights  under,  and  enforcement  of,  and,  after  an  Event  of  Default,  the
renegotiation or  restructuring  of this Agreement and any amendment,  waiver or
consent relating thereto (including, without limitation, the reasonable fees and
disbursements  of  counsel  for the  Pledgee,  not to  exceed  actual  fees  and
disbursements);  (ii) pay and hold the Pledgee harmless from and against any and
all  present  and  future  stamp or  documentary  taxes or any  other  excise or
property  taxes,  charges or similar  levies  which arise from any payment  made
hereunder or from the execution,  delivery or registration of, or otherwise with
respect to this Agreement and save the Pledgee harmless from and against any and
all  liabilities  with respect to or resulting from any delay or omission to pay
any such  taxes,  charges  or  levies;  and (iii)  indemnify  the  Pledgee,  its
officers, directors, employees, representatives and agents from and hold each of
them harmless against any and all costs, losses, liabilities, claims, damages or
expenses  actually  incurred  by any of  them  (whether  or not  any of  them is
designated a party  thereto)  arising out of or by reason of any  investigation,
litigation  or other  proceeding  related to this  Agreement or any  transaction
contemplated  hereby,  including,  without  limitation,  the reasonable fees and
disbursements of counsel, not to exceed actual fees and disbursements,  incurred
in  connection  with any such  investigation,  litigation  or other  proceeding.
Notwithstanding  anything in this  Agreement to the contrary,  the Pledgor shall
not  be  responsible  to  the  Pledgee  or  any  officer,  director,   employee,
representative  or agent  of the  foregoing  (an  "Indemnified  Party")  for any
losses,  damages,  liabilities  or expenses  which result from such  Indemnified
Party's gross  negligence or willful  misconduct.  If and to the extent that the
obligations  of the  Pledgor  under this  Section 11 are  unenforceable  for any
reason,  the  Pledgor  hereby  agrees to make the  maximum  contribution  to the
payment  and  satisfaction  of  such  obligations  which  is  permissible  under
applicable  law. The Pledgor's  obligations  under this Section 11 shall survive
any termination of this Agreement.

         12. FURTHER  ASSURANCES.  The Pledgor agrees that it will join with the
Pledgee in  executing  and, at its own  expense,  file and refile under the Code
such financing statements,  continuation  statements and other documents in such
offices as the Pledgee may deem necessary or appropriate  and wherever  required
or  permitted by law in order to perfect and  preserve  the  Pledgee's  security
interest in the Collateral  and hereby  authorizes the Pledgee to file financing
statements and amendments  thereto relative to all or any part of the Collateral
without the  signature of the Pledgor  where  permitted by law, and agrees to do
such further acts and things and to promptly  execute and deliver to the Pledgee
such  additional  conveyances,  assignments,  agreements and  instruments as the
Pledgee  may  reasonably  require or deem  advisable  to carry  into  effect the
purposes of this Agreement or to further assure and confirm unto the Pledgee its
rights, powers and remedies hereunder.

         13. THE PLEDGEE AS AGENT.

         (a) The Pledgee will hold in  accordance  with this  Agreement  and the
Loan  Agreement  all items of the  Collateral  at any time  received  under this
Agreement.  It is expressly  understood  and agreed that the  obligations of the
Pledgee as holder of the  Collateral  and interests  therein and with respect to
the disposition  thereof,  and otherwise  under this  Agreement,  are only those
expressly set forth in this Agreement and the Loan Agreement.

         (b) The Pledgee shall be deemed to have  exercised  reasonable  care in
the  custody  and  preservation  of  the  Collateral  in its  possession  if the
Collateral is accorded treatment  substantially  equal to that which the Pledgee
accords its own property,  it being  understood  that the Pledgee shall not have
responsibility  for (i)  ascertaining  or taking  action with  respect to calls,
conversions,  exchanges,  maturities,  tenders or other matters  relative to any
Collateral,  whether or not the  Pledgee has or is deemed to have  knowledge  of
such matters,  or (ii) taking any necessary steps to preserve rights against any
parties with respect to any Collateral.

         14.  REPRESENTATIONS AND WARRANTIES.  The Pledgor hereby represents and
warrants that (i) it is the legal record and  beneficial  owner of, and has good
and  marketable  title to,  the  Pledged  Stock  described  in Section 2 hereof,
subject to no pledge, lien, mortgage, hypothecation,  security interest, charge,
option or other encumbrance whatsoever,  except the liens and security interests
created by this  Agreement or expressly  permitted by this Agreement or the Loan
Agreement;  (ii) it has full power,  authority and legal right to pledge all the
Pledged Stock  pursuant to this  Agreement;  (iii) no consent of any other party
(including,  without  limitation,  any stockholder or creditor of the Pledgor or
the Subsidiary) and no order, consent, license, permit, approval,  validation or
authorization of, exemption by, notice to or registration,  recording, filing or
declaration with, any governmental or public body or authority is required to be
obtained  by  the  Pledgor  in  connection  with  the  execution,   delivery  or
performance of this Agreement or consummation of the  transactions  contemplated
hereby, including, without limitation, the exercise by the Pledgee of the voting
or other rights provided for in this Agreement or the remedies in respect of the
Collateral  pursuant to this Agreement,  except as may be required in connection
with the  disposition  of the Pledged  Securities by laws affecting the offering
and sale of securities  generally (or except as may already have been obtained);
(iv) all shares of Pledged  Stock have been duly and validly  issued,  are fully
paid and nonassessable;  and (v) the security interest in the Pledged Securities
created and  perfected  by the pledge and  delivery  of the  Pledged  Securities
pursuant to this  Agreement is not subject to any prior lien or  encumbrance  or
any agreement  purporting to grant to any third party a lien or  encumbrance  on
the  property  or  assets  of  the  Pledgor  which  would  include  the  Pledged
Securities.

         15. COVENANTS OF THE PLEDGOR. The Pledgor covenants and agrees that (i)
the Pledgor will defend the Pledgee's right,  title and security interest in and
to the  Pledged  Securities  and the  proceeds  thereof  against  the claims and
demands of all persons whomsoever;  (ii) the Pledgor will have like title to and
right to pledge any other property at any time hereafter  pledged to the Pledgee
as Collateral  hereunder and will likewise defend the right thereto and security
interest therein of the Pledgee; and (iii) the Pledgor will not, with respect to
any Collateral, enter into any shareholder agreements, voting agreements, voting
trusts,  trust deeds,  irrevocable  proxies or any other  similar  agreements or
instruments.

         16. PLEDGOR'S OBLIGATIONS ABSOLUTE, ETC. The obligations of the Pledgor
under this Agreement shall be absolute and  unconditional in accordance with its
terms and shall remain in full force and effect without regard to, and shall not
be released,  suspended,  discharged,  terminated or otherwise  affected by, any
circumstance or occurrence whatsoever,  including,  without limitation:  (a) any
change in the time,  place or manner of payment of, or in any other term of, all
or any of the Secured Obligations,  any waiver, indulgence,  renewal, extension,
amendment or modification  of or addition,  consent or supplement to or deletion
from or any other action or inaction under or in respect of the Loan  Agreement,
the  Note,  any  other  Financing  Document,  or  any of  the  other  documents,
instruments  or  agreements  relating  to the Secured  Obligations  or any other
instrument or agreement referred to therein or any assignment or transfer of any
thereof;  (b) any lack of validity or enforceability of the Loan Agreement,  any
other  Financing  Document,  or any other  documents,  instruments  or agreement
referred  to therein or any  assignment  or  transfer  of any  thereof;  (c) any
furnishing of any  additional  security to the Pledgee,  or its assignees or any
acceptance  thereof  or any  release  of any  security  by  the  Pledgee  or its
assignees;  (d) any limitation on any party's liability or obligations under any
such instrument or agreement or any invalidity or unenforceability,  in whole or
in part,  of any such  instrument  or  agreement  or any term  thereof;  (e) any
bankruptcy, insolvency,  reorganization,  composition,  adjustment, dissolution,
liquidation  or other  like  proceeding  relating  to the  Pledgor or any of its
Subsidiaries,  or any action taken with respect to this Agreement by any trustee
or receiver, or by any court, in any such proceeding, whether or not the Pledgor
shall have notice or knowledge  of any of the  foregoing;  or (f) any  exchange,
release or nonperfection of any other collateral,  or any release,  or amendment
or waiver of or consent to departure  from any guaranty or security,  for all or
any of the Secured Obligations.

         17. NOTICES, ETC. All notices and other communications  hereunder shall
be given in the manner specified in Section 909 of the Loan Agreement.

         18. POWER OF ATTORNEY.  The Pledgor hereby  absolutely and  irrevocably
constitutes  and  appoints the Pledgee the  Pledgor's  true and lawful agent and
attorney-in-fact,  with full power of substitution,  in the name of the Pledgor:
(a) to execute  and do all such  assurances,  acts and things  which the Pledgor
ought to do but has failed to do under the covenants and provisions contained in
this  Agreement;  (b) to take any and all such action as the Pledgee may, in its
sole  discretion,  determine  as  necessary  or  advisable  for the  purpose  of
maintaining, preserving or protecting the security constituted by this Agreement
or any of the rights,  remedies,  powers or privileges of the Pledgee under this
Agreement;  and (c) generally, in the name of the Pledgor exercise all or any of
the powers, authorities, and discretions conferred on or reserved to the Pledgee
by or pursuant to this  Agreement,  and (without  prejudice to the generality of
any of the foregoing) to seal and deliver or otherwise perfect any instrument or
document of conveyance,  agreement,  or act as the Pledgee may deem proper in or
for the purpose of exercising any of such powers,  authorities  or  discretions.
The  Pledgor  hereby  ratifies  and  confirms,  and hereby  agrees to ratify and
confirm,  whatever  lawful  acts the  Pledgee  shall do or  purport to do in the
exercise  of the power of  attorney  granted  to the  Pledgee  pursuant  to this
Section 18, which power of attorney, being given for security, is irrevocable.

         19.  TERMINATION,  RELEASE.  Upon the termination of the Loan Agreement
and the full payment and  performance  of all of the Secured  Obligations,  this
Agreement shall  terminate,  and the Pledgee,  at the request and expense of the
Pledgor,  will  execute  and  deliver  to the  Pledgor  a proper  instrument  or
instruments  acknowledging  the  satisfaction and termination of this Agreement,
and will duly assign,  transfer and deliver to the Pledgor (without recourse and
without any  representation or warranty) such of the Collateral as may be in the
possession  of the Pledgee  and as has not  theretofore  been sold or  otherwise
applied or released pursuant to this Agreement,  together with any moneys at the
time held by the Pledgee hereunder.

         20. MISCELLANEOUS. The Pledgor agrees with the Pledgee that each of the
obligations  and  liabilities of the Pledgor to the Pledgee under this Agreement
may be  enforced  against  the  Pledgor  without  the  necessity  of joining the
Subsidiary,  any other holders of pledges of or security interests in any of the
Collateral,  or any  other  person as a party.  This  Agreement  shall  create a
continuing  security  interest in the  Collateral  and shall be binding upon the
Pledgor and its  successors and assigns and shall inure to the benefit of and be
enforceable by the Pledgee,  and its successors and assigns.  This Agreement may
be  changed,  waived,  discharged  or  terminated  only in  accordance  with the
provisions of the Loan Agreement. Unless otherwise defined herein or in the Loan
Agreement,  terms  defined in Article 9 of the Code in the State of Georgia  are
used herein as therein defined.  The headings in this Agreement are for purposes
of  reference  only and  shall  not limit or define  the  meaning  hereof.  This
Agreement may be executed in any number of counterparts,  each of which shall be
an original, but all of which shall constitute one instrument. In the event that
any provision of this Agreement shall prove to be invalid or unenforceable, such
provision  shall be deemed to be  severable  from the other  provisions  of this
Agreement which shall remain binding on all parties hereto.

         21. GOVERNING LAW. This Agreement and the rights and obligations of the
parties  hereunder  shall be construed in accordance with and be governed by the
internal laws of the State of Georgia.

         IN WITNESS  WHEREOF,  the  Pledgor  and the  Pledgee  have  caused this
Agreement  to be executed by their duly elected  officers  duly  authorized  and
Pledgor has caused its corporate seal to be hereunto affixed, all as of the date
first above written.

                            CRYOLIFE, INC.


                            By:_____________________________
                               Title:_______________________

                                (CORPORATE SEAL)


                            NATIONSBANK, N.A. (SOUTH)


                            By:_____________________________
                               Title:_______________________









                                   SCHEDULE 1

                                       TO

                       STOCK PLEDGE AND SECURITY AGREEMENT
                           DATED AS OF AUGUST 30, 1996
                                      FROM
                                 CRYOLIFE, INC.
                                       TO
                            NATIONSBANK, N.A. (SOUTH)

                                  PLEDGED STOCK


                                   Number and Type             Percentage of
Name of Corporation                  of Shares                  Total Shares

CryoLife International, Inc.            1000                        100%





                                   EXHIBIT C-2

                             IRREVOCABLE STOCK POWER


         FOR  VALUE  RECEIVED,  the  undersigned,   CRYOLIFE,  INC.,  a  Florida
corporation (hereinafter collectively referred to as the "Assignor"),  has fully
and  irrevocably  granted,  assigned and  transferred  and hereby does fully and
irrevocably         grant,         assign        and         transfer         to
______________________________________________________________________________
and the successors,  transferees,  assigns and personal  representatives thereof
(hereinafter collectively referred to as the "Assignee") the following property:

               _________ shares of Common Stock of , a corporation,  represented
         by     certificate     number(s)      _________________________________
         __________________________________________________.

         Assignor hereby irrevocably appoints Assignee to be Assignor's true and
lawful attorney-in-fact, with full power of substitution, and empowers Assignee,
for and in the  name and  stead of  Assignor,  to sell,  transfer,  hypothecate,
liquidate or otherwise  dispose of all of or any portion of the  above-described
securities, from time to time, and, for that purpose, to make, sign, execute and
deliver  any  documents  or  perform  any other  act  necessary  for such  sale,
transfer, hypothecation, liquidation or other disposition. Assignor acknowledges
that this  appointment is coupled with an interest and shall not be revocable by
Assignor's death,  dissolution or any other reason. Assignor hereby ratifies and
approves all acts that Assignee or any  substitute  therefor  shall do by virtue
hereof.

         IN WITNESS WHEREOF,  the undersigned has executed and sealed this power
as of this ____ day of _________________________, ________.

 
                              CRYOLIFE, INC.



                              By:______________________________                 
                                 President

                                                (CORPORATE SEAL)




                                    EXHIBIT D

                               GUARANTY AGREEMENT


         In order to  induce  NATIONSBANK,  N.A.  (SOUTH),  a  national  banking
association  (hereinafter  referred to as  "Lender"),  to extend credit or other
financial  accommodations  or grant  forbearances  to CRYOLIFE,  INC., a Florida
corporation  (hereinafter  referred  to as  "Borrower"),  and for other good and
valuable  consideration,  the receipt and  adequacy of all of the  foregoing  as
legally sufficient consideration being hereby acknowledged,  the undersigned , a
_________________  corporation (hereinafter referred to as "Guarantor"),  hereby
agrees in favor of Lender as follows:

         1. GUARANTY OF OBLIGATIONS. Subject to the terms and conditions hereof,
Guarantor hereby  irrevocably  guarantees to Lender the prompt payment when due,
whether  at  stated  maturity,  by  acceleration  or  otherwise,  of  all of the
Obligations (as hereinafter  defined) which may be now existing or may hereafter
arise and whether for principal,  interest,  fees or other charges and including
any and all expenses  (including without limitation  reasonable  attorney's fees
and  expenses)   incurred  by  Lender  in  collecting  or  otherwise   enforcing
performance  of any of the  Obligations.  Any and all payments made by Guarantor
hereunder shall be made free and clear of and without deduction for any set-off,
counterclaim,  or withholdings  so that, in each case,  Lender shall receive the
full amount that it would  otherwise  be entitled to receive with respect to the
Obligations.  Guarantor  acknowledges  and agrees that this  Guaranty  Agreement
(this  "Guaranty")  is a guaranty of payment and not of collection  and that the
liability of Guarantor  under this  Guaranty  shall be immediate and primary and
shall  not be  contingent  upon the  exercise  or  enforcement  by Lender of any
remedies Lender may have against Borrower or any other person or the enforcement
of any lien or realization  upon any  collateral  Lender may at any time possess
for any of the Obligations.

         2.       OBLIGATIONS AND CREDIT DOCUMENTS DEFINED.

         (a) The  term  "Obligations"  as used  herein  shall  mean  any and all
indebtedness,  liabilities or obligations of Borrower to Lender which may now or
hereafter arise from or in any way relate to the Third Amended and Restated Loan
Agreement, dated as of August 30, 1996, between Borrower and Lender, or the Note
referred  to  therein,  or any other  agreement,  instrument  or other  document
executed  by  Borrower  with  or in  favor  of  Lender  under  or in  connection
therewith,   or  any   extensions,   renewals,   refinancings,   restructurings,
modifications  or  replacements,  in  whole  or in  part,  of or for  any of the
foregoing.

         (b) The term  "Obligations"  as used  herein also  expressly  includes,
without   limitation,   any  interest  which  would  accrue  on  the  applicable
Obligations  described  above but for the  filing by or  against  Borrower  of a
proceeding under any bankruptcy, insolvency, receivership or moratorium law.

         (c) The term "Credit  Documents"  as used herein shall mean and include
any and all  present or future  loan  agreements,  letter of credit  agreements,
lease   agreements,   security   agreements,   pledge   agreements,   collateral
assignments,  security deeds, mortgages, other security instruments,  promissory
notes, guaranties,  subordination agreements,  and any and all other agreements,
instruments  or  documents  which may now exist or may  hereafter be executed by
Borrower as evidence of or as collateral  for any or all of the  Obligations  or
pursuant to which any or all of the Obligations may be now or hereafter  created
or secured or which now or hereafter relate in any other way to the Obligations.

         3. GUARANTY  ABSOLUTE.  Except to the extend expressly provided herein,
this  Guaranty  shall  in  all  respects  be  an  absolute,   unconditional  and
irrevocable guaranty of payment of the Obligations and Guarantor guarantees that
the Obligations will be paid strictly in accordance with the terms of the Credit
Documents under which they arise, regardless of any law, regulation or order now
or hereafter in effect in any  jurisdiction  affecting  any of such terms or the
rights of Lender with respect  thereto.  The  liability of Guarantor  under this
Guaranty  shall remain in full force and effect without regard to, and shall not
be released, suspended,  discharged,  terminated, modified or otherwise affected
by any circumstance or occurrence  whatsoever,  including without limitation any
of the  following  (whether  or not  Guarantor  consents  thereto  or has notice
thereof):  (i) any change in or waiver of the time,  place or manner of payment,
or any other term, of any of the Obligations or Credit Documents,  any waiver of
or any renewal, extension,  increase,  amendment or modification of or addition,
consent or supplement to or deletion from, or any other action or inaction under
or in  respect  of,  any of the  Obligations  or Credit  Documents  or any other
document,  instrument  or  agreement  referred to therein or any  assignment  or
transfer  of any of the  Obligations  or  Credit  Documents;  (ii)  any  lack of
validity,  legality  or  enforceability  of  any of the  Obligations  or  Credit
Documents or any other document, instrument, or agreement referred to therein or
of any assignment or transfer of any of the  foregoing;  (iii) any furnishing to
Lender of any  additional  collateral  for any of the  Obligations  or any sale,
exchange,  release or surrender of, or realization on, any collateral for any of
the  Obligations;  (iv) any  settlement,  release  or  compromise  of any of the
Obligations or Credit Documents,  any collateral  therefor,  or any liability of
any other party (including  without limitation any other guarantor) with respect
to any of the Obligations or Credit  Documents,  or any subordination of payment
of any of the Obligations to the payment of any other indebtedness, liability or
obligation  of  Borrower;  (v)  any  bankruptcy,   insolvency,   reorganization,
composition,  adjustment,  merger,  consolidation,  dissolution,  liquidation or
other like proceeding or occurrence  relating to Borrower or any other change in
the  ownership,  composition  or nature of  Borrower;  (vi) any  non-perfection,
subordination,  release or voidability of any security interest, security title,
pledge,  collateral assignment or other lien of Lender on any collateral for any
of the  Obligations  or this  Guaranty;  (vii) any  application  of sums paid by
Borrower or any other person with respect to any of the  Obligations,  except to
the extent actually  applied against the  Obligations,  regardless of what other
liabilities of Borrower  remain  unpaid;  (viii) the failure of Lender to assert
any claim or demand or to enforce  any right or remedy  against  Borrower or any
other person (including any other guarantor of any of the Obligations) under the
provisions of any of the Credit Documents or otherwise, or any failure of Lender
to exercise any right or remedy against any other guarantor of or any collateral
for any of the Obligations; (ix) any other act or failure to act by Lender which
may  adversely  affect  Guarantor;  or (x) any other  circumstance  which  might
otherwise  constitute a defense against,  or a legal or equitable  discharge of,
Guarantor's liability under this Guaranty.

         4.  GUARANTY  CONTINUING;  REINSTATEMENT.  This  Guaranty  shall in all
respects be a continuing and irrevocable  guaranty of payment (and not merely of
collection)  and  shall  remain  in  full  force  and  effect  until  all of the
Obligations  shall have been indefeasibly paid in full and Lender shall be under
no obligation to make any additional  loans or extend any  additional  credit or
financial  accommodations  to Borrower which would  constitute  Obligations once
made or extended. If claim is ever made upon Lender for repayment or recovery of
any  amount  received  by  Lender  in  payment  or on  account  of  any  of  the
Obligations,  and if Lender  repays all or part of said  amount by reason of (i)
any  judgment,  decree  or order  of any  court or  administrative  body  having
jurisdiction  over  Lender  or any of its  property  or (ii) any  settlement  or
compromise  of any  such  claim  effected  by  Lender  with  any  such  claimant
(including without limitation Borrower or a trustee, conservator or receiver for
Borrower),  then and in such  event  Guarantor  agrees  that any such  judgment,
decree,  order,  settlement  or  compromise  shall be  binding  upon  Guarantor,
notwithstanding any revocation or cancellation of this Guaranty or of any of the
Credit  Documents,  and Guarantor shall be and remain liable to Lender hereunder
for the amount so repaid or  recovered  to the same extent as if such amount had
never originally been paid to Lender and Guarantor's obligations and liabilities
to Lender  under  this  Guaranty  shall be  reinstated  to such  extent and this
Guaranty and any  collateral  for this  Guaranty  shall remain in full force and
effect (or shall be  reinstated)  to such  extent.  Guarantor  hereby  expressly
waives the benefit of any applicable  statute of limitations  and agrees that it
shall be liable  under this  Guaranty  whenever  Lender  seeks to  enforce  such
liability against Guarantor or its property.

     5. WAIVERS AND CONSENTS.  Guarantor hereby waives: (i) notice of acceptance
of this Guaranty by Lender; (ii) notice of the creation, existence, acquisition,
extension,  or renewal of any of the Obligations;  (iii) notice of the amount of
the Obligations outstanding from time to time, subject,  however, to Guarantor's
right to make inquiry of Lender at reasonable  intervals to ascertain the amount
of Obligations then outstanding;  (iv) notice of any default or event of default
under any of the Credit  Documents or with respect to any of the  Obligations or
notice of any other adverse change in Borrower's financial condition or means or
ability to pay any of the  Obligations or perform its  obligations  under any of
the  Credit  Documents  or  notice  of  any  other  fact  which  might  increase
Guarantor's  risk hereunder;  (v) notice of presentment,  demand,  protest,  and
notice of  dishonor  or  nonpayment  as to any  instrument;  (vi)  notice of any
acceleration  or other demand for payment of any of the  Obligations;  and (vii)
all other  notices and demands to which  Guarantor  might  otherwise be entitled
with respect to any of the  Obligations or the Credit  Documents or with respect
to Lender's enforcement of its rights and remedies thereunder. Guarantor further
waives any right  Guarantor  may have,  by  statute  (such as  O.C.G.A.  Section
10-7-24) or otherwise, to require Lender to seek recourse first against Borrower
or  any  other  person,  or to  realize  upon  any  collateral  for  any  of the
Obligations,  as a condition  precedent to enforcing  Guarantor's  liability and
obligations  under this  Guaranty,  and  Guarantor  further  waives any  defense
arising by reason of any incapacity or other disability of Borrower or by reason
of any other defense which Borrower may have on any of the  Obligations or under
any of the Credit Documents.  Guarantor consents and agrees that, without notice
to or consent by Guarantor  and without  affecting or impairing the liability of
Guarantor  under this  Guaranty,  Lender may  compromise  or settle,  extend the
period of duration or the time for the payment,  discharge or performance of any
of the Obligations or Credit Documents,  or may refuse to enforce or may release
all  or any  parties  to any  or  all  of  the  Obligations  (including  without
limitation any other guarantor thereof) or any collateral therefor, or may grant
other  indulgences to Borrower or such other parties in respect thereof,  or may
waive,  amend or  supplement  in any manner the  provisions of any of the Credit
Documents or any other document, instrument or agreement relating to or securing
any of the Obligations  (other than this Guaranty),  or may release,  surrender,
exchange,  modify,  or  compromise  any and all  collateral  securing any of the
Obligations  or in which  Lender  may at any time have a lien,  or may refuse to
enforce  its  rights  or may make any  compromise  or  settlement  or  agreement
therefor, in respect of any and all of such collateral, or with any party to any
of the Obligations or Credit Documents, or with any other person, or may release
or  substitute  any one or more of the  other  endorsers  or  guarantors  of the
Obligations  whether parties to this Guaranty or not, or may exchange,  enforce,
waive or release any  collateral  for any  guaranty  of any of the  Obligations.
Guarantor  further  consents and agrees that Lender shall be under no obligation
to marshal any assets in favor of  Guarantor  or against or in payment of any of
the Obligations.

         6.  SUBROGATION  AND OTHER  RIGHTS.  Guarantor  agrees that no payment,
performance or enforcement of Guarantor's liabilities and obligations under this
Guaranty shall cause Guarantor,  by subrogation or otherwise,  to acquire any of
Lender's rights against Borrower or any property of Borrower (or any interest in
such rights) unless and until Lender has received full and indefeasible  payment
of all of the Obligations.

         7. CROSS-COLLATERALIZATION.  Guarantor's obligations and liabilities to
Lender under this Guaranty  shall be secured by any and all security  interests,
security titles, pledges, collateral assignments or other liens which Lender may
now or  hereafter  have or acquire  in, to or on any real or  personal  property
assets of Guarantor,  whether such assets now exist or are  hereafter  acquired,
except to the extent that Guarantor's  obligations and liabilities hereunder are
expressly excluded from the coverage of any such lien under the express terms of
the mortgage,  security deed, security agreement,  pledge agreement,  collateral
assignment or other document which granted or grants such lien.

         8. GUARANTOR DUE DILIGENCE AND BENEFIT. Guarantor is fully aware of the
financial  condition,  assets  and  prospects  of  Borrower,  and  Guarantor  is
executing  and  delivering  this  Guaranty  based  solely upon  Guarantor's  own
independent  investigation  thereof  and in no  part  upon  any  representation,
warranty or statement of Lender with respect to Borrower's  financial condition,
assets or  prospects.  Guarantor  is in a position  to and hereby  assumes  full
responsibility  for  obtaining  any and all  information  concerning  Borrower's
financial condition, assets and prospects as Guarantor may now or hereafter deem
material  to  Guarantor's  decision to enter into and become  liable  under this
Guaranty and Guarantor is not relying upon, nor does Guarantor  expect Lender to
furnish Guarantor with any information which may be now or hereafter in Lender's
possession  concerning  Borrower's  financial  condition,  assets or  prospects.
Guarantor hereby knowingly accepts the full range of risks encompassed  within a
contract of guaranty,  which risks Guarantor  understands  may include,  without
limitation,  the possibility that Borrower may incur additional  indebtedness to
Lender for which Guarantor may be liable  hereunder after  Borrower's  financial
condition  or means or ability  to pay its  lawful  debts when they fall due has
deteriorated. Guarantor further acknowledges and agrees that any credit or other
financial accommodations now or hereafter extended by Lender to Borrower and any
and all forbearances with respect to Borrower or its assets which Lender may now
or hereafter grant are and will be of direct interest,  benefit and advantage to
Guarantor.

         9. LENDER'S  ACCOUNTS AND RECORDS;  APPLICATION OF PAYMENTS.  Guarantor
agrees  that,  in the absence of manifest  error,  any and all books and records
relating to the  Obligations  which are prepared and  maintained by Lender shall
constitute  prima facie evidence of the existence and amount of the Obligations.
In the event that Lender sends to Borrower any periodic or other  statements  of
account  with  respect  to any or all of the  Obligations,  each such  statement
rendered by Lender  shall,  in the absence of manifest  error,  be deemed final,
binding and conclusive  upon Guarantor  unless Lender is notified by Borrower in
writing to the contrary  within  thirty (30) days after the date such  statement
was sent by Lender to  Borrower  (and each such  notice  shall only be deemed an
objection  to  those  items   specifically   objected  to  therein).   Guarantor
irrevocably  waives the right to direct the  application of any and all payments
and  collections at any time  hereafter  received by Lender from or on behalf of
Borrower,  Guarantor or otherwise  with  respect to any of the  Obligations  and
Guarantor  does hereby  irrevocably  agree that Lender shall have the continuing
exclusive  right to apply and re-apply any and all such payments and collections
received at any time hereafter by Lender against the  Obligations in such manner
and order as Lender may deem  advisable,  notwithstanding  any contrary entry by
Lender upon any of its books and records.

         10.  AUTOMATIC   ACCELERATION  OF  GUARANTY.  In  the  event  that  any
proceeding  is  instituted  by or  against  Borrower  under  the  United  States
Bankruptcy Code or any other bankruptcy, receivership, insolvency, or moratorium
law (and, in the case of any such involuntary  proceeding which is not consented
to or  acquiesced  in  by  Borrower  or  Guarantor,  the  continuation  of  such
proceeding  without the same being dismissed or stayed for thirty (30) days), as
between Guarantor and Lender, all of the Obligations shall be deemed immediately
due and payable,  without notice or demand of any kind by Lender,  and Guarantor
agrees  immediately to pay the Obligations in full,  irrespective of whether any
or  all of  the  Obligations  can  then  be  accelerated  against  Borrower  and
irrespective  of any right which  Borrower  then may have under any  bankruptcy,
receivership,  insolvency or  moratorium  law to cure defaults and reinstate the
maturities of the Obligations.

         11.  GUARANTOR  INFORMATION.  Guarantor  agrees  that,  so long as this
Guaranty remains in effect, Guarantor shall furnish to Lender from time to time,
at such  intervals  and by such dates as may be  required  by Lender,  financial
statements for Guarantor in form and substance  satisfactory  to Lender together
with such other information relating to Guarantor's financial condition,  assets
or prospects as Lender may request,  and  Guarantor  shall permit  Lender or its
representatives  to visit and inspect  Guarantor's  properties  and  Guarantor's
books and records during  reasonable  business hours and to discuss  Guarantor's
financial condition, assets, and prospects with Lender.

         12. SET-OFF AGAINST DEPOSITS.  If an event of default shall occur under
any of the Credit Documents,  Lender,  without notice or demand of any kind upon
Guarantor,  may hold and set-off against such of the  Obligations  (whether then
matured or  unmatured)  as Lender may elect any balance or amount in any deposit
or other account of any nature  whatsoever now or hereafter  maintained by or on
behalf of Guarantor  with Lender,  regardless of whether such account is general
or special and regardless of whether such account is individual or joint.

         13. NOTICES TO GUARANTOR. All notices, demands and other communications
hereunder  by Lender to Guarantor  shall be deemed to have been validly  served,
given or  delivered  by  Lender  when  hand-delivered  against  receipt,  or one
business day after being entrusted to a reputable  national  overnight  delivery
service,  or two business days after being  deposited in the United States mail,
postage  prepaid,  or, in the case of a  telegraphic  or telecopy  notice,  when
transmitted,  and in each case directed or addressed to Guarantor at Guarantor's
address  or  telecopy  number set forth  beneath  Guarantor's  signature  below.
Guarantor may designate a different  address or telecopy  number for Guarantor's
receipt of notices or other communications hereunder but no such change shall be
effective unless and until Lender actually  receives written notice thereof from
Guarantor.

         14.  COLLECTION  COSTS.  Guarantor  shall be liable to Lender for,  and
shall  pay  to  Lender  on  demand,  all  costs  (including  without  limitation
reasonable  attorney's  fees  and  expenses)  actually  incurred  by  Lender  in
enforcing performance of or collecting any payments due under this Guaranty.

         15.  ASSIGNMENT  AND  TRANSFER.  This  Guaranty  shall be binding  upon
Guarantor and Guarantor's heirs, legal  representatives,  successors and assigns
and  shall  inure  to the  benefit  of and be  enforceable  by  Lender  and  its
successors,  transferees  and assigns.  Without  limiting the  generality of the
preceding sentence, Lender may assign or grant participations in all or any part
of the Obligations, whereupon such assignee or participant shall become entitled
to all of the rights in respect thereof granted to Lender herein.

         16. GOVERNING LAW. This Guaranty shall be governed by the internal laws
of the State of Georgia (without giving effect to its conflicts of law rules).

         17.  SUBORDINATION  OF  BORROWER'S  OBLIGATIONS  TO  GUARANTOR.  As  an
independent  covenant,  Guarantor hereby expressly  covenants and agrees for the
benefit of Lender  that all  present  or future  indebtedness,  obligations  and
liabilities  of Borrower to Guarantor of whatsoever  description  (collectively,
the "Junior  Claims") shall be subordinate and junior in right of payment to all
Obligations of Borrower to Lender  (collectively,  the "Senior  Claims").  If an
event of default under any Credit Document shall occur,  then,  unless and until
such event of default  shall have been cured or shall have  ceased to exist,  no
direct or  indirect  payment  (in  cash,  property,  securities  by  set-off  or
otherwise) shall be made by Borrower to Guarantor on account of or in any manner
in respect of any Junior  Claim  except  such  payments  and  distributions  the
proceeds  of which  shall be  applied to the  Senior  Claims.  In the event of a
Proceeding (as  hereinafter  defined),  all Senior Claims shall first be paid in
full before any direct or indirect payment or distribution  (in cash,  property,
securities by set-off or otherwise)  shall be made to Guarantor on account of or
in  any  manner  in  respect  of any  Junior  Claim  except  such  payments  and
distributions  the proceeds of which shall be applied to the Senior Claims.  For
the purposes of the previous  sentence,  a "Proceeding"  shall occur if Borrower
shall make an  assignment  for the  benefit  of  creditors,  file a petition  in
bankruptcy, have entered against or in favor of it an order for relief under the
Bankruptcy Code or similar law of any other jurisdiction,  generally fail to pay
its debts as they come due (either as to number or amount), admit in writing its
inability to pay its debts generally as they mature, make a voluntary assignment
for the benefit of creditors,  commence any proceeding  relating to it under any
reorganization,  arrangement,  readjustment of debt,  dissolution or liquidation
law or statute of any  jurisdiction,  whether now or hereafter in effect,  or by
any act,  indicate  its consent  to,  approval  of or  acquiescence  in any such
proceeding or in the appointment of any receiver of, or trustee or custodian (as
defined in the  Bankruptcy  Code) for  itself,  or any  substantial  part of its
property,  or a trustee or a receiver  shall be appointed  for Borrower or for a
substantial  part of the  property of Borrower and such  appointment  remains in
effect for more than sixty (60) days or  Borrower  shall  indicate  its  consent
thereto,  approval  therefor or  acquiescence  therein,  or a petition under any
bankruptcy,  reorganization,  arrangement,  readjustment of debt, dissolution or
liquidation  law or statute of any  jurisdiction  (whether  now or  hereafter in
effect) shall be filed against Borrower and such petition shall not be dismissed
within sixty (60) days after such  filing,  an order for relief shall be entered
in such  proceeding,  or Borrower shall indicate its consent  thereto,  approval
therefor or acquiescence therein. In the event any direct or indirect payment or
distribution is made to Guarantor in contravention of this Section, such payment
or distribution  shall be deemed received in trust for the benefit of Lender and
shall  be  immediately   paid  over  to  Lender  for  application   against  the
Obligations. Guarantor agrees to execute such additional documents as Lender may
reasonably request to evidence the subordination provided for in this Section.

         18.  MISCELLANEOUS.  (a) This Guaranty  (together  with any  collateral
documents  executed  by  Guarantor  to secure its  obligations  and  liabilities
hereunder)  constitutes  the sole and entire  agreement  between  Guarantor  and
Lender with respect to the subject matter hereof and supersedes and replaces any
and all prior agreements, understandings, negotiations or correspondence between
them  with  respect  thereto,  including  without  limitation  any and all prior
guaranty agreements executed by Guarantor in favor of Lender with respect to any
or all of the Obligations.

         (b) This Guaranty is intended to be an instrument  under seal.  Time is
of the essence of this Guaranty.

         (c) Words  importing the singular  number  hereunder  shall include the
plural  number and vice versa and any  pronouns  used herein  shall be deemed to
cover all  genders.  The term  "person"  as used  herein  means any  individual,
corporation, partnership, joint venture, limited liability company, association,
joint-stock  company,  trust or other entity, or any government or any agency or
political subdivision thereof.

         (d)  Wherever  possible,  any  provision  in  this  Guaranty  which  is
prohibited or unenforceable in any jurisdiction  shall, as to such jurisdiction,
be  ineffective  only to the  extent  of such  prohibition  or  unenforceability
without  invalidating the remaining  provisions hereof, and any such prohibition
or  unenforceability  in any one  jurisdiction  shall not  invalidate  or render
unenforceable such provision in any other jurisdiction.

         (e) No  amendment  or waiver of any  provision  of this  Guaranty,  nor
consent to any departure by Guarantor  therefrom,  shall be effective or binding
upon Lender unless Lender shall first have given written  consent  thereto.  Any
such amendment, waiver or consent which is so granted by Lender shall apply only
to the  specific  occasion  which is the  subject of such  amendment,  waiver or
consent and shall not apply to the  occurrence  of the same or any similar event
on any future  occasion.  No failure on the part of Lender to  exercise,  and no
delay by Lender in  exercising,  any right  hereunder  shall operate as a waiver
thereof,  nor  shall any  single  or  partial  exercise  of any right  hereunder
preclude  any other or further  exercise  thereof or the  exercise  of any other
right by  Lender.  No notice to or  demand  on  Guarantor  in any case by Lender
hereunder shall entitle Guarantor to any further notice or demand in any similar
or other  circumstances  or  constitute a waiver of the rights of Lender to take
any other or future action in any  circumstances  without notice or demand.  The
remedies provided to Lender in this Guaranty are cumulative and not exclusive of
any other remedies provided by law.

         (f) This Guaranty, each of the Credit Documents and all other documents
relating  thereto,  including  without  limitation  any  consents,  waivers  and
modifications that may be hereafter executed and delivered with respect thereto,
may be reproduced by Lender by photographic,  photostatic,  microfilm,  or other
similar process and Lender may destroy any original documents so reproduced, and
Guarantor  hereby  stipulates  and  agrees  that,  to the  extent  permitted  by
applicable law, any such reproduction  shall be as admissible in evidence as the
original itself in any judicial or administrative proceeding (whether or not the
original shall be in existence and whether or not such  reproduction was made by
Lender in the ordinary course of its business),  and any enlargement,  facsimile
or further  reproduction  of such  reproduction  shall likewise be admissible in
evidence.

         (g) This Guaranty may be executed in one or more  counterparts and each
such counterpart shall constitute an original and all such counterparts together
shall constitute one and the same instrument.

         (h) All Section  headings  herein are for convenience of reference only
and shall not limit or  otherwise  affect the meaning or  interpretation  of the
provisions of this Guaranty.

         (i) If this Guaranty is executed by more than one  Guarantor,  the term
"Guarantor" as used herein shall include all such persons  collectively and each
such person  individually  and all such persons  shall be jointly and  severally
liable under this Guaranty.  If more than one person is named above as Borrower,
the term  "Borrower" as used herein shall include all such persons  collectively
and each such person individually.

         (j) To the maximum extent permitted by law, the Guarantor covenants and
agrees so long as the  Obligations  remain  outstanding  to maintain its primary
depository relationships with Lender.

         19. JURY TRIAL WAIVER;  CONSENT TO  JURISDICTION  AND VENUE.  GUARANTOR
HEREBY  WAIVES,  TO THE FULLEST  EXTENT  PERMITTED BY APPLICABLE  LAW, ANY RIGHT
GUARANTOR MAY HAVE UNDER ANY  APPLICABLE  LAW TO A TRIAL BY JURY WITH RESPECT TO
ANY SUIT OR LEGAL ACTION WHICH MAY BE COMMENCED BY OR AGAINST GUARANTOR,  LENDER
OR BORROWER CONCERNING THE INTERPRETATION,  CONSTRUCTION,  VALIDITY, ENFORCEMENT
OR PERFORMANCE OF THIS GUARANTY OR ANY OF THE CREDIT DOCUMENTS. IN THE EVENT ANY
SUCH SUIT OR LEGAL  ACTION IS COMMENCED BY LENDER,  GUARANTOR  HEREBY  EXPRESSLY
AGREES,  CONSENTS  AND  SUBMITS  TO THE  PERSONAL  JURISDICTION  OF ANY STATE OR
FEDERAL COURT SITTING IN FULTON  COUNTY,  GEORGIA,  WITH RESPECT TO SUCH SUIT OR
LEGAL ACTION,  AND GUARANTOR ALSO  EXPRESSLY  CONSENTS AND SUBMITS TO AND AGREES
THAT VENUE IN ANY SUCH SUIT OR LEGAL  ACTION IS PROPER IN SAID COURTS AND COUNTY
AND  GUARANTOR  HEREBY  EXPRESSLY  WAIVES  ANY AND  ALL  PERSONAL  RIGHTS  UNDER
APPLICABLE  LAW OR IN EQUITY TO  OBJECT  TO THE  JURISDICTION  AND VENUE OF SAID
COURTS AND COUNTY. THE JURISDICTION AND VENUE OF THE COURTS AND COUNTY CONSENTED
AND  SUBMITTED  TO AND AGREED  UPON IN THIS  SECTION ARE NOT  EXCLUSIVE  BUT ARE
CUMULATIVE  AND IN  ADDITION  TO THE  JURISDICTION  AND VENUE OF ANY OTHER COURT
UNDER ANY APPLICABLE LAW OR IN EQUITY.


                  [Remainder of page intentionally left blank]





         IN WITNESS WHEREOF,  the undersigned  Guarantor has signed,  sealed and
delivered this Guaranty as of this ____ day of _____________________, _______.






                                  By:_______________________________
                                     Title:_________________________

                                            (CORPORATE SEAL)


                                  GUARANTOR'S NOTICE ADDRESS:



                                  Attn:_____________________________
                                  Telecopy No.:_____________________










199632.3
                                    EXHIBIT E

                          SUBSIDIARY SECURITY AGREEMENT


         THIS  AGREEMENT  is made  and  entered  into as of  __________,  _____,
between  NATIONSBANK,  N.A. (SOUTH), a national banking association which is the
successor by merger to Bank South, a Georgia banking corporation  formerly known
as Bank South,  N.A.,  having its main  office at 600  Peachtree  Street,  N.E.,
Atlanta,        Georgia        30308        ("Secured        Party"),        and
______________________________________, a ___________________ corporation having
its chief executive office and principal place of business at ("Debtor").

                               STATEMENT OF FACTS

         CryoLife,  Inc., a Florida  corporation  which is the parent company of
Debtor (the "Parent"),  and Secured Party are parties to a certain Third Amended
and Restated Loan Agreement, dated as of August 30, 1996 (said agreement, as the
same may be  amended,  supplemented  or  restated,  is herein  called the "Third
Restated  Loan  Agreement"),  pursuant to which Secured Party has agreed to make
certain loans  available to the Parent.  It is a condition  precedent to Secured
Party's  obligation  to make loans to the Parent under the Third  Restated  Loan
Agreement that the Debtor guarantee  repayment of such loans and that the Debtor
secure its guarantee obligations as provided herein.

         In  consideration  of any and all loans or other  extensions  of credit
which may be now or  hereafter  made from time to time by  Secured  Party to the
Parent under the Third  Restated Loan  Agreement,  as well as for other good and
valuable   consideration,   the  receipt  and   adequacy  of  which  are  hereby
acknowledged, Debtor and Secured Party do hereby agree as follows:

                               STATEMENT OF FACTS

         1.  SECURITY  INTEREST.  (a) Debtor  hereby  grants to Secured  Party a
present and  continuing  security  interest in and lien on all of the Collateral
described in Sections l(b) and l(c) below to secure the payment and  performance
of all of the Obligations described in Section 2 below.

         (b) The term "Collateral" as used herein shall mean and include all now
existing or hereafter  arising rights,  titles and interests of Debtor in, to or
under the following  types or items of property of Debtor,  whether now owned or
hereafter  existing or hereafter  created,  acquired or arising and  wheresoever
located, and all cash and non-cash proceeds thereof:

         (i)   ALL ACCOUNTS  RECEIVABLE,  ETC. - All accounts,  contract rights,
               chattel paper, instruments,  documents and general intangibles of
               Debtor,  including  without  limitation  all  causes  of  action,
               corporate   or  other   records,   deposit   accounts,   patents,
               trademarks,  service marks, trade names,  copyrights,  good will,
               customer  lists,  tax  refund  claims,   computer  programs,  and
               software,  and all claims  under  guaranties,  letters of credit,
               security interests or other security held by or granted to Debtor
               to  secure  payment  of  any of its  accounts,  contract  rights,
               chattel paper, instruments or general intangibles, and all rights
               to indemnification  and all other intangible property of any kind
               (collectively, the "Accounts Receivable");

         (ii)  ALL  INVENTORY,  ETC.  - All  of  Debtor's  inventory,  including
               without limitation all goods intended for sale or lease by Debtor
               or for display or  demonstration,  all work in  process,  all raw
               materials,  all  finished  goods,  and all  other  materials  and
               supplies of every nature and description used or intended for use
               in connection with the manufacture,  printing, packing, shipping,
               advertising,  selling,  leasing  or  furnishing  of such goods or
               otherwise used or consumed in Debtor's business and all documents
               evidencing and all warranty rights and other general  intangibles
               relating to any of the foregoing (collectively, the "Inventory");
               provided, however, that the inventory shall not include any human
               tissue; and

         (iii) ALL  EQUIPMENT,  ETC.  -  All  machinery,  apparatus,  equipment,
               furniture,  fixtures, leasehold improvements,  motor vehicles and
               other tangible personal property (other than Inventory as defined
               above) of Debtor of every kind and  description  used in Debtor's
               operations  or business or owned by Debtor or in which Debtor has
               an interest,  and all parts,  accessories and accessions  thereto
               and  substitutions and replacements  therefor,  and all documents
               evidencing and all warranty rights and other general  intangibles
               of Debtor  relating to any of the  foregoing  (collectively,  the
               "Equipment").

         Notwithstanding  anything herein to the contrary,  the Collateral shall
not  include  any of Debtor's  Intellectual  Property  Rights (as defined in the
Third Restated Loan  Agreement)  but the  Collateral  shall include the proceeds
thereof.

         (c)  Unless  otherwise  defined  herein,  all terms  contained  in this
Agreement shall have the meanings provided for by the Uniform Commercial Code as
in effect in the State of  Georgia  to the  extent  the same are used or defined
therein.  In addition,  the term "proceeds" as used herein includes  whatever is
receivable  or received  when any  Collateral  or any proceeds  thereof is sold,
collected,  exchanged or  otherwise  disposed of,  whether such  disposition  is
voluntary or  involuntary,  and also includes  without  limitation all rights to
payment (including  returned premiums) with respect to any insurance relating to
such Collateral. In addition, all references herein to a particular type or item
of Collateral shall be deemed to include all now existing or hereafter  acquired
books and records of Debtor  relating  to such  Collateral  (including,  without
limitation, all computer materials and records). The Collateral also includes in
all cases all monies and other property of Debtor of any other kind which may be
now or hereafter in the  possession of or under the control of Secured Party and
all deposit or other  accounts of Debtor with Secured  Party and all balances or
other property now or hereafter held or on deposit therein.

         2. OBLIGATIONS  SECURED.  This Agreement and the security  interest and
lien granted hereunder to Secured Party secures all obligations which may be now
or hereafter  owing by Debtor to Secured  Party under this  Agreement as well as
any and all  indebtedness,  obligations or other liabilities which may be now or
hereafter  owing by the  Debtor to  Secured  Party  under or on  account  of the
Guaranty Agreement,  dated of even date herewith,  by Debtor in favor of Secured
Party (the "Guaranty"), or under the Third Restated Loan Agreement or any of the
other Financing  Documents as defined therein,  and including without limitation
any  interest  which,  but for the filing by or against  Debtor of a petition in
bankruptcy,  would accrue on any of the foregoing  indebtedness,  obligations or
liabilities. All of the foregoing indebtedness, obligations or other liabilities
are herein collectively called the "Obligations".

         3.  REPRESENTATIONS  AND  WARRANTIES.   Debtor  hereby  represents  and
warrants to Secured Party that:

         (a)  Debtor  has  full  power  and  authority,  and has  completed  all
proceedings  and obtained all  approvals  and  consents  necessary,  to execute,
deliver and perform this Agreement and the transactions contemplated hereby.

         (b) Such  execution,  delivery,  and performance  will not violate,  or
cause a default under or result in a lien (other than Secured  Party's  security
interest  and lien  hereunder)  upon any  property  of Debtor  pursuant  to, any
applicable law, rule or regulation or any agreement, indenture, judgment, order,
decree, or instrument binding upon or affecting Debtor or any of the Collateral.

         (c) This Agreement constitutes the legal, valid, and binding obligation
of Debtor,  enforceable  against Debtor in accordance  with its terms (except as
such enforceability may be limited by bankruptcy,  insolvency,  or other similar
laws  affecting the  enforcement  of creditor's  rights or by general  equitable
principles),  and this Agreement grants to Secured Party a valid and enforceable
security interest in or other lien on the Collateral.

         (d) Debtor's chief executive office and principal place of business are
located at Debtor's address shown above.

         (e) Debtor has good and marketable  title to the Collateral (or, in the
case of any  after-acquired  Collateral,  Debtor  will have good and  marketable
title to the Collateral at the time Debtor acquires rights in such Collateral).

         (f) Except for the  security  interest  and lien  granted  hereunder in
favor of Secured  Party,  no person has (or,  in the case of any  after-acquired
Collateral,  at the time Debtor acquires  rights therein,  will have) any right,
title,  claim, or other interest (whether in the nature of a security  interest,
other lien or charge,  or  otherwise)  in,  against or to any  Collateral or any
interest therein.

         (g) All information heretofore, herein or hereafter supplied to Secured
Party by or on behalf of Debtor with respect to any of the Collateral is or will
be true and correct in all material respects at the time so supplied.

         (h) Debtor has delivered to Secured Party all  instruments,  documents,
chattel paper,  and other items of Collateral in which Secured Party's  security
interest or lien hereunder  must be perfected by possession and the  certificate
of title with respect to each motor vehicle, if any, included in the Collateral,
together with such additional  writings,  including,  without  limitation,  duly
executed blank and undated assignments and stock powers, with respect thereto as
Secured Party shall request.

         All of the foregoing  representations  and warranties shall survive the
execution, delivery and acceptance of this Agreement by Secured Party and Debtor
and the closing of the transactions contemplated hereby.

         4.  COVENANTS  AND  AGREEMENTS OF DEBTOR.  Debtor hereby  covenants and
agrees with Lender as follows:

         (a)  Debtor  shall  do all  acts  that may be  necessary  to  maintain,
preserve, and protect the Collateral.

         (b) Debtor shall not use or permit any Collateral to be used
in violation of any applicable law, rule or regulation, or any provision of this
Agreement or any other  agreement  with Secured  Party related  thereto,  or any
policy of insurance covering such Collateral.

         (c) Debtor shall pay promptly when due all taxes, assessments, charges,
encumbrances and liens now or hereafter imposed upon or affecting any Collateral
or Secured  Party's  security  interest or other lien  hereunder  (including all
property, excise, intangible, use, sales, stamp and other such taxes), except to
the extent expressly permitted in the Third Restated Loan Agreement.

         (d) Debtor shall appear in and defend any action or proceeding that may
adversely affect its title to or Secured Party's interests in the Collateral.

         (e)  Except  to  the  extent  permitted  in  the  Third  Restated  Loan
Agreement,  Debtor shall not sell, encumber, lease, rent or otherwise dispose of
or transfer  any  Collateral  or any right or interest  therein and Debtor shall
keep the  Collateral  free of all levies,  security  interests  or other  liens,
charges or encumbrances.

         (f) Debtor shall comply in all material  respects with all laws,  rules
and regulations  (including those governing  environmental  matters) relating to
the possession,  operation, storage,  maintenance,  disposal, and control of the
Collateral.

         (g)  Debtor  agrees  that  such  care as  Secured  Party  gives  to the
safekeeping of its own property of like kind shall constitute reasonable care of
such Collateral when it may be in Secured Party's possession.

         (h) If and to the extent  requested  by  Secured  Party,  Debtor  shall
account fully for and promptly  deliver to Secured Party,  in the form received,
all  documents,   chattel  paper,   instruments,   and  agreements  constituting
Collateral hereunder and all proceeds of the Collateral  received,  all endorsed
to Secured Party or in blank.

         (i) Debtor shall keep accurate,  and complete records of the Collateral
and shall  provide  Secured  Party with such records and such other  reports and
information relating to the Collateral as Secured Party may request from time to
time.

         (j) Debtor shall keep, procure,  execute, and deliver from time to time
any and all, indorsements, notifications,  registrations, assignments, financing
statements,  fixture  filings,  certificate  of title  applications,  and  other
writings deemed necessary or appropriate by Secured Party to perfect,  maintain,
and protect its security  interest in or other lien on the Collateral  hereunder
and the priority  thereof,  and Debtor shall take such other  actions as Secured
Party may request to protect the value of the Collateral and of Secured  Party's
security interest in the Collateral,  including,  without limitation,  obtaining
such landlord waivers, mortgagee waivers and other assurances from third parties
regarding  Secured  Party's  access  to and  right to  foreclose  on or sell the
Collateral  and right to realize the practical  benefits of such  foreclosure or
sale as Secured Party may request.  Unless  prohibited by applicable law, Debtor
hereby authorizes  Secured Party to execute and file any financing  statement or
fixture  filing on  Debtor's  behalf,  and the  parties  further  agree that any
carbon,  photographic,   or  other  reproduction  of  this  Agreement  shall  be
sufficient as a financing  statement and may be filed in any appropriate  office
in lieu thereof.

         (k) Debtor shall reimburse  Secured Party upon demand for all costs and
expenses,  including, without limitation,  actual and reasonable attorney's fees
and disbursements,  Secured Party may now or hereafter incur while exercising or
enforcing any right, power, or remedy provided to Secured Party by this Security
Agreement or by law, all of which costs and expenses  shall  constitute  part of
the Obligations secured hereunder.

         (l) Debtor  shall give  Secured  Party not less than  thirty  (30) days
prior  written  notice  of any  change in  Debtor's  chief  executive  office or
principal  place of business or Debtor's legal name or trade name(s) or style(s)
from that set forth in this Agreement.

         (m) Debtor shall keep its records concerning the Collateral at Debtor's
address set forth above or at Debtor's other  location(s)  (if any) set forth on
Schedule 1 attached to this  Agreement  and shall not remove such  records  from
such location(s) without the prior written consent of Secured Party.

         (n) Debtor shall keep all  Collateral  consisting  of goods (other than
Inventory in transit and mobile goods) at the address for Debtor set forth above
or at Debtor's other locations (if any) set forth on Schedule 1 attached to this
Agreement,  and Debtor shall not,  without the prior written approval of Secured
Party,  remove any  Collateral  therefrom  except for sales of  Inventory in the
ordinary  course  of  business  and the  disposition  of  obsolete  or  worn-out
Equipment in accordance  with this Agreement and except for the storage of goods
at  locations  other than those shown above or on Schedule 1 attached  hereto if
(i) Debtor gives  Secured Party  written  notice of the new storage  location at
least thirty (30) days prior to storing such  Collateral at such location,  (ii)
Secured Party's security interest in such Collateral  hereunder is and continues
to be duly  perfected,  (iii) all documents and other receipts in respect of any
Collateral  maintained at such premises are promptly delivered to Secured Party,
and (iv) the owner (and, if requested by Secured  Party,  any mortgagee) of such
premises  agrees in writing with Secured Party not to assert any lien in respect
of such  Collateral  and to permit Secured Party to have the right to enter upon
and use such premises in order to inspect,  store,  process,  assemble or remove
the Collateral therefrom after the occurrence of an Event of Default.

         (o) Debtor shall furnish Secured Party with such information  regarding
the Collateral (and any account  debtors  thereunder) as Secured Party from time
to time may request.

         (p) Debtor shall keep the  Collateral in good  condition and repair and
shall not cause or permit any waste of any of the Collateral.

         (q) Debtor shall  insure the  Collateral,  with Secured  Party named as
loss payee under all property  coverages and as an additional  insured under all
liability  coverages,  in form and amount, with insurers,  and against risks and
liabilities which are satisfactory to Secured Party in all respects,  and Debtor
hereby assigns all such policies and all proceeds  thereof  (including  returned
premiums) to Secured Party, to secure the Obligations, agrees to deliver them to
Secured  Party at its request,  and agrees that Secured Party may make any claim
thereunder,  cancel the  insurance  on default by Debtor,  collect  and  receive
payment and indorse any instrument in payment of loss or return premium or other
refund or return, and apply such amounts received,  at Secured Party's election,
to replacement of the Collateral or to the Obligations.  Debtor shall not use or
permit  the  use of any of the  Collateral  in  any  manner  which  will  render
inapplicable or invalid any insurance  coverage  therefor.  Debtor shall deliver
the  originals of all property  insurance  policies  covering the  Collateral to
Secured  Party  together  with loss  payable  endorsements  thereon  in form and
substance satisfactory to Secured Party and in the name of Secured Party as loss
payee  thereunder.  Each  policy of  insurance  or each such  endorsement  shall
contain a clause  requiring  the  insurer to give not less than thirty (30) days
prior written notice to Secured Party in the event of cancellation of the policy
for  nonpayment  of premium  and a clause to the effect  that the  interests  of
Secured  Party  thereunder  shall not be impaired or  invalidated  by any act or
neglect of Debtor nor by the  occupation  of the  premises  covered  thereby for
purposes more hazardous than are permitted by said policy.

         (r) Debtor agrees that all risk of loss of the Collateral  shall at all
times be and remain upon Debtor  irrespective of whether such Collateral is then
in Debtor's or Secured Party's possession.

         (s) Debtor  agrees that any of the  Collateral  consisting of Equipment
shall be and remain personal property and shall not, by reason of its attachment
or other  connection  to any real  property,  either become or be deemed to be a
fixture or  appurtenance  to such real property and shall at all times be deemed
severable therefrom.

         (t) Debtor  shall permit  Secured  Party (or any person  designated  by
Secured Party) from time to time to inspect the Collateral and to inspect, audit
and make copies of or extracts  from all books and records  maintained  by or on
behalf of Debtor pertaining to the Collateral (including computer records),  all
at such times and places as Secured Party may request from time to time.

     5. POWER OF ATTORNEY.  Debtor hereby agrees that from time to time, without
presentment, notice or demand, and without affecting or impairing in any way the
rights of Secured  Party with  respect to the  Collateral,  the  obligations  of
Debtor hereunder or the other  Obligations,  Secured Party may, but shall not be
obligated  to and shall  incur no  liability  to  Debtor or any third  party for
failing to, take any action which Debtor is obligated by this  Agreement to take
but which the Debtor  fails to take,  and Debtor  also  hereby  appoints  (which
appointment is coupled with an interest and shall be irrevocable so long as this
Agreement is in effect)  Secured Party as its  attorney-in-fact  with full power
and  authority  at any  time to take any of the  following  actions  during  the
existence  of any Event of  Default  hereunder  in either  Debtor's  or  Secured
Party's name (but Secured  Party shall have no  obligation to and shall incur no
liability to Debtor or any third party for failing to exercise any such power or
authority):  (a) to collect  by legal  proceedings  or  otherwise  and  indorse,
receive and receipt for all dividends,  interest,  payments, proceeds, and other
sums and  property  now or  hereafter  payable  on or on  account  of any of the
Collateral;  (b) to enter into any extension,  reorganization,  deposit, merger,
consolidation,  or other agreement pertaining to, or deposit, surrender, accept,
hold or apply other  property in exchange  for,  any of the  Collateral;  (c) to
insure,  process, and preserve any of the Collateral or to take any other action
which Debtor is obligated by this  Agreement to take; (d) to transfer any of the
Collateral  to its own or its  nominee's  name;  (e) to make any  compromise  or
settlement,  and take any action it deems advisable,  with respect to any of the
Collateral; (f) to prepare, file and sign Debtor's name to any proof of claim in
bankruptcy  (or any similar  document)  against any account debtor on any of the
Collateral;  (g) to receive,  open and dispose of Debtor's  mail  pertaining  to
anyof the  Collateral  consisting  of  Accounts  Receivables  and notify  postal
authorities to deliver such mail to such address as Secured Party may designate;
(h) to indorse Debtor's name upon any checks or other proceeds of any Collateral
and deposit same to any account of Secured Party;  (i) to indorse  Debtor's name
on any other  document,  instrument  or other  agreement  relating to any of the
Collateral;  (j) to send verifications of Accounts Receivable to account debtors
thereunder;  (k) to use the  information  recorded on or  contained  in any data
processing  equipment,  other computer  hardware or any software relating to any
Collateral;  (l) to make,  adjust or enforce  claims under any insurance  policy
relating to any Collateral;  (m) to do all other acts and things  necessary,  in
Secured Party's judgment,  to fulfill Debtor's obligations under this Agreement;
and (n) to pay any and all taxes,  assessments,  charges,  encumbrances or liens
now or hereafter imposed upon or affecting any of the Collateral.  The foregoing
power of attorney may be exercised by Secured  Party in its  discretion,  in its
name or Debtor's name, and without prior notice to or demand upon Debtor. Debtor
agrees to reimburse  Secured  Party on demand for any sums  advanced or expenses
incurred by Secured Party in exercising  any of the foregoing  rights and powers
together  with  interest  accruing  thereon daily at the highest rate Debtor has
contracted to pay on any of the Obligations.  Debtor's reimbursement obligations
under this Section shall constitute part of the Obligations secured hereunder.

         6. EVENTS OF DEFAULT. An event of default under this Agreement shall be
deemed to exist upon the  occurrence  of any of the  following  event (each such
event being herein called an "Event of Default"):

         (a) If any representation, or warranty of Debtor made in this Agreement
proves to have been untrue, incorrect,  misleading or incomplete in any material
respect as of the date made or deemed made;

         (b) Failure of Debtor to perform, observe, discharge or comply with any
of the covenants set forth in Section 4 (other than  subsection  (e), (k) or (l)
thereof) of this  Agreement,  which failure is not cured within thirty (30) days
of the giving by Secured Party to Debtor of written notice of same;

         (c)  Failure  of  Debtor  punctually  and  fully to  perform,  observe,
discharge or comply with any of the other covenants set forth in this Agreement;

         (d) The  occurrence  of any other  Event of Default  under (and as such
term is defined in) the Third Restated Loan Agreement.

         7.  SECURED  PARTY'S  REMEDIES.  Upon the  occurrence  and  during  the
continuation  of any one or more of the  foregoing  Events of  Default,  Secured
Party  may,  at its  option,  and  without  notice to or demand on Debtor and in
addition  to all rights  and  remedies  available  to  Secured  Party  under the
Guaranty  Agreement  or the Third  Restated  Loan  Agreement or any of the other
Financing Documents,  or at law, in equity, or otherwise,  do any one or more of
the following:

         (a)  Secured  Party may  declare  any or all of the  Obligations  to be
immediately  due and payable and foreclose or otherwise  enforce Secured Party's
security  interest in or other lien hereunder on any or all of the Collateral in
any manner permitted by law or provided for in this Agreement.

         (b)  Secured  Party may  recover  from  Debtor all costs and  expenses,
including,  without limitation,  actual and reasonable attorney's fees, incurred
or paid by Secured Party in exercising or enforcing any right,  power, or remedy
with respect to any or all of the Collateral provided to it by this Agreement or
by applicable law. Notwithstanding anything herein to the contrary, the Debtor's
liability under this Agreement for the Secured Party's attorney's fees shall not
exceed the attorney's fees actually incurred by the Secured Party.

         (c)  Secured  Party may require  Debtor to  assemble  any or all of the
Collateral and make it available to Secured Party at such place or places as may
be designated by Secured Party.

         (d) Secured Party may enter onto any property  where any  Collateral is
located and take possession thereof with or without judicial process.

         (e) Prior to Lender's disposition of any Collateral,  Secured Party may
store, process,  complete,  repair or recondition it or otherwise prepare it for
disposition in any manner and to the extent Secured Party deems appropriate (but
Secured Party shall not be obligated to do so).

         (f) Secured  Party may  transfer any of the  Collateral  into its name,
notify any account  debtor under or other person  obligated on any Collateral to
make payments  thereunder  directly to Secured Party,  and otherwise  collect or
enforce  payment  of any of the  Collateral  (but  Secured  Party  shall have no
obligation to do any of the foregoing).

         (g)  Secured  Party  may  sell  or  otherwise  dispose  of  any  of the
Collateral at one or more public or private sales at Debtor's or Secured Party's
place of business or any other place or places,  including without limitation at
any  brokers  board or  security  exchange,  in lots or in bulk,  for cash or on
credit,  all as Secured Party,  in its discretion,  may deem  advisable.  Debtor
agrees that seven (7) days' prior written notice from Secured Party to Debtor of
any public sale of any  Collateral  or the date after which any private  sale of
any Collateral will be held shall constitute  reasonable notice thereof and such
sale may be held at such  locations as Secured  Party may designate in each said
notice.  Secured Party shall have the right to conduct any such sale on Debtor's
premises,  without any charge therefor, and any such sales may be adjourned from
time to time in accordance with  applicable law.  Secured Party may purchase all
or any part of the  Collateral  at any public sale or, if  permitted by law, any
private  sale and, in lieu of actual  payment of such  purchase  price,  Secured
Party may set-off the amount of such price against the Obligations.

         (h) Secured Party is hereby  granted by Debtor a license or other right
to use during the term of this Agreement, without charge, any or all of Debtor's
labels, patents,  software,  copyrights,  trade secrets, trade names, trademarks
and advertising  materials,  or any other property of any similar nature,  as it
pertains  to any of the  Collateral,  in  advertising  for sale and  selling any
Collateral or in completing  Debtor's  performance  under or collecting any sums
owing in respect of any  Collateral,  and Debtor's rights under all licenses and
all  franchise  agreements  relating  to any of the  Collateral  shall  inure to
Secured  Party's  benefit to the extent of Secured  Party's  rights,  titles and
interests in or to the Collateral under this Agreement.

         (i) Secured Party also may, without prior notice or demand of any kind,
hold and set-off against such of the Obligations  (whether matured or unmatured)
as Secured  Party may elect any balance of amount to the credit of Debtor in any
deposit,  agency,  reserve,  holdback or other account of any nature  whatsoever
which may be now or hereafter  maintained by or on behalf of Debtor with Secured
Party in any of its offices,  regardless  of whether any such account is general
or special and regardless of whether any such account is individual or joint.

         8. APPLICATION OF PROCEEDS.  (a) All monies and other proceeds received
by  Secured  Party  upon  any  collection,  sale  or  other  disposition  of any
Collateral,  together  with all other  monies  and other  proceeds  received  by
Secured Party hereunder, shall be applied as follows:

                        First,  to the  payment  of  the  reasonable  costs  and
                   expenses of such sale,  collection or other disposition which
                   may have been incurred by Secured  Party,  including  without
                   limitation actual and reasonable  attorney's fees as provided
                   in  Section  7(b)  above and all other  reasonable  expenses,
                   liabilities and advances made or incurred by Secured Party in
                   connection therewith;

                        Second, to the payment of all other Obligations then due
                   in such order as Secured Party may elect; and

                        Third,  after  payment in full of all  Obligations  then
                   due, any surplus then  remaining  from such proceeds shall be
                   paid to Debtor; and

         (b) Debtor  shall  remain  liable to Secured  Party for any  deficiency
owing on the Obligations after the application of the proceeds of the Collateral
as provided above.

         9. INDEMNITY.  Debtor hereby agrees to indemnity Secured Party and hold
Secured Party  harmless  from and against any claim,  liability,  loss,  damage,
expense,  suit,  action or proceeding  which may now or hereafter be suffered or
incurred by Secured Party as a result of Debtor's failure to observe, perform or
discharge Debtor's duties or obligations hereunder or Secured Party's holding or
administering this Agreement or any Collateral unless with respect to any of the
above Secured Party is finally determined to have acted with gross negligence or
to have engaged in willful  misconduct.  Without  limiting the generality of the
foregoing,  this indemnity shall extend to any claims  asserted  against Secured
Party by any person under any environmental,  occupational safety and hazard, or
other  similar  laws,  rules or  regulations  by reason of Debtor's or any other
person's  failure  to  comply  with any such  laws,  rules or  regulations.  The
indemnity  obligations  of Debtor under this Section shall  constitute a part of
the  Obligations  secured  hereunder and shall survive the  termination  of this
Agreement.

         10. MISCELLANEOUS.  (a) Any waiver,  forbearance or failure or delay by
Secured Party in exercising  any of its rights,  powers,  or remedies  hereunder
shall not preclude the further  exercise  thereof,  and every right,  power,  or
remedy of Secured Party  hereunder shall continue in full force and effect until
such  right,  power or remedy is  specifically  waived in a writing  executed by
Secured  Party.  Debtor  waives  any right to require  Secured  Party to proceed
against  any  person or to  exhaust  any  Collateral  or to pursue any remedy in
Secured Party's power.

         (b)  This   Agreement   may  be  executed  in  any  number  of  several
counterparts,  each of which when so executed  shall be deemed to be an original
and all of which  counterparts  taken together shall constitute one and the same
instrument.

         (c) This Agreement  contains the entire agreement between Secured Party
and Debtor with respect to the  Collateral and supersedes and replaces the Prior
Security  Agreement as well as any and all other prior agreements,  commitments,
understandings,   negotiations  or  correspondence  between  them  with  respect
thereto.  If any provision of this Agreement shall be held invalid or prohibited
under applicable law, this Agreement shall be invalid or ineffective only to the
extent of such invalidity or prohibition,  without invalidating the remainder of
this Agreement.

         (d) The  rights,  powers,  and  remedies  of Secured  Party  under this
Agreement shall be in addition to all other rights, powers, or remedies given to
Secured Party by applicable law or by any other agreement,  all of which rights,
powers and remedies  shall be  cumulative  and may be exercise  successively  or
concurrently  without  impairing  Secured Party's security  interest in or other
lien on any of the Collateral.

         (e) All singular  terms used herein  shall  include the plural and vice
versa.  All  pronouns  used  herein  shall be deemed to cover all  genders.  All
headings  used  herein  are for  convenience  of  reference  only and  shall not
constitute a substantive part of this Agreement.

         (f) This  Agreement may not be amended or modified  except by a writing
signed by each of the parties hereto.

         (g) Except as may be otherwise  expressly provided herein, all notices,
requests and demands to or upon any party  hereto  shall be given in  accordance
with the notice provisions of the Third Restated Loan Agreement.

         (h) All rights of Secured Party under this Agreement shall inure to the
benefit of its successors and assigns,  and all obligations of Debtor  hereunder
shall bind its successors, and assigns.

         (i) This  Agreement and all security  interests and other liens granted
or  conveyed  hereunder  shall  remain  in full  force and  effect  and shall be
irrevocable  until such time as (x) no Obligations  are  outstanding and (y) the
Third Restated Loan  Agreement is no longer in effect.  Debtor hereby waives any
right Debtor may have upon payment in full of the Obligations to require Secured
Party to terminate  its security  interest in the  Collateral  or any  financing
statement relating thereto until this Agreement is terminated in accordance with
the foregoing terms.

         (j) This Agreement  shall be construed in accordance  with and governed
by the laws of the State of Georgia  without  giving effect to its choice of law
rules.

         (k) Time is of the essence of this Agreement.

         IN  WITNESS  WHEREOF,  Debtor  and  Secured  Party  have  executed  and
delivered this Agreement,  and Debtor has affixed its seal hereto, as of the day
and year first above set forth.

                                    DEBTOR:




                                    By:__________________________________
                                    Title:_______________________________


                                          (CORPORATE SEAL)



                                     SECURED PARTY:

                                     NATIONSBANK, N.A. (SOUTH)


                                     By:_________________________________
                                     Title:______________________________









                                  SCHEDULE 1 TO
                               SECURITY AGREEMENT
                           DATED ______________, _____
                 BETWEEN ___________________________, AS DEBTOR,
                 AND NATIONSBANK, N.A. (SOUTH), AS SECURED PARTY


Additional Locations for Debtor:







                                              ---------------------------------
                                              DEBTOR'S INITIALS:


                                              ---------------------------------
                                              SECURED PARTY'S INITIALS:


                                              ---------------------------------




                                    EXHIBIT F

                                   CERTIFICATE
                                       OF
                                 CRYOLIFE, INC.


          The undersigned officers of CRYOLIFE, INC. (the "Borrower"),
a Florida  corporation,  hereby  certify and  covenant  in their  representative
capacities on behalf of the Borrower as follows:

            1. The Borrower is a corporation duly organized, validly
existing and in good standing  under the laws of the State of Florida,  with all
requisite corporate power and authority to own, operate and lease its properties
and to carry on its  business,  and is duly  qualified  to do  business in every
jurisdiction in which the property owned, leased or operated by it or the nature
of the business conducted by it makes such qualification necessary.

         2.  Attached  hereto  as  Exhibit  1 is a  true  and  correct  copy  of
resolutions  of the  Directors  of the  Borrower  which were duly  adopted as of
August ___, 1996 (the "Resolutions"). Signed originals of the Resolutions appear
in the minute book of the Borrower.  The Resolutions  were adopted in accordance
with law and in accordance with the by-laws of the Borrower.  A true and correct
copy of the  Borrower's  By-Laws,  as in effect on the date hereof,  is attached
hereto as Exhibit 2. The  Resolutions  are in full force and effect and have not
been amended, altered or repealed as of the date hereof.

         3. The  Borrower  has duly  authorized,  executed  and  delivered,  and
approved by all necessary corporate action, the following documents (hereinafter
collectively referred to as the "Financing  Documents") pursuant to, and in full
compliance  with,  authority  granted by the  Directors  of the  Borrower in the
Resolutions:
                                                                         
Document                                              Date                      Other Party

Third Amended and Restated Loan Agreement (the        Date hereof               NationsBank, N.A. (South) (the
"Loan Agreement")                                                               "Lender")
- ---------------                                                                 -------

$10,000,000 Promissory Note                           Date hereof               Lender

Amended and Restated Security Agreement               Date hereof               Lender

Stock Pledge Agreement                                Date hereof               Lender
The Borrower hereby acknowledges receipt of an executed counterpart or photocopy (as executed) of each of the Financing Documents. 4. The Borrower has the corporate power to execute the Financing Documents and to perform the obligations required to be performed by the Borrower under the terms of the Financing Documents. 5. As of the date hereof, and after giving effect to the execution and delivery of the Financing Documents, each of the representations and warranties of the Borrower in the Financing Documents is true and correct in all material respects and no Default or Event of Default (as such terms are defined in the Financing Documents) has occurred and is continuing. 6. The seal affixed to this certificate and the Financing Documents is the legally adopted, proper and only official corporate seal of the Borrower. 7. The Borrower's chief executive office and principal place of business (within the meaning of Official Code of Georgia Annotated Section 11-9-401(1)(b)) is located in Cobb County, Georgia and its principal executive office (within the meaning of Section 6323(f) of the Internal Revenue Code of 1954, as amended) is located in Cobb County, Georgia. 8. Borrower's federal taxpayer identification number is 59-2417093. IN WITNESS WHEREOF, the undersigned have hereunto set their signatures as of this 30th day of August, 1996. _________________________________________________ Steven G. Anderson, President and Chief Executive Officer of CryoLife, Inc. _________________________________________________ Edwin B. Cordell, Jr., Vice President and Chief Financial Officer of CryoLife, Inc. EXHIBIT 1 BOARD RESOLUTIONS OF CRYOLIFE, INC. (THE "CORPORATION") WHEREAS, the Corporation desires to continue to borrow money and obtain other financial accommodations from time to time from NationsBank, N.A. (South), successor by merger to Bank South, a Georgia banking corporation formerly known as Bank South, N.A. (the "Lender"), pursuant to the terms of a Third Amended and Restated Loan Agreement substantially in the form presented to the Corporation's directors and to be entered into between the Corporation and the Lender (the "Third Restated Loan Agreement"); and WHEREAS, the Corporation's indebtedness to the Lender for any and all loans made by the Lender to the Corporation under the Third Restated Loan Agreement will be evidenced by a promissory note to be executed by the Corporation in favor of the Lender substantially in the form of Exhibit A attached to the Third Restated Loan Agreement (the "Note"); and WHEREAS, the Corporation's indebtedness to the Lender for the loans made under the Third Restated Loan Agreement will be secured by all or substantially all of the Corporation's property pursuant to an Amended and Restated Security Agreement to be executed by the Corporation in favor of the Lender substantially in the form of Exhibit B attached to the Third Restated Loan Agreement (the "Restated Security Agreement"); and WHEREAS, the Corporation's indebtedness to the Lender for the loans made under the Third Restated Loan Agreement will also be secured by a pledge of all of the capital stock of CryoLife International, Inc., a subsidiary of the Corporation, pursuant to a Stock Pledge and Security Agreement to be executed by the Corporation in favor of the Lender substantially in the form of Exhibit C-1 attached to the Third Restated Loan Agreement (the "Stock Pledge Agreement"); and WHEREAS, the Board of Directors of the Corporation deems it to be in the best interest of the Corporation and its shareholders that the Corporation enter into the Third Restated Loan Agreement, the Note, the Restated Security Agreement and the Stock Pledge Agreement (collectively, the "Financing Documents"); NOW, THEREFORE, BE IT RESOLVED that the Financing Documents, together with all transactions contemplated thereby, are hereby approved in their entirety; and FURTHER RESOLVED, that the president or any vice president of the Corporation are each hereby severally authorized and directed to execute and deliver on behalf of the Corporation the Financing Documents, all in substantially the same forms as were presented to the Corporation's directors, but with such changes thereto as the president or any vice president shall deem to be in the best interest of the Corporation; and FURTHER RESOLVED, each of the aforesaid officers of the Corporation are hereby severally authorized and directed to do or to cause to be done all such other acts and things on behalf of the Corporation (including the execution and delivery of such other documents, security agreements, collateral assignments, subordination agreements, other instruments, financing statements, stock powers or transfers, certificates and agreements) as any such officer may deem necessary or desirable in order to carry out and effectuate fully the purposes of the foregoing resolutions. EXHIBIT G CERTIFICATE OF CRYOLIFE INTERNATIONAL, INC. The undersigned officers of CRYOLIFE INTERNATIONAL, INC. (the "Guarantor"), a Florida corporation, hereby certify and covenant in their representative capacities on behalf of the Guarantor as follows: 1. The Guarantor is a corporation duly organized, validly existing and in good standing under the laws of the State of Florida, with all requisite corporate power and authority to own, operate and lease its properties and to carry on its business, and is duly qualified to do business in every jurisdiction in which the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification necessary. 2. Attached hereto as Exhibit 1 is a true and correct copy of resolutions of the Directors of the Guarantor which were duly adopted as of August ____, 1996 (the "Resolutions"). Signed originals of the Resolutions appear in the minute book of the Guarantor. The Resolutions were adopted in accordance with law and in accordance with the by-laws of the Guarantor. A true and correct copy of the Guarantor's By-Laws, as in effect on the date hereof, is attached hereto as Exhibit 2. The Resolutions are in full force and effect and have not been amended, altered or repealed as of the date hereof. 3. The Guarantor has duly authorized, executed and delivered, and approved by all necessary corporate action, the following documents (hereinafter collectively referred to as the "Financing Documents") pursuant to, and in full compliance with, authority granted by the Directors of the Guarantor in the Resolutions: Document Date Other Party Guaranty Agreement Date hereof NationsBank, N.A. (South) (the "Lender") Security Agreement Date hereof Lender The Guarantor hereby acknowledges receipt of an executed counterpart or photocopy (as executed) of each of the Financing Documents. 4. The Guarantor has the corporate power to execute the Financing Documents and to perform the obligations required to be performed by the Guarantor under the terms of the Financing Documents. 5. As of the date hereof, and after giving effect to the execution and delivery of the Financing Documents, each of the representations and warranties of the Guarantor in the Financing Documents is true and correct in all material respects and no Default or Event of Default (as such terms are defined in the Financing Documents) has occurred and is continuing. 6. The seal affixed to this certificate and the Financing Documents is the legally adopted, proper and only official corporate seal of the Guarantor. 7. The Guarantor's chief executive office and principal place of business (within the meaning of Official Code of Georgia Annotated Section 11-9-401(1)(b)) is located in Cobb County, Georgia and its principal executive office (within the meaning of Section 6323(f) of the Internal Revenue Code of 1954, as amended) is located in Cobb County, Georgia. 8. Guarantor's federal taxpayer identification number is 58-2053258. IN WITNESS WHEREOF, the undersigned have hereunto set their signatures as of this 30th day of August, 1996. __________________________________________ Steven G. Anderson, President of CryoLife International, Inc. EXHIBIT 1 BOARD RESOLUTIONS OF CRYOLIFE INTERNATIONAL, INC. (THE "CORPORATION") WHEREAS, CryoLife, Inc. (the "Parent"), the parent company of the Corporation, desires to continue to borrow money and obtain other financial accommodations from time to time from NationsBank, N.A. (South), successor by merger to Bank South, a Georgia banking corporation formerly known as Bank South, N.A. (the "Lender"), pursuant to the terms of a Third Amended and Restated Loan Agreement substantially in the form presented to the Corporation's directors and to be entered into between the Parent and the Lender (the "Third Restated Loan Agreement"); and WHEREAS, it is a condition precedent to such loans that the Corporation guarantee the obligations of the Parent to the Lender, pursuant to a Guaranty Agreement to be executed by the Corporation in favor of Lender substantially in the form attached as Exhibit D to the Third Restated Loan Agreement (the "Guaranty"); and WHEREAS, the Corporation's obligations to the Lender under the Guaranty will be secured by all or substantially all of the Corporation's property pursuant to a Security Agreement to be executed by the Corporation in favor of the Lender substantially in the form of Exhibit E attached to the Third Restated Loan Agreement (the "Security Agreement"); and WHEREAS, the Board of Directors of the Corporation deems it to be in the best interest of the Corporation and its shareholders that the Corporation enter into the Guaranty and the Security Agreement (collectively, the "Financing Documents"); NOW, THEREFORE, BE IT RESOLVED that the Financing Documents, together with all transactions contemplated thereby, are hereby approved in their entirety; and FURTHER RESOLVED, that the president or any vice president of the Corporation are each hereby severally authorized and directed to execute and deliver on behalf of the Corporation the Financing Documents, all in substantially the same forms as were presented to the Corporation's directors, but with such changes thereto as the president or any vice president shall deem to be in the best interest of the Corporation; and FURTHER RESOLVED, each of the aforesaid officers of the Corporation are hereby severally authorized and directed to do or to cause to be done all such other acts and things on behalf of the Corporation (including the execution and delivery of such other documents, security agreements, collateral assignments, subordination agreements, other instruments, financing statements, stock powers or transfers, certificates and agreements) as any such officer may deem necessary or desirable in order to carry out and effectuate fully the purposes of the foregoing resolutions. EXHIBIT H August 30, 1996 NationsBank, N.A. (South) 600 Peachtree Street, N.E. Atlanta, Georgia 30308 Gentlemen: We have served as counsel for CryoLife, Inc., a Florida corporation (the "Borrower"), and for CryoLife International, Inc., a Florida corporation (the "Guarantor"), in connection with the loan transactions of even date which arise under the Third Amended and Restated Loan and Security Agreement, dated as of August 30, 1996, between the Borrower and the Lender (the "Loan Agreement"). This opinion letter is delivered pursuant to Section 605 of the Loan Agreement. Capitalized terms used and not otherwise defined herein are used herein with the meanings ascribed to them in the Loan Agreement and in the Interpretative Standards (as defined below); provided, however, that in the event of any conflict in the definitions contained in the Loan Agreement (on the one hand) and in the Interpretative Standards (on the other hand), the definitions in the Loan Agreement shall control. This opinion letter is limited by, and is in accordance with, the January 1, 1992 edition of the Interpretative Standards applicable to Legal Opinions to Third Parties in Corporate Transactions adopted by the Legal Opinion Committee of the Corporate and Banking Law Section of the State Bar of Georgia (the "Interpretative Standards"), which Interpretative Standards are incorporated in this opinion letter by this reference. In connection with this representation, we have examined fully executed counterparts of the following documents (items (a) through (f) below are hereinafter referred collectively as the "Credit Documents"): (a) The Loan Agreement; (b) The Note; (c) The Security Agreement; (d) The Stock Pledge Agreement; (e) The Subsidiary Guaranty executed by the Guarantor; (f) The Subsidiary Security Agreement executed by the Guarantor; (g) Acknowledgement copies of the financing statements on Form UCC-1 (the "Financing Statements") under the Uniform Commercial Code (the "UCC") as in effect in the State of Georgia (the "State"), naming the Borrower and the Guarantor, respectively, as debtors, and the Lender, as secured party, and filed on ____________, 1996, in the Office of the Clerk of the Superior Court of Cobb County, Georgia (the "Filing Office"); (h) Reports of examinations (the "Search Reports"), dated August ___, 1996, and conducted under the Borrower's and the Guarantor's name by Equifax Business Information Services (which is an independent contractor and is not affiliated with or supervised by our firm) in the federal and state tax lien, judgment lien and UCC financing statement records of the Filing Office; and (i) The other documents and material written agreements listed on Schedule I attached hereto. In the capacity described above, we have also considered such matters of law and of fact, together with such other records and documents of the Borrower and the Guarantor, certificates of officers or other representatives of the Borrower and the Guarantor, certificates of public officials, and such other documents as we have deemed appropriate for the opinions and confirmations herein set forth. With your permission in rendering the opinions and confirmations set forth herein, we have assumed the following, in addition to the assumptions set forth in the Interpretative Standards, without any investigation or inquiry on our part: (i) The due authorization, execution and delivery of all Credit Documents by all parties thereto (other than the Borrower and the Guarantor); (ii) That the Credit Documents constitute the binding obligations of the parties thereto (other than the Borrower and the Guarantor) and that each party thereto (other than the Borrower and the Guarantor) has all requisite power and authority to perform its respective obligations thereunder; (iii) That the only interest, fees and other charges contracted for or to be reserved, charged, taken or paid in connection with the Transaction are those set forth in the Credit Documents and that all such interest, fees and charges will be reserved, charged, taken and applied by Lender solely as described in the Credit Documents, and that no interest shall be reserved, charged, taken or paid under the Credit Documents on unpaid interest and that under no circumstances shall the rate of interest paid or payable under the Credit Documents (including any fees, charges, premiums or similar amounts which may be characterized as interest) exceed 5.0% per month (whether due to prepayment, acceleration or otherwise); (iv) The Borrower has, prior to or concurrently with its execution and delivery of the Security Agreement, rights in and the unrestricted right to convey the Collateral covered thereby, including that portion of such Collateral which constitutes property of a type (x) in which a security interest may be granted and perfected under the provisions of Article 9 of the UCC and (y) as to which the federal laws of the United States have not preempted the UCC with respect to the validity, enforceability, perfection or priority of security interests therein (such portion of such Collateral being hereinafter collectively referred to as the "Borrower UCC Collateral"); (v) The Guarantor has, prior to or concurrently with its execution and delivery of the Subsidiary Security Agreement, rights in and the unrestricted right to convey the Collateral covered thereby, including that portion of such Collateral which constitutes property of a type (x) in which a security interest may be granted and perfected under the provisions of Article 9 of the UCC and (y) as to which the federal laws of the United States have not preempted the UCC with respect to the validity, enforceability, perfection or priority of security interests therein (such portion of such Collateral being hereinafter collectively referred to as the "Guarantor UCC Collateral"; the Borrower UCC Collateral and the Guarantor UCC Collateral being hereinafter collectively referred to as the "UCC Collateral"); (vi) The principal place of business and chief executive office of the Borrower and the Guarantor are located in the State; (vii) All of the UCC Collateral of the Borrower and the Guarantor is situated or located within the State other than that which is in transit to or from such a location or is mobile equipment; (viii) The Search Reports are accurate and complete; and (ix) The Financing Statements give (i) the correct federal taxpayer identification number for the debtor named thereon and (ii) a correct address of the secured party named thereon from which information concerning the security interest to be perfected thereby may be obtained. The opinions set forth herein are limited to the laws of the State, the general corporation laws of the State of Florida and any applicable federal laws of the United States. Based upon the foregoing, and subject to the other exceptions, assumptions and qualifications set forth or incorporated herein by reference, it is our opinion that: 1. The Borrower was duly organized as a corporation, and is existing and in good standing, under the laws of the State of Florida. 2. The Borrower has the corporate power to execute and deliver the Credit Documents to which Borrower is a party, to perform its obligations thereunder, to own and use its Assets and to conduct its business. 3. The Borrower has duly authorized the execution and delivery of the Credit Documents to which Borrower is a party and all performance by the Borrower thereunder. 4. The Borrower has duly executed and delivered the Credit Documents to which it is a party. 5. The execution and delivery by the Borrower of the Credit Documents to which Borrower is a party do not, and if the Borrower were now to perform its obligations thereunder such performance would not, result in any: (i) violation of the Certificate of Incorporation or By-Laws of the Borrower; (ii) violation of any existing federal or State constitution, statute, regulation, rule, order or law to which the Borrower or its Assets are subject; (iii) breach of or default under any material written agreements; (iv) creation or imposition of any contractual lien or security interest in, on or against the Borrower's Assets under any material written agreements (except as contemplated by the Credit Documents); or (v) violation of any judicial or administrative decree, writ, judgment or order to which, to our knowledge, the Borrower or its Assets are subject. With your permission, we have assumed that the term "material written agreements" used in clauses (iii) and (iv) above includes only those agreements listed as such on Schedule I attached hereto. 6. The Guarantor was duly organized as a corporation, and is existing and in good standing, under the laws of the State of Florida. 7. The Guarantor has the corporate power to execute and deliver the Credit Documents to which Guarantor is a party, to perform its obligations thereunder, to own and use its Assets and to conduct its business. 8. The Guarantor has duly authorized the execution and delivery of the Credit Documents to which Guarantor is a party and all performance by the Guarantor thereunder. 9. The Guarantor has duly executed and delivered the Credit Documents to which it is a party. 10. The execution and delivery by the Guarantor of the Credit Documents to which Guarantor is a party do not, and if the Guarantor were now to perform its obligations thereunder such performance would not, result in any: (i) violation of the Certificate of Incorporation or By-Laws of the Guarantor; (ii) violation of any existing federal or State constitution, statute, regulation, rule, order or law to which the Guarantor or its Assets are subject; (iii) breach of or default under any material written agreements; (iv) creation or imposition of any contractual lien or security interest in, on or against the Guarantor's Assets under any material written agreements (except as contemplated by the Credit Documents); or (v) violation of any judicial or administrative decree, writ, judgment or order to which, to our knowledge, the Guarantor or its Assets are subject. With your permission, we have assumed that the term "material written agreements" used in clauses (iii) and (iv) above includes only those agreements listed as such on Schedule I attached hereto. 11. No consent, approval, authorization or other action by, or notice to or filing with, any court or administrative or governmental body of the United States or the State is required in connection with the execution and delivery by the Borrower or the Guarantor of the Credit Documents or the incurrence by the Borrower or the Guarantor of their respective obligations thereunder, except such consents, approvals, authorizations, registrations or filings as have been made or obtained and are in full force and effect. 12. Each Credit Document executed by the Borrower or the Guarantor is enforceable against it. 13. While the laws of the State relating to matters of interest and usury are not without ambiguities, and assuming that the Borrower is not required or deemed to pay any interest or other charges for the use of money in connection with the Transactions in excess of 5% per month, a court applying the laws of the State should conclude that the Credit Documents are in compliance with the State's interest and usury laws; provided, however, that we express no opinion herein as to any provision of any Credit Document (if any) that may be construed to require or permit interest to be charged or paid on unpaid interest except to the extent permitted under Official Code of Georgia Annotated ("O.C.G.A.") Section 7-4-17. 14. None of the Loans contemplated by the Loan Agreement, including without limitation the use of the proceeds thereof, will violate or result in a violation of Regulation G, T, U or X of the Board of Governors of the Federal Reserve System. 15. (a) Each of the Security Agreement and the Subsidiary Security Agreement is effective to create a security interest in the UCC Collateral covered thereby; (b) The Financing Statements are in appropriate form for filing in the State and no taxes or fees, other than normal filing fees, are required to be paid in connection with such filing, and the filing of the Financing Statements is effective to perfect the security interest to be created by the Security Agreement and the Subsidiary Security Agreement, respectively, in that portion of the UCC Collateral in which a security interest may be perfected by the filing of a UCC financing statement in the State (the "Security Interest"); (c) Based solely on the Search Reports, for which we take no responsibility, and assuming that no additional filings have been made since the effective time thereof, the Security Interest has the priority accorded to a UCC security interest perfected by the filing of a UCC financing statement in the Filing Office; and (d) The opinions expressed in paragraphs 15(a), (b) and (c) above are subject to the following additional exceptions and qualifications: (i) The effect of bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting the rights of creditors, including the U.S. Bankruptcy Code in its entirety and State laws regarding fraudulent transfers, obligations and conveyances or regarding receiverships; (ii) In the case of proceeds, as such term is defined in the UCC, continuation of the perfection of the Security Interest therein is limited to the degree set forth in O.C.G.A. Section 11-9-306; (iii) Continuation statements relating to the Financing Statements must be filed within six (6) months prior to the expiration of five (5) years from the date of filing thereof and within the same period prior to each succeeding fifth (5th) anniversary of such filing date; (iv) Additional filings may be necessary with respect to the UCC Collateral if the Borrower or the Guarantor changes its name, identity or corporate structure or the jurisdiction in which the UCC Collateral is located or in the event the Borrower or the Guarantor changes the location of its principal place of business or chief executive office; (v) It may not be possible to create or perfect any security interest in any of the UCC Collateral consisting of accounts or general intangibles arising under service agreements, or the proceeds thereof, that are subject to an agreement that is or purports to be non-assignable or that may not be assigned under applicable law; and (vi) We express no opinion herein with respect to the perfection or priority of the Security Interest in any portion of the UCC Collateral which may constitute a fixture (as such term is defined in the UCC). Based upon the foregoing, and subject to the other exceptions, assumptions and qualifications set forth or incorporated by reference herein, we hereby confirm to you that: A. To our knowledge, no litigation or other proceedings against the Borrower or the Guarantor or any of their respective Assets is pending or overtly threatened by a written communication to the Borrower or the Guarantor. B. The Borrower and the Guarantor are each qualified to transact business as a foreign corporation in the States of Georgia. The foregoing statement is based solely upon certificates provided by an agency of that state as described on Schedule I attached hereto, copies of which have been delivered to you at the closing of the Transaction, and is limited to the meaning ascribed to such certificate by the applicable state agency. This opinion letter has been delivered solely for the benefit of the addressees pursuant to the Loan Agreement and may not be relied upon by any other person or entity or for any other purpose without the express written permission of the undersigned. Very truly yours, ARNALL GOLDEN & GREGORY By:________________________________ _____________________, a partner SCHEDULE 1 OTHER DOCUMENTS REVIEWED 1. Copies of the Certificates of Incorporation of Borrower and Guarantor as certified on August __, 1996 by the Office of the Secretary of State of Florida; 2. Good standing certificates (or equivalent) for Borrower and Guarantor as issued on August __, 1996 by the Office of the Secretary of State of Florida; 3. Good standing certificates (or equivalent) for Borrower and Guarantor as issued on August __, 1996 by the Office of the Secretary of State of Georgia; and 4. Certificates of Borrower and Guarantor, each dated as of August 30, 1996, executed and delivered by Borrower and Guarantor, respectively, pursuant to Section 605 of the Loan Agreement and to which are attached certified copies of Borrower's and Guarantor's by-laws and authorizing board resolutions. MATERIAL WRITTEN AGREEMENTS 1. EXHIBIT I WAIVER AND CONSENT THIS WAIVER AND CONSENT is made as of this _____ day of August, 1996, by the undersigned in favor of NATIONSBANK, N.A. (SOUTH), a national banking association having offices at 600 Peachtree Street, N.E., Atlanta, Georgia 30308 (the "Lender"). STATEMENT OF FACTS The undersigned is the lessor of the real property and related improvements and fixtures located at _______________________________________ hereinafter collectively called the "Real Property". The Lender and CRYOLIFE, INC. and/or its subsidiary CRYOLIFE INTERNATIONAL, INC., hereinafter collectively called "Debtor", the lessee of the Real Property, may now or hereafter enter into one or more security agreements under which the Lender may be granted a security interest in some or all of the Debtor's now owned or hereafter acquired accounts, contract rights, general intangibles, documents, instruments, inventory, equipment, machinery, furniture, fixtures and leasehold improvements and all proceeds of any or all of the foregoing as well as all books and records (including without limitation computer and accounting records) of the Debtor pertaining to any or all of the foregoing, hereinafter collectively called the "Personal Property". Some or all of the Personal Property will be placed, stored or otherwise located on the Real Property. NOW, THEREFORE, for and in consideration of the foregoing premises, $5.00 in hand paid by the Lender to the undersigned, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned does hereby consent and agree in favor of Lender as follows: STATEMENT OF TERMS 1. The undersigned consents to and acquiesces in the Debtor's grant of a security interest in the Personal Property in favor of the Lender. 2. The undersigned hereby waives, relinquishes and releases any right, privilege or power which the undersigned now has, or may hereafter have, under or by virtue of any law or any agreement, instrument or other document, to claim or assert any right, title or interest in or to the Personal Property, including without limitation any right, privilege or power to levy or distrain upon the Personal Property for rent, in arrears, in advance or both. 3. The Lender may exercise any rights, privileges, options or powers which it may have with respect to the Personal Property without regard to the undersigned's right, title or interest in and to the Real Property, including, without limitation, any right, privilege or option which the Lender may have to enter upon the Real Property and inspect, or to take possession of and remove, the Personal Property, or any part thereof, pursuant to the terms and conditions of any agreement between Debtor and the Lender or pursuant to any applicable law; provided, that Lender shall reimburse the undersigned for the reasonable costs of repairing any actual physical damage to the Real Property caused by Lender in removing the Personal Property (but Lender shall not be liable for any other diminution in the value of the Real Property resulting from the removal of any of the Personal Property therefrom). 4. If the Lender elects to take possession of all or any part of the Personal Property pursuant to the terms of any agreement between Debtor and the Lender or pursuant to any applicable law, the Lender shall have access to the Real Property for the purposes of inspecting, preserving or removing the Personal Property and the Lender may, in its discretion and without liability to the undersigned except as expressly provided below, leave all or any part of the Personal Property on the Real Property for a period of not more than ninety (90) days after the Lender takes such possession; provided, that Lender shall pay to the undersigned pro-rated rent (based on the base rent rate then payable by Debtor to the undersigned) for the days that Lender is in actual possession of the Real Property if and to the extent that Debtor fails to pay the same. 5. The undersigned agrees to give the Lender prior written notice (at Lender's address set forth above or at such other address as Lender may hereafter designate by written notice to the undersigned) of any payment default by Debtor under its lease of the Real Property and Lender shall have the right (but not the obligation) to cure such payment default within ten (10) days after Lender's receipt of such payment default notice and the undersigned shall not terminate the Debtor's lease of the Real Property on account of such payment default until Lender's cure right expires. 6. The validity and enforceability of this Waiver and Consent shall not be impaired, diminished, annulled or affected in any manner whatsoever by the modification, alteration, extension or renewal of any debt or other obligation of Debtor to the Lender. 7. This Waiver and Consent shall be binding upon and enforceable against the undersigned and its heirs, legal representatives, successors and assigns, and shall inure to the benefit of the Lender and its successors and assigns. 8. Words importing the singular number hereunder shall include the plural number and vice versa, and any pronoun used herein shall be deemed to include all genders. 9. This Waiver and Consent supersedes and replaces any prior waivers or consents executed by the undersigned in favor of the Lender with respect to the Personal Property, the Real Property and the Debtor. IN WITNESS WHEREOF, the undersigned has executed this Waiver and Consent and affixed its seal hereto as of the day and year first written above. (Individual Mortgagee or Lessor Sign Here) Signed, sealed and delivered this ____ day (SEAL) of ______________________, 1996, in Name:___________________________ the presence of: Notary Public [NOTARIAL SEAL] (Corporate or Partnership Mortgagee or Lessor Sign Here) (CORPORATE SEAL) By:______________________________ ATTEST:____________________ Title:___________________________ Title:_____________________ Signed, sealed and delivered this _____ day of _________________, 1996, in the presence of: Notary Public [NOTARIAL SEAL] EXHIBIT J COMPLIANCE CERTIFICATE This Certificate is delivered pursuant to that certain Third Amended and Restated Loan Agreement, dated as of March 30, 1996 (the Agreement), by and between CRYOLIFE, INC., a Florida corporation (the Borrower), and NATIONSBANK, N.A. (SOUTH), a national banking association (the Lender). All capitalized terms used in this Certificate which are defined in the Agreement are used in this Certificate with the same meanings given such terms in the Agreement. Unless otherwise defined in the Agreement, all accounting terms used herein shall have the meaning given such terms under generally accepted accounting principles consistently applied (GAAP). I hereby certify, to the best of my knowledge and belief and in my representative capacity on behalf of the Borrower, to the Lender as follows: 1. I am the duly qualified and acting chief financial officer of the Borrower. 2. I have prepared or reviewed the financial statements of the Borrower as of and for the period ending _________________________, _____, true, complete and correct copies of which are attached hereto as Exhibit 1 (collectively, the Financial Statements). 3. The Financial Statements were prepared in accordance with GAAP and fairly present the financial position and results of operations of the Borrower (and its consolidated subsidiaries, if any) as of and for the period ending on the date of the Financial Statements (subject to normal year-end adjustments). 4. I further certify that as of, and for the period ending on, the date of the Financial Statements, and except as may be disclosed on Exhibit 2 attached hereto (all of the following being calculated on a consolidated basis and in accordance with GAAP and the Agreement): (a) The Borrowers Current Ratio was not less than 2.0 to 1.0 at any time during such period; (b) The Borrowers Leverage Ratio did not exceed 1.0 to 1.0 at any time during such period; (c) The Borrowers Debt Coverage Ratio was not less than 1.3 to 1.0 for such period; (d) The Borrowers Net Worth was not less than [insert $15,500,000 thru 12/31/96, and during each fiscal year thereafter insert the prior fiscal years required amount plus $500,000] at any time during such period; and (e) The Borrowers Capital Expenditures for such fiscal year (or for the portion thereof ending with such period) did not exceed $2,000,000 in total. Attached hereto as Exhibit 3 are calculations demonstrating whether or not the Borrower was in compliance, as of and for the period ending on the date of the Financial Statements, with the covenants in the Loan Agreement which are summarized in items (a) through (e) above. 5. No Default or Event of Default has occurred and is continuing as of the date of this Certificate other than those Defaults or Events of Defaults (if any) which are described on the aforesaid Exhibit 2 attached hereto. I represent the foregoing information to be true and correct to the best of my knowledge and belief and I execute this Certificate in my representative capacity on behalf of the Borrower as of this ____ day of _____________________, _____. Name:________________________________ Title:_______________________________


                                  EXHIBIT 11.1

STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
Three Months Ended Nine Months Ended September 30 September 30 ----------------------------- ----------------------- 1996 1995 1996 1995 ---- ---- ---- ---- Pimary: Average shares outstanding 9,528,700 9,379,664 9,484,482 9,363,622 Net effect of dilutive stock options based on the treasury stock method using the greater of quarter-end market price or average market price 396,096 276,078 409,532 170,962 ----------- ---------- ------------ ----------- Totals 9,924,796 9,655,742 9,894,014 9,534,584 ========= ========== ============ =========== Net Income $1,261,429 $685,325 $3,032,390 $1,634,834 =========== ========== ============ =========== Per share amount $.13 $.07 $.31 $.17 =========== ========== ============ =========== Fully diluted: Average shares outstanding 9,528,700 9,379,664 9,484,482 9,363,622 Net effect of dilutive stock options based on the treasury stock method using the greater of quarter-end market price or average market price 396,096 276,078 409,532 170,962 ----------- ---------- ------------ ----------- Totals 9,924,796 9,655,742 9,894,014 9,534,584 =========== ========== ============ =========== Net Income $1,261,429 $685,325 $3,032,390 $1,634,834 =========== ========== ============ =========== Per share amount $.13 $.07 $.31 $.17 =========== ========== ============ ===========
 


5 THIS SCHEDULE CONTAINS SUMMARY FINANCIAL DATA INFORMATION EXTRACTED FROM THE COMPANY'S UNAUDITED FINANCIAL STATEMENTS CONTAINED IN ITS REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. 0000784199 CRYOLIFE, INC. 9-MOS DEC-31-1996 SEP-30-1996 97,145 2,145,688 7,311,881 (88,737) 353,427 17,446,326 15,231,276 5,579,541 32,109,252 4,540,416 0 0 0 101,060 23,885,217 32,109,252 0 28,542,326 0 9,731,419 14,090,993 81,600 39,269 4,719,914 1,687,524 3,032,390 0 0 0 3,032,390 0.31 0.31